Hits from PDB |
Structure Title |
EC number |
6AL0 | THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 267 | 3.4.24 |
6AL1 | THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 184 | 3.4.24 |
6AL3 | LYS49 PLA2 BPII DERIVED FROM THE VENOM OF PROTOBOTHROPS FLAVOVIRIDIS. | 3.1.1.4 |
6ALZ | CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE 1 BOUND TO THE NATURAL INHIBITOR TAUTOMYCETIN | 3.1.3.16 |
6AMB | CRYSTAL STRUCTURE OF THE AFADIN RA1 DOMAIN IN COMPLEX WITH HRAS | 3.6.5.2 |
6AMF | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23K/L36E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6AML | PHOSPHOTRIESTERASE VARIANT S8 | 3.1.8.1 |
6AMO | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 7.0 | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6AN2 | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 7.5 | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6AN8 | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 8.0 | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6ANE | CRYSTAL STRUCTURE OF IDEONELLA SAKAIENSIS PET HYDROLASE | 3.1.1.101 |
6ANQ | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 8.5 | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6AOC | CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2,4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6AP6 | CRYSTAL STRUCTURE OF DAD2 IN COMPLEX WITH TOLFENAMIC ACID | 3.1 |
6AP7 | CRYSTAL STRUCTURE OF DAD2 IN COMPLEX WITH 2-(2-METHYL-3-NITROANILINO)BENZOIC ACID | 3.1 |
6AP8 | CRYSTAL STRUCTURE OF RICE D14 BOUND TO 2-(2-METHYL-3-NITROANILINO)BENZOIC ACID | 3.1 |
6APA | CRYSTAL STRUCTURE OF TEM1 BETA-LACTAMASE MUTANT I263A | 3.5.2.6 |
6APE | CRYSTAL STRUCTURE OF BIFUNCTIONAL PROTEIN FOLD FROM HELICOBACTER PYLORI | 1.5.1.5 3.5.4.9 |
6APH | CRYSTAL STRUCTURE OF ADENOSYLHOMOCYSTEINASE FROM ELIZABETHKINGIA ANOPHELIS NUHP1 IN COMPLEX WITH NAD AND ADENOSINE | 3.3.1.1 |
6APM | HEN EGG-WHITE LYSOZYME (WT), SOLVED WITH SERIAL MILLISECOND CRYSTALLOGRAPHY USING SYNCHROTRON RADIATION | 3.2.1.17 |
6APR | STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS | 3.4.23.6 3.4.23.21 |
6APX | CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PHOSPHATASE 1 CATALYTIC DOMAIN (C258S) AS A MALTOSE BINDING PROTEIN FUSION IN COMPLEX WITH THE MONOBODY YSX1 | 3.1.3.16 3.1.3.48 |
6AQR | SAGA DUB MODULE UBP8(C146A)/SGF11/SUS1/SGF73 BOUND TO MONOUBIQUITIN | 3.4.19.12 |
6AR6 | CLOSTRIDIOIDES DIFFICILE TOXINB WITH DLD-4 DARPIN | 3.4.22 2.4.1 |
6ARK | CRYSTAL STRUCTURE OF COMPOUND 10 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
6ARX | CRYSTAL STRUCTURE OF AN INSECTICIDE-RESISTANT ACETYLCHOLINESTERASE MUTANT FROM THE MALARIA VECTOR ANOPHELES GAMBIAE IN THE LIGAND-FREE STATE | 3.1.1.7 |
6ARY | CRYSTAL STRUCTURE OF AN INSECTICIDE-RESISTANT ACETYLCHOLINESTERASE MUTANT FROM THE MALARIA VECTOR ANOPHELES GAMBIAE IN COMPLEX WITH A DIFLUOROMETHYL KETONE INHIBITOR | 3.1.1.7 |
6ASA | KRAS MUTANT-D33E IN GDP-BOUND | 3.6.5.2 |
6ASE | KRAS MUTANT-A59G IN GDP-BOUND | 3.6.5.2 |
6ASH | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN K WITH A NON-ACTIVE SITE INHIBITOR AT 1.42 ANGSTROM RESOLUTION | 3.4.22.38 |
6ASW | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 9.0 | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6ASY | BIP-ATP2 | 3.6.4.10 |
6ATD | OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 | 3.1.3.48 |
6ATK | CRYSTAL STRUCTURE OF THE HUMAN CORONAVIRUS 229E SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN AMINOPEPTIDASE N | 3.4.11.2 |
6AU1 | STRUCTURE OF THE PGAB (BPSB) GLYCOSIDE HYDROLASE DOMAIN FROM BORDETELLA BRONCHISEPTICA | 3.2.1 |
6AUK | CRYSTAL STRUCTURE OF ROTAVIRUS NON STRUCTURAL PROTEIN 2 (NSP2) MUTANT S313D | 3.6.4 |
6AUM | CRYSTAL STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH TRANS-4-[4-(3-TRIFLUOROMETHOXYPHENYL-L-UREIDO)-CYCLOHEXYLOXY]-BENZOIC ACID. | 3.3.2.10 3.1.3.76 |
6AUN | CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 BETA | 3.1.1.4 3.1.1.5 3.1.2.2 |
6AVL | ORTHORHOMBIC TRYPSIN (295 K) IN THE PRESENCE OF 50% XYLOSE | 3.4.21.4 |
6AVM | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 9.5 WITH CROSS-LINKING TO SECOND BASE TEMPLATE OVERHANG | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6AVO | CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES | 3.4.25.1 |
6AVS | COMPLEX STRUCTURE OF JMJD5 AND SYMMETRIC MONOMETHYL-ARGININE (MMA) | 1.14.11.27 1.14.11 3.4 |
6AVT | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING D4TTP AT PH 9.5 WITH CROSS-LINKING TO FIRST BASE TEMPLATE OVERHANG | 2.7.7.49 2.7.7.7 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6AVV | CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA SOBER1 | 3.1.1 |
6AVW | CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA SOBER1 L63A | 3.1.1 |
6AVX | CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA SOBER1 F65L | 3.1.1 |
6AX1 | STRUCTURE OF HUMAN MONOACYLGLYCEROL LIPASE BOUND TO A COVALENT INHIBITOR | 3.1.1.23 |
6AX3 | COMPLEX STRUCTURE OF JMJD5 AND SYMMETRIC DIMETHYL-ARGININE (SDMA) | 1.14.11.27 1.14.11 3.4 |
6AY2 | STRUCTURE OF CATHB WITH COVALENTLY LINKED COMPOUND 28 | 3.4.22.1 |
6AYK | CRYSTAL STRUCTURE OF TEM1 BETA-LACTAMASE MUTANT I263A IN THE PRESENCE OF 1.2 MPA XENON | 3.5.2.6 |
6AYM | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) | 3.2.2.9 3.2.2.30 |
6AYO | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH 5'-DEOXY-5'-PROPYL-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
6AYQ | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH METHYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
6AYR | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH BUTYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
6AYS | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH HEXYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
6AYT | CRYSTAL STRUCTURE OF CAMPYLOBACTER JEJUNI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH PYRAZINYLTHIO-DADME-IMMUCILLIN-A | 3.2.2.9 3.2.2.30 |
6AYU | CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE T84S FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.3.11 |
6AYV | CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE T84A FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.3.11 |
6AYY | CRYSTAL STRUCTURE OF APO FRUCTOSE-1,6-BISPHOSPHATASE FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.3.11 |
6AZB | CRYSTAL STRUCTURE OF PHYSCOMITRELLA PATENS KAI2-LIKE E | 3 |
6AZC | CRYSTAL STRUCTURE OF PHYSCOMITRELLA PATENS KAI2-LIKE E S166A | 3 |
6AZD | CRYSTAL STRUCTURE OF PHYSCOMITRELLA PATENS KAI2-LIKE H | 3 |
6AZI | 1.75 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF D-ALANYL-D-ALANINE ENDOPEPTIDASE FROM ENTEROBACTER CLOACAE IN COMPLEX WITH COVALENTLY BOUND BORONIC ACID | 3.4.16.4 |
6B09 | CRYSTAL STRUCTURE OF HSNUDT16 IN COMPLEX WITH DIADPR (SOAKED) | 3.6.1.62 3.6.1.64 |
6B0B | CRYSTAL STRUCTURE OF HUMAN APOBEC3H | 3.5.4.38 |
6B0V | CRYSTAL STRUCTURE OF SMALL MOLECULE ARS-107 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
6B0Y | CRYSTAL STRUCTURE OF SMALL MOLECULE ARS-917 COVALENTLY BOUND TO K-RAS G12C | 3.6.5.2 |
6B19 | ARCHITECTURE OF HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX CORE | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B1E | THE STRUCTURE OF DPP4 IN COMPLEX WITH VILDAGLIPTIN | 3.4.14.5 |
6B1F | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 4234 BY SOAKING | 3.5.2.6 |
6B1H | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 4234 BY CO-CRYSTALLIZATION | 3.5.2.6 |
6B1J | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 5107 BY SOAKING | 3.5.2.6 |
6B1O | THE STRUCTURE OF DPP4 IN COMPLEX WITH VILDAGLIPTIN ANALOG | 3.4.14.5 |
6B1Q | HYDROGEN BONDING COMPLEMENTARY, NOT SIZE COMPLEMENTARITY IS KEY IN THE FORMATION OF THE DOUBLE HELIX | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6B1R | HYDROGEN BONDING COMPLEMENTARY, NOT SIZE COMPLEMENTARITY IS KEY IN THE FORMATION OF THE DOUBLE HELIX | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6B1S | HYDROGEN BONDING COMPLEMENTARY, NOT SIZE COMPLEMENTARITY IS KEY IN THE FORMATION OF THE DOUBLE HELIX | 2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6B1W | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 5107 BY CO-CRYSTALLIZATION | 3.5.2.6 |
6B1X | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 5153 BY SOAKING | 3.5.2.6 |
6B1Y | CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 5153 BY CO-CRYSTALLIZATION | 3.5.2.6 |
6B22 | CRYSTAL STRUCTURE OXA-24 BETA-LACTAMASE COMPLEXED WITH WCK 4234 BY CO-CRYSTALLIZATION | 3.5.2.6 |
6B2N | CRYSTAL STRUCTURE OF TEM-1 BETA-LACTAMASE MUTANT M182N | 3.5.2.6 |
6B36 | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH (S)-N-(3-FLUORO-2-(2-(1-(PHENYLSULFONYL)PIPERAZIN-2-YL)ETHYL)PHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B38 | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(3-FLUORO-2-(2-((2S,6R)-6-METHYL-1-(PHENYLSULFONYL)PIPERAZIN-2-YL)ETHYL)PHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B3C | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(3-FLUORO-2-(2-((2S,6R)-6-METHYL-1-(PHENYLSULFONYL)PIPERAZIN-2-YL)ETHYL)PHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B3F | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(3-FLUORO-2-(2-((2S,5S)-5-METHYL-1-(PHENYLSULFONYL)PIPERAZIN-2-YL)ETHYL)PHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B3G | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(3-FLUORO-2-(2-((2S,6S)-6-METHYL-1-(PHENYLSULFONYL)PIPERAZIN-2-YL)ETHYL)PHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B3H | CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH N-(2-(2-((6R,9S)-2,2-DIOXIDO-2-THIA-1,7-DIAZABICYCLO[4.3.1]DECAN-9-YL)ETHYL)-3-FLUOROPHENYL)-3,3-BIS(4-FLUOROPHENYL)PROPANAMIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6B3Q | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH INSULIN | 3.4.24.56 |
6B40 | BBRAGL-3'TIR SYNAPTIC COMPLEX WITH NICKED DNA REFINED WITH C2 SYMMETRY | 2.3.2.27 3.1 |
6B42 | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HHINT1) 2'-DEOXY-AMP COMPLEX AT 1.13A RESOLUTION | 3 |
6B4K | CRYSTAL STRUCTURE OF HUMAN DDX19B(AMPPNP) | 3.6.4.13 |
6B4N | A HYDROXYMETHYL FUNCTIONALITY AT THE 4-POSITION OF THE 2-PHENYLOXAZOLE MOIETY OF HIV-1 PROTEASE INHIBITORS INVOLVING THE P2' LIGANDS | 2.7.7.49 3.1.13.2 3.1.26.13 |
6B4O | 1.73 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF GLUTATHIONE REDUCTASE FROM ENTEROCOCCUS FAECALIS IN COMPLEX WITH FAD | 3.3.1.1 1.8.1.7 |
6B5C | STRUCTURAL BASIS FOR KATANIN SELF-ASSEMBLY | 3.6.4.3 5.6.1.1 |
6B5D | STRUCTURAL BASIS FOR KATANIN SELF-ASSEMBLY | 3.6.4.3 5.6.1.1 |
6B5X | BETA-LACTAMASE, UNMIXED SHARDS CRYSTAL FORM | 3.5.2.6 |
6B5Y | BETA-LACTAMASE, MIXED WITH CEFTRIAXONE, 30MS TIME POINT, SHARDS CRYSTAL FORM | 3.5.2.6 |
6B5Z | IMPASE (AF2372) WITH 25 MM ASP | 3.1.3.11 3.1.3.25 |
6B60 | IMPASE (AF2372) WITH 25 MM GLUTAMATE | 3.1.3.11 3.1.3.25 |
6B61 | IMPASE (AF2372) WITH 25 MM ASP | 3.1.3.11 3.1.3.25 |
6B62 | IMPASE (AF2372) WITH 400 MM GLUTAMATE | 3.1.3.11 3.1.3.25 |
6B63 | IMPASE (AF2372) WITH 25 MM ASP | 3.1.3.11 3.1.3.25 |
6B64 | IMPASE (AF2372) WITH 25 MM ASP | 3.1.3.11 3.1.3.25 |
6B65 | IMPASE (AF2372) R92Q/K164E | 3.1.3.11 3.1.3.25 |
6B66 | IMPASE (AF2372) R92Q/K164E WITH 400 MM GLUTAMATE | 3.1.3.11 3.1.3.25 |
6B67 | HUMAN PP2CALPHA (PPM1A) COMPLEXED WITH CYCLIC PEPTIDE C(MPSIPYVA) | 3.1.3.16 |
6B68 | BETA-LACTAMASE, 100MS TIMEPOINT, MIXED, SHARDS CRYSTAL FORM | 3.5.2.6 |
6B69 | BETA-LACTAMASE, 500MS TIMEPOINT, MIXED, SHARDS CRYSTAL FORM | 3.5.2.6 |
6B6A | BETA-LACTAMASE, 2SECS TIMEPOINT, MIXED, SHARDS CRYSTAL FORM | 3.5.2.6 |
6B6B | BETA-LACTAMASE, UNMIXED NEEDLES CRYSTAL FORM | 3.5.2.6 |
6B6C | BETA-LACTAMASE, MIXED WITH CEFTRIAXONE, NEEDLES CRYSTAL FORM, 30MS | 3.5.2.6 |
6B6D | BETA-LACTAMASE, MIXED WITH CEFTRIAXONE, NEEDLES CRYSTAL FORM, 100MS | 3.5.2.6 |
6B6E | BETA-LACTAMASE, MIXED WITH CEFTRIAXONE, NEEDLES CRYSTAL FORM, 500MS | 3.5.2.6 |
6B6F | BETA-LACTAMASE, MIXED WITH CEFTRIAXONE, NEEDLES CRYSTAL FORM, 2SEC | 3.5.2.6 |
6B6N | ORTHORHOMBIC TRYPSIN (295 K) IN THE PRESENCE OF 50% MPD | 3.4.21.4 |
6B6O | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 20% XYLOSE AS CRYOPROTECTANT | 3.4.21.4 |
6B6P | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 30% XYLOSE AS CRYOPROTECTANT | 3.4.21.4 |
6B6Q | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 50% XYLOSE AS CRYOPROTECTANT | 3.4.21.4 |
6B6R | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 50% MPD AS CRYOPROTECTANT | 3.4.21.4 |
6B6S | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 50% ETHANOL AS CRYOPROTECTANT | 3.4.21.4 |
6B6T | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 50% METHANOL AS CRYOPROTECTANT | 3.4.21.4 |
6B70 | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN, FAB H11-E LIGHT CHAIN AND INSULIN | 3.4.24.56 |
6B74 | STRUCTURES OF THE TWO-CHAIN HUMAN PLASMA FACTOR XIIA CO-CRYSTALLIZED WITH POTENT INHIBITORS | 3.4.21.38 |
6B77 | STRUCTURES OF THE TWO-CHAIN HUMAN PLASMA FACTOR XIIA CO-CRYSTALLIZED WITH POTENT INHIBITORS | 3.4.21.38 |
6B7K | GH43 ENDO-ARABINANASE FROM BACILLUS LICHENIFORMIS | 3.2.1.99 |
6B7Q | CRYSTAL STRUCTURE OF LEGIONELLA EFFECTOR PROTEIN SDEA (LPG2157) AA. 211-910 | 3.4.22 2.3.2 2.4.2.31 |
6B7U | STRUCTURE OF HEN EGG-WHITE LYSOZYME WITHOUT HIGH-PRESSURE PRE-TREATMENT | 3.2.1.17 |
6B7V | STRUCTURE OF HEN EGG-WHITE LYSOZYME PRE-TREATED WITH HIGH-PRESSURE HOMOGENIZATION AT 120 MPA | 3.2.1.17 |
6B7W | STRUCTURE OF HEN EGG-WHITE LYSOZYME PRE-TREATED WITH HIGH PRESSURE (600 MPA) UNDER ISOBARIC CONDITION | 3.2.1.17 |
6B7Y | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME | 3.4.24.56 |
6B7Z | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11 HEAVY CHAIN AND FAB H11 LIGHT CHAIN | 3.4.24.56 |
6B88 | E. COLI LEPB IN COMPLEX WITH GNE0775 ((4S,7S,10S)-10-((S)-4-AMINO-2-(2-(4-(TERT-BUTYL)PHENYL)-4-METHYLPYRIMIDINE-5-CARBOXAMIDO)-N-METHYLBUTANAMIDO)-16,26-BIS(2-AMINOETHOXY)-N-(2-IMINOETHYL)-7-METHYL-6,9-DIOXO-5,8-DIAZA-1,2(1,3)-DIBENZENACYCLODECAPHANE-4-CARBOXAMIDE) | 3.4.21.89 |
6B89 | E. COLI LPTB IN COMPLEX WITH ADP AND NOVOBIOCIN | 3.6.3 7.5.2 |
6B8B | E. COLI LPTB IN COMPLEX WITH ADP AND A NOVOBIOCIN DERIVATIVE | 3.6.3 7.5.2 |
6B8E | MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 180 K | 3.1.3.48 |
6B8R | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS V23K/L36Q AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6B8T | MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 240 K | 3.1.3.48 |
6B8X | MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 278 K | 3.1.3.48 |
6B8Z | MULTICONFORMER MODEL OF WT PTP1B WITH BB3 AT 273 K | 3.1.3.48 |
6B90 | MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 100 K (ALTERNATIVE REFINEMENT OF PDB 1SUG SHOWING CONFORMATIONAL HETEROGENEITY) | 3.1.3.48 |
6B95 | MULTICONFORMER MODEL OF K197C PTP1B TETHERED TO COMPOUND 2 AT 100 K | 3.1.3.48 |
6B96 | CRYSTAL STRUCTURE OF PDE2 IN COMPLEX WITH COMPOUND 16 | 3.1.4.17 |
6B97 | CRYSTAL STRUCTURE OF PDE2 IN COMPLEX WITH COMPLEX 9 | 3.1.4.17 |
6B98 | PDE2 IN COMPLEX WITH COMPOUND 1 | 3.1.4.17 |
6B9D | HUMAN ATL1 MUTANT - R77A BOUND TO GDP | 3.6.5 |
6B9E | HUMAN ATL1 MUTANT - R77A / F151S BOUND TO GDP | 3.6.5 |
6B9F | HUMAN ATL1 MUTANT - F151S BOUND TO GDPALF4- | 3.6.5 |
6B9G | HUMAN ATL1 GTPASE DOMAIN BOUND TO GDP | 3.6.5 |
6B9O | STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE | 3.2.1.24 |
6B9P | STRUCTURE OF GH 38 JACK BEAN ALPHA-MANNOSIDASE IN COMPLEX WITH A 36-VALENT IMINOSUGAR CLUSTER INHIBITOR | 3.2.1.24 |
6BA0 | PYRIMIDINE-SPECIFIC RIBONUCLEOSIDE HYDROLASE FROM GARDNERELLA VAGINALIS | 3.2 |
6BA8 | YBTT - TYPE II THIOESTERASE FROM YERSINIABACTIN NRPS/PKS BIOSYNTHETIC PATHWAY | 3.1.2 |
6BA9 | YBTT - TYPE II THIOESTERASE FROM YERSINIABACTIN NRPS/PKS BIOSYNTHETIC PATHWAY- S89A MUTANT | 3.1.2 |
6BAI | MULTICONFORMER MODEL OF APO K197C PTP1B AT 100 K | 3.1.3.48 |
6BBM | MECHANISMS OF OPENING AND CLOSING OF THE BACTERIAL REPLICATIVE HELICASE: THE DNAB HELICASE AND LAMBDA P HELICASE LOADER COMPLEX | 3.6.4.12 |
6BBO | CRYSTAL STRUCTURE OF HUMAN APOBEC3H/RNA COMPLEX | 3.5.4.38 |
6BC1 | A COMPLEX BETWEEN PH DOMAIN OF P190RHOGEF AND ACTIVATED RAC1 BOUND TO A GTP ANALOG | 3.6.5.2 |
6BCM | STRUCTURE OF A SELF-INHIBITED N475A VARIANT OF THE VENEZUELAN EQUINE ENCEPHALITIS VIRUS (VEEV) NSP2 CYSTEINE PROTEASE | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6BDF | 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY | 3.4.25.1 |
6BDT | CRYSTAL STRUCTURE OF HUMAN CALPAIN-3 PROTEASE CORE MUTANT-C129S | 3.4.22.54 |
6BDV | CRYSTAL STRUCTURE OF CASPASE 3 S150A | 3.4.22.56 |
6BDZ | ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB | 3.4.24.81 |
6BE6 | ADAM10 EXTRACELLULAR DOMAIN | 3.4.24.81 |
6BF6 | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME | 3.4.24.56 |
6BF7 | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN, FAB H11-E LIGHT CHAIN | 3.4.24.56 |
6BF8 | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH INSULIN | 3.4.24.56 |
6BF9 | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN, FAB H11-E LIGHT CHAIN | 3.4.24.56 |
6BFC | CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH INSULIN | 3.4.24.56 |
6BFD | BACE CRYSTAL STRUCTURE WITH HYDROXY PYRROLIDINE INHIBITOR | 3.4.23.46 |
6BFE | BACE CRYSTAL STRUCTURE WITH HYDROXY PYRROLIDINE INHIBITOR | 3.4.23.46 |
6BFJ | CASPASE-3 MUTANT - T245D,S249D | 3.4.22.56 |
6BFK | CASPASE-3 MUTANT- T245A | 3.4.22.56 |
6BFL | CASPASE-3 MUTANT- D9A,D28A,T245D | 3.4.22.56 |
6BFO | CASPASE-3 MUTANT- T245D | 3.4.22.56 |
6BFP | BOVINE TRYPSIN BOUND TO POTENT INHIBITOR | 3.4.21.4 |
6BFW | BACE CRYSTAL STRUCTURE WITH HYDROXY MORPHOLINE INHIBITOR | 3.4.23.46 |
6BFX | BACE CRYSTAL STRUCTURE WITH HYDROXY PYRROLIDINE INHIBITOR | 3.4.23.46 |
6BG0 | CASPASE-3 MUTANT - D9A,D28A,S150D | 3.4.22.56 |
6BG1 | CASPASE-3 MUTANT - D9A,D28A,S150E | 3.4.22.56 |
6BG3 | STRUCTURE OF (3S,4S)-1-BENZYL-4-(3-(3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PIPERIDIN-3-YL ACETATE BOUND TO DCN1 | 3.2.1.17 |
6BG4 | CASPASE-3 MUTANT- T152D | 3.4.22.56 |
6BG5 | STRUCTURE OF 1-(BENZO[D][1,3]DIOXOL-5-YLMETHYL)-1-(1-PROPYLPIPERIDIN-4-YL)-3-(3-(TRIFLUOROMETHYL)PHENYL)UREA BOUND TO DCN1 | 3.2.1.17 |
6BGG | SOLUTION NMR STRUCTURES OF THE BRD3 ET DOMAIN IN COMPLEX WITH A CHD4 PEPTIDE | 3.6.4.12 |
6BGK | CASPASE-3 MUTANT- D9A,D28A,T152D | 3.4.22.56 |
6BGL | DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS | 3.4.25.1 |
6BGO | SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS | 3.4.25.1 |
6BGP | CRYSTAL STRUCTURE OF HUMAN CALPAIN-3 PROTEASE CORE MUTANT-C129A | 3.4.22.54 |
6BGQ | CASPASE-3 MUTANT - S150D | 3.4.22.56 |
6BGR | CASPASE-3 MUTANT - S150E | 3.4.22.56 |
6BGS | CASPASE-3 MUTANT - S150Y | 3.4.22.56 |
6BH8 | CRYSTAL STRUCTURE OF ZMPSTE24 IN COMPLEX WITH PHOSPHORAMIDON | 3.4.24.84 |
6BH9 | CASPASE-3 MUTANT - T152A | 3.4.22.56 |
6BHA | CASPASE-3 MUTANT - T152V | 3.4.22.56 |
6BHJ | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 38-MER HAIRPIN TEMPLATE-PRIMER RNA-DNA APTAMER | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BI8 | X-RAY STRUCTURE OF MERS CORONAVIRUS PAPAIN-LIKE PROTEASE IN COMPLEX WITH HUMAN ISG15 | 2.7.7.48 3.4.19.12 3.4.22.69 3.6.4.12 3.6.4.13 |
6BIB | 1.95 A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX WITH A TRIAZOLE-BASED MACROCYCLIC INHIBITOR | 3.4.22.66 3.6.1.15 2.7.7.48 |
6BIC | 2.25 A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX WITH A TRIAZOLE-BASED MACROCYCLIC INHIBITOR | 3.4.22.66 3.6.1.15 2.7.7.48 |
6BID | 1.15 A RESOLUTION STRUCTURE OF NOROVIRUS 3CL PROTEASE IN COMPLEX WITH A TRIAZOLE-BASED MACROCYCLIC INHIBITOR | 3.4.22.66 3.6.1.15 2.7.7.48 |
6BJD | CRYSTAL STRUCTURE OF HUMAN CALPAIN-3 PROTEASE CORE IN COMPLEX WITH E-64 | 3.4.22.54 |
6BJE | CRYSTAL STRUCTURE OF LYSOPHOSPHOLIPASE A2 CONJUGATED WITH PHENYLMETHYLSULFONYL FLUORIDE | 3.1.2 |
6BJR | CRYSTAL STRUCTURE OF PROTHROMBIN MUTANT S101C/A470C | 3.4.21.5 |
6BKB | STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3A | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6BKC | STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3B | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6BKD | STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3D | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6BKI | CRYSTAL STRUCTURE OF T101A VARIANT MOUSE CATHEPSIN K AT 2.94 ANGSTROM RESOLUTION. | 3.4.22.38 |
6BKJ | CRYSTAL STRUCTURE OF HUMAN CALPAIN-3 PROTEASE CORE IN COMPLEX WITH LEUPEPTIN | 3.4.22.54 |
6BLB | 1.88 ANGSTROM RESOLUTION CRYSTAL STRUCTURE HOLLIDAY JUNCTION ATP-DEPENDENT DNA HELICASE (RUVB) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ADP | 3.6.4.12 |
6BLF | PDE2 COMPLEXED WITH 2-[6-FLUORO-8-METHYLSULFONYL-9-[(1R)-1-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-1,2,3,4-TETRAHYDROCARBAZOL-1-YL]ACETIC ACID | 3.1.4.17 |
6BLK | MYCOBACTERIAL SENSOR HISTIDINE KINASE MPRB | 3.1.3 2.7.13.3 |
6BMR | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244 | 3.1.3.48 |
6BMU | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244 | 3.1.3.48 |
6BMV | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504 | 3.1.3.48 |
6BMW | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504 | 3.1.3.48 |
6BMX | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844 | 3.1.3.48 |
6BMY | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844 | 3.1.3.48 |
6BN3 | CTX-M-151 CLASS A EXTENDED-SPECTRUM BETA-LACTAMASE APO CRYSTAL STRUCTURE AT 1.3 ANGSTROM RESOLUTION | 3.5.2.6 |
6BN5 | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2 | 3.1.3.48 |
6BO1 | MONO-ADDUCT FORMED AFTER 3 DAYS IN THE REACTION OF DICHLORIDO(1,3-DIMETHYLBENZIMIDAZOL-2-YLIDENE)(ETA6-P-CYMENE)RUTHENIUM(II) WITH HEWL | 3.2.1.17 |
6BO2 | ADDUCTS FORMED AFTER 1 MONTH IN THE REACTION OF DICHLORIDO(1,3-DIMETHYLBENZIMIDAZOL-2-YLIDENE)(ETA6-P-CYMENE)RUTHENIUM(II) WITH HEWL | 3.2.1.17 |
6BO6 | EUBACTERIUM ELIGENS BETA-GLUCURONIDASE BOUND TO UNC4917 GLUCURONIC ACID CONJUGATE | 3.2.1.23 |
6BOF | CRYSTAL STRUCTURE OF KRAS A146T-GDP DEMONSTRATING OPEN SWITCH 1 CONFORMATION | 3.6.5.2 |
6BOG | CRYSTAL STRUCTURE OF RAPA, A SWI2/SNF2 PROTEIN THAT RECYCLES RNA POLYMERASE DURING TRANSCRIPTION | 3.6.4 |
6BOJ | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN AND UCR2 REGULATORY HELIX WITH BPN5004 | 3.1.4.53 |
6BOQ | HUMAN APE1 SUBSTRATE COMPLEX WITH AN A/A MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOR | HUMAN APE1 SUBSTRATE COMPLEX WITH AN G/G MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOS | HUMAN APE1 SUBSTRATE COMPLEX WITH AN A/C MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOT | HUMAN APE1 SUBSTRATE COMPLEX WITH AN C/C MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOU | HUMAN APE1 SUBSTRATE COMPLEX WITH AN T/C MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOV | HUMAN APE1 SUBSTRATE COMPLEX WITH AN A/G MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BOW | HUMAN APE1 SUBSTRATE COMPLEX WITH AN T/T MISMATCH ADJACENT THE THF | 3.1 4.2.99.18 |
6BP1 | CRYSTAL STRUCTURE OF HUMAN KRAS A59G MUTANT IN COMPLEX WITH GCP | 3.6.5.2 |
6BPF | CTX-M-151 CLASS A EXTENDED-SPECTRUM BETA-LACTAMASE CRYSTAL STRUCTURE IN COMPLEX WITH AVIBACTAM AT 1.32 ANGSTROM RESOLUTION | 3.5.2.6 |
6BPL | E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G907 | 3.6.3 7.5.2.6 |
6BPP | E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G092 | 3.6.3 7.5.2.6 |
6BQ0 | STRUCTURE OF HUMAN MONOACYLGLYCEROL LIPASE BOUND TO A COVALENT INHIBITOR | 3.1.1.23 |
6BQJ | CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH TRIPEPTIDIC ACYL SULFONAMIDE INHIBITOR (COMPOUND 16) | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6BQK | CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH TRIPEPTIDIC ACYL SULFONAMIDE INHIBITOR (COMPOUND 18) | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6BQM | SECRETED SERINE PROTEASE VESC FROM VIBRIO CHOLERAE | 3.4.21 |
6BR5 | N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND | 3.2.1.18 |
6BR6 | N2 NEURAMINIDASE IN COMPLEX WITH A NOVEL ANTIVIRAL COMPOUND | 3.2.1.18 |
6BRE | HEN EGG-WHITE LYSOZYME COCRYSTALLIZED WITH CADMIUM SULPHATE USING CUKALPHA SOURCE. | 3.2.1.17 |
6BRG | THE SAM DOMAIN OF MOUSE SAMHD1 IS CRITICAL FOR ITS ACTIVATION AND REGULATION | 3.1.5 |
6BRH | THE SAM DOMAIN OF MOUSE SAMHD1 IS CRITICAL FOR ITS ACTIVATION AND REGULATION | 3.1.5 |
6BS6 | SUSG WITH MIXED LINKAGE AMYLOSACCHARIDE | 3.2.1.1 |
6BS8 | THE CLASS 3 DNAB INTEIN FROM MYCOBACTERIUM SMEGMATIS | 3.6.4.12 |
6BSG | STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BSH | STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE | 2.7.7.7 3.4.23.16 2.7.7.49 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BSI | STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BSJ | STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON-PREFERRED FOR RNA HYDROLYSIS | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BSL | BMP1 COMPLEXED WITH A REVERSE HYDROXYMATE - COMPOUND 22 | 3.4.24.19 |
6BSM | BMP1 COMPLEXED WITH A REVERSE HYDROXAMATE - COMPOUND 4 | 3.4.24.19 |
6BT1 | STRUCTURE OF THE HUMAN NOCTURNIN CATALYTIC DOMAIN | 3.1.13.4 3.1.3 |
6BT2 | STRUCTURE OF THE HUMAN NOCTURNIN CATALYTIC DOMAIN WITH BOUND SULFATE ANION | 3.1.13.4 3.1.3 |
6BT6 | CTX-M-14 S237A BETA-LACTAMASE IN COMPLEX WITH A NON-COVALENT TETRAZOLE INHIBITOR | 3.5.2.6 |
6BTN | BMP1 COMPLEXED WITH A REVERSE HYDROXYMATE - COMPOUND 1 | 3.4.24.19 |
6BTO | BMP1 COMPLEXED WITH (2~{S})-2-[[(1~{R},3~{S},4~{S})-2-[(2~{R})-2-[2-(OXIDANYLAMINO)-2-OXIDANYLIDENE-ETHYL]HEPTANOYL]-2-AZABICYCLO[2.2.1]HEPTAN-3-YL]CARBONYLAMINO]-2-PHENYL-ETHANOIC ACID | 3.4.24.19 |
6BTP | BMP1 COMPLEXED WITH A HYDROXAMATE | 3.4.24.19 |
6BTQ | BMP1 COMPLEXED WITH A HYDROXAMATE - COMPOUND 2 | 3.4.24.19 |
6BU3 | CTX-M-27 BETA-LACTAMASE IN COMPLEX WITH A NON-COVALENT TETRAZOLE INHIBITOR | 3.5.2.6 |
6BU9 | DROSOPHILA DICER-2 BOUND TO BLUNT DSRNA | 3.1.26.3 3.6.1.3 3.1.21.1 3.1.26 |
6BUA | DROSOPHILA DICER-2 APO HOMOLOGY MODEL (HELICASE, PLATFORM-PAZ, RNASEIII DOMAINS) | 3.1.26.3 3.6.1.3 3.1.21.1 3.1.26 |
6BUM | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA | 3.5.2.15 |
6BUN | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA | 3.5.2.15 |
6BUO | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA | 3.5.2.15 |
6BUP | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA COMPLEXED WITH CYANURIC ACID | 3.5.2.15 |
6BUQ | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA COMPLEXED WITH BARBITURIC ACID | 3.5.2.15 |
6BUR | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA COMPLEXED WITH BARBITURIC ACID | 3.5.2.15 |
6BUX | CRYSTAL STRUCTURE OF APOBEC3G CATALYTIC DOMAIN COMPLEX WITH SUBSTRATE SSDNA | 3.5.4 |
6BUY | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH GLYCINE | 3.4.11.2 |
6BV0 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH ARGININE | 3.4.11.2 |
6BV1 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH ASPARTIC ACID | 3.4.11.2 |
6BV2 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH ISOLEUCINE | 3.4.11.2 |
6BV3 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH LEUCINE | 3.4.11.2 |
6BV4 | CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N WITH METHIONINE | 3.4.11.2 |
6BV5 | STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA AFTER 45-MINUTE SOAK WITH JUGLONE | 3.1.26.5 |
6BV6 | STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA AFTER 3-HOUR SOAK WITH JUGLONE | 3.1.26.5 |
6BV8 | STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA COMPLEXED WITH MN AFTER 3-HOUR SOAK WITH JUGLONE | 3.1.26.5 |
6BV9 | STRUCTURE OF PROTEINACEOUS RNASE P 1 (PRORP1) FROM A. THALIANA AFTER OVERNIGHT SOAK WITH JUGLONE | 3.1.26.5 |
6BVH | TRYPSIN COMPLEXED WITH A MODIFIED SUNFLOWER TRYPSIN INHIBITOR, SFTI-TCTR(N12,N14) | 3.4.21.4 |
6BVI | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6BVJ | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6BVK | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6BVL | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6BVM | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6BWY | DNA SUBSTRATE SELECTION BY APOBEC3G | 3.5.4 |
6BX8 | HUMAN MESOTRYPSIN (PRSS3) COMPLEXED WITH TISSUE FACTOR PATHWAY INHIBITOR VARIANT (TFPI1-KD1-K15R-I17C-I34C) | 3.4.21.4 |
6BYF | CRYSTAL STRUCTURE OF THE CORE CATALYTIC DOMAIN OF PP-IP PHOSPHATASE SIW14 FROM S. CEREVISIAE IN COMPLEX WITH CITRATE | 3.1.3.48 3.6.1.52 |
6BYZ | STRUCTURE OF CYSTEINE-FREE HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH SUBSTRATE-SELECTIVE MACROCYCLIC INHIBITOR 37 | 3.4.24.56 |
6BZ2 | CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 PROTEASE WITH A NOVEL HIV-1 INHIBITOR GRL-14213A OF 6-5-5-RING FUSED CROWN-LIKE TETRAHYDROPYRANOFURAN AS THE P2-LIGAND, A CYCLOPROPYLAMINOBENZOTHIAZOLE AS THE P2'-LIGAND AND 3,5-DIFLUOROPHENYLMETHYL AS THE P1-LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6BZ9 | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH AC-FLTD-CMK | 3.4.22.36 |
6BZH | STRUCTURE OF MOUSE RIG-I TANDEM CARDS | 3.6.4.13 |
6BZI | CRYSTAL STRUCTURE OF HALOGENASE PLTM IN COMPLEX WITH ETHYL MERCURY AND MERCURY | 3.8.1.1 |
6BZQ | CRYSTAL STRUCTURE OF HALOGENASE PLTM IN COMPLEX WITH FAD | 3.8.1.1 |
6BZT | CRYSTAL STRUCTURE OF HALOGENASE PLTM L111Y MUTANT IN COMPLEX WITH FAD | 3.8.1.1 |
6BZY | STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6BZZ | CRYSTAL STRUCTURE OF HALOGENASE PLTM IN COMPLEX WITH PARTIALLY BOUND FAD | 3.8.1.1 |
6C01 | HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C) | 3.1.4.1 3.6.1.9 |
6C02 | HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE 3 (ENPP3, NPP3, CD203C), INACTIVE (T205A), N594S, WITH ALPHA,BETA-METHYLENE-ATP (AMPCPP) | 3.1.4.1 3.6.1.9 |
6C0B | STRUCTURAL BASIS FOR RECOGNITION OF FRIZZLED PROTEINS BY CLOSTRIDIUM DIFFICILE TOXIN B | 3.4.22 2.4.1 |
6C0D | CRYSTAL STRUCTURE OF AN AMIDASE (HYDANTOINASE/CARBAMOYLASE FAMILY) FROM BURKHOLDERIA PHYMATUM | 3.5.1.87 |
6C0J | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0K | CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0L | CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0M | THE SYNTHESIS, BIOLOGICAL EVALUATION AND STRUCTURAL INSIGHTS OF UNSATURATED 3-N-SUBSTITUTED SIALIC ACIDS AS PROBES OF HUMAN PARAINFLUENZA VIRUS-3 HAEMAGGLUTININ-NEURAMINIDASE | 3.2.1.18 |
6C0N | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0O | CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0P | CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0R | CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C0S | FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL (4-{6-[(1S)-2-[(3R)-1-ACETYLPIPERIDIN-3-YL]-1-({(2E)-3-[5-CHLORO-2- (1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}AMINO)ETHYL]-3-CHLOROPYRIDAZIN-4-YL}PHENYL) CARBAMATE | 3.4.21.27 |
6C0V | MOLECULAR STRUCTURE OF HUMAN P-GLYCOPROTEIN IN THE ATP-BOUND, OUTWARD-FACING CONFORMATION | 3.6.3.44 7.6.2.2 7.6.2.1 |
6C2I | STRUCTURE OF BACE-1 (BETA-SECRETASE) IN COMPLEX WITH : N-(3-((1R,5S,6R)-3-AMINO-5-METHYL-2-OXA-4-AZABICYCLO[4.1.0]HEPT-3-EN-5-YL)-4-FLUOROPHENYL)-5-METHOXYPYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6C2N | CRYSTAL STRUCTURE OF HCV NS3/4A DOUBLE MUTANT VARIANT Y56H/D168A IN COMPLEX WITH DANOPREVIR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6C2W | CRYSTAL STRUCTURE OF HUMAN PROTHROMBIN MUTANT S101C/A470C | 3.4.21.5 |
6C3R | CRICKET PARALYSIS VIRUS RNAI SUPPRESSOR PROTEIN CRPV-1A | 3.4.22 2.7.7.48 |
6C44 | ZIKA VIRUS CAPSID PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 |
6C45 | CRYSTAL STRUCTURE OF HUMAN INORGANIC PYROPHOSPHATASE IN THE P212121 SPACE GROUP | 3.6.1.1 |
6C62 | AN UNEXPECTED VESTIGIAL PROTEIN COMPLEX REVEALS THE EVOLUTIONARY ORIGINS OF AN S-TRIAZINE CATABOLIC ENZYME. | 3.5.1.84 3.5.1.131 |
6C6G | AN UNEXPECTED VESTIGIAL PROTEIN COMPLEX REVEALS THE EVOLUTIONARY ORIGINS OF AN S-TRIAZINE CATABOLIC ENZYME. INHIBITOR BOUND COMPLEX. | 3.5.1.84 3.5.1.131 |
6C6I | CRYSTAL STRUCTURE OF A CHIMERIC NDM-1 METALLO-BETA-LACTAMASE HARBORING THE IMP-1 L3 LOOP | 3.5.2.6 |
6C79 | CONFORMATIONAL CHANGES IN A CLASS A BETA LACTAMASE THAT PRIME IT FOR CATALYSIS | 3.5.2.6 |
6C7A | CONFORMATIONAL CHANGES IN A CLASS A BETA LACTAMASE THAT PRIME IT FOR CATALYSIS | 3.5.2.6 |
6C7D | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH N-(1-ADAMANTYL)-1-(2-CHLOROPHENYL)-4-METHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C7E | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 1-(2-CHLOROPHENYL)-N,4-DIMETHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C7F | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 1-(2-CHLORO-5-ISOBUTOXY-PHENYL)-N,4-DIMETHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C7G | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH N-(1-ADAMANTYL)-1-(2-CHLORO-5-ISOBUTOXY-PHENYL)-4-METHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C7I | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 1-(2-CHLORO-5-METHOXY-PHENYL)-N-ISOBUTYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C7J | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 1-(5-TERT-BUTOXY-2-CHLORO-PHENYL)-N-ISOBUTYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-A]QUINOXALINE-8-CARBOXAMIDE | 3.1.4.17 |
6C8X | WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH A PHENYLBORONIC ACID (P2') ANALOG OF DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C8Y | D30N HIV-1 PROTEASE IN COMPLEX WITH A PHENYLBORONIC ACID (P2') ANALOG OF DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6C90 | HUMAN MTR4 HELICASE IN COMPLEX WITH ZCCHC8-CTD | 3.6.4.13 |
6C9C | CRYSTAL STRUCTURE OF LPXC FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH RACEMIC LIGAND PT803 | 3.5.1.108 |
6C9X | THE CRYSTAL STRUCTURE OF THE ALPHA-GLUCOSIDASE (GH 31) FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH VOGLIBOSE | 3.2.1 |
6C9Z | THE CRYSTAL STRUCTURE OF THE ALPHA-GLUCOSIDASE (GH 31) W169Y MUTANT FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH VOGLIBOSE | 3.2.1 |
6CA1 | THE CRYSTAL STRUCTURE OF THE W169Y MUTANT OF ALPHA-GLUCOSIDASE (GH 31) FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH MIGLITOL | 3.2.1 |
6CA3 | THE CRYSTAL STRUCTURE OF THE W169Y MUTANT OF ALPHA-GLUCOSIDASE (GH 31) FROM RUMINOCOCCUS OBEUM ATCC 29174 IN COMPLEX WITH MIGLITOL | 3.2.1 |
6CA4 | CRYSTAL STRUCTURE OF HUMANIZED D. RERIO TDP2 BY 14 MUTATIONS | 3.1.4 |
6CAC | CRYSTAL STRUCTURE OF NDM-1 METALLO-BETA-LACTAMASE HARBORING AN INSERTION OF A PRO RESIDUE IN L3 LOOP | 3.5.2.6 |
6CAH | NMR-BASED STRUCTURE OF THE FHA-2 DOMAIN FROM MYCOBACTERIUM TUBERCULOSIS ABC TRANSPORTER RV1747 | 3.6.3 7 |
6CAX | CRYSTAL STRUCTURE OF LPXC FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH PT805 | 3.5.1.108 |
6CAZ | CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM LEGIONELLA PNEUMOPHILA | 3.5.1.88 |
6CB2 | CRYSTAL STRUCTURE OF ESCHERICHIA COLI UPPP | 3.6.1.27 |
6CBD | CRYSTAL STRUCTURE OF HUMAN ARGONAUTE2 BOUND TO THREE TRYPTOPHANS | 3.1.26 |
6CBU | CRYSTAL STRUCTURE OF C4S3: A COMPUTATIONALLY DESIGNED IMMUNOGEN TO TARGET CARBOHYDRATE-OCCLUDED EPITOPES ON THE HIV ENVELOPE | 3.6.1.7 |
6CC7 | STRUCTURE OF FUNGAL GH62 FROM THIELAVIA TERRETRIS | 3.2.1.55 |
6CCJ | NMR STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M DOMAIN) | 2.7.7 3.1 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 |
6CDL | HIV-1 WILD TYPE PROTEASE WITH GRL-03214A, 6-5-5-RING FUSED UMBRELLA-LIKE TETRAHYDROPYRANOFURAN AS THE P2-LIGAND, A CYCLOPROPYLAMINOBENZOTHIAZOLE AS THE P2'-LIGAND AND 3,5-DIFLUOROPHENYLMETHYL AS THE P1-LIGAND | 3.4.23.16 |
6CE1 | CRYSTAL STRUCTURE OF PEPTIDYL ARGININE DEIMINASE TYPE III (PADI3) | 3.5.3.15 |
6CE5 | NMR STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M-DOMAIN) IN THE PRESENCE OF MYO-INOSITOL HEXAKISPHOSPHATE | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6CE6 | STRUCTURE OF HDAC6 ZINC-FINGER UBIQUITIN BINDING DOMAIN SOAKED WITH 3,3'-(BENZO[1,2-D:5,4-D']BIS(THIAZOLE)-2,6-DIYL)DIPROPIONIC ACID | 3.5.1.98 3.5.1 |
6CE8 | CRYSTAL STRUCTURE OF FRAGMENT 2-(BENZO[D]THIAZOL-2-YL)ACETIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CEA | CRYSTAL STRUCTURE OF FRAGMENT 3-(QUINOLIN-2-YL)PROPANOIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CEC | CRYSTAL STRUCTURE OF FRAGMENT 3-(3-METHOXY-2-QUINOXALINYL)PROPANOIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CED | CRYSTAL STRUCTURE OF FRAGMENT 3-(3-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)PROPANOIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CEE | CRYSTAL STRUCTURE OF FRAGMENT 3-(1-METHYL-2-OXO-1,2-DIHYDROQUINOXALIN-3-YL)PROPIONIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CEF | CRYSTAL STRUCTURE OF FRAGMENT 3-(1,3-BENZOTHIAZOL-2-YL)PROPANOIC ACID BOUND IN THE UBIQUITIN BINDING POCKET OF THE HDAC6 ZINC-FINGER DOMAIN | 3.5.1.98 3.5.1 |
6CEL | CBH1 (E212Q) CELLOPENTAOSE COMPLEX | 3.2.1.91 |
6CES | CRYO-EM STRUCTURE OF GATOR1-RAG | 3.6.5 |
6CFD | ADEP4 BOUND TO E. FAECIUM CLPP | 3.4.21.92 |
6CFP | CRYSTAL STRUCTURE OF POLYMERASE ACID PROTEIN (PA) FROM INFLUENZA A VIRUS, WILSON-SMITH/1933 (H1N1) BOUND TO FRAGMENT HIT BSI-70565 1-{1-[4-FLUOROPHENYL)METHYL]-2-METHYL-1H-IMIDAZOL-4-YL}ETHAN-1-ONE | 3.1 |
6CG0 | CRYO-EM STRUCTURE OF MOUSE RAG1/2 HFC COMPLEX (3.17 A) | 3.1 2.3.2.27 |
6CGA | STRUCTURE OF THE PR-DUB COMPLEX | 3.4.19.12 |
6CGF | CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
6CHA | STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION | 3.4.21.1 |
6CIJ | CRYO-EM STRUCTURE OF MOUSE RAG1/2 HFC COMPLEX CONTAINING PARTIAL HMGB1 LINKER(3.9 A) | 3.1 2.3.2.27 |
6CIK | PRE-REACTION COMPLEX, RAG1(E962Q)/2-INTACT/NICKED 12/23RSS COMPLEX IN MN2+ | 3.1 2.3.2.27 |
6CIL | PRE-REACTION COMPLEX, RAG1(E962Q)/2-INTACT/INTACT 12/23RSS COMPLEX IN MN2+ | 3.1 2.3.2.27 |
6CIM | PRE-REACTION COMPLEX, RAG1(E962Q)/2-NICKED/INTACT 12/23RSS COMPLEX IN MN2+ | 3.1 2.3.2.27 |
6CIW | HEN EGG WHITE LYSOZYME COCRYSTALLIZED WITH 1,3-DI(2-PYRIDYL)PROPANE | 3.2.1.17 |
6CK7 | CRYSTAL STRUCTURE OF A PEPTIDE DEFORMYLASE FROM LEGIONELLA PNEUMOPHILA BOUND TO ACTINONIN | 3.5.1.88 |
6CKZ | HUMAN CASPASE-3 IN COMPLEX WITH AC-DW3-KE | 3.4.22.56 |
6CL0 | HUMAN CASPASE-3 IN COMPLEX WITH AC-ATS009-KE | 3.4.22.56 |
6CL1 | CASPASE-7 IN COMPLEX WITH AC-DW3-KE | 3.4.22.60 |
6CL2 | CASPASE-7 IN COMPLEX WITH AC-ATS009-KE | 3.4.22.60 |
6CL4 | LIPC12 - LIPASE FROM METAGENOMICS | 3.1.1.3 |
6CLZ | MT1-MMP HPX DOMAIN WITH BLADE 4 LOOP BOUND TO NANODISCS | 3.4.24.80 |
6CM1 | MT1-MMP HPX DOMAIN WITH BLADE 2 LOOP BOUND TO NANODISCS | 3.4.24.80 |
6CM2 | SAMHD1 HD DOMAIN BOUND TO DECITABINE TRIPHOSPHATE | 3.1.5 |
6CM4 | STRUCTURE OF THE D2 DOPAMINE RECEPTOR BOUND TO THE ATYPICAL ANTIPSYCHOTIC DRUG RISPERIDONE | 3.2.1.17 |
6CMP | CLOSED STRUCTURE OF INACTIVE SHP2 MUTANT C459E | 3.1.3.48 |
6CMQ | STRUCTURE OF HUMAN SHP2 WITHOUT N-SH2 DOMAIN | 3.1.3.48 |
6CMR | CLOSED STRUCTURE OF ACTIVE SHP2 MUTANT E76D BOUND TO SHP099 INHIBITOR | 3.1.3.48 |
6CMS | CLOSED STRUCTURE OF ACTIVE SHP2 MUTANT E76K BOUND TO SHP099 INHIBITOR | 3.1.3.48 |
6CNI | CRYSTAL STRUCTURE OF H105A PGAM5 DIMER | 3.1.3.16 |
6CNL | CRYSTAL STRUCTURE OF H105A PGAM5 DODECAMER | 3.1.3.16 |
6CO2 | STRUCTURE OF AN ENGINEERED PROTEIN (NUDT16TI) IN COMPLEX WITH 53BP1 TUDOR DOMAINS | 3.6.1.62 3.6.1.64 |
6CPA | CRYSTAL STRUCTURE OF THE COMPLEX OF CARBOXYPEPTIDASE A WITH A STRONGLY BOUND PHOSPHONATE IN A NEW CRYSTALLINE FORM: COMPARISON WITH STRUCTURES OF OTHER COMPLEXES | 3.4.17.1 |
6CPM | STRUCTURE OF THE USP15 DEUBIQUITINASE DOMAIN IN COMPLEX WITH A THIRD-GENERATION INHIBITORY UBV | 3.4.19.12 |
6CPS | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN ATAD2 WITH A DISULFIDE BRIDGE | 3.6.1 |
6CPT | CRYSTAL STRUCTURE OF YEAST CAPDE2 IN COMPLEX WITH IBMX | 3.1.4 |
6CPU | CRYSTAL STRUCTURE OF YEAST CAPDE2 | 3.1.4 |
6CQC | RNASE P PROTEIN FROM THERMOTOGA MARITIMA IN COMPLEX WITH 1-(4-FLUOROPHENYL)-2-THIOUREA | 3.1.26.5 |
6CQS | SEDIMINISPIROCHAETA SMARAGDINAE SPS-1 METALLO-BETA-LACTAMASE | 3.5.2.6 |
6CQT | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (-) STEREOISOMER OF VX | 3.1.1.7 |
6CQU | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE WITH REACTIVATOR HI-6 | 3.1.1.7 |
6CQV | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(+) AND HI-6 | 3.1.1.7 |
6CQW | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH VX(-) AND HI-6 | 3.1.1.7 |
6CQX | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX(+) | 3.1.1.7 |
6CQY | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH EMPA AND HI-6 | 3.1.1.7 |
6CQZ | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY VX | 3.1.1.7 |
6CRF | CRYSTAL STRUCTURE OF SHP2 E76K GOF MUTANT IN THE OPEN CONFORMATION | 3.1.3.48 |
6CRG | CRYSTAL STRUCTURE OF SHP2 E76K GOF MUTANT IN COMPLEX WITH SHP099 | 3.1.3.48 |
6CRM | CRYSTAL STRUCTURE OF RECQ CATALYTIC CORE FROM C. SAKAZAKII BOUND TO AN UNFOLDED G-QUADRUPLEX | 3.6.4.12 |
6CRP | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 ABORTIVE PRODUCT 1 (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CRR | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL NATIVE VIRION (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CRS | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 A-PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CRU | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CS3 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EXPANDED 1 PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CS4 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 A-PARTICLE (PH 5.5 AND 33 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CS5 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 ABORTIVE PRODUCT 2 (PH 7.2 AND 4 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CS6 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 A-PARTICLE (PH 5.5 AND ROOM TEMPERATURE) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CSA | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (PH 5.5 AND ROOM TEMPERATURE) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CSG | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL NATIVE VIRION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CSH | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (PH 5.5 AND 33 DEGREES CELSIUS) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CTY | CRYSTAL STRUCTURE OF DIHYDROOROTASE PYRC FROM YERSINIA PESTIS IN COMPLEX WITH ZINC AND MALATE AT 2.4 A RESOLUTION | 3.5.2.3 |
6CU6 | CRYSTAL STRUCTURE OF GMPPNP-BOUND G12R MUTANT OF HUMAN KRAS4B | 3.6.5.2 |
6CUO | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6CUP | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6CUR | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6CUS | HADDOCK STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M-DOMAIN) IN COMPLEX WITH MYO-INOSITOL HEXAKISPHOSPHATE | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6CV1 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL PARTICLE (AFTER INCUBATION WITH HEPARIN-DERIVED HEXASACCHARIDE) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CV2 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL VIRION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CV3 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CV4 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (AFTER INCUBATION WITH LOW MOLECULAR WEIGHT HEPARIN) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CV5 | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL PARTICLE (AFTER INCUBATION WITH LOW MOLECULAR WEIGHT HEPARIN) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CV8 | HADDOCK STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M-DOMAIN) IN COMPLEX WITH INOSITOL 1,4,5-TRISPHOSPHATE | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6CVB | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6'-SIALYL-N-ACETYLLACTOSAMINE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6CVM | ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE | 3.2.1.23 |
6CVO | HUMAN APRATAXIN (APTX) BOUND TO NICKED RNA-DNA, AMP AND ZN PRODUCT COMPLEX | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CVP | HUMAN APRATAXIN (APTX) R199H BOUND TO RNA-DNA, AMP AND ZN PRODUCT COMPLEX | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CVQ | HUMAN APRATAXIN (APTX) H201Q BOUND TO RNA-DNA, AMP AND ZN PRODUCT COMPLEX | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CVR | HUMAN APRATAXIN (APTX) S242N BOUND TO RNA-DNA, AMP AND ZN PRODUCT COMPLEX | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CVS | HUMAN APRATAXIN (APTX) L248M BOUND TO DNA, AMP AND ZN PRODUCT | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CVT | HUMAN APRATAXIN (APTX) V263G BOUND TO RNA-DNA, AMP AND ZN PRODUCT COMPLEX | 3.1.11.7 3.1.12.2 3.6.1.71 3.6.1.72 |
6CW4 | HADDOCK STRUCTURE OF THE ROUS SARCOMA VIRUS MATRIX PROTEIN (M-DOMAIN) IN COMPLEX WITH INOSITOL 1,3,5-TRISPHOSPHATE | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6CWJ | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA COMPLEXED WITH 1,3-ACETONE DICARBOXYLIC ACID | 3.5.2.15 |
6CWU | PROTEIN TYROSINE PHOSPHATASE 1B F135Y MUTANT | 3.1.3.48 |
6CWV | PROTEIN TYROSINE PHOSPHATASE 1B A122S MUTANT | 3.1.3.48 |
6CWX | CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE P/MRP PROTEINS RPP20/RPP25 | 3.1.26.5 |
6CX1 | CRYO-EM STRUCTURE OF SENECA VALLEY VIRUS-ANTHRAX TOXIN RECEPTOR 1 COMPLEX | 3.6.4.13 3.4.19.12 3.4.22.28 2.7.7.48 |
6CXD | CRYSTAL STRUCTURE OF PEPTIDASE B FROM YERSINIA PESTIS CO92 AT 2.75 A RESOLUTION | 3.4.11.23 |
6CXS | CRYSTAL STRUCTURE OF CLOSTRIDIUM PERFRINGENS BETA-GLUCURONIDASE BOUND WITH A NOVEL, POTENT INHIBITOR 4-(8-(PIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-[1,2,3]TRIAZINO[4',5':4,5]THIENO[2,3-C]ISOQUINOLIN-5-YL)MORPHOLINE | 3.2.1.23 |
6CY9 | SA11 ROTAVIRUS NSP2 WITH DISULFIDE BRIDGE | 3.6.4 |
6CYA | ROTAVIRUS SA11 NSP2 S313A MUTANT | 3.6.4 |
6CYB | PDE2 IN COMPLEX WITH COMPOUND 7 | 3.1.4.17 |
6CYC | PDE2 IN COMPLEX WITH COMPOUND 5 | 3.1.4.17 |
6CYD | PDE2 IN COMPLEX WITH COMPOUND 7 | 3.1.4.17 |
6CYK | CTX-M-14 N106S MUTANT | 3.5.2.6 |
6CYM | REVERSIBLE COVALENT DIRECT THROMBIN INHIBITORS | 3.4.21.5 |
6CYN | CTX-M-14 N106S/D240G MUTANT | 3.5.2.6 |
6CYQ | CRYSTAL STRUCTURE OF CTX-M-14 S70G/N106S BETA-LACTAMASE IN COMPLEX WITH HYDROLYZED CEFOTAXIME | 3.5.2.6 |
6CYU | CRYSTAL STRUCTURE OF CTX-M-14 S70G/N106S/D240G BETA-LACTAMASE IN COMPLEX WITH HYDROLYZED CEFOTAXIME | 3.5.2.6 |
6CZ1 | CRYSTAL STRUCTURE OF ATPASE DOMAIN OF HUMAN GRP78 BOUND TO VER155008 | 3.6.4.10 |
6CZ5 | CRYSTAL STRUCTURE OF SMALL MOLECULE AMP-ACRYLAMIDE COVALENTLY BOUND TO DDX3 S228C | 3.6.4.13 |
6CZK | CRYSTAL STRUCTURE OF WILD-TYPE HUMAN PRO-CATHEPSIN H | 3.4.22.16 |
6CZO | THE KNL1-PP1 HOLOENZYME | 3.1.3.16 |
6CZS | CRYSTAL STRUCTURE OF HUMAN PRO-CATHEPSIN H C26S MUTANT | 3.4.22.16 |
6D06 | HUMAN ADAR2D E488Y MUTANT COMPLEXED WITH DSRNA CONTAINING AN ABASIC SITE OPPOSITE THE EDITED BASE | 3.5.4.37 |
6D0D | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-087-13 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6D0E | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-084-13 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6D15 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH COMPOUND 1 | 3.5.2.6 |
6D16 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH COMPOUND 2 | 3.5.2.6 |
6D17 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH COMPOUND 3 | 3.5.2.6 |
6D18 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH COMPOUND 6 | 3.5.2.6 |
6D19 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH COMPOUND 9 | 3.5.2.6 |
6D1A | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 1 | 3.5.2.6 |
6D1B | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 2 | 3.5.2.6 |
6D1C | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 3 | 3.5.2.6 |
6D1D | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 6 | 3.5.2.6 |
6D1E | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 7 | 3.5.2.6 |
6D1F | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 8 | 3.5.2.6 |
6D1G | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 9 | 3.5.2.6 |
6D1H | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 11 | 3.5.2.6 |
6D1I | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 12 | 3.5.2.6 |
6D1J | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 13 | 3.5.2.6 |
6D1K | CRYSTAL STRUCTURE OF NDM-1 COMPLEXED WITH COMPOUND 14 | 3.5.2.6 |
6D1N | APO STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 | 3.2.1.31 |
6D1R | STRUCTURE OF STAPHYLOCOCCUS AUREUS RNASE P PROTEIN AT 2.0 ANGSTROM | 3.1.26.5 |
6D26 | CRYSTAL STRUCTURE OF THE PROSTAGLANDIN D2 RECEPTOR CRTH2 WITH FEVIPIPRANT | 3.2.1.17 |
6D27 | CRYSTAL STRUCTURE OF THE PROSTAGLANDIN D2 RECEPTOR CRTH2 WITH CAY10471 | 3.2.1.17 |
6D2Z | STRUCTURE OF HUMAN USB1 WITH URIDINE-ADENOSINE, INACTIVE H208Q MUTANT | 3.1.4 |
6D30 | STRUCTURE OF HUMAN USB1 WITH URIDINE-URIDINE, INACTIVE H208Q MUTANT | 3.1.4 |
6D31 | STRUCTURE OF HUMAN USB1 WITH ADENOSINE 5'-MONOPHOSPHATE | 3.1.4 |
6D36 | STRUCTURE OF HUMAN ARH3 BOUND TO ADP-RIBOSE AND MAGNESIUM | 3.2.1.143 3.5.1 3.2.2 |
6D3A | STRUCTURE OF HUMAN ARH3 D314E BOUND TO ADP-RIBOSE AND MAGNESIUM | 3.2.1.143 3.5.1 3.2.2 |
6D3B | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) APO FORM | 3.2.1.18 |
6D3F | CRYSTAL STRUCTURE OF THE PTP EPSILON D2 DOMAIN | 3.1.3.48 |
6D3G | PER-2 CLASS A EXTENDED-SPECTRUM BETA-LACTAMASE CRYSTAL STRUCTURE IN COMPLEX WITH AVIBACTAM AT 2.4 ANGSTROM RESOLUTION | 3.5.2.6 |
6D3R | THERMOSTABLILIZED DEPHOSPHORYLATED CHICKEN CFTR | 3.6.3.49 5.6.1.6 |
6D3S | THERMOSTABILIZED PHOSPHORYLATED CHICKEN CFTR | 3.6.3.49 5.6.1.6 |
6D3X | HIGHLY POTENT AND SELECTIVE PLASMIN INHIBITORS BASED ON THE SUNFLOWER TRYPSIN INHIBITOR-1 SCAFFOLD ATTENUATE FIBRINOLYSIS IN PLASMA | 3.4.21.7 |
6D3Y | HIGHLY POTENT AND SELECTIVE PLASMIN INHIBITORS BASED ON THE SUNFLOWER TRYPSIN INHIBITOR-1 SCAFFOLD ATTENUATE FIBRINOLYSIS IN PLASMA | 3.4.21.7 |
6D3Z | PROTEASE SFTI COMPLEX | 3.4.21.7 |
6D40 | HIGHLY POTENT AND SELECTIVE PLASMIN INHIBITORS BASED ON THE SUNFLOWER TRYPSIN INHIBITOR-1 SCAFFOLD ATTENUATE FIBRINOLYSIS IN PLASMA | 3.4.21.7 |
6D41 | BACTERIODES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO D-GLUCARO-1,5-LACTONE | 3.2.1.31 |
6D4D | CRYSTAL STRUCTURE OF THE PTP EPSILON D1 DOMAIN | 3.1.3.48 |
6D4F | CRYSTAL STRUCTURE OF PTP EPSILON D2 DOMAIN (A455N/V457Y/E597D) | 3.1.3.48 |
6D55 | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D56 | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D59 | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5B | STRUCTURE OF CALDICELLULOSIRUPTOR DANIELII CBM3 MODULE OF GLYCOSIDE HYDROLASE WP_045175321 | 3.2.1 |
6D5C | STRUCTURE OF CALDICELLULOSIRUPTOR DANIELII GH10 MODULE OF GLYCOSIDE HYDROLASE WP_045175321 | 3.2.1 3.2.1.8 |
6D5D | STRUCTURE OF CALDICELLULOSIRUPTOR DANIELII GH48 MODULE OF GLYCOSIDE HYDROLASE WP_045175321 | 3.2.1 |
6D5E | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5G | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5H | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5J | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5L | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5M | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5N | HEXAGONAL THERMOLYSIN (295) IN THE PRESENCE OF 50% XYLOSE | 3.4.24.27 |
6D5O | HEXAGONAL THERMOLYSIN (295 K) IN THE PRESENCE OF 50% DMF | 3.4.24.27 |
6D5P | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 20% XYLOSE AS CRYOPROTECTANT | 3.4.24.27 |
6D5Q | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 30% XYLOSE AS CRYOPROTECTANT | 3.4.24.27 |
6D5R | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 50% XYLOSE AS CRYOPROTECTANT | 3.4.24.27 |
6D5S | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 50% MPD AS CRYOPROTECTANT | 3.4.24.27 |
6D5T | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 50% MPD AS CRYOPROTECTANT | 3.4.24.27 |
6D5U | HEXAGONAL THERMOLYSIN CRYOCOOLED TO 100 K WITH 50% METHANOL AS CRYOPROTECTANT | 3.4.24.27 |
6D5V | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D5W | RAS:SOS:RAS IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR | 3.6.5.2 |
6D65 | CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY PHOSPHATASE 1 CATALYTIC DOMAIN (C258S) AS A MALTOSE BINDING PROTEIN FUSION IN COMPLEX WITH THE DESIGNED AR PROTEIN OFF7 | 3.1.3.16 3.1.3.48 |
6D66 | CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY 1 CATALYTIC DOMAIN (C258S) AS A MALTOSE BINDING PROTEIN FUSION IN COMPLEX WITH THE DESIGNED AR PROTEIN MBP3_16 | 3.1.3.16 3.1.3.48 |
6D67 | CRYSTAL STRUCTURE OF THE HUMAN DUAL SPECIFICITY PHOSPHATASE 1 CATALYTIC DOMAIN (C258S) AS A MALTOSE BINDING PROTEIN FUSION (MALTOSE BOUND FORM) IN COMPLEX WITH THE DESIGNED AR PROTEIN MBP3_16 | 3.1.3.16 3.1.3.48 |
6D6E | TRICLINIC LYSOZYME (295 K) IN THE PRESENCE OF 47% XYLOSE | 3.2.1.17 |
6D6F | TRICLINIC LYSOZYME CRYOCOOLED TO 100 K WITH 47% XYLOSE AS CRYOPROTECTANT | 3.2.1.17 |
6D6G | TRICLINIC LYSOZYME (295 K) IN THE PRESENCE OF 47% MPD | 3.2.1.17 |
6D6H | TRICLINIC LYSOZYME CRYOCOOLED TO 100 K WITH 47% MPD AS CRYOPROTECTANT | 3.2.1.17 |
6D6W | BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 BOUND TO GLUCURONATE | 3.2.1.31 |
6D71 | CRYSTAL STRUCTURE OF THE HUMAN MIRO1 N-TERMINAL GTPASE BOUND TO GTP | 3.6.5 |
6D7H | CTX-M-14 APOENZYME | 3.5.2.6 |
6D7I | CTX-M-14 APOENZYME D233N POINT MUTANT | 3.5.2.6 |
6D89 | BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE 1 WITH N-TERMINAL LOOP DELETION | 3.2.1.31 |
6D96 | STRUCTURE OF INFLUENZA NEURAMINIDASE FROM STRAIN A/BREVIGMISSION/1/1918(H1N1) EXPRESSED IN HEK-293E CELLS | 3.2.1.18 |
6D9I | PEKIN DUCK EGG LYSOZYME ISOFORM II (DEL-II) | 3.2.1.17 |
6D9M | T4-LYSOZYME FUSION TO GEOBACTER GGDEF | 3.2.1.17 |
6DBI | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS NICKED DNA INTERMEDIATES | 2.3.2.27 3.1 |
6DBJ | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS NICKED DNA INTERMEDIATES | 2.3.2.27 3.1 |
6DBL | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBO | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBQ | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBR | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH ONE MELTED RSS AND ONE UNMELTED RSS | 2.3.2.27 3.1 |
6DBT | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBU | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBV | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS AND 23-RSS SUBSTRATE DNAS | 2.3.2.27 3.1 |
6DBW | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS SUBSTRATE DNA | 2.3.2.27 3.1 |
6DBX | CRYO-EM STRUCTURE OF RAG IN COMPLEX WITH 12-RSS SUBSTRATE DNA | 2.3.2.27 3.1 |
6DBY | CRYSTAL STRUCTURE OF NUDIX 1 FROM ARABIDOPSIS THALIANA | 3.6.1.55 3.6.1.67 3.6.1.22 |
6DBZ | CRYSTAL STRUCTURE OF NUDIX 1 FROM ARABIDOPSIS THALIANA COMPLEXED WITH ISOPENTENYL DIPHOSPHATE | 3.6.1.55 3.6.1.67 3.6.1.22 |
6DCM | THE ATOMIC RESOLUTION CRYSTAL STRUCTURE OF KRINGLE 2 VARIANT BOUND WITH EACA | 3.4.21.7 |
6DCR | E. COLI PRIA HELICASE WINGED HELIX DOMAIN DELETION PROTEIN | 3.6.4 |
6DCX | IASPP-PP-1C STRUCTURE AND TARGETING OF P53 | 3.1.3.16 |
6DCY | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 5-HYDROXY-2-METHYL-4-OXO-4H-PYRAN-3-CARBOXYLIC ACID | 3.1 |
6DCZ | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-4-OXO-4H-PYRAN-2-CARBOXYLIC ACID | 3.1 |
6DD3 | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/D407A) OF NT5C2-537X IN THE ACTIVE STATE | 3.1.3.5 |
6DD5 | CRYSTAL STRUCTURE OF THE CAS6 DOMAIN OF MARINOMONAS MEDITERRANEA MMB-1 CAS6-RT-CAS1 FUSION PROTEIN | 3.1 |
6DDB | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/R367Q) OF NT5C2-537X IN THE BASAL STATE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET | 3.1.3.5 |
6DDC | CRYSTAL STRUCTURE OF THE SINGLE MUTANT (D52N) OF NT5C2-537X IN THE BASAL STATE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET | 3.1.3.5 |
6DDH | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/R367Q) OF NT5C2-537X IN THE ACTIVE STATE, NORTHEAST STRUCTURAL GENOMICS TARGET | 3.1.3.5 |
6DDK | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/R367Q) OF THE FULL-LENGTH NT5C2 IN THE BASAL STATE | 3.1.3.5 |
6DDL | CRYSTAL STRUCTURE OF THE SINGLE MUTANT (D52N) OF NT5C2-Q523X IN THE BASAL STATE | 3.1.3.5 |
6DDO | CRYSTAL STRUCTURE OF THE SINGLE MUTANT (D52N) OF THE FULL-LENGTH NT5C2 IN THE BASAL STATE | 3.1.3.5 |
6DDQ | CRYSTAL STRUCTURE OF THE DOUBLT MUTANT (R39Q/D52N) OF THE FULL-LENGTH NT5C2 IN THE BASAL STATE | 3.1.3.5 |
6DDT | MOUSE BETA-MANNOSIDASE (MANBA) | 3.2.1.25 |
6DDU | MOUSE BETA-MANNOSIDASE BOUND TO BETA-D-MANNOSE (MANBA) | 3.2.1.25 |
6DDX | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/L375F) OF NT5C2-537X IN THE ACTIVE STATE, NORTHEAST STRUCTURAL GENOMICS TARGET | 3.1.3.5 |
6DDY | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/K359Q) OF NT5C2-537X IN THE ACTIVE STATE, NORTHEAST STRUCTURAL GENOMICS TARGET | 3.1.3.5 |
6DDZ | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/R238W) OF NT5C2-537X IN THE ACTIVE STATE, NORTHEAST STRUCTURAL GENOMICS TARGET | 3.1.3.5 |
6DE0 | CRYSTAL STRUCTURE OF THE SINGLE MUTANT (D52N) OF NT5C2-Q523X IN THE ACTIVE STATE | 3.1.3.5 |
6DE1 | CRYSTAL STRUCTURE OF THE SINGLE MUTANT (D52N) OF THE FULL-LENGTH NT5C2 IN THE ACTIVE STATE | 3.1.3.5 |
6DE2 | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (D52N/L375F) OF THE FULL-LENGTH NT5C2 IN THE ACTIVE STATE | 3.1.3.5 |
6DE3 | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT (R39Q/D52N) OF THE FULL-LENGTH NT5C2 IN THE ACTIVE STATE | 3.1.3.5 |
6DE8 | CRYSTAL STRUCTURE OF BIFUNCTIONAL ENZYME FOLD-METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE FROM CAMPYLOBACTER JEJUNI | 1.5.1.5 3.5.4.9 |
6DEB | CRYSTAL STRUCTURE OF BIFUNCTIONAL ENZYME FOLD-METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE IN THE COMPLEX WITH METHOTREXATE FROM CAMPYLOBACTER JEJUNI | 1.5.1.5 3.5.4.9 |
6DEF | VPS1 GTPASE-BSE FUSION COMPLEXED WITH GMPPCP | 3 |
6DEU | HUMAN CASPASE-6 A109T | 3.4.22.59 |
6DEV | HUMAN CASPASE-6 E35K | 3.4.22.59 |
6DFI | CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII | 3.4.21.91 3.6.1.15 3.6.4.13 |
6DFM | CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH 8-AMINOADENOSINE | 3.6.4.10 |
6DFO | CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH 8-BROMOADENOSINE | 3.6.4.10 |
6DG4 | STRUCTURE OF THE CHAETOMIUM THERMOPHILUM ULP1-LIKE SUMO PROTEASE CATALYTIC DOMAIN | 3.4.22.68 |
6DGD | PRIA HELICASE BOUND TO DSDNA OF A DNA REPLICATION FORK | 3.6.4 |
6DGE | CRYSTAL STRUCTURE OF THE DIMETHYLARGININE DIMETHYLAMINOHYDROLASE ADDUCT WITH N5-(1-IMINO-2-CHLOROETHYL)-L-LYSINE | 3.5.3.18 |
6DGF | UBIQUITIN VARIANT BOUND TO USP2 | 3.4.19.12 |
6DGX | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH DARUNAVIR | 2.7.7.49 3.1.13.2 3.1.26.13 |
6DHC | X-RAY STRUCTURE OF BACE1 IN COMPLEX WITH A BICYCLIC ISOXAZOLINE CARBOXAMIDE AS THE P3 LIGAND | 3.4.23.46 |
6DHI | BUTELASE 1: AUTO-CATALYTIC CLEAVAGE AS AN EVOLUTIONARY CONSTRAINT FOR MACROCYCLIZING ENDOPEPTIDASES | 3.4.22.34 |
6DHJ | CRYSTAL STRUCTURES OF CYANURIC ACID HYDROLASE FROM MOORELLA THERMOACETICA | 3.5.2.15 |
6DHT | BACTEROIDES OVATUS GH9 BACOVA_02649 | 3.2.1.151 |
6DHV | STRUCTURE OF ARABIDOPSIS FATTY ACID AMIDE HYDROLASE | 3.5.1.99 |
6DI8 | CRYSTAL STRUCTURE OF BOVINE ALPHA-CHYMOTRYPSIN IN SPACE GROUP P65 | 3.4.21.1 |
6DIE | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH ZENOBIA FRAGMENT BENZENE-1,2,4-TRICARBOXYLIC ACID FROM SINGLE SOAK | 3.1.4 |
6DIF | WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH TIPRANAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DIH | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH SIGMA ALDRICH COMPOUND PH004941 | 3.1.4 |
6DIL | HIV-1 PROTEASE WITH SINGLE MUTATION L76V IN COMPLEX WITH TIPRANAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DIM | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH ZENOBIA FRAGMENT ZT1982 FROM COCKTAIL SOAK | 3.1.4 |
6DJ1 | WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH LOPINAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DJ2 | HIV-1 PROTEASE WITH SINGLE MUTATION L76V IN COMPLEX WITH LOPINAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DJ5 | HIV-1 PROTEASE WITH MUTATION L76V IN COMPLEX WITH GRL-0519 (TRIS-TETRAHYDROFURAN AS P2 LIGAND) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DJ7 | HIV-1 PROTEASE WITH MUTATION L76V IN COMPLEX WITH GRL-5010 (GEM-DIFLUORO-BIS-TETRAHYDROFURAN AS P2 LIGAND) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DJ9 | STRUCTURE OF THE USP15 DUSP DOMAIN IN COMPLEX WITH A HIGH-AFFINITY UBIQUITIN VARIANT (UBV) | 3.4.19.12 |
6DJA | ZN-DEPENDENT 5/B/6 METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS | 3.5.2.6 |
6DJD | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH ZENOBIA FRAGMENT ZT1982 (SINGLE SOAK) | 3.1.4 |
6DJF | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ502 | 3.1.4 |
6DJG | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ503 | 3.1.4 |
6DJH | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ515 | 3.1.4 |
6DJJ | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ532 | 3.1.4 |
6DKF | CASEINOLYTIC PROTEASE (CLPP) FROM STAPHYLOCOCCUS AUREUS MUTANT - V7A | 3.4.21.92 |
6DKK | STRUCTURE OF BONT | 3.4.24.69 |
6DKN | CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA DECAPPING NUCLEASE DXO1 | 3.6.1 |
6DL7 | HUMAN MITOCHONDRIAL CLPP IN COMPLEX WITH ONC201 (TIC10) | 3.4.21.92 |
6DLG | CRYSTAL STRUCTURE OF A SHIP1 SURFACE ENTROPY REDUCTION MUTANT | 3.1.3.86 3.1.3.56 3.1.3.36 |
6DLO | CRYSTAL STRUCTURE OF LRRK2 WD40 DOMAIN DIMER | 2.7.11.1 3.6.5 |
6DLP | CRYSTAL STRUCTURE OF LRRK2 WD40 DOMAIN DIMER | 2.7.11.1 3.6.5 |
6DLU | CRYO-EM OF THE GMPPCP-BOUND HUMAN DYNAMIN-1 POLYMER ASSEMBLED ON THE MEMBRANE IN THE CONSTRICTED STATE | 3.6.5.5 |
6DLV | CRYO-EM OF THE GTP-BOUND HUMAN DYNAMIN-1 POLYMER ASSEMBLED ON THE MEMBRANE IN THE SUPER CONSTRICTED STATE | 3.6.5.5 |
6DMH | A MULTICONFORMER LIGAND MODEL OF ACYLENZYME INTERMEDIATE OF MEROPENEM BOUND TO AN SFC-1 E166A MUTANT | 3.5.2.6 |
6DMI | A MULTICONFORMER LIGAND MODEL OF 5T5 BOUND TO BACE-1 | 3.4.23.46 |
6DMN | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: SOAKED IN 2 MM CA2+ AND 200 MM K+ AT 21 C | 3.1.26.4 |
6DMV | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: SOAKED FOR 40 S IN 2 MM MG2+ AND 200 MM K+ AT 21 C | 3.1.26.4 |
6DNO | CRYSTAL STRUCTURE OF PROTEIN PHOSPHATASE 1 (PP1) BOUND TO THE MUSCLE GLYCOGEN-TARGETING SUBUNIT (GM) | 3.1.3.16 |
6DO2 | CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH 7-DEAZA-2'-C-METHYLADENOSINE | 3.6.4.10 |
6DO8 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 80 S AT 21 C | 3.1.26.4 |
6DO9 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 120 S AT 21 C | 3.1.26.4 |
6DOA | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 480 S AT 21 C | 3.1.26.4 |
6DOB | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 200 S AT 21 C | 3.1.26.4 |
6DOC | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 240 S AT 21 C | 3.1.26.4 |
6DOD | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 360 S AT 21 C | 3.1.26.4 |
6DOE | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 420 S AT 21 C | 3.1.26.4 |
6DOF | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 540 S AT 21 C | 3.1.26.4 |
6DOG | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 600 S AT 21 C | 3.1.26.4 |
6DOH | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: SOAK IN 0.5 MM EGTA AND 200 MM K+ AT 21 C | 3.1.26.4 |
6DOI | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID (1.54 ANGSTROM WAVELENGTH): SOAK IN 0.5 MM EGTA AND 200 MM K+ AT 21 C | 3.1.26.4 |
6DOJ | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 5 MM K+ FOR 120 S AT 21 C | 3.1.26.4 |
6DOK | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 25 MM K+ FOR 120 S AT 21 C (DATASET 1) | 3.1.26.4 |
6DOL | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 25 MM K+ FOR 120 S AT 21 C (DATASET 2) | 3.1.26.4 |
6DOM | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 50 MM K+ FOR 120 S AT 21 C | 3.1.26.4 |
6DON | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 100 MM K+ FOR 120 S AT 21 C (DATASET 1) | 3.1.26.4 |
6DOO | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 100 MM K+ FOR 120 S AT 21 C (DATASET 2) | 3.1.26.4 |
6DOP | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 120 S AT 21 C (DATASET 1) | 3.1.26.4 |
6DOQ | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 120 S AT 21 C (DATASET 2) | 3.1.26.4 |
6DOR | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 300 MM K+ FOR 120 S AT 21 C (DATASET 1) | 3.1.26.4 |
6DOS | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 300 MM K+ FOR 120 S AT 21 C (DATASET 2) | 3.1.26.4 |
6DOT | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 40 S AT 21 C | 3.1.26.4 |
6DOU | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 120 S AT 21 C | 3.1.26.4 |
6DOV | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 80 S AT 21 C | 3.1.26.4 |
6DOW | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 160 S AT 21 C | 3.1.26.4 |
6DOX | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 360 S AT 21 C | 3.1.26.4 |
6DOY | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM LI+ FOR 120 S AT 21 C | 3.1.26.4 |
6DOZ | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 1 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP0 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2.5 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP1 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP2 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 7.5 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP3 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 10 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP4 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 20 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP5 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 40 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP6 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 80 MM MG2+ AND 75 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP7 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 500 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DP8 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM LI+ FOR 240 S AT 21 C | 3.1.26.4 |
6DP9 | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPA | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 4 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPB | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 8 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPC | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 12 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPD | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 16 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPE | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 20 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPF | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 40 MM MN2+ AND 200 MM K+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPG | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 E188A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 4 MM MN2+ AND 200 MM K+ FOR 240 S AT 21 C | 3.1.26.4 |
6DPH | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 E188A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MN2+ AND 200 MM K+ FOR 120 S AT 21 C | 3.1.26.4 |
6DPI | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 K196A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 10 MM MG2+ AND 200 MM RB+ FOR 40 S AT 21 C | 3.1.26.4 |
6DPJ | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 K196A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 4 MM MN2+ AND 200 MM K+ FOR 80 S AT 21 C | 3.1.26.4 |
6DPK | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 K196A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 4 MM MN2+ AND 200 MM K+ FOR 240 S AT 21 C | 3.1.26.4 |
6DPL | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 K196A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 10 MM MG2+ AND 200 MM RB+ FOR 720 S AT 21 C | 3.1.26.4 |
6DPM | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 K196A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 10 MM MG2+ AND 200 MM RB+ FOR 1800 S AT 21 C | 3.1.26.4 |
6DPN | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 E188A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 200 S AT 21 C | 3.1.26.4 |
6DPO | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 E188A IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 2 MM MG2+ AND 200 MM K+ FOR 360 S AT 21 C | 3.1.26.4 |
6DPP | CRYSTAL STRUCTURE OF BACILLUS HALODURANS RIBONUCLEASE H1 IN COMPLEX WITH AN RNA/DNA HYBRID: REACTION IN 5 MM MG2+ AND 200 MM RB+ FOR 240 S AT 21 C | 3.1.26.4 |
6DPT | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE WITH NANOMOLAR INHIBITOR | 3.5.2.6 |
6DPX | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE WITH INHIBITOR | 3.5.2.6 |
6DPY | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE WITH INHIBITOR | 3.5.2.6 |
6DPZ | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE WITH INHIBITOR | 3.5.2.6 |
6DR1 | YOPH PTP1B CHIMERA 2 PTPASE | 3.1.3.48 |
6DR7 | YOPH PTP1B WPD LOOP CHIMERA 2 PTPASE BOUND TO VANADATE | 3.1.3.48 |
6DR9 | CRYSTAL STRUCTURE OF THE YOPH PTP1B CHIMERA 3 PTPASE APO FORM | 3.1.3.48 |
6DRB | CRYSTAL STRUCTURE OF THE YOPH PTP1B WPD LOOP CHIMERA 3 PTPASE BOUND TO TUNGSTATE | 3.1.3.48 |
6DRE | ADP-RIBOSYLTRANSFERASE TOXIN/IMMUNITY PAIR | 3.2.2.24 3.2.2.19 |
6DRU | XYLOSIDASE FROM ASPERGILLUS NIGER | 3.2.1.177 |
6DRV | BETA-GALACTOSIDASE | 3.2.1.23 |
6DT3 | 1.2 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF NUCLEOSIDE TRIPHOSPHATASE NUDI FROM KLEBSIELLA PNEUMONIAE IN COMPLEX WITH HEPES | 3.6.1.9 3.6.1.12 3.6.1 3.6.1.23 |
6DT6 | CRYSTAL STRUCTURE OF THE YOPH PTP1B CHIMERA 3 PTPASE BOUND TO VANADATE | 3.1.3.48 |
6DTD | HIGH-RESOLUTION CRYSTAL STRUCTURE OF CAS13B FROM PREVOTELLA BUCCAE | 3.1 |
6DTE | GLCNAC-INSPIRED CYCLOPHELLITOL BOUND TO NAGZ | 3.2.1.52 |
6DTW | HIV-1 REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH JLJ 578 | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
6DTX | WILDTYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH JLJ 578 | 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1 |
6DU2 | STRUCTURE OF SCP1 D96N BOUND TO REST-PS861/4 PEPTIDE | 3.1.3.16 |
6DU3 | STRUCTURE OF SCP1 D96N BOUND TO REST-PS861/4 PEPTIDE | 3.1.3.16 |
6DUF | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6DUG | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6DUH | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE Y181I MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6DUI | CRYSTAL STRUCTURE OF LPXC FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH PT801 | 3.5.1.108 |
6DUX | 2.25 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF 6-PHOSPHO-ALPHA-GLUCOSIDASE FROM KLEBSIELLA PNEUMONIAE IN COMPLEX WITH NAD. | 3.2.1.122 |
6DV0 | HIV-1 WILD TYPE PROTEASE WITH GRL-02815A, A THIOCHROMAN HETEROCYCLE WITH (S)-BOC-AMINE FUNCTIONALITY AS THE P2 LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DV4 | HIV-1 WILD TYPE PROTEASE WITH GRL-04315A, A TETRAHYDRONAPHTHALENE CARBOXAMIDE WITH (R)-BOC-AMINE AND (S)-HYDROXYL FUNCTIONALITIES AS THE P2 LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6DVV | 2.25 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF 6-PHOSPHO-ALPHA-GLUCOSIDASE FROM KLEBSIELLA PNEUMONIAE IN COMPLEX WITH NAD AND MN2+. | 3.2.1.122 |
6DW3 | SAMHD1 BOUND TO CYTARABINE-TP IN THE CATALYTIC POCKET | 3.1.5 |
6DW4 | SAMHD1 BOUND TO CLADRIBINE-TP IN THE CATALYTIC POCKET AND ALLOSTERIC POCKET | 3.1.5 |
6DW5 | SAMHD1 BOUND TO GEMCITABINE-TP IN THE CATALYTIC POCKET | 3.1.5 |
6DW7 | SAMHD1 WITHOUT CATALYTIC NUCLEOTIDES | 3.1.5 |
6DWD | SAMHD1 BOUND TO CLOFARABINE-TP IN THE CATALYTIC POCKET AND ALLOSTERIC POCKET | 3.1.5 |
6DWF | CRYSTAL STRUCTURE OF COMPLEX OF BBKI MUTANT, L55R WITH BOVINE TRYPSIN | 3.4.21.4 |
6DWJ | SAMHD1 BOUND TO VIDARABINE-TP IN THE CATALYTIC POCKET | 3.1.5 |
6DWK | SAMHD1 BOUND TO FLUDARABINE-TP IN THE CATALYTIC POCKET | 3.1.5 |
6DWQ | SUBTILISIN SERINE PROTEASE MODIFIED WITH THE PROTEASE INHIBITOR CYANOBENZYLSULFONYLFLUORIDE | 3.4.21.62 |
6DWR | TRYPSIN SERINE PROTEASE MODIFIED WITH THE PROTEASE INHIBITOR CYANOBENZYLSULFONYLFLUORIDE | 3.4.21.4 |
6DWS | CRYSTAL STRUCTURE OF HUMAN GRP78 IN COMPLEX WITH (2R,3R,4S,5R)-2-(6-AMINO-8-((2-CHLOROBENZYL)AMINO)-9H-PURIN-9-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | 3.6.4.10 |
6DXH | STRUCTURE OF USP5 ZINC-FINGER UBIQUITIN BINDING DOMAIN CO-CRYSTALLIZED WITH 4-(4-TERT-BUTYLPHENYL)-4-OXOBUTANOATE | 3.4.19.12 |
6DXT | STRUCTURE OF USP5 ZINC-FINGER UBIQUITIN BINDING DOMAIN CO-CRYSTALLIZED WITH 3-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)PROPANOATE | 3.4.19.12 |
6DXW | HUMAN N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) PRECURSOR (C126A) | 3.5.1.60 3.5.1.23 |
6DXX | HUMAN N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) IN COMPLEX WITH NON-COVALENT BENZOTHIAZOLE-PIPERAZINE INHIBITOR ARN19702, IN PRESENCE OF TRITON X-100 | 3.5.1.60 3.5.1.23 |
6DXY | MURINE N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) | 3.5.1.60 3.5.1.23 |
6DXZ | RABBIT N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) IN COMPLEX WITH NON-COVALENT BENZOTHIAZOLE-PIPERAZINE INHIBITOR ARN19702, IN PRESENCE OF TRITON X-100 | 3.5.1.60 3.5.1.23 |
6DY0 | RABBIT N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) COVALENTLY BOUND TO BETA-LACTAM INHIBITOR ARN726, IN PRESENCE OF TRITON X-100 | 3.5.1.60 3.5.1.23 |
6DY1 | RABBIT N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) WITH FATTY ACID (MYRISTATE), IN PRESENCE OF TRITON X-100 | 3.5.1.60 3.5.1.23 |
6DY2 | GUINEA PIG N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) COVALENTLY BOUND TO BETA-LACTAM INHIBITOR ARN726 | 3.5.1.60 3.5.1.23 |
6DY3 | CAENORHABDITIS ELEGANS N-ACYLETHANOLAMINE-HYDROLYZING ACID AMIDASE (NAAA) ORTHOLOG | 3.5.1.60 |
6DYU | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (3R,4S)-1-((4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL)-4-((PROP-2-YN-1-YLTHIO)METHYL)PYRROLIDIN-3-OL | 3.2.2.9 3.2.2.30 |
6DYV | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (3R,4S)-1-((4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL)-4-((PENT-4-YN-1-YLTHIO)METHYL)PYRROLIDIN-3-OL | 3.2.2.9 3.2.2.30 |
6DYW | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (3R,4S)-1-((4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL)-4-(((3-(1-BENZYL-1H-1,2,3-TRIAZOL-4-YL)PROPYL)THIO)METHYL)PYRROLIDIN-3-OL | 3.2.2.9 3.2.2.30 |
6DYY | CRYSTAL STRUCTURE OF HELICOBACTER PYLORI 5'-METHYLTHIOADENOSINE/S-ADENOSYL HOMOCYSTEINE NUCLEOSIDASE (MTAN) COMPLEXED WITH (3R,4S)-1-((4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL)-4-(((3-(1-BUTYL-1H-1,2,3-TRIAZOL-4-YL)PROPYL)THIO)METHYL)PYRROLIDIN-3-OL | 3.2.2.9 3.2.2.30 |
6DZF | ORTHORHOMBIC TRYPSIN CRYOCOOLED TO 100 K WITH 20% XYLOSE AS CRYOPROTECTANT | 3.4.21.4 |
6DZH | HRAS G13D BOUND TO GDP (H13GDP) | 3.6.5.2 |
6DZQ | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-6-METHYL-4-OXO-4H-PYRAN-2-CARBOXYLIC ACID | 3.1 |
6E0Q | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 4,6-DIHYDROXY-2-METHYL-5-OXOCYCLOHEPTA-1,3,6-TRIENE-1-CARBOXYLIC ACID | 3.1 |
6E0U | STAPHYLOCOCCUS PSEUDINTERMEDIUS EXFOLIATIVE TOXIN EXI | 3.4.21 |
6E3M | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 6-(3-CARBOXYPHENYL)-3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E3N | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-4-OXO-6-(O-TOLYL)-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E3O | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 6-(2-ETHYLPHENYL)-3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E3P | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 6-(3-(1H-TETRAZOL-5-YL)PHENYL)-3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E4B | THE CRYSTAL STRUCTURE OF A PUTATIVE ALPHA-RIBAZOLE-5'-P PHOSPHATASE FROM ESCHERICHIA COLI STR. K-12 SUBSTR. MG1655 | 3.1.3.73 |
6E4C | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-6-(2-METHYL-4-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)PHENYL)-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E54 | CRYSTAL STRUCTURE OF LPXC FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH LIGAND PT802 | 3.5.1.108 |
6E5B | HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH COMPOUND 1 | 3.4.25.1 |
6E5M | CRYSTALLOGRAPHIC STRUCTURE OF THE CYCLIC NONAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 32 2 1 | 3.4.21.4 |
6E5Z | CRYSTAL STRUCTURE OF HUMAN DJ-1 WITH A NATURAL MODIFICATION ON CYS-106 | 3.1.2 3.5.1 3.5.1.124 |
6E67 | STRUCTURE OF BETA2 ADRENERGIC RECEPTOR FUSED TO A GS PEPTIDE | 3.2.1.17 |
6E69 | ORTHO-SUBSTITUTED PHENYL SULFONYL FLUORIDE AND FLUOROSULFATE AS POTENT ELASTASE INHIBITORY FRAGMENTS | 3.4.21.37 |
6E6F | KRAS G13D BOUND TO GPPNHP (K13GNP) | 3.6.5.2 |
6E6G | KRAS G13D BOUND TO GDP (K13GDP) | 3.6.5.2 |
6E6H | NRAS G13D BOUND TO GPPNHP (N13GNP) | 3.6.5.2 |
6E6P | HRAS G13D BOUND TO GPPNHP (HA,B,C13GNP) | 3.6.5.2 |
6E6V | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-6-METHYL-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E6W | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 3-HYDROXY-6-(2-METHYL-4-(1H-TETRAZOL-5-YL)PHENYL)-4-OXO-1,4-DIHYDROPYRIDINE-2-CARBOXYLIC ACID | 3.1 |
6E6X | THE N-TERMINAL DOMAIN OF PA ENDONUCLEASE FROM THE INFLUENZA H1N1 VIRUS IN COMPLEX WITH 1-(4-(1H-TETRAZOL-5-YL)PHENYL)-5-HYDROXY-2-METHYLPYRIDIN-4(1H)-ONE | 3.1 |
6E7J | HIV-1 WILD TYPE PROTEASE WITH GRL-042-17A, 3-PHENYLHEXAHYDRO-2H-CYCLOPENTA[D]OXAZOL-2-ONE WITH A BICYCLIC OXAZOLIDINONE SCAFFOLD AS THE P2 LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6E7K | STRUCTURE OF THE LIPOPROTEIN LIPASE GPIHBP1 COMPLEX THAT MEDIATES PLASMA TRIGLYCERIDE HYDROLYSIS | 3.1.1.34 3.1.1.32 |
6E9A | HIV-1 WILD TYPE PROTEASE WITH GRL-034-17A, (3AS, 5R, 6AR)-2-OXOHEXAHYD CYCLOPENTA[D]-5-OXAZOLYL URETHANE WITH A BICYCLIC OXAZOLIDINONE SCAFF AS THE P2 LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6EA1 | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6DA) AND CATALYTIC ZINC ION | 3.4.11 |
6EA2 | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6H) AND CATALYTIC ZINC ION | 3.4.11 |
6EA4 | ERAP2 BOUND TO ARYL SULFONAMIDE UNCOMPETITIVE INHIBITOR | 3.4.11 |
6EA6 | STRUCTURE OF VACV POXIN 2'3' CGAMP-SPECIFIC NUCLEASE | 3.1 |
6EA9 | STRUCTURE OF VACV POXIN IN POST-REACTIVE STATE WITH GP[2'-5']AP[3'] | 3.1 |
6EAA | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6I) AND CATALYTIC ZINC ION | 3.4.11 |
6EAB | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6J) AND CATALYTIC ZINC ION | 3.4.11 |
6EAT | CRYSTALLOGRAPHIC STRUCTURE OF THE CYCLIC NONAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 21 21 21. | 3.4.21.4 |
6EAU | CRYSTALLOGRAPHIC STRUCTURE OF THE OCTAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 21 21 21. | 3.4.21.4 |
6EAV | CRYSTALLOGRAPHIC STRUCTURE OF THE CYCLIC HEPTAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 4(1) 2(1) 2 | 3.4.21.4 |
6EAW | CRYSTALLOGRAPHIC STRUCTURE OF THE CYCLIC HEPTAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 21 21 21 | 3.4.21.4 |
6EAX | CRYSTALLOGRAPHIC STRUCTURE OF THE CYCLIC HEXAPEPTIDE DERIVED FROM THE BTCI INHIBITOR BOUND TO BETA-TRYPSIN IN SPACE GROUP P 21 21 21 | 3.4.21.4 |
6EC6 | RUMINOCOCCUS GNAVUS BETA-GLUCURONIDASE | 3.2.1.23 |
6ECA | LACTOBACILLUS RHAMNOSUS BETA-GLUCURONIDASE | 3.2.1.23 |
6ECB | VLM2 THIOESTERASE DOMAIN WILD TYPE STRUCTURE 1 | 3.1.2 |
6ECC | VLM2 THIOESTERASE DOMAIN WILD TYPE STRUCTURE 2 | 3.1.2 |
6ECD | VLM2 THIOESTERASE DOMAIN WITH GENETICALLY ENCODED 2,3-DIAMINOPROPIONIC ACID BOUND WITH A TETRADEPSIPEPTIDE | 3.1.2 |
6ECE | VLM2 THIOESTERASE DOMAIN WITH GENETICALLY ENCODED 2,3-DIAMINOPROPIONIC ACID BOUND WITH A DODECADEPSIPEPTIDE, SPACE GROUP H3 | 3.1.2 |
6ECF | VLM2 THIOESTERASE DOMAIN WITH GENETICALLY ENCODED 2,3-DIAMINOPROPIONIC ACID BOUND WITH A DODECADEPSIPEPTIDE, SPACE GROUP P1 | 3.1.2 |
6ECL | CRYSTAL STRUCTURE OF A 1,2,4-TRIAZOLE ALLOSTERIC RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE | 3.1.13.2 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 2.7.7 3.1 |
6ECP | THE HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP AND INHIBITOR LY249543 | 1.5.1.5 3.5.4.9 6.3.4.3 |
6ECQ | THE HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP AND INHIBITOR LY345899 | 1.5.1.5 3.5.4.9 6.3.4.3 |
6ECR | THE HUMAN METHYLENETETRAHYDROFOLATE DEHYDROGENASE/CYCLOHYDROLASE (FOLD) COMPLEXED WITH NADP | 1.5.1.5 3.5.4.9 6.3.4.3 |
6ED2 | FAECALIBACTERIUM PRAUSNITZII BETA-GLUCURONIDASE | 3.2.1.23 |
6EDM | STRUCTURE OF APO-CDD-1 BETA-LACTAMASE | 3.5.2.6 |
6EDR | CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH 4'-THIORIBOSE NAD+ | 3.2.2.6 2.4.99.20 |
6EE3 | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6K) AND CATALYTIC ZINC ION | 3.4.11 |
6EE4 | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6M) AND CATALYTIC ZINC ION | 3.4.11 |
6EE6 | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6O) AND CATALYTIC ZINC ION | 3.4.11 |
6EED | X-RAY CRYSTAL STRUCTURE OF PF-M1 IN COMPLEX WITH INHIBITOR (6P) AND CATALYTIC ZINC ION | 3.4.11 |
6EEG | CRYSTAL STRUCTURE OF STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS T62E AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6EEK | CRYSTAL STRUCTURE OF APO STAPHYLCOCCAL NUCLEASE VARIANT DELTA+PHS T62E/V66K, PH 7 AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6EF0 | YEAST 26S PROTEASOME BOUND TO UBIQUITINATED SUBSTRATE (1D* MOTOR STATE) | 3.4.25.1 |
6EF1 | YEAST 26S PROTEASOME BOUND TO UBIQUITINATED SUBSTRATE (5D MOTOR STATE) | 3.4.25.1 |
6EF2 | YEAST 26S PROTEASOME BOUND TO UBIQUITINATED SUBSTRATE (5T MOTOR STATE) | 3.4.25.1 |
6EF3 | YEAST 26S PROTEASOME BOUND TO UBIQUITINATED SUBSTRATE (4D MOTOR STATE) | 3.4.25.1 |
6EFJ | CRYSTAL STRUCTURE OF NDM-1 WITH COMPOUND 9 | 3.5.2.6 |
6EFU | CRYSTAL STRUCTURE OF THE DOUBLE MUTANT L167W / P172L OF THE BETA-GLUCOSIDASE FROM TRICHODERMA HARZIANUM | 3.2.1.21 |
6EG2 | CRYSTAL STRUCTURE OF HUMAN BRM IN COMPLEX WITH COMPOUND 16 | 3.6.4 |
6EG3 | CRYSTAL STRUCTURE OF HUMAN BRM IN COMPLEX WITH COMPOUND 15 | 3.6.4 |
6EHH | CRYSTAL STRUCTURE OF MOUSE MTH1 MUTANT L116M WITH INHIBITOR TH588 | 3.6.1.55 3.6.1.56 |
6EHN | STRUCTURAL INSIGHT INTO A PROMISCUOUS CE15 ESTERASE FROM THE MARINE BACTERIAL METAGENOME | 3.1.1 |
6EI1 | CRYSTAL STRUCTURE OF THE COVALENT COMPLEX BETWEEN DEUBIQUITINASE ZUFSP (ZUP1) AND UBIQUITIN-PA | 3.4.19.12 |
6EIC | CRYSTAL STRUKTURE OF RV0183, A MONOGLYCERIDE LIPASE FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.1.23 |
6EIT | COXSACKIEVIRUS A24V IN COMPLEX WITH THE D1-D2 FRAGMENT OF ICAM-1 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6EJ2 | BACE1 COMPOUND 28 | 3.4.23.46 |
6EJ3 | BACE1 COMPOUND 23 | 3.4.23.46 |
6EJ5 | A CONSERVED STRUCTURAL ELEMENT IN THE RNA HELICASE UPF1 REGULATES ITS CATALYTIC ACTIVITY IN AN ISOFORM-SPECIFIC MANNER | 3.6.4 |
6EK1 | CRYSTAL STRUCTURE OF TYPE IIP RESTRICTION ENDONUCLEASE PFOI | 3.1.21.4 |
6EKN | CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE7. | 3.4.24.65 |
6EKO | CRYSTAL STRUCTURE OF TYPE IIP RESTRICTION ENDONUCLEASE PFOI WITH COGNATE DNA | 3.1.21.4 |
6EKR | CRYSTAL STRUCTURE OF TYPE IIP RESTRICTION ENDONUCLEASE KPN2I | 3.1.21.4 |
6EKS | VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH OSELTAMIVIR CARBOXYLATE | 3.2.1.18 |
6EKU | VIBRIO CHOLERAE NEURAMINIDASE COMPLEXED WITH ZANAMIVIR | 3.2.1.18 |
6ELA | CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH INHIBITOR BE4. | 3.4.24.65 |
6ELI | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6ELX | ORYZA SATIVA DWARF14 | 3.1 |
6ELY | CRYSTAL STRUCTURE OF MISTLETOE LECTIN I (ML-I) FROM VISCUM ALBUM IN COMPLEX WITH 4-N-FURFURYLCYTOSINE AT 2.84 A RESOLUTION | 3.2.2.22 |
6EMI | CRYSTAL STRUCTURE OF A VARIANT OF HUMAN BUTYRYLCHOLINESTERASE EXPRESSED IN BACTERIA. | 3.1.1.8 |
6EN3 | CRYSTAL STRUCTURE OF FULL LENGTH ENDOS FROM STREPTOCOCCUS PYOGENES IN COMPLEX WITH G2 OLIGOSACCHARIDE. | 3.4.22 6.3.2 |
6EN5 | CRYSTAL STRUCTURE A OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH A DIPROLYL INHIBITOR. | 3.2.1 3.4.15.1 |
6ENB | LTA4 HYDROLASE (E297Q) MUTANT IN COMPLEX WITH PRO-GLY-PRO PEPTIDE | 3.3.2.6 3.4.11.4 |
6ENC | LTA4 HYDROLASE IN COMPLEX WITH COMPOUND11 | 3.3.2.6 3.4.11.4 |
6END | LTA4 HYDROLASE IN COMPLEX WITH COMPOUND15 | 3.3.2.6 3.4.11.4 |
6ENM | CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH HYDROXAMATE INHIBITOR LP168. | 3.4.24.65 |
6ENP | ATOMIC RESOLUTION STRUCTURE OF HUMAN RNASE 6 IN THE PRESENCE OF PHOSPHATE ANIONS IN P21 SPACE GROUP. | 3.1.27 |
6ENX | ZEBRAFISH SIRT5 IN COMPLEX WITH STALLED BICYCLIC INTERMEDIATE OF INHIBITORY COMPOUND 10 | 3.5.1 2.3.1 |
6EO0 | ZEBRAFISH SIRT5 IN COMPLEX WITH STALLED PEPTIDYLIMIDATE AND BICYCLIC INTERMEDIATE OF INHIBITORY COMPOUND 29 | 3.5.1 2.3.1 |
6EO8 | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVEL GLUCOSE-CONJUGATED POTENT INHIBITOR | 3.4.21.5 |
6EO9 | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVEL GLUCOSE-CONJUGATED POTENT INHIBITOR | 3.4.21.5 |
6EOB | CRYSTAL STRUCTURE OF AMPYLATED GRP78 IN APO FORM (CRYSTAL FORM 1) | 3.6.4.10 |
6EOC | CRYSTAL STRUCTURE OF AMPYLATED GRP78 IN APO FORM (CRYSTAL FORM 2) | 3.6.4.10 |
6EOE | CRYSTAL STRUCTURE OF AMPYLATED GRP78 WITH NUCLEOTIDE | 3.6.4.10 |
6EOF | CRYSTAL STRUCTURE OF AMPYLATED GRP78 IN ADP STATE | 3.6.4.10 |
6EOK | CRYSTAL STRUCTURE OF E. COLI L-ASPARAGINASE II | 3.5.1.1 |
6EOO | DPP8 - APO, SPACE GROUP 20 | 3.4.14.5 |
6EOX | CRYSTAL STRUCTURE OF MMP12 IN COMPLEX WITH CARBOXYLIC INHIBITOR LP165. | 3.4.24.65 |
6EP4 | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH DECAMETHONIUM | 3.1.1.8 |
6EPB | STRUCTURE OF CHITINASE 42 FROM TRICHODERMA HARZIANUM | 3.2.1.14 |
6EPJ | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 6 | 3.6.1.3 3.6.1 |
6EPK | CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6EPL | RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) | 3.6.5.2 |
6EPM | RAS GUANINE NUCLEOTIDE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT F1 | 3.6.5.2 |
6EPN | RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT F2 | 3.6.5.2 |
6EPO | RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT F3 | 3.6.5.2 |
6EPP | RAS GUANINE EXCHANGE FACTOR SOS1 (REM-CDC25) IN COMPLEX WITH KRAS(G12C) AND FRAGMENT SCREENING HIT F4 | 3.6.5.2 |
6EPR | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND UZH-DS15 | 3.6.1.3 3.6.1 |
6EPS | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND UZH-DQ41 | 3.6.1.3 3.6.1 |
6EPT | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 12 | 3.6.1.3 3.6.1 |
6EPU | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 2 | 3.6.1.3 3.6.1 |
6EPV | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 5 | 3.6.1.3 3.6.1 |
6EPW | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND UZH-DU32 | 3.6.1.3 3.6.1 |
6EPX | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 3 | 3.6.1.3 3.6.1 |
6EQ2 | MTH1 IN COMPLEX WITH FRAGMENT 6 | 3.6.1.55 3.6.1.56 |
6EQ3 | MTH1 IN COMPLEX WITH FRAGMENT 9 | 3.6.1.55 3.6.1.56 |
6EQ4 | MTH1 IN COMPLEX WITH FRAGMENT 8 | 3.6.1.55 3.6.1.56 |
6EQ5 | MTH1 IN COMPLEX WITH FRAGMENT 4 | 3.6.1.55 3.6.1.56 |
6EQ6 | MTH1 IN COMPLEX WITH FRAGMENT 1 | 3.6.1.55 3.6.1.56 |
6EQ7 | MTH1 IN COMPLEX WITH FRAGMENT 11 | 3.6.1.55 3.6.1.56 |
6EQD | CRYSTAL STRUCTURE OF A POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM IDEONELLA SAKAIENSIS COLLECTED AT LONG WAVELENGTH | 3.1.1.101 |
6EQE | HIGH RESOLUTION CRYSTAL STRUCTURE OF A POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6EQF | CRYSTAL STRUCTURE OF A POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM IDEONELLA SAKAIENSIS IN SPACEGROUP P212121 | 3.1.1.101 |
6EQH | CRYSTAL STRUCTURE OF A POLYETHYLENE TEREPHTHALATE DEGRADING HYDROLASE FROM IDEONELLA SAKAIENSIS IN SPACEGROUP C2221 | 3.1.1.101 |
6EQM | CRYSTAL STRUCTURE OF HUMAN BACE-1 IN COMPLEX WITH CNP520 | 3.4.23.46 |
6EQP | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ETHOPROPAZINE | 3.1.1.8 |
6EQQ | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH HUPRINE 19 | 3.1.1.8 |
6EQS | HUMAN SIRT5 IN COMPLEX WITH STALLED PEPTIDYLIMIDATE INTERMEDIATE OF INHIBITORY COMPOUND 29 | 3.5.1 2.3.1 |
6EQV | X-RAY STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN BOUND WITH THE COMPETITIVE INHIBITOR PHAC-CIT-VAL-ARG-AMBA | 3.4.21.75 |
6EQW | X-RAY STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN BOUND WITH THE COMPETITIVE INHIBITOR 4-AMINOMETHYL-PHENYLACETYL-ARG-VAL-ARG-AMBA | 3.4.21.75 |
6EQX | X-RAY STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN BOUND WITH THE COMPETITIVE INHIBITOR ARG-ARG-ARG-VAL-ARG-AMBA | 3.4.21.75 |
6ERF | COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA | 3.6.4 4.2.99 |
6ERG | COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA | 3.6.4 4.2.99 |
6ERH | COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA | 3.6.4 4.2.99 |
6ES1 | CRYSTAL STRUCTURE OF THE BINDING DOMAIN FROM BOTULINUM NEUROTOXIN A2 BOUND TO EXTRACELLULAR DOMAIN OF HUMAN RECEPTOR SV2C | 3.4.24.69 |
6ES8 | HIV CAPSID HEXAMER WITH IP6 LIGAND | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6ESJ | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH PROPIDIUM | 3.1.1.8 |
6ESL | CRYSTAL STRUCTURE OF THE LEGIONELLA PNEUMOPPILA LAPA | 3.4.11.10 |
6ESM | CRYSTAL STRUCTURE OF MMP9 IN COMPLEX WITH INHIBITOR BE4. | 3.4.24.35 |
6EST | INTERACTION OF THE PEPTIDE CF3-LEU-ALA-NH-C6H4-CF3(TFLA) WITH PORCINE PANCREATIC ELASTASE. X-RAY STUDIES AT 1.8 ANGSTROMS | 3.4.21.36 |
6ESY | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THIOFLAVINE T | 3.1.1.8 |
6ET6 | CRYSTAL STRUCTURE OF MURAMIDASE FROM ACINETOBACTER BAUMANNII AB 5075UW PROPHAGE | 3.2.1.17 |
6ETJ | HUMAN PFKFB3 IN COMPLEX WITH KAN0438241 | 2.7.1.105 3.1.3.46 |
6ETK | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 1) | 3.1.27.5 4.6.1.18 |
6ETL | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 2) | 3.1.27.5 4.6.1.18 |
6ETM | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 3) | 3.1.27.5 4.6.1.18 |
6ETN | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 4) | 3.1.27.5 4.6.1.18 |
6ETO | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 5) | 3.1.27.5 4.6.1.18 |
6ETP | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 6) | 3.1.27.5 4.6.1.18 |
6ETQ | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 7) | 3.1.27.5 4.6.1.18 |
6ETR | ATOMIC RESOLUTION STRUCTURE OF RNASE A (DATA COLLECTION 8) | 3.1.27.5 4.6.1.18 |
6ETY | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU3371 | 3.4.17.21 |
6ETZ | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB | 3.2.1.23 |
6EUC | REACTIVATING OXIME BOUND TO TC ACHE'S CATALYTIC GORGE. | 3.1.1.7 |
6EUD | CRYSTAL STRUCTURE OF E. COLI DEXH-BOX NTPASE HRPB | 3.6.4.13 |
6EUE | RIVASTIGMINE ANALOGUE BOUND TO TC ACHE. | 3.1.1.7 |
6EUG | THE GH43, BETA 1,3 GALACTOSIDASE, BT3683 WITH GALACTOIMIDAZOLE | 3.2.1.73 |
6EUL | BUTYRYLCOLINESTERASE EXPRESSED IN CHO CELLS CO-CRYSTALLISED WITH A RIVASTIGMINE ANALOGUE | 3.1.1.8 |
6EUM | CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH DZ-307 | 3.5.2.6 |
6EW9 | CRYSTAL STRUCTURE OF DEGS STRESS SENSOR PROTEASE IN COMPLEX WITH ACTIVATING DNRLGLVYQF PEPTIDE | 3.4.21.107 |
6EWE | CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH DZ-308 | 3.5.2.6 |
6EWK | T. CALIFORNICA ACHE IN COMPLEX WITH A 3-HYDROXY-2-PYRIDINE ALDOXIME. | 3.1.1.7 |
6EWY | RIPA PEPTIDOGLYCAN HYDROLASE (RV1477, MYCOBACTERIUM TUBERCULOSIS) N-TERMINAL DOMAIN | 3.4 |
6EX7 | CRYSTAL STRUCTURE OF NDM-1 METALLO-BETA-LACTAMASE IN COMPLEX WITH CD IONS AND A HYDROLYZED BETA-LACTAM LIGAND - NEW REFINEMENT | 3.5.2.6 |
6EX9 | CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE DOMAIN WITH INHIBITOR PEPTIDE | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6EXI | NAD-FREE CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM BRADYRHIZOBIUM ELKANII COMPLEXED WITH ADENOSINE | 3.3.1.1 |
6EY7 | HUMAN CYTOMEGALOVIRUS TERMINASE NUCLEASE DOMAIN, MN SOAKED, INHIBITOR BOUND | 3.1 |
6EYC | RE-REFINEMENT OF THE MCM2-7 DOUBLE HEXAMER USING ISOLDE | 3.6.4.12 |
6EYF | BUTYRYLCOLINESTERASE EXPRESSED IN CHO CELLS CO-CRYSTALLISED WITH A RIVASTIGMINE ANALOGUE | 3.1.1.8 |
6EZ2 | HUMAN BUTYRYLCHOLINESTERASE CARBAMYLATED. | 3.1.1.8 |
6EZ9 | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU3372 | 3.4.17.21 |
6EZF | PDE2 IN COMPLEX WITH MOLECULE 5 | 3.1.4.17 |
6EZG | TORPEDO CALIFORNICA ACHE IN COMPLEX WITH INDOLIC MULTI-TARGET DIRECTED LIGAND | 3.1.1.7 |
6EZH | TORPEDO CALIFORNICA ACHE IN COMPLEX WITH INDOLIC MULTI-TARGET DIRECTED LIGAND | 3.1.1.7 |
6EZP | CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-CHLORO-N-(1-CYANOCYCLOPROPYL)-5-OXO-12,17-DIOXA-4-AZATRICYCLO[16.2.2.06,11]DOCOSA-1(21),6(11),7,9,14,18(22),19-HEPTAENE-3-CARBOXAMIDE | 3.4.22.15 |
6EZR | CRYSTAL STRUCTURE OF GH20 EXO BETA-N-ACETYLGLUCOSAMINIDASE FROM VIBRIO HARVEYI | 3.2.1.52 |
6EZS | CRYSTAL STRUCTURE OF GH20 EXO BETA-N-ACETYLGLUCOSAMINIDASE FROM VIBRIO HARVEYI IN COMPLEX WITH N-ACETYLGLUCOSAMINE | 3.2.1.52 |
6EZT | CRYSTAL STRUCTURE OF GH20 EXO BETA-N-ACETYLGLUCOSAMINIDASE D437A INACTIVE MUTANT FROM VIBRIO HARVEYI | 3.2.1.52 |
6EZU | SCHISTOSOMA MANSONI PHOSPHODIESTERASE 4A | 3.1.4 |
6EZX | CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-CHLORO-N-(1-CYANOCYCLOPROPYL)-5-OXO-17-OXA-4-AZATRICYCLO[16.2.2.06,11]DOCOSA-1(21),6,8,10,14,18(22),19-HEPTAENE-3-CARBOXAMIDE | 3.4.22.15 |
6F06 | CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(AZETIDIN-3-YL)-19-CHLORO-N-(1-CYANOCYCLOPROPYL)-5-OXO-12,17-DIOXA-4-AZATRICYCLO[16.2.2.06,11]DOCOSA-1(21),6,8,10,14,18(22),19-HEPTAENE-3-CARBOXAMIDE | 3.4.22.15 |
6F09 | BINARY COMPLEX OF 14-3-3 ZETA WITH UBIQUITIN SPECIFIC PROTEASE 8 (USP8) PSER718 PEPTIDE | 3.4.19.12 |
6F0L | S. CEREVISIAE MCM DOUBLE HEXAMER BOUND TO DUPLEX DNA | 3.6.4.12 |
6F0O | BOTULINUM NEUROTOXIN A3 HC DOMAIN | 3.4.24.69 |
6F1C | C1RC1S COMPLEX | 3.4.21.41 |
6F1D | CUB2 DOMAIN OF C1R | 3.4.21.41 |
6F1G | THE STRUCTURE OF ABNB-E201A, AN INTRACELLULAR 1,5-ALPHA-L-ARABINANASE FROM GEOBACILLUS STEAROTHERMOPHILUS, IN COMPLEX WITH ARABINOPENTAOSE | 3.2.1.99 |
6F1H | C1RC1S COMPLEX | 3.4.21.41 |
6F1J | STRUCTURE OF A TALAROMYCES PINOPHILUS GH62 ARABINOFURANOSIDASE IN COMPLEX WITH ARADNJ AT 1.25A RESOLUTION | 3.2.1.55 |
6F1L | LYSOZYME CRYSTALLIZED IN PRESENCE OF 100 MM SODIUM PHOSPHATE AT PH 4.5 | 3.2.1.17 |
6F1M | LYSOZYME CRYSTALLIZED IN PRESENCE OF 100 MM SODIUM PHOSPHATE AT PH 4.5: LOW-HUMIDITY FORM | 3.2.1.17 |
6F1O | ORTHORHOMBIC LYSOZYME CRYSTALLIZED AT 298 K AND PH 4.5 | 3.2.1.17 |
6F1P | TETRAGONAL LYSOZYME CRYSTALLIZED AT 298 K AND PH 4.5 WITH PHOSPHATE BOUND | 3.2.1.17 |
6F1R | TETRAGONAL LYSOZYME CRYSTALLIZED AT 298 K AND PH 4.5 WITH PHOSPHATE BOUND: CONTROL EXPERIMENT | 3.2.1.17 |
6F1X | COMPLEX BETWEEN MTH1 AND COMPOUND 7 (A 7-AZAINDOLE-2-AMIDE DERIVATIVE) | 3.6.1.55 3.6.1.56 |
6F20 | COMPLEX BETWEEN MTH1 AND COMPOUND 1 (A 7-AZAINDOLE-4-ESTER DERIVATIVE) | 3.6.1.55 3.6.1.56 |
6F22 | COMPLEX BETWEEN MTH1 AND COMPOUND 29 (A 4-AMINO-2,7-DIAZAINDOLE DERIVATIVE) | 3.6.1.55 3.6.1.56 |
6F23 | COMPLEX BETWEEN MTH1 AND COMPOUND 16 (A 4-AMINO-7-AZAINDOLE DERIVATIVE) | 3.6.1.55 3.6.1.56 |
6F25 | CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH C35. | 3.1.1.7 |
6F2F | CRYSTAL STRUCTURE OF PROTEASE 1 FROM PYROCOCCUS HORIKOSHII CO-CYSTALLIZED IN PRESENCE OF 10 MM TB-XO4 AND AMMONIUM SULFATE. | 3.5.1.124 3.4.22 |
6F2H | STRUCTURE OF PROTEASE 1 FROM PYROCOCCUS HORIKOSHII CO-CRYSTALLIZED IN PRESENCE OF 10 MM TB-XO4 AND POTASSIUM IODIDE. | 3.5.1.124 3.4.22 |
6F2I | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME CO-CRYSTALLIZED IN PRESENCE OF 100 MM TB-XO4 | 3.2.1.17 |
6F2J | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME CO-CRYSTALLIZED IN PRESENCE OF 100 MM TB-XO4 AND 100 MM SODIUM SULFATE | 3.2.1.17 |
6F2K | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME CO-CRYSTALLIZED IN PRESENCE OF 100 MM TB-XO4 AND 100 MM POTASSIUM PHOSPHATE MONOBASIC. | 3.2.1.17 |
6F2N | CRYSTAL STRUCTURE OF BCII METALLO-BETA-LACTAMASE IN COMPLEX WITH KDU197 | 3.5.2.6 |
6F2T | CRYSTAL STRUCTURE OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) | 3.1.4.1 3.6.1.9 |
6F2V | CRYSTAL STRUCTURE OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) IN COMPLEX WITH AMP | 3.1.4.1 3.6.1.9 |
6F2Y | CRYSTAL STRUCTURE OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) IN COMPLEX WITH AP4A | 3.1.4.1 3.6.1.9 |
6F30 | CRYSTAL STRUCTURE OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) IN COMPLEX WITH UDPGLCNAC | 3.1.4.1 3.6.1.9 |
6F33 | CRYSTAL STRUCTURE OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) IN COMPLEX WITH AMPNPP | 3.1.4.1 3.6.1.9 |
6F39 | C1R HOMODIMER CUB1-EGF-CUB2 | 3.4.21.41 |
6F3K | COMBINED SOLID-STATE NMR, SOLUTION-STATE NMR AND EM DATA FOR STRUCTURE DETERMINATION OF THE TETRAHEDRAL AMINOPEPTIDASE TET2 FROM P. HORIKOSHII | 3.4.11 |
6F3M | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH ADENOSINE, K+ AND ZN2+ CATIONS | 3.3.1.1 |
6F3N | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM PSEUDOMONAS AERUGINOSA COCRYSTALLIZED WITH SAH IN THE PRESENCE OF K+ AND ZN2+ CATIONS | 3.3.1.1 |
6F3O | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH ADENINE, K+ AND ZN2+ CATIONS | 3.3.1.1 |
6F3P | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH 3'-DEOXYADENOSINE AND K+ CATION | 3.3.1.1 |
6F3Q | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ADENINE AND RB+ CATION | 3.3.1.1 |
6F4C | NICOTIANA BENTHAMIANA ALPHA-GALACTOSIDASE | 3.2.1.22 |
6F4M | HUMAN JMJD5 IN ITS APO FORM. | 1.14.11.47 1.14.11 3.4 |
6F4N | HUMAN JMJD5 IN COMPLEX WITH MN AND 2OG. | 1.14.11.47 1.14.11 3.4 |
6F4O | HUMAN JMJD5 IN COMPLEX WITH MN(II) AND SUCCINATE. | 1.14.11.47 1.14.11 3.4 |
6F4P | HUMAN JMJD5 IN COMPLEX WITH MN, NOG AND RPS6 (129-144) (COMPLEX-1) | 1.14.11.47 1.14.11 3.4 |
6F4Q | HUMAN JMJD5 (Q275C) IN COMPLEX WITH MN(II), NOG AND RPS6-A138C (129-144) (COMPLEX-2) | 1.14.11.47 1.14.11 3.4 |
6F4R | HUMAN JMJD5 (N308C) IN COMPLEX WITH MN(II), NOG AND RCCD1 (139-143) (COMPLEX-3) | 1.14.11.47 1.14.11 3.4 |
6F4S | HUMAN JMJD5 (N308C) IN COMPLEX WITH MN(II), 2OG AND RCCD1 (139-143) (COMPLEX-4) | 1.14.11.47 1.14.11 3.4 |
6F4T | HUMAN JMJD5 (W414C) IN COMPLEX WITH MN(II), NOG AND RCCD1 (139-143) (COMPLEX-5) | 1.14.11.47 1.14.11 3.4 |
6F5G | COMPLETE PCSK9 C-TER DOMAIN IN COMPLEX WITH VHH P.140 | 3.4.21 |
6F5H | CRYSTAL STRUCTURE OF USP7 IN COMPLEX WITH A 4-HYDROXYPIPERIDINE BASED INHIBITOR | 3.4.19.12 |
6F5L | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR JHU2379 | 3.4.17.21 |
6F5M | CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED HUMAN LEUKOCYTE ELASTASE IN COMPLEX WITH A THIAZOLIDINEDIONE INHIBITOR | 3.4.21.37 |
6F5O | A MECHANISM FOR THE ACTIVATION OF THE INFLUENZA VIRUS TRANSCRIPTASE | 3.1 |
6F60 | THE X-RAY STRUCTURE OF BOVINE PANCREATIC RIBONUCLEASE IN COMPLEX WITH A FIVE-COORDINATE PLATINUM(II) COMPOUND CONTAINING A SUGAR LIGAND | 3.1.27.5 4.6.1.18 |
6F6Q | CARBOXYPEPTIDASE T MUTANT L254N WITH SULPHAMOIL ARGININE | 3.4.17.18 |
6F6R | CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH N-{3-[1-((S)-2-HYDROXY-5-OXO-TETRAHYDRO-FURAN-3-YLCARBAMOYL)-ETHYL]-1-METHYL-2,4-DIOXO-1,2,3,4-TETRAHYDRO-PYRIMIDIN-5-YL}-4-(QUINOXALIN-2-YLAMINO)-BENZAMIDE | 3.4.22.36 |
6F6U | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-7B | 3.1.4.53 |
6F75 | CARBOXYPEPTIDASE T MUTANT L254N WITH SULPHAMOIL LEUCINE | 3.4.17.18 |
6F76 | ANTIBODY DERIVED (ABD-8) SMALL MOLECULE BINDING TO KRAS. | 3.6.5.2 |
6F79 | CARBOXYPEPTIDASE T MUTANT L211Q WITH SULPHAMOIL ARGININE | 3.4.17.18 |
6F7I | HUMAN MALT1(329-728) IN COMPLEX WITH MLT-747 | 3.4.22 |
6F7Q | HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES | 3.1.1.8 |
6F8B | LASB BOUND TO THIOL BASED INHIBITOR | 3.4.24.26 |
6F8R | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-54 | 3.1.4.53 |
6F8T | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-4A | 3.1.4.53 |
6F8U | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-20B | 3.1.4.53 |
6F8V | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-18B | 3.1.4.53 |
6F8W | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-18A | 3.1.4.53 |
6F8X | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-26G | 3.1.4.53 |
6F9H | CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 4-S-ALPHA-D-GLUCOPYRANOSYL-(1,4-DIDEOXY-4-THIO-NOJIRIMYCIN) | 3.2.1.2 |
6F9J | CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 4-O-ALPHA-D-MANNOPYRANOSYL-(1-DEOXYNOJIRIMYCIN) | 3.2.1.2 |
6F9L | CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 3-DEOXY-3-FLUORO-MALTOSE | 3.2.1.2 |
6F9O | CRYSTAL STRUCTURE OF COLD-ADAPTED HALOALKANE DEHALOGENASE DPCA FROM PSYCHROBACTER CRYOHALOLENTIS K5 | 3.8.1.5 |
6F9R | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT-ASP. | 3.2.1 3.4.15.1 |
6F9S | CRYSTAL STRUCTURE OF THE C-TERMINAL RECA DOMAIN OF DDX6 IN COMPLEX WITH A CONSERVED PEPTIDE FROM LSM14 | 3.6.4.13 |
6F9T | CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT. | 3.2.1 3.4.15.1 |
6F9U | CRYSTAL STRUCTURE OF HUMAN TESTIS ANGIOTENSIN-1 CONVERTING ENZYME IN COMPLEX WITH SAMPATRILAT-ASP. | 3.2.1 3.4.15.1 |
6F9V | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SAMPATRILAT. | 3.2.1 3.4.15.1 |
6F9X | LYSOZYME CRYSTALLIZED IN PRESENCE OF 100 MM LITHIUM SULPHATE AT PH 4.5 | 3.2.1.17 |
6F9Y | LYSOZYME CRYSTALLIZED IN PRESENCE OF 10 MM LITHIUM SULPHATE AT PH 4.5 | 3.2.1.17 |
6F9Z | LYSOZYME CRYSTALLIZED IN PRESENCE OF 5 MM AMMONIUM SULPHATE AT PH 4.5 | 3.2.1.17 |
6FA0 | LYSOZYME CRYSTALLIZED IN PRESENCE OF 100 MM AMMONIUM SULPHATE AT PH 4.5 | 3.2.1.17 |
6FA1 | ANTIBODY DERIVED (ABD-4) SMALL MOLECULE BINDING TO KRAS. | 3.6.5.2 |
6FA2 | ANTIBODY DERIVED (ABD-5) SMALL MOLECULE BINDING TO KRAS. | 3.6.5.2 |
6FA3 | ANTIBODY DERIVED (ABD-6) SMALL MOLECULE BINDING TO KRAS. | 3.6.5.2 |
6FA4 | ANTIBODY DERIVED (ABD-7) SMALL MOLECULE BINDING TO KRAS. | 3.6.5.2 |
6FAO | DISCOVERY AND CHARACTERIZATION OF A THERMOSTABLE GH6 ENDOGLUCANASE FROM A COMPOST METAGENOME | 3.2.1.4 |
6FAT | THE CRYSTAL STRUCTURE OF A FERULOYL ESTERASE C FROM FUSARIUM OXYSPORUM. | 3.1.1 |
6FB0 | CRYSTAL STRUCTURE OF A TAILORED I-CREI HOMING ENDONUCLEASE PROTEIN (3115 VARIANT) IN COMPLEX WITH ITS TARGET DNA (HAEMOGLOBIN BETA SUBUNIT GENE) IN THE PRESENCE OF CALCIUM | 3.1 |
6FB1 | CRYSTAL STRUCTURE OF A TAILORED I-CREI HOMING ENDONUCLEASE PROTEIN (3115 VARIANT) IN COMPLEX WITH ITS TARGET DNA (HAEMOGLOBIN BETA SUBUNIT GENE) IN THE PRESENCE OF MAGNESIUM | 3.1 |
6FB2 | CRYSTAL STRUCTURE OF A TAILORED I-CREI HOMING ENDONUCLEASE PROTEIN (3115 VARIANT) IN COMPLEX WITH ITS TARGET DNA (HAEMOGLOBIN BETA SUBUNIT GENE) IN THE PRESENCE OF MANGANESE | 3.1 |
6FB5 | CRYSTAL STRUCTURE OF A TAILORED I-CREI HOMING ENDONUCLEASE PROTEIN (3115 VARIANT) IN COMPLEX WITH AN ALTERED VERSION OF ITS TARGET DNA (HAEMOGLOBIN BETA SUBUNIT GENE) AT 5NNN REGION IN THE PRESENCE OF MAGNESIUM | 3.1 |
6FB6 | CRYSTAL STRUCTURE OF A TAILORED I-CREI HOMING ENDONUCLEASE PROTEIN (3115 VARIANT) IN COMPLEX WITH AN ALTERED VERSION OF ITS TARGET DNA (HAEMOGLOBIN BETA SUBUNIT GENE) AT 5NNN REGION IN THE PRESENCE OF MANGANESE | 3.1 |
6FB7 | CRYSTAL STRUCTURE OF THE I-CREI HOMING ENDONUCLEASE D75N VARIANT IN COMPLEX WITH ITS TARGET DNA IN THE PRESENCE OF MANGANESE | 3.1 |
6FB8 | CRYSTAL STRUCTURE OF THE I-CREI HOMING ENDONUCLEASE D75N VARIANT IN COMPLEX WITH AN ALTERED VERSION OF ITS TARGET DNA AT 5NNN REGION IN THE PRESENCE OF MAGNESIUM | 3.1 |
6FB9 | CRYSTAL STRUCTURE OF THE I-CREI HOMING ENDONUCLEASE D75N VARIANT IN COMPLEX WITH AN ALTERED VERSION OF ITS TARGET DNA AT 5NNN REGION IN THE PRESENCE OF MANGANESE | 3.1 |
6FBU | CRYSTAL STRUCTURE OF THE DNA REPAIR ENZYME ENDONUCLEASE-VIII (NEI) FROM E. COLI (E2Q) IN COMPLEX WITH AP-SITE CONTAINING DNA SUBSTRATE | 3.2.2 4.2.99.18 |
6FDC | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN IN COMPLEX WITH GEBR-32A | 3.1.4.53 |
6FDG | NOVEL CRYSTAL STRUCTURE OF DHNA-COA THIOESTERASE FROM STAPHYLOCOCCUS AUREUS | 3.1.2 |
6FDI | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-226 | 3.1.4.53 |
6FDK | STRUCTURE OF CHLAMYDIA TRACHOMATIS EFFECTOR PROTEIN CDU1 BOUND TO UBIQUITIN | 3.4.22 |
6FDQ | STRUCTURE OF CHLAMYDIA TRACHOMATIS EFFECTOR PROTEIN CDU1 BOUND TO COMPOUND 5 | 3.4.22 |
6FDS | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-226 | 3.1.4 |
6FDU | STRUCTURE OF CHLAMYDIA TRACHOMATIS EFFECTOR PROTEIN CDU1 BOUND TO COMPOUND 3 | 3.4.22 |
6FDW | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-356 | 3.1.4 |
6FDX | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1086 | 3.1.4 |
6FE3 | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1439 | 3.1.4 |
6FE5 | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR JHU 2249 | 3.4.17.21 |
6FE7 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-356 | 3.1.4.53 |
6FEB | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-1086 | 3.1.4.53 |
6FET | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-1439 | 3.1.4.53 |
6FEV | PHOSPHOTRIESTERASE PTE_A53_4 | 3.1.8.1 |
6FFA | FMDV LEADER PROTEASE BOUND TO SUBSTRATE ISG15 | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
6FFH | CRYSTAL STRUCTURE OF MGLUR5 IN COMPLEX WITH FENOBAM AT 2.65 A | 3.2.1.17 |
6FFI | CRYSTAL STRUCTURE OF MGLUR5 IN COMPLEX WITH MMPEP AT 2.2 A | 3.2.1.17 |
6FFN | STRUCTURE-BASED DESIGN AND SYNTHESIS OF MACROCYCLIC HUMAN RHINOVIRUS 3C PROTEASE INHIBITORS | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6FFS | STRUCTURE-BASED DESIGN AND SYNTHESIS OF MACROCYCLIC HUMAN RHINOVIRUS 3C PROTEASE INHIBITORS | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6FFW | PHOSPHOTRIESTERASE PTE_A53_5 | 3.1.8.1 |
6FG5 | SCHISTOSOMA MANSONI PHOSPHODIESTERASE 4A | 3.1.4 |
6FGE | CRYSTAL STRUCTURE OF HUMAN ZUFSP/ZUP1 IN COMPLEX WITH UBIQUITIN | 3.4.19.12 |
6FGY | CRYSTAL STRUCTURE OF HUMAN BACE-1 IN COMPLEX WITH AMINO-1,4-OXAZINE COMPOUND 4 | 3.4.23.46 |
6FHS | CRYOEM STRUCTURE OF INO80CORE | 3.6.4.12 |
6FHV | CRYSTAL STRUCTURE OF PENICILLIUM OXALICUM GLUCOAMYLASE | 3.2.1.3 |
6FHW | STRUCTURE OF HORMOCONIS RESINAE GLUCOAMYLASE | 3.2.1.3 |
6FID | BOVINE TRYPSIN SOLVED BY S-SAD ON ID30B | 3.4.21.4 |
6FIR | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II SOAKED WITH 5MM3-PHENYL-N-(9H-PURIN-6-YL)BENZAMIDE | 3.1.3.5 |
6FIS | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II SOAKED WITH 10MM 7-BENZYLOXYMETHYL-7H-ADENINE | 3.1.3.5 |
6FIT | FHIT-TRANSITION STATE ANALOG | 3.6.1.29 |
6FIU | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II SOAKED WITH 10MM 2-(6-([1,1'-BIPHENYL]-3-CARBOXAMIDO)-9H-PURIN-9-YL)ACETIC ACID | 3.1.3.5 |
6FIV | STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR | 3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1 |
6FIW | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II CO-CRYSTALLIZED WITH 10MM SODIUM ((4-(3'-((7H-PURIN-6-YL)CARBAMOYL)-[1,1'-BIPHENYL]-3-YL)-1H-IMIDAZOL-1-YL) METHYL) PHOSPHONATE | 3.1.3.5 |
6FJ2 | STRUCTURE OF THERMOLYSIN SOLVED FROM SAD DATA COLLECTED AT THE PEAK OF THE ZN ABSORPTION EDGE ON ID30B | 3.4.24.27 |
6FJ4 | STRUCTURE OF FAE SOLVED BY SAD FROM DATA COLLECTED AT THE PEAK OF THE SELENIUM ABSORPTION EDGE ON ID30B | 3.2.1.8 |
6FJS | PROTEINASE~K SIRAS PHASED STRUCTURE OF ROOM-TEMPERATURE, SERIALLY COLLECTED SYNCHROTRON DATA | 3.4.21.64 |
6FJT | 4-CHLORO-BENZAMIDINE IN COMPLEX WITH THROMBIN | 3.4.21.5 |
6FJW | STREPTOCOCCUS THERMOPHILUS CAS6 | 3.1 |
6FK4 | STRUCTURE OF 3' PHOSPHATASE NEXO (WT) FROM NEISSERIA BOUND TO DNA SUBSTRATE | 3.1.11.2 |
6FK5 | STRUCTURE OF 3' PHOSPHATASE NEXO (D146N) FROM NEISSERIA BOUND TO DNA SUBSTRATE IN PRESENCE OF MAGNESIUM ION | 3.1.11.2 |
6FKE | STRUCTURE OF 3' PHOSPHATASE NEXO (D146N) FROM NEISSERIA BOUND TO PRODUCT DNA HAIRPIN | 3.1.11.2 |
6FKH | CHLOROPLAST F1FO CONFORMATION 2 | 3.6.3.14 7.1.2.2 |
6FKI | CHLOROPLAST F1FO CONFORMATION 3 | 3.6.3.14 7.1.2.2 |
6FKX | CRYSTAL STRUCTURE OF AN ACETYL XYLAN ESTERASE FROM A DESERT METAGENOME | 3.1.1.72 |
6FKY | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-(BENZYLTHIO)SUCCINYL-CPS1 PEPTIDE | 3.5.1 2.3.1 |
6FKZ | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-(PHENYLTHIO)SUCCINYL-CPS1 PEPTIDE | 3.5.1 2.3.1 |
6FL1 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG MUTANT T221P AND A FAPY-DG CONTAINING DNA | 3.2.2.23 4.2.99.18 |
6FL4 | A. THALIANA NUDT1 IN COMPLEX WITH 8-OXO-DGTP | 3.6.1.55 3.6.1.67 3.6.1.22 |
6FLD | CARBAMYLATED T. CALIFORNICA ACETYLCHOLINETERASE BOUND TO UNCHARGED HYBRID REACTIVATOR 1 | 3.1.1.7 |
6FLG | CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3(S)-(NAPHTHYLTHIO)SUCCINYL-CPS1 PEPTIDE | 3.5.1 2.3.1 |
6FLL | SPECTROSCOPIC AND STRUCTURAL STUDY OF QW, A EGFP MUTANT SHOWING PHOTOSWITCHING PROPERTIES | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6FM6 | CRYSTAL STRUCTURE OF THE CLASS C BETA-LACTAMASE TRU-1 FROM AEROMONAS ENTEROPELOGENES | 3.5.2.6 |
6FM7 | CRYSTAL STRUCTURE OF THE CLASS C BETA-LACTAMASE TRU-1 FROM AEROMONAS ENTEROPELOGENES IN COMPLEX WITH AVIBACTAM | 3.5.2.6 |
6FML | CRYOEM STRUCTURE INO80CORE NUCLEOSOME COMPLEX | 3.6.4.12 |
6FMS | IMISX-EP OF SE-LSPA | 3.4.23.36 |
6FMT | IMISX-EP OF HG-BACA SOAKING SAD | 3.6.1.27 |
6FMV | IMISX-EP OF HG-BACA SOAKING SIRAS | 3.6.1.27 |
6FMW | IMISX-EP OF HG-BACA COCRYSTALLIZATION | 3.6.1.27 |
6FMX | IMISX-EP OF W-PGPB | 3.1.3.27 |
6FN6 | MODIFYING REGION (DH-ER-KR) OF AN INSECT FATTY ACID SYNTHASE (FAS) | 1.1.1.100 1.3.1.10 2.3.1.38 2.3.1.39 2.3.1.41 2.3.1.85 3.1.2.14 4.2.1.59 1.3.1.39 |
6FNN | CALDIARCHAEUM SUBTERRANEUM UBIQUITIN:RPN11-HOMOLOG COMPLEX | 3.4.19.12 |
6FNY | CRYSTAL STRUCTURE OF A CHOLINE SULFATASE FROM SINORHIZOBIUM MELLILOTI | 3.1.6.6 |
6FO1 | HUMAN R2TP SUBCOMPLEX CONTAINING 1 RUVBL1-RUVBL2 HEXAMER BOUND TO 1 RBD DOMAIN FROM RPAP3. | 3.6.4.12 |
6FOG | X-RAY STRUCTURE OF HOMO SAPIENS FUMARYLACETOACETATE HYDROLASE DOMAIN CONTAINING PROTEIN 1 (FAHD1) IN COMPLEX WITH INHIBITOR OXALATE AT 1.94A RESOLUTION. | 3.7.1.5 4.1.1.3 4.1.1.112 |
6FOH | X-RAY STRUCTURE OF HOMO SAPIENS FUMARYLACETOACETATE HYDROLASE DOMAIN CONTAINING PROTEIN 1 (FAHD1) AT 1.56A RESOLUTION. | 3.7.1.5 4.1.1.3 4.1.1.112 |
6FOR | PHOSPHOTRIESTERASE PTE_A53_6 | 3.1.8.1 |
6FPC | STRUCTURE OF THE PRO-PRO ENDOPEPTIDASE (PPEP-2) FROM PAENIBACILLUS ALVEI | 3.4.24.89 |
6FQE | PHOSPHOTRIESTERASE PTE_A53_4 | 3.1.8.1 |
6FQN | CARBAMYLATED T. CALIFORNICA ACETYLCHOLINETERASE BOUND TO UNCHARGED HYBRID REACTIVATOR 2 | 3.1.1.7 |
6FR2 | SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH LK864 | 3.3.2.10 3.1.3.76 |
6FRD | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-637 | 3.1.4 |
6FRE | CRYSTAL STRUCTURE OF G-1F/H73A MUTANT OF SSP DNAB MINI-INTEIN VARIANT M86 | 3.6.4.12 |
6FRG | CRYSTAL STRUCTURE OF G-1F MUTANT OF SSP DNAB MINI-INTEIN VARIANT M86 | 3.6.4.12 |
6FRH | CRYSTAL STRUCTURE OF SSP DNAB MINI-INTEIN VARIANT M86 | 3.6.4.12 |
6FRO | CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME CO-CRYSTALLIZED IN PRESENCE OF 100 MM TB-XO4 AND 100 MM POTASSIUM IODIDE. | 3.2.1.17 |
6FRQ | STRUCTURE OF TETRAGONAL HEN EGG-WHITE LYSOZYME CO-CRYSTALLIZED IN PRESENCE OF 100 MM TB-XO4 AND 100 MM POTASSIUM SODIUM TARTRATE TETRAHYDRATE. | 3.2.1.17 |
6FRV | STRUCTURE OF THE CATALYTIC DOMAIN OF ASPERGILLUS NIGER GLUCOAMYLASE | 3.2.1.3 |
6FRZ | PHOSPHOTRIESTERASE PTE_A53_7 | 3.1.8.1 |
6FS3 | PHOSPHOTRIESTERASE PTE_A53_1 | 3.1.8.1 |
6FS6 | INFLUENZA A/CALIFORNIA/04/2009 (PH1N1) ENDONUCLEASE WITH BOUND INHIBITOR, BALOXAVIR ACID (BXA) | 3.1 |
6FS7 | INFLUENZA A/CALIFORNIA/04/2009 (PH1N1) ENDONUCLEASE WITH I38T MUTATION WITH BOUND INHIBITOR, BALOXAVIR ACID (BXA) | 3.1 |
6FS8 | INFLUENZA B/MEMPHIS/13/03 ENDONUCLEASE WITH BOUND INHIBITOR, BALOXAVIR ACID (BXA) | 3.1 |
6FS9 | INFLUENZA B/MEMPHIS/13/03 ENDONUCLEASE WITH I38T MUTATION WITH BOUND INHIBITOR, BALOXAVIR ACID (BXA) | 3.1 |
6FSB | INFLUENZA B/MEMPHIS/13/03 ENDONUCLEASE WITH I38T MUTATION | 3.1 |
6FSD | MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH 2-(4-BIPHENYLYLOXY)-N-[3-(1-PIPERIDINYL)PROPYL]-ACETAMIDE HYDROCHLORIDE (10) | 3.1.1.7 |
6FSE | MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH 1-(4-(4-ETHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)-2-((4'-METHOXY-[1,1'-BIPHENYL]-4-YL)OXY)ETHANONE DIHYDROCHLORIDE (15) | 3.1.1.7 |
6FSJ | CRYSTAL STRUCTURE OF TCE-TREATED LYSOZYME | 3.2.1.17 |
6FSM | CRYSTAL STRUCTURE OF TCE-TREATED THERMOLYSIN | 3.4.24.27 |
6FSX | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY | 3.8.1.3 |
6FT0 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-425 | 3.1.4.53 |
6FTA | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-3098 | 3.1.4.53 |
6FTM | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-048 | 3.1.4 |
6FTQ | CRYSTAL STRUCTURE OF HUMAN BETA-UREIDOPROPIONASE (BETA-ALANINE SYNTHASE) - MUTANT T299C | 3.5.1.6 |
6FTR | SERIAL FEMTOSECOND CRYSTALLOGRAPHY AT MEGAHERTZ PULSE RATES | 3.2.1.17 |
6FTW | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-048 | 3.1.4.53 |
6FTY | COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 5 | 3.4.21.46 |
6FTZ | COMPLEMENT FACTOR D COMPLEXED WITH COMPOUND 6 | 3.4.21.46 |
6FU1 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A N-ALKYL HYDROXAMATE | 3.5.1.98 |
6FU6 | PHOSPHOTRIESTERASE PTE_C23_2 | 3.1.8.1 |
6FUG | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR 3-((3-((3-(AMINOMETHYL)PHENYL)AMINO)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)AMINO)PHENOL | 3.4.21.46 |
6FUH | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR (4-((3-(AMINOMETHYL)PHENYL)AMINO)QUINAZOLIN-2-YL)-L-VALINE | 3.4.21.46 |
6FUI | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR 3-((3-((3-(AMINOMETHYL)PHENYL)AMINO)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YL)AMINO)PHENOL | 3.4.21.46 |
6FUJ | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR N-(3'-(AMINOMETHYL)-[1,1'-BIPHENYL]-3-YL)-3-METHYLBUTANAMIDE | 3.4.21.46 |
6FUT | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR (S)-3'-(AMINOMETHYL)-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE | 3.4.21.46 |
6FV0 | CRYSTAL STRUCTURE OF THE TPR DOMAIN OF KLC1 IN COMPLEX WITH THE C-TERMINAL PEPTIDE OF TORSINA | 3.6.4 |
6FV1 | STRUCTURE OF HUMAN CORONAVIRUS NL63 MAIN PROTEASE IN COMPLEX WITH THE ALPHA-KETOAMIDE (S)-N-((S)-4-(BENZYLAMINO)-3,4-DIOXO-1-((S)-2-OXOPYRROLIDIN-3-YL)BUTAN-2-YL)-2-CINNAMAMIDO-4-METHYLPENTANAMIDE (CINNAMOYL-LEUCINE-GLNLACTAM-CO-CO-NH-BENZYL) | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6FV2 | STRUCTURE OF HUMAN CORONAVIRUS NL63 MAIN PROTEASE IN COMPLEX WITH THE ALPHA-KETOAMIDE (S)-N-BENZYL-3-((S)-2-CINNAMAMIDO-3-PHENYLPROPANAMIDO)-2-OXO-4-((S)-2-OXOPYRROLIDIN-3-YL)BUTANAMIDE (CINNAMOYL-PHENYLALANINE-GLNLACTAM-CO-CO-NH-BENZYL) | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6FV3 | CRYSTAL STRUCTURE OF N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE FROM MYCOBACTERIUM SMEGMATIS. | 3.5.1.25 |
6FV9 | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-007 | 3.1.4 |
6FVK | PHOSPHOTRIESTERASE PTE_C23_3 | 3.1.8.1 |
6FVP | PHOSPHOTRIESTERASE PTE_C23_4 | 3.1.8.1 |
6FW1 | PHOSPHOTRIESTERASE PTE_C23_5 | 3.1.8.1 |
6FW2 | CRYSTAL STRUCTURE OF HUMAN MARC1 | 1 3.2.1.17 1.7 |
6FW3 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-007 | 3.1.4.53 |
6FW5 | TESA A MAJOR THIOESTERASE FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.2 |
6FWE | PHOSPHOTRIESTERASE PTE_C23_6 | 3.1.8.1 |
6FWR | STRUCTURE OF DING IN COMPLEX WITH SSDNA | 3.6.4.12 |
6FWS | STRUCTURE OF DING IN COMPLEX WITH SSDNA AND ADPBEF | 3.6.4.12 |
6FX7 | CRYSTAL STRUCTURE OF IN VITRO EVOLVED AF1521 | 3.2.2 |
6FXH | HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II SOAKED WITH 10MM 3-PHENYL-N-(9H-PURIN-6-YL)BENZAMIDE | 3.1.3.5 |
6FXO | CRYSTAL STRUCTURE OF MAJOR BIFUNCTIONAL AUTOLYSIN | 3.5.1.28 3.2.1.96 |
6FYZ | DEVELOPMENT AND CHARACTERIZATION OF A CNS-PENETRANT BENZHYDRYL HYDROXAMIC ACID CLASS IIA HISTONE DEACETYLASE INHIBITOR | 3.5.1.98 |
6FZ1 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT L360F | 3.1.1.3 |
6FZ7 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT L184F | 3.1.1.3 |
6FZ8 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT L184F/A187F | 3.1.1.3 |
6FZ9 | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT A187F/L360F | 3.1.1.3 |
6FZA | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT A187F | 3.1.1.3 |
6FZC | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 VARIANT L184F/L360F | 3.1.1.3 |
6FZD | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 VARIANT L184F/A187F/L360F | 3.1.1.3 |
6FZK | NMR STRUCTURE OF UB2H, REGULATORY DOMAIN OF PBP1B FROM E. COLI | 2.4.1.129 3.4.16.4 |
6FZX | LASB, HYDROXYMATE INHIBITOR COMPLEX | 3.4.24.26 |
6G00 | CRYSTAL STRUCTURE OF A GH8 XYLANASE FROM TEREDINIBACTER TURNERAE | 3.2.1 3.2.1.4 |
6G01 | COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH TAMIPHOSPHOR MONOMETHYL ESTER | 3.2.1.18 |
6G02 | COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS WITH TAMIPHOSPHOR OMEGA-AZIDOHEXYL ESTER | 3.2.1.18 |
6G09 | CRYSTAL STRUCTURE OF A GH8 XYLOBIOSE COMPLEX FROM TEREDINIBACTER TURNERAE | 3.2.1 3.2.1.4 |
6G0B | CRYSTAL STRUCTURE OF A GH8 XYLOTRIOSE COMPLEX FROM TEREDINIBACTER TURNERAE | 3.2.1 3.2.1.4 |
6G0C | CRYSTAL STRUCTURE OF SDEA CATALYTIC CORE | 3.4.22 2.3.2 2.4.2.31 |
6G0I | ACTIVE FE-PP1 | 3.1.3.16 |
6G0J | INACTIVE FE-PP1 | 3.1.3.16 |
6G0M | PHOSPHOTRIESTERASE PTE_C23_7 | 3.1.8.1 |
6G0N | CRYSTAL STRUCTURE OF A GH8 CATALYTIC MUTANT XYLOHEXAOSE COMPLEX XYLANASE FROM TEREDINIBACTER TURNERAE | 3.2.1 3.2.1.4 |
6G17 | NON-AGED FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT TABUN | 3.1.1.7 |
6G19 | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 74-DEGREE HELICAL TWIST | 3.6.4.13 |
6G1J | PHOSPHOTRIESTERASE PTE_C23M_1 | 3.1.8.1 |
6G1P | APO FORM OF ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE | 3.5.1 3.2.1.143 3.2.2 |
6G1Q | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH ADP-RIBOSE | 3.5.1 3.2.1.143 3.2.2 |
6G1S | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 87-DEGREE HELICAL TWIST | 3.6.4.13 |
6G1U | CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 9-AMINO-6-CHLORO-1,2,3,4-TETRAHYDRO-10-METHYLACRIDIN-10-IUM | 3.1.1.7 |
6G1V | CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 12-AMINO-3-CHLORO-6,7,10,11-TETRAHYDRO-5,9-DIMETHYL-7,11-METHANOCYCLOOCTA[B]QUINOLIN-5-IUM | 3.1.1.7 |
6G1W | CRYSTAL STRUCTURE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH 2-{1-[2-(6-CHLORO-1,2,3,4-TETRAHYDROACRIDIN-9-YLAMINO)ETHYL]-1H-1,2,3-TRIAZOL-4-YL}-N-[4-(HYDROXY)-3-METHOXYBENZYL]ACETAMIDE | 3.1.1.7 |
6G1X | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 91-DEGREE HELICAL TWIST | 3.6.4.13 |
6G21 | CRYSTAL STRUCTURE OF AN ESTERASE FROM ASPERGILLUS ORYZAE | 3.1.1.73 |
6G22 | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PEU | 3.1.3 |
6G23 | PHOSPHOTRIESTERASE PTE_C23M_2 | 3.1.8.1 |
6G28 | HUMAN [PROTEIN ADP-RIBOSYLARGENINE] HYDROLASE ARH1 IN COMPLEX WITH ADP-RIBOSE | 3.2.2.19 |
6G2A | HUMAN [PROTEIN ADP-RIBOSYLARGENINE] HYDROLASE ARH1 IN COMPLEX WITH ADP-HPM | 3.2.2.19 |
6G2L | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PMTMU | 3.1.3 |
6G2M | CRYSTAL STRUCTURE OF HUMAN MITOCHONDRIAL 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PAU | 3.1.3 |
6G2N | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'(3')-DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH THE INHIBITOR PB-PAU | 3.1.3 |
6G2V | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G2W | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G2X | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G2Y | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G2Z | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G30 | CRYSTAL STRUCTURE OF THE P97 D2 DOMAIN IN A HELICAL SPLIT-WASHER CONFORMATION | 3.6.4.6 |
6G3L | PHOSPHOTRIESTERASE PTE_C23_A203L_3 | 3.1.8.1 |
6G3M | PHOSPHOTRIESTERASE PTE_C23M_4 | 3.1.8.1 |
6G3O | CRYSTAL STRUCTURE OF HUMAN HDAC2 IN COMPLEX WITH (R)-6-[3,4-DIOXO-2-(4-TRIFLUOROMETHOXY-PHENYLAMINO)-CYCLOBUT-1-ENYLAMINO]-HEPTANOIC ACID HYDROXYAMIDE | 3.5.1.98 |
6G3X | NATIVE STRUCTURE OF THE MOUSE 8-OXOGUANINE DNA GLYCOSYLASE MOGG1 | 3.2.2 4.2.99.18 |
6G3Y | STRUCTURE OF THE MOUSE 8-OXOGUANINE DNA GLYCOSYLASE MOGG1 IN COMPLEX WITH LIGAND TH5675 | 3.2.2 4.2.99.18 |
6G40 | STRUCTURE OF THE MOUSE 8-OXOGUANINE DNA GLYCOSYLASE MOGG1 IN COMPLEX WITH LIGAND TH9525 | 3.2.2 4.2.99.18 |
6G46 | RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN-1-YL)THIAZOLE-4-CARBOXYLIC ACID | 3.1.3.2 |
6G48 | SPOROSARCINA PASTEURII UREASE INHIBITED BY SILVER | 3.5.1.5 |
6G4G | FULL LENGTH ECTODOMAIN OF ECTONUCLEOTIDE PHOSPHODIESTERASE/PYROPHOSPHATASE-3 (NPP3) INCLUDING THE SMB DOMAINS BUT WITH A PARTIALLY DISORDERED ACTIVE SITE STRUCTURE | 3.1.4.1 3.6.1.9 |
6G4M | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE BOUND TO UNCHARGED HYBRID REACTIVATOR 1 | 3.1.1.7 |
6G4N | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE BOUND TO UNCHARGED HYBRID REACTIVATOR 2 | 3.1.1.7 |
6G4O | NON-AGED FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY TABUN ANALOG NEDPA BOUND TO UNCHARGED REACTIVATOR 1 | 3.1.1.7 |
6G4P | NON-AGED FORM OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY TABUN ANALOG NEDPA BOUND TO UNCHARGED REACTIVATOR 2 | 3.1.1.7 |
6G5C | INTERACTION OF TIO2 NANOPARTICLES (NM-101) WITH LYSOZYME | 3.2.1.17 |
6G5F | CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 | 3.4.24.69 |
6G5G | CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 2 | 3.4.24.69 |
6G5J | SECRETED PHOSPHOLIPASE A2 TYPE X IN COMPLEX WITH LIGAND | 3.1.1.4 |
6G5K | CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 | 3.4.24.69 |
6G5R | STRUCTURE OF THE UB2H DOMAIN OF E.COLI PBP1B IN COMPLEX WITH LPOB | 2.4.1.129 3.4.16.4 |
6G5V | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN LYSOZYME AND A PLATINUM(II) TERPYRIDINE COMPOUND (PH 7.0) | 3.2.1.17 |
6G5Y | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN LYSOZYME AND A PLATINUM(II) TERPYRIDINE COMPOUND (ACID PH) | 3.2.1.17 |
6G63 | RNASE E IN COMPLEX WITH SRNA RRPA | 3.1.26.12 |
6G7O | CRYSTAL STRUCTURE OF HUMAN ALKALINE CERAMIDASE 3 (ACER3) AT 2.7 ANGSTROM RESOLUTION | 3.5.1 3.5.1.23 |
6G84 | STRUCTURE OF CDC14 BOUND TO CBK1 PXL MOTIF | 3.1.3.48 |
6G85 | STRUCTURE OF CDC14 BOUND TO CBK1 PXL MOTIF | 3.1.3.48 |
6G86 | STRUCTURE OF CDC14 BOUND TO SIC1 PXL MOTIF | 3.1.3.48 |
6G8A | LYSOZYME SOLVED BY NATIVE SAD FROM A DATASET COLLECTED IN 5 SECONDS AT 1 A WAVELENGTH WITH JUNGFRAU DETECTOR | 3.2.1.17 |
6G8B | E. COLI AMINOPEPTIDASE N SOLVED BY NATIVE SAD FROM A DATASET COLLECTED IN 60 SECOND WITH JUNGFRAU DETECTOR | 3.4.11.2 |
6G8U | CRYSTAL STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN X (RESIDUES 2-427) | 3.4.24.69 |
6G8V | CRYSTAL STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN X (RESIDUES 2-442) | 3.4.24.69 |
6G9F | STRUCTURAL BASIS FOR THE INHIBITION OF E. COLI PBP2 | 3.4.16.4 |
6G9P | STRUCTURAL BASIS FOR THE INHIBITION OF E. COLI PBP2 | 3.4.16.4 |
6G9S | STRUCTURAL BASIS FOR THE INHIBITION OF E. COLI PBP2 | 3.4.16.4 |
6G9T | CRYSTAL STRUCTURE OF CMY-136 CLASS C BETA-LACTAMASE | 3.5.2.6 |
6G9Z | CRYSTAL STRUCTURE OF HUMAN HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN 1 (HHINT1) CRYSTALLIZED AT P212121 SPACE GROUP, WITH VISIBLE EXTENDED FRAGMENT OF N-TERMINUS | 3 |
6GBD | MURINE PROTEIN TYROSINE PHOSPHATASE PTPN13 PDZ3 DOMAIN | 3.1.3.48 |
6GBE | MURINE PROTEIN TYROSINE PHOSPHATASE PTPN13 PDZ3 DOMAIN-PRK2 PEPTIDE COMPLEX | 3.1.3.48 |
6GBJ | REPERTOIRES OF FUNCTIONALLY DIVERSE ENZYMES THROUGH COMPUTATIONAL DESIGN AT EPISTATIC ACTIVE-SITE POSITIONS | 3.1.8.1 |
6GBK | REPERTOIRES OF FUNCTIONALLY DIVERSE ENZYMES THROUGH COMPUTATIONAL DESIGN AT EPISTATIC ACTIVE-SITE POSITIONS | 3.1.8.1 |
6GBL | REPERTOIRES OF FUNCTIONALLY DIVERSE ENZYMES THROUGH COMPUTATIONAL DESIGN AT EPISTATIC ACTIVE-SITE POSITIONS | 3.1.8.1 |
6GBN | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM CYTOPHAGA HUTCHINSONII IN COMPLEX WITH ADENOSINE | 3.3.1.1 |
6GBW | THROMBIN IN COMPLEX WITH MI2100 ((S)-N-(2-(AMINOMETHYL)-5-CHLOROBENZYL)-1-((BENZYLSULFONYL)-L-ARGINYL)PYRROLIDINE-2-CARBOXAMIDE) | 3.4.21.5 |
6GCD | DNA BINDING DOMAIN OF RESTRICTION ENDONUCLEASE MCRBC IN COMPLEX WITH 5-HYDROXYMETHYLCYTOSINE DNA | 3.1.21 |
6GCE | DNA BINDING DOMAIN OF RESTRICTION ENDONUCLEASE MCRBC IN COMPLEX WITH 5-FORMYLCYTOSINE DNA | 3.1.21 |
6GCH | STRUCTURE OF CHYMOTRYPSIN-*TRIFLUOROMETHYL KETONE INHIBITOR COMPLEXES. COMPARISON OF SLOWLY AND RAPIDLY EQUILIBRATING INHIBITORS | 3.4.21.1 |
6GCN | TRUNCATED FTSH FROM A. AEOLICUS IN R32 | 3.4.24 |
6GCO | TRUNCATED FTSH FROM A. AEOLICUS IN P312 | 3.4.24 |
6GDD | DIHYDROOROTASE FROM AQUIFEX AEOLICUS UNDER 1200 BAR OF HYDROSTATIC PRESSURE | 3.5.2.3 |
6GDE | DIHYDROOROTASE FROM AQUIFEX AEOLICUS STANDARD (P,T) | 3.5.2.3 |
6GDF | DIHYDROOROTASE FROM AQUIFEX AEOLICUS UNDER 600 BAR OF HYDROSTATIC PRESSURE | 3.5.2.3 |
6GDI | STRUCTURE OF P-GLYCOPROTEIN(ABCB1) IN THE POST-HYDROLYTIC STATE | 3.6.3.44 7.6.2.2 7.6.2.1 |
6GF0 | LYSOZYME STRUCTURE DETERMINED FROM SFX DATA USING A SHEET-ON-SHEET CHIPLESS CHIP | 3.2.1.17 |
6GFI | STRUCTURE OF HUMAN MESOTRYPSIN IN COMPLEX WITH APPI VARIANT T11V/M17R/I18F/F34V | 3.4.21.4 |
6GFM | CRYSTAL STRUCTURE OF THE ESCHERICHIA COLI NUCLEOSIDASE PPNN (PPPGPP-FORM) | 3.2.2 3.2.2.10 3.2.2.4 |
6GH9 | USP15 CATALYTIC DOMAIN IN COMPLEX WITH SMALL MOLECULE | 3.4.19.12 |
6GHA | USP15 CATALYTIC DOMAIN STRUCTURE | 3.4.19.12 |
6GHC | MODIFICATION DEPENDENT ECOKMCRA RESTRICTION ENDONUCLEASE | 3.1.21 |
6GHX | ALZHEIMER'S AMYLOID-BETA PEPTIDE FRAGMENT 31-35 IN COMPLEX WITH CD-SUBSTITUTED THERMOLYSIN | 3.4.24.27 |
6GID | HIGH RESOLUTION CRYSTAL STRUCTURE OF SUBSTRATE-FREE HUMAN NEPRILYSIN | 3.4.24.11 |
6GIT | PURPLE ACID PHYTASE FROM WHEAT ISOFORM B2 - PRODUCT COMPLEX | 3.1.3.2 |
6GIU | HUMAN IMPASE WITH L-690330 | 3.1.3.25 3.1.3.94 |
6GIZ | PURPLE ACID PHYTASE FROM WHEAT ISOFORM B2 - SUBSTRATE COMPLEX | 3.1.3.2 |
6GJ0 | HUMAN IMPASE WITH MN | 3.1.3.25 3.1.3.94 |
6GJ2 | PURPLE ACID PHYTASE FROM WHEAT ISOFORM B2 - COMPLEX WITH INOSITOL HEXASULPHATE | 3.1.3.2 |
6GJ5 | CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 15 | 3.6.5.2 |
6GJ6 | CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 18 | 3.6.5.2 |
6GJ7 | CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH 22 | 3.6.5.2 |
6GJ8 | CRYSTAL STRUCTURE OF KRAS G12D (GPPCP) IN COMPLEX WITH BI 2852 | 3.6.5.2 |
6GJ9 | PURPLE ACID PHYTASE FROM WHEAT ISOFORM B2 - REGENERATION COMPLEX | 3.1.3.2 |
6GJA | PURPLE ACID PHYTASE FROM WHEAT ISOFORM B2 - H229A MUTANT | 3.1.3.2 |
6GJK | A DEGRADATION PRODUCT OF PD 404182 (P2742) BOUND TO HISTONE DEACETYLASE-LIKE AMIDOHYDROLASE | 3.5.1 |
6GJQ | HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 | 3.6.3.49 5.6.1.6 |
6GJS | HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T4 | 3.6.3.49 5.6.1.6 |
6GJU | HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES T2A AND T4 | 3.6.3.49 5.6.1.6 |
6GJZ | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT IN COMPLEX WITH AMPPNP | 3.6.4.13 |
6GK2 | HELICAL RECONSTRUCTION OF BCL10 CARD AND MALT1 DEATH DOMAIN COMPLEX | 3.4.22 |
6GK4 | HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T8 | 3.6.3.49 5.6.1.6 |
6GKD | HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A | 3.6.3.49 5.6.1.6 |
6GKH | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT IN COMPLEX WITH ADP-ALF4 | 3.6.4.13 |
6GKM | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT IN COMPLEX WITH ATP (10 MM) | 3.6.4.13 |
6GL0 | STRUCTURE OF ZGENGAGH5_4 IN COMPLEX WITH A CELLOTRIOSE | 3.2.1.4 |
6GL2 | STRUCTURE OF ZGENGAGH5_4 WILD TYPE AT 1.2 ANGSTROM RESOLUTION | 3.2.1.4 |
6GLE | CRYSTAL STRUCTURE OF HMTH1 IN COMPLEX WITH TH SCAFFOLD 1 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLF | CRYSTAL STRUCTURE OF HMTH1 F27A IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLG | CRYSTAL STRUCTURE OF HMTH1 F27A IN COMPLEX WITH LW14 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLH | CRYSTAL STRUCTURE OF HMTH1 F27A IN COMPLEX WITH LW14 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLI | CRYSTAL STRUCTURE OF HMTH1 F27A IN COMPLEX WITH TH SCAFFOLD 1 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLJ | CRYSTAL STRUCTURE OF HMTH1 F27A IN COMPLEX WITH TH SCAFFOLD 1 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLK | CRYSTAL STRUCTURE OF HMTH1 N33A IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLL | CRYSTAL STRUCTURE OF HMTH1 N33A IN COMPLEX WITH LW14 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLM | CRYSTAL STRUCTURE OF HMTH1 N33A IN COMPLEX WITH LW14 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLN | CRYSTAL STRUCTURE OF HMTH1 N33A IN COMPLEX WITH TH SCAFFOLD 1 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLO | CRYSTAL STRUCTURE OF HMTH1 N33G IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLP | CRYSTAL STRUCTURE OF HMTH1 N33G IN COMPLEX WITH LW14 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLQ | CRYSTAL STRUCTURE OF HMTH1 N33G IN COMPLEX WITH LW14 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLR | CRYSTAL STRUCTURE OF HMTH1 N33G IN COMPLEX WITH TH SCAFFOLD 1 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLS | CRYSTAL STRUCTURE OF HMTH1 N33G IN COMPLEX WITH TH SCAFFOLD 1 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLT | CRYSTAL STRUCTURE OF HMTH1 D120N IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLU | CRYSTAL STRUCTURE OF HMTH1 D120N IN COMPLEX WITH LW14 IN THE PRESENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GLV | CRYSTAL STRUCTURE OF HMTH1 D120N IN COMPLEX WITH TH SCAFFOLD 1 IN THE ABSENCE OF ACETATE | 3.6.1.55 3.6.1.56 |
6GN6 | ALPHA-L-FUCOSIDASE ISOENZYME 1 FROM PAENIBACILLUS THIAMINOLYTICUS | 3.2.1.51 |
6GNL | ZR(IV)-SUBSTITUTED KEGGIN DIRECTLY BINDING TO THE SIDE CHAIN OF HEN EGG-WHITE LYSOZYME (HEWL) | 3.2.1.17 |
6GO2 | CARBOXYPEPTIDASE T WITH N-SULFAMOYL-L-LEUCINE | 3.4.17.18 |
6GO3 | TDT CHIMERA (LOOP1 OF POL MU) - APOENZYME | 2.7.7.31 2.7.7.7 3.1.11 |
6GO4 | TDT CHIMERA (LOOP1 OF POL MU) - BINARY COMPLEX WITH DDCTP | 2.7.7.31 2.7.7.7 3.1.11 |
6GO5 | TDT CHIMERA (LOOP1 OF POL MU) - TERNARY COMPLEX WITH 1-NT GAPPED DNA SUBSTRATE | 2.7.7.31 2.7.7.7 3.1.11 |
6GO6 | TDT CHIMERA (LOOP1 OF POL MU) - TERNARY COMPLEX WITH DOWNSTREAM DSDNA | 2.7.7.31 2.7.7.7 3.1.11 |
6GO7 | TDT CHIMERA (LOOP1 OF POL MU) - FULL DNA SYNAPSIS COMPLEX | 2.7.7.31 2.7.7.7 3.1.11 |
6GOA | STRUCTURAL BASIS FOR OXA-48 DIMERIZATION - R189A MUTANT | 3.5.2.6 |
6GOB | X-RAY STRUCTURE OF THE ADDUCT FORMED UPON REACTION OF LYSOZYME WITH A PD(II) COMPLEX BEARING N,N-PYRIDYLBENZIMIDAZOLE DERIVATIVE WITH AN ALKYLATED SULPHONATE SIDE CHAIN | 3.2.1.17 |
6GOD | KRAS FULL LENGTH WILD-TYPE GPPNHP | 3.6.5.2 |
6GOE | KRAS FULL LENGTH G12V GPPNHP | 3.6.5.2 |
6GOF | KRAS FULL LENGTH G12D GPPNHP | 3.6.5.2 |
6GOG | KRAS-169 Q61H GPPNHP | 3.6.5.2 |
6GOH | X-RAY STRUCTURE OF THE ADDUCT FORMED UPON REACTION OF LYSOZYME WITH A PT(II) COMPLEX BEARING N,N-PYRIDYLBENZIMIDAZOLE DERIVATIVE WITH AN ALKYLATED SULPHONATE SIDE CHAIN | 3.2.1.17 |
6GOI | X-RAY STRUCTURE OF THE ADDUCT FORMED UPON REACTION OF LYSOZYME WITH A PD(II) COMPLEX BEARING N,N-PYRIDYLBENZIMIDAZOLE DERIVATIVE WITH AN ALKYLATED TRIPHENYLPHOSPHONIUM CATION | 3.2.1.17 |
6GOJ | X-RAY STRUCTURE OF THE ADDUCT FORMED UPON REACTION OF LYSOZYME WITH A PT(II) COMPLEX BEARING N,N-PYRIDYLBENZIMIDAZOLE DERIVATIVE WITH AN ALKYLATED TRIPHENYLPHOSPHONIUM CATION | 3.2.1.17 |
6GOK | X-RAY STRUCTURE OF THE ADDUCT FORMED UPON REACTION OF BOVINE PANCREATIC RIBONUCLEASE WITH A PD(II) COMPLEX BEARING N,N-PYRIDYLBENZIMIDAZOLE DERIVATIVE WITH AN ALKYLATED SULPHONATE SIDE CHAIN | 3.1.27.5 4.6.1.18 |
6GOM | KRAS-169 Q61H GPPNHP + PPIN-1 | 3.6.5.2 |
6GP5 | BETA-1,4-GALACTANASE FROM BACTEROIDES THETAIOTAOMICRON | 3.2.1.89 |
6GPA | BETA-1,4-GALACTANASE FROM BACTEROIDES THETAIOTAOMICRON WITH GALACTOSE | 3.2.1.89 |
6GPG | STRUCTURE OF THE RIG-I SINGLETON-MERTEN SYNDROME VARIANT C268F | 3.6.4.13 |
6GQT | KRAS-169 Q61H GPPNHP + PPIN-2 | 3.6.5.2 |
6GQW | KRAS-169 Q61H GPPNHP + CH-1 | 3.6.5.2 |
6GQX | KRAS-169 Q61H GPPNHP + CH-2 | 3.6.5.2 |
6GQY | KRAS-169 Q61H GPPNHP + CH-3 | 3.6.5.2 |
6GRN | CELLOBIOHYDROLASE I (CEL7A) FROM TRICHODERMA REESEI WITH S-DIHYDROXYPROPRANOLOL IN THE ACTIVE SITE | 3.2.1.91 |
6GRU | CRYSTAL STRUCTURE OF HUMAN NUDT5 | 3.6.1.13 3.6.1.58 2.7.7.96 |
6GRY | GLUCURONOYL ESTERASE FROM SOLIBACTER USITATUS. | 3.1.1 |
6GS2 | CRYSTAL STRUCTURE OF THE GATD/MURT ENZYME COMPLEX FROM STAPHYLOCOCCUS AUREUS | 6.3.5.13 3.5.1.2 |
6GSP | RIBONUCLEASE T1/3'-GMP, 15 WEEKS | 3.1.27.3 4.6.1.24 |
6GSZ | CRYSTAL STRUCTURE OF NATIVE ALFA-L-RHAMNOSIDASE FROM ASPERGILLUS TERREUS | 3.2.1.40 |
6GT6 | CRYSTAL STRUCTURE OF RECOMBINANT COAGULATION FACTOR BETA-XIIA | 3.4.21.38 |
6GTA | ALPHA-GALACTOSIDASE MUTANT D378A FROM THERMOTOGA MARITIMA IN COMPLEX WITH INTACT CYCLOHEXENE-BASED CARBASUGAR MIMIC OF GALACTOSE WITH 3,5 DIFLUOROPHENYL LEAVING GROUP | 3.2.1.22 |
6GTC | TRANSITION STATE STRUCTURE OF CPF1(CAS12A) I1 CONFORMATION | 3.1.21.1 3.1.27.2 4.6.1.22 |
6GTE | TRANSIENT STATE STRUCTURE OF CRISPR-CPF1 (CAS12A) I3 CONFORMATION | 3.1.21.1 3.1.27.2 4.6.1.22 |
6GTF | TRANSIENT STATE STRUCTURE OF CRISPR-CPF1 (CAS12A) I5 CONFORMATION | 3.1.21.1 3.1.27.2 4.6.1.22 |
6GTG | TRANSITION STATE STRUCTURE OF CPF1(CAS12A) I4 CONFORMATION | 3.1.21.1 3.1.27.2 4.6.1.22 |
6GTH | SERIAL FEMTOSECOND CRYSTALLOGRAPHY AT MEGAHERTZ PULSE RATES | 3.5.2.6 |
6GUD | SIDEROPHORE HYDROLASE ESTB FROM ASPERGILLUS FUMIGATUS | 3.1 |
6GUG | SIDEROPHORE HYDROLASE ESTB MUTANT S148A FROM ASPERGILLUS FUMIGATUS | 3.1 |
6GUI | SIDEROPHORE HYDROLASE ESTB MUTANT H267N FROM ASPERGILLUS FUMIGATUS | 3.1 |
6GUL | SIDEROPHORE HYDROLASE ESTB MUTANT E211Q FROM ASPERGILLUS FUMIGATUS | 3.1 |
6GUP | SIDEROPHORE HYDROLASE ESTB FROM ASPERGILLUS FUMIGATUS | 3.1 |
6GUR | SIDEROPHORE HYDROLASE ESTB FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH TAFC | 3.1 |
6GUU | STRUCTURE OF CHD5 PHD2 - TANDEM CHROMODOMAINS | 3.6.4.12 |
6GVD | ALPHA-GALACTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CYCLOHEXENE-BASED CARBASUGAR MIMIC OF GALACTOSE | 3.2.1.22 |
6GVV | MUTANT M16A OF RNA DEPENDENT RNA POLYMERASE 3D FROM FOOT-AND-MOUTH DISEASE VIRUS | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
6GVY | MUTANT M16A OF RNA DEPENDENT RNA POLYMERASE 3D FROM FOOT-AND-MOUTH DISEASE VIRUS COMPLEXED WITH AN TEMPLATE -PRIMER RNA | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
6GWE | CRYSTAL STRUCTURE OF THROMBIN BOUND TO P2 MACROCYCLE | 3.4.21.5 |
6GWF | ALPHA-GALACTOSIDASE MUTANT D387A FROM THERMOTOGA MARITIMA IN COMPLEX WITH INTACT CYCLOHEXENE-BASED CARBASUGAR MIMIC OF GALACTOSE WITH 2,4-DINITRO LEAVING GROUP | 3.2.1.22 |
6GWG | ALPHA-GALACTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CYCLOHEXENE-BASED CARBASUGAR MIMIC OF GALACTOSE COVALENTLY LINKED TO THE NUCLEOPHILE | 3.2.1.22 |
6GX3 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH AN HYDROXAMATE 1 | 3.5.1.98 |
6GX8 | ALPHA-GALACTOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH HYDROLYSED CYCLOHEXENE-BASED CARBASUGAR MIMIC OF GALACTOSE | 3.2.1.22 |
6GXA | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH AN HYDROXAMATE 2 | 3.5.1.98 |
6GXD | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY: FACD752MS AFTER REACTION INITIATION | 3.8.1.3 |
6GXF | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY: RADDAM1 | 3.8.1.3 |
6GXH | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY: FACD 0MS AFTER REACTION INITIATION | 3.8.1.3 |
6GXL | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY: RADDAM2 | 3.8.1.3 |
6GXQ | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1335 | 3.1.4 |
6GXT | THE HIT-AND-RETURN SYSTEM ENABLES EFFICIENT TIME-RESOLVED SERIAL SYNCHROTRON CRYSTALLOGRAPHY: FACD2052MS AFTER REACTION INITIATION | 3.8.1.3 |
6GXU | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH AN HYDROXAMATE 3 | 3.5.1.98 |
6GXW | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH AN HYDROXAMATE 4 | 3.5.1.98 |
6GYM | STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) | 3.6.4.12 |
6GZA | STRUCTURE OF MURINE LEUKEMIA VIRUS CAPSID C-TERMINAL DOMAIN | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6GZS | STRUCTURE OF CHLAMYDIA TRACHOMATIS EFFECTOR PROTEIN CHLADUB1 BOUND TO UBIQUITIN | 3.4.22 |
6GZU | STRUCTURE OF CHLAMYDIA ABORTUS EFFECTOR PROTEIN CHLADUB | 3.4.22 |
6GZV | IDENTIFICATION OF A DRUGGABLE VP1-VP3 INTERPROTOMER POCKET IN THE CAPSID OF ENTEROVIRUSES | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6H0K | HEN EGG-WHITE LYSOZYME STRUCTURE DETERMINED WITH DATA FROM THE EUXFEL, THE FIRST MHZ FREE ELECTRON LASER, 7.47 KEV PHOTON ENERGY | 3.2.1.17 |
6H0L | HEN EGG-WHITE LYSOZYME STRUCTURE DETERMINED WITH DATA FROM THE EUXFEL, 9.22 KEV PHOTON ENERGY | 3.2.1.17 |
6H0S | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE LACTOCOCCUS LACTIS FPG MUTANT G226P AND A FAPY-DG CONTAINING DNA | 3.2.2.23 4.2.99.18 |
6H0T | CRYSTAL STRUCTURE OF NATIVE RECOMBINANT HUMAN BILE SALT ACTIVATED LIPASE | 3.1.1.13 3.1.1.3 3.1.1.6 |
6H0V | CRYSTAL STRUCTURE OF TABUN SURROGATE NEDPA INHIBITED RECOMBINANT HUMAN BILE SALT ACTIVATED LIPASE | 3.1.1.13 3.1.1.3 3.1.1.6 |
6H12 | CRYSTAL STRUCTURE OF TCACHE COMPLEXED TO 1-(6-OXO-1,2,3,4,6,10B-HEXAHYDROPYRIDO[2,1-A]ISOINDOL-10-YL)-3-(4-(((1-(2-((1,2,3,4-TETRAHYDROACRIDIN-9-YL)AMINO)ETHYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)METHYL)PYRIDIN-2-YL)UREA | 3.1.1.7 |
6H13 | CRYSTAL STRUCTURE OF TCACHE COMPLEXED TO1-(4-((METHYL((1-(2-((1,2,3,4-TETRAHYDROACRIDIN-9-YL)AMINO)ETHYL)-1H-1,2,3-TRIAZOL-4-YL)METHYL)AMINO)METHYL)PYRIDIN-2-YL)-3-(6-OXO-1,2,3,4,6,10B-HEXAHYDROPYRIDO[2,1-A]ISOINDOL-10-YL)UREA | 3.1.1.7 |
6H14 | CRYSTAL STRUCTURE OF TCACHE COMPLEXED TO 1-(6-OXO-1,2,3,4,6,10B-HEXAHYDROPYRIDO[2,1-A]ISOINDOL-10-YL)-3-(4-(1-(2-((1,2,3,4-TETRAHYDROACRIDIN-9-YL)AMINO)ETHYL)-1H-1,2,3-TRIAZOL-4-YL)PYRIDIN-2-YL)UREA | 3.1.1.7 |
6H18 | CRYSTAL STRUCTURE OF SARIN SURROGATE NIMP INHIBITED RECOMBINANT HUMAN BILE SALT ACTIVATED LIPASE | 3.1.1.13 3.1.1.3 3.1.1.6 |
6H19 | CRYSTAL STRUCTURE OF ETHYL-PARAOXON INHIBITED RECOMBINANT HUMAN BILE SALT ACTIVATED LIPASE (AGED FORM) | 3.1.1.13 3.1.1.3 3.1.1.6 |
6H1A | CRYSTAL STRUCTURE OF VX SURROGATE NEMP INHIBITED RECOMBINANT HUMAN BILE SALT ACTIVATED LIPASE | 3.1.1.13 3.1.1.3 3.1.1.6 |
6H1P | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB - DATA COLLECTED AT ROOM TEMPERATURE | 3.2.1.23 |
6H1Z | AFGH61B WILD-TYPE | 3.2.1 |
6H23 | CRYSTAL STRUCTURE OF THE HCLPP Y118A MUTANT WITH AN ACTIVATING SMALL MOLECULE | 3.4.21.92 |
6H27 | STRUCTURE OF S70C BLAC FROM MYCOBACTERIUM TUBERCULOSIS | 3.5.2.6 |
6H28 | STRUCTURE OF S70A BLAC FROM MYCOBACTERIUM TUBERCULOSIS OBTAINED FROM CRYSTALS PRODUCED IN THE ABSENCE OF DTT | 3.5.2.6 |
6H2A | STRUCTURE OF S70A BLAC FROM MYCOBACTERIUM TUBERCULOSIS OBTAINED FROM CRYSTALS PRODUCED IN THE PRESENCE OF DTT | 3.5.2.6 |
6H2C | STRUCTURE OF BLAC FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO THE TRANS-ENAMINE ADDUCT DERIVED FROM CLAVULANIC ACID. | 3.5.2.6 |
6H2G | STRUCTURE OF BLAC FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO THE PROPIONALDEHYDE ESTER ADDUCT OF CLAVULANIC ACID. | 3.5.2.6 |
6H2H | STRUCTURE OF BLAC FROM MYCOBACTERIUM TUBERCULOSIS COVALENTLY BOUND TO AVIBACTAM. | 3.5.2.6 |
6H2I | STRUCTURE OF BLAC FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO THE TRANS-ENAMINE ADDUCT OF TAZOBACTAM. | 3.5.2.6 |
6H2J | CRYSTAL STRUCTURE OF THE HSDR SUBUNIT OF THE ECOR124I RESTRICTION ENZYME WITH THE C-TERMINAL DOMAIN | 3.1.21.3 |
6H2K | STRUCTURE OF BLAC FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO THE TRANS-ENAMINE ADDUCT OF SULBACTAM. | 3.5.2.6 |
6H2P | CRYSTAL STRUCTURE OF ARG184GLN MUTANT OF HUMAN PROLIDASE WITH MN IONS AND CACODYLATE LIGAND | 3.4.13.9 |
6H2Q | CRYSTAL STRUCTURE OF ARG184GLN MUTANT OF HUMAN PROLIDASE WITH MN IONS AND LEUPRO LIGAND | 3.4.13.9 |
6H46 | HUMAN KRAS IN COMPLEX WITH DARPIN K13 | 3.6.5.2 |
6H47 | HUMAN KRAS IN COMPLEX WITH DARPIN K19 | 3.6.5.2 |
6H4A | HUMAN MALT1(329-728) IN COMPLEX WITH MLT-748 | 3.4.22 |
6H4C | A POLYAMOROUS REPRESSOR: DECIPHERING THE EVOLUTIONARY STRATEGY USED BY THE PHAGE-INDUCIBLE CHROMOSOMAL ISLANDS TO SPREAD IN NATURE. | 3.6.1.23 |
6H4D | CRYSTAL STRUCTURE OF RSGA FROM PSEUDOMONAS AERUGINOSA | 3.6.1 |
6H4H | USP28 CATALYTIC DOMAIN VARIANT E593D IN COMPLEX WITH UBPA | 3.4.19.12 |
6H4J | USP25 CATALYTIC DOMAIN | 3.4.19.12 |
6H4K | STRUCTURE OF THE USP25 C-TERMINAL DOMAIN | 3.4.19.12 |
6H56 | EFFECTOR DOMAIN OF PSEUDOMONAS AERUGINOSA VGRG2B | 3.4.24 |
6H57 | CRYSTAL STRUCTURE OF S. CEREVISIAE DEAH-BOX RNA HELICASE DHR1, ESSENTIAL FOR SMALL RIBOSOMAL SUBUNIT BIOGENESIS | 3.6.4.13 |
6H5E | CRYSTAL STRUCTURE OF THE GATD/MURT ENZYME COMPLEX FROM STAPHYLOCOCCUS AUREUS WITH BOUND AMPPNP | 6.3.5.13 3.5.1.2 |
6H5O | CRYSTAL STRUCTURE OF PBP2A FROM MRSA IN COMPLEX WITH PIPERACILLIN AT ACTIVE SITE. | 3.4.16.4 |
6H5W | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME C-DOMAIN IN COMPLEX WITH OMAPATRILAT. | 3.2.1 3.4.15.1 |
6H5X | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT. | 3.2.1 3.4.15.1 |
6H61 | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 89 DEGREE TWIST AND WITHOUT NUCLEOTIDE | 3.6.4.13 |
6H66 | CRYOEM STRUCTURE OF THE MDA5-DSRNA FILAMENT WITH 93 DEGREE TWIST AND WITHOUT NUCLEOTIDE | 3.6.4.13 |
6H6K | THE STRUCTURE OF THE FKR MUTANT OF THE ARCHAEAL TRANSLATION INITIATION FACTOR 2 GAMMA SUBUNIT IN COMPLEX WITH GDPCP, OBTAINED IN THE ABSENCE OF MAGNESIUM SALTS IN THE CRYSTALLIZATION SOLUTION. | 3.6.5.3 |
6H79 | SSX STRUCTURE OF LYSOZYME IN FLOW - METAL-KAPTON MICROFLUIDIC DEVICE | 3.2.1.17 |
6H7X | FIRST X-RAY STRUCTURE OF FULL-LENGTH HUMAN RUVB-LIKE 2. | 3.6.4.12 |
6H7Y | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 1-79-1 | 3.4.17.21 |
6H7Z | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-65-1 | 3.4.17.21 |
6H80 | DENGUE-RDRP3-INHIBITOR COMPLEX CO-CRYSTALLISATION | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6H8J | 1.45 A RESOLUTION OF SPOROSARCINA PASTEURII UREASE INHIBITED IN THE PRESENCE OF NBPTO | 3.5.1.5 |
6H8L | STRUCTURE OF PEPTIDOGLYCAN DEACETYLASE PDAC FROM BACILLUS SUBTILIS | 3.5.1 |
6H8M | CRYSTAL STRUCTURE OF THE THIRD SRCR DOMAIN OF MURINE NEUROTRYPSIN. | 3.4.21 |
6H8N | STRUCTURE OF PEPTIDOGLYCAN DEACETYLASE PDAC FROM BACILLUS SUBTILIS - MUTANT D285S | 3.5.1 |
6H8O | CRYSTAL STRUCTURE OF THE MASTER-REP PROTEIN NUCLEASE DOMAIN FROM THE FABA BEAN NECROTIC YELLOWS VIRUS | 2.7.7 3.1.21 3.6.1 |
6H8R | CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP) IN COMPLEX WITH COMPOUND 2 | 3.1.3.48 |
6H8S | CRYSTAL STRUCTURE OF THE MOUSE PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP) IN COMPLEX WITH COMPOUND BI-0314 | 3.1.3.48 |
6H8T | CRYSTAL STRUCTURE OF PAPAIN MODIFY BY ACHIRAL RU(II)COMPLEX | 3.4.22.2 |
6H9D | MURAMIDASE DOMAIN OF SPMX FROM ASTICACCAULIS EXCENTRICUS | 3.2.1.17 |
6H9R | DENGUE-RDRP3-INHIBITOR COMPLEX SOAKING | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6H9U | CRYSTAL STRUCTURE OF THE BIP NBD AND MANF SAP COMPLEX | 3.6.4.10 |
6HA5 | AFGH61B L90V/D131S/M134L/A141W VARIANT | 3.2.1 |
6HA7 | CRYSTAL STRUCTURE OF THE BIP NBD AND MANF COMPLEX | 3.6.4.10 |
6HA9 | STRUCTURE OF AN ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS COMPLEXED WITH XXXG(2F)-BETA-DNP | 3.2.1.151 3.2.1.4 |
6HAA | STRUCTURE OF A COVALENT COMPLEX OF ENDO-XYLOGLUCANASE FROM CELLVIBRIO JAPONICUS AFTER REACTING WITH XXXG(2F)-BETA-DNP | 3.2.1.151 3.2.1.4 |
6HAB | CRYSTAL STRUCTURE OF BIP V461F (APO) | 3.6.4.10 |
6HAK | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DOUBLE STRANDED RNA REPRESENTS THE RT TRANSCRIPTION INITIATION COMPLEX PRIOR TO NUCLEOTIDE INCORPORATION | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6HAQ | AFGH61B WILD-TYPE COPPER LOADED | 3.2.1 |
6HAX | CRYSTAL STRUCTURE OF PROTAC 2 IN COMPLEX WITH THE BROMODOMAIN OF HUMAN SMARCA2 AND PVHL:ELONGINC:ELONGINB | 3.6.4 |
6HAY | CRYSTAL STRUCTURE OF PROTAC 1 IN COMPLEX WITH THE BROMODOMAIN OF HUMAN SMARCA2 AND PVHL:ELONGINC:ELONGINB | 3.6.4 |
6HAZ | CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN SMARCA2 IN COMPLEX WITH SMARCA-BD LIGAND | 3.6.4 |
6HB8 | CRYSTAL STRUCTURE OF OXA-517 BETA-LACTAMASE | 3.5.2.6 |
6HBG | ECHOVIRUS 18 NATIVE PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6HBH | ECHOVIRUS 18 A-PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6HBJ | ECHOVIRUS 18 EMPTY PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6HC6 | THE STRUCTURE OF BSAP, A ZINC AMINOPEPTIDASE FROM BACILLUS SUBTILIS | 3.4.11.6 3.4.11.10 |
6HC7 | THE CRYSTAL STRUCTURE OF BSAP, A ZINC AMINOPEPTIDASE FROM BACILLUS SUBTILIS (MEDIUM RESOLUTION) | 3.4.11.6 3.4.11.10 |
6HCX | INFLUENZA VIRUS N9 NEURAMINIDASE A COMPLEX WITH ZANAMIVIR MOLECULE (TERN). | 3.2.1.18 |
6HDE | STRUCTURE OF ESCHERICHIA COLI DUTPASE Q93H MUTANT | 3.6.1.23 |
6HDN | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 3-METHYL-8-((8-METHYL-8-AZABICYCLOOCTAN-3-YL)AMINO)-1,7-NAPHTHYRIDIN-2(1H)-ONE | 3.6.1.3 3.6.1 |
6HDO | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH 8-(((1R,2R,3R,5S)-2-(2-(1,1-DIOXIDOTETRAHYDRO-2H-THIOPYRAN-4-YL)ETHYL)-8-AZABICYCLO[3.2.1]OCTAN-3-YL)AMINO)-3-METHYL-5-(5-METHYLPYRIDIN-3-YL)QUINOLIN-2(1H)-ONE | 3.6.1.3 3.6.1 |
6HE7 | 20S PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS | 3.4.25.1 |
6HE9 | PAN-PROTEASOME IN STATE 2 | 3.4.25.1 |
6HEB | INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (TERN). | 3.2.1.18 |
6HEG | CRYSTAL STRUCTURE OF ESCHERICHIA COLI DEAH/RHA HELICASE HRPB | 3.6.4.13 |
6HEH | STRUCTURE OF THE CATALYTIC DOMAIN OF USP28 (INSERTION DELETED) | 3.4.19.12 |
6HEI | STRUCTURE OF THE CATALYTIC DOMAIN OF USP28 (INSERTION DELETED) BOUND TO UBIQUITIN-PA | 3.4.19.12 |
6HEJ | STRUCTURE OF HUMAN USP28 | 3.4.19.12 |
6HEM | STRUCTURE OF THE C-TERMINAL DOMAIN OF USP25 (748-1048) | 3.4.19.12 |
6HF6 | CRYSTAL STRUCTURE OF THE PROTEASE 1 (E29A,E60A,E80A) FROM PYROCOCCUS HORIKOSHII CO-CRYSTALLIZED WITH TB-XO4. | 3.5.1.124 3.4.22 |
6HFC | INFLUENZA A VIRUS N9 NEURAMINIDASE NATIVE (TERN). | 3.2.1.18 |
6HFD | HUMAN DIHYDROOROTASE MUTANT F1563L APO STRUCTURE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFE | HUMAN DIHYDROOROTASE MUTANT F1563T APO STRUCTURE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFF | HUMAN DIHYDROOROTASE MUTANT F1563Y APO STRUCTURE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFH | HUMAN DIHYDROOROTASE MUTANT F1563A CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.0 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFI | HUMAN DIHYDROOROTASE MUTANT F1563A APO STRUCTURE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFJ | HUMAN DIHYDROOROTASE MUTANT F1563A CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFK | HUMAN DIHYDROOROTASE MUTANT F1563L CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 6.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFL | HUMAN DIHYDROOROTASE MUTANT F1563L CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.0 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFN | HUMAN DIHYDROOROTASE MUTANT F1563L CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFP | HUMAN DIHYDROOROTASE MUTANT F1563T CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.0 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFQ | HUMAN DIHYDROOROTASE MUTANT F1563T CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFR | HUMAN DIHYDROOROTASE MUTANT F1563Y CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.0 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFS | HUMAN DIHYDROOROTASE MUTANT F1563Y CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 6.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFU | HUMAN DIHYDROOROTASE MUTANT F1563Y CO-CRYSTALLIZED WITH CARBAMOYL ASPARTATE AT PH 7.5 | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HFY | INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH DANA (DUCK/ENGLAND/56). | 3.2.1.18 |
6HG0 | INFLUENZA A VIRUS N9 NEURAMINIDASE COMPLEX WITH NANA (TERN/AUSTRALIA). | 3.2.1.18 |
6HG1 | HYBRID DIHYDROOROTASE DOMAIN OF HUMAN CAD WITH E. COLI FLEXIBLE LOOP IN APO STATE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HG2 | HYBRID DIHYDROOROTASE DOMAIN OF HUMAN CAD WITH E. COLI FLEXIBLE LOOP, BOUND TO FLUOROOROTATE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HG3 | HYBRID DIHYDROOROTASE DOMAIN OF HUMAN CAD WITH E. COLI FLEXIBLE LOOP, BOUND TO DIHYDROOROTATE | 6.3.5.5 2.1.3.2 3.5.2.3 |
6HG5 | INFLUENZA A VIRUS N6 NEURAMINIDASE COMPLEX WITH OSELTAMIVIR (DUCK/ENGLAND/56). | 3.2.1.18 |
6HGB | INFLUENZA A VIRUS N6 NEURAMINIDASE NATIVE STRUCTURE (DUCK/ENGLAND/56). | 3.2.1.18 |
6HGC | STRUCTURE OF CALYPSO IN COMPLEX WITH DEUBAD OF ASX | 3.4.19.12 |
6HGV | SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH TALINOLOL | 3.3.2.10 3.1.3.76 |
6HGW | SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 2-(4-FLUOROPHENYL)-N-(4-PHENOXYBENZYL)ETHANAMINE | 3.3.2.10 3.1.3.76 |
6HGX | SOLUBLE EPOXIDE HYDROLASE IN COMPLEX WITH 1-(4-((4-(TERT-BUTYL)MORPHOLIN-2-YL)METHOXY)PHENYL)-3-CYCLOHEXYLUREA | 3.3.2.10 3.1.3.76 |
6HGY | CRYSTAL STRUCTURE OF CATHEPSIN K WITH N-DESMETHYL THALASSOSPIRAMIDE C | 3.4.22.38 |
6HGZ | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH ADP-RIBOSE | 3.5.1 3.2.1.143 3.2.2 |
6HH3 | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH ADP-HPD | 3.5.1 3.2.1.143 3.2.2 |
6HH4 | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH ADP-RIBOSYL-L-ARGININE | 3.5.1 3.2.1.143 3.2.2 |
6HH5 | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH ADP-HPM | 3.5.1 3.2.1.143 3.2.2 |
6HH6 | HUMAN POLY(ADP-RIBOSE) GLYCOHYDROLASE IN COMPLEX WITH ADP-HPM | 3.2.1.143 |
6HHC | ALLOSTERIC INHIBITION AS A NEW MODE OF ACTION FOR BAY 1213790, A NEUTRALIZING ANTIBODY TARGETING THE ACTIVATED FORM OF COAGULATION FACTOR XI | 3.4.21.27 |
6HHM | CRYSTAL STRUCTURE OF THE FAMILY S1_7 ULVAN-SPECIFIC SULFATASE FA22070 FROM FORMOSA AGARIPHILA | 3.1.6.1 3.1.6 |
6HI3 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 4 | 3.6.1.3 3.6.1 |
6HI4 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 7 | 3.6.1 |
6HI5 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 8 | 3.6.1 |
6HI6 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 9 | 3.6.1 |
6HI7 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 10 | 3.6.1 |
6HI8 | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 11 | 3.6.1 |
6HIA | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 13 | 3.6.1.3 3.6.1 |
6HIB | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 14 | 3.6.1 |
6HIC | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 15 | 3.6.1 |
6HID | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 16 | 3.6.1 |
6HIE | THE ATAD2 BROMODOMAIN IN COMPLEX WITH COMPOUND 17 | 3.6.1.3 3.6.1 |
6HKI | CRYSTAL STRUCTURE OF SURFACE ENTROPY MUTANT OF HUMAN O-GLCNAC HYDROLASE | 3.2.1.169 |
6HKJ | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-19-1 | 3.4.17.21 |
6HKS | CRYSTAL STRUCTURE OF THE PTPN3 PDZ DOMAIN BOUND TO THE HPV16 E6 ONCOPROTEIN C-TERMINAL PEPTIDE | 3.1.3.48 |
6HKZ | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR RNA 2-49-1 | 3.4.17.21 |
6HLB | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC PEPTIDE C[SUCCINYL-PHE-2-NAL-(ARG)4-LYS]-ARG-4-AMBA | 3.4.21.75 |
6HLD | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC PEPTIDE C[SUCCINYL-PHE-2-NAL-(ARG)3-LYS]-LYS-4-AMBA | 3.4.21.75 |
6HLE | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE P6-P2-CYCLIZED PEPTIDE H-LYS-ARG-ARG-TLE-LYS-4-AMBA | 3.4.21.75 |
6HMF | D-FAMILY DNA POLYMERASE - DP1 SUBUNIT (3'-5' PROOF-READING EXONUCLEASE) H451 PROOF-READING DEFICIENT VARIANT | 2.7.7.7 3.1.11.1 |
6HMK | POLYADPRIBOSYL GLYCOHYDROLASE IN COMPLEX WITH PDD00016690 | 3.2.1.143 |
6HML | POLYADPRIBOSYL GLYCOSIDASE IN COMPLEX WITH PDD00017299 | 3.2.1.143 |
6HMM | POLYADPRIBOSYL GLYCOHYDROLASE IN COMPLEX WITH PDD00013907 | 3.2.1.143 |
6HMN | POLYADPRIBOSYL GLYCOSIDASE IN COMPLEX WITH PDD00014909 | 3.2.1.143 |
6HMS | CRYO-EM MAP OF DNA POLYMERASE D FROM PYROCOCCUS ABYSSI IN COMPLEX WITH DNA | 2.7.7.7 3.1.11.1 |
6HOO | CRYSTAL STRUCTURE OF RATIONALLY DESIGNED OXA-48LOOP18 BETA-LACTAMASE | 3.5.2.6 |
6HOY | HUMAN SIRT6 IN COMPLEX WITH ADP-RIBOSE AND THE INHIBITOR TRICHOSTATIN A | 3.5.1 2.3.1.286 |
6HOZ | ADP-RIBOSYLSERINE HYDROLASE ARH3 OF LATIMERIA CHALUMNAE IN COMPLEX WITH INOSINE DIPHOSPHATE RIBOSE (IDPR) | 3.5.1 3.2.1.143 3.2.2 |
6HP0 | COMPLEX OF NEURAMINIDASE FROM H1N1 INFLUENZA VIRUS IN COMPLEX WITH OSELTAMIVIR TRIAZOL DERIVATIVE | 3.2.1.18 |
6HPB | CRYSTAL STRUCTURE OF THE E.COLI HICAB TOXIN-ANTITOXIN COMPLEX | 3.1 |
6HPD | THE STRUCTURE OF A BETA-GLUCURONIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 | 3.2.1.23 3.2.1.31 |
6HPF | STRUCTURE OF INACTIVE E165Q MUTANT OF FUNGAL NON-CBM CARRYING GH26 ENDO-B-MANNANASE FROM YUNNANIA PENICILLATA IN COMPLEX WITH ALPHA-62-61-DI-GALACTOSYL-MANNOTRIOSE | 3.2.1.78 |
6HPH | CRYSTAL STRUCTURE OF HUMAN PIF1 HELICASE IN COMPLEX WITH AMP-PNP | 3.6.4.12 |
6HPQ | CRYSTAL STRUCTURE OF HUMAN PIF1 HELICASE IN COMPLEX WITH AMP-PNP, BROMINATED CRYSTAL FORM. | 3.6.4.12 |
6HPT | CRYSTAL STRUCTURE OF HUMAN PIF1 HELICASE, APOFORM. | 3.6.4.12 |
6HQ9 | CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN ERCC6-L2 | 3.6.4 |
6HQY | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH PCI-34051 | 3.5.1.98 |
6HR2 | CRYSTAL STRUCTURE OF PROTAC 2 IN COMPLEX WITH THE BROMODOMAIN OF HUMAN SMARCA4 AND PVHL:ELONGINC:ELONGINB | 3.6.4 |
6HR4 | APO FORM OF PENICILLIN-BINDING PROTEIN 3 FROM P. AERUGINOSA | 3.4.16.4 |
6HR5 | STRUCTURE OF THE S1_25 FAMILY SULFATASE MODULE OF THE RHAMNOSIDASE FA22250 FROM FORMOSA AGARIPHILA | 3.1.6 3.2.1.40 |
6HR6 | NITROCEFIN ACYLATION OF SINGLE CATALYTIC SERINE OF PENICILLIN-BINDING PROTEIN 3 FROM P. AERUGINOSA | 3.4.16.4 |
6HR9 | NITROCEFIN ACYLATION OF BOTH CATALYTIC SERINES OF THE Y409 MUTANT OF PENICILLIN-BINDING PROTEIN 3 FROM P. AERUGINOSA | 3.4.16.4 |
6HRQ | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH NCC-149 | 3.5.1.98 |
6HSF | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 MUTANT H292M COMPLEXED WITH PCI-34051 | 3.5.1.98 |
6HSG | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 H292M MUTANT COMPLEXED WITH NCC-149 | 3.5.1.98 |
6HSH | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH QUISINOSTAT | 3.5.1.98 |
6HSK | CRYSTAL STRUCTURE OF A HUMAN HDAC8 L6 LOOP MUTANT COMPLEXED WITH QUISINOSTAT | 3.5.1.98 |
6HSX | THROMBIN IN COMPLEX WITH A D-PHE-PRO-DIAMINOPYRIDINE DERIVATIVE | 3.4.21.5 |
6HSZ | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 2 | 3.5.1.98 |
6HT2 | STRUCTURE OF HEWL BY ELECTRON DIFFRACTION AND MICROFOCUS DIFFRACTION | 3.2.1.17 |
6HT4 | NMR STRUCTURE OF NS5A-D2 (JFH1) PEPTIDE (304-323) | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6HT8 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 3 | 3.5.1.98 |
6HT9 | MOUSE FETUIN-B IN COMPLEX WITH CRAYFISH ASTACIN | 3.4.24.21 |
6HTG | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 4 | 3.5.1.98 |
6HTH | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 5 | 3.5.1.98 |
6HTI | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 6 | 3.5.1.98 |
6HTT | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 7 | 3.5.1.98 |
6HTZ | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 8 | 3.5.1.98 |
6HU0 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 9 | 3.5.1.98 |
6HU1 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 10 | 3.5.1.98 |
6HU2 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A BENZOHYDROXAMATE INHIBITOR 11 | 3.5.1.98 |
6HU3 | CRYSTAL STRUCTURE OF SCHISTOSOMA MANSONI HDAC8 COMPLEXED WITH A TRIAZOLE HYDROXAMATE INHIBITOR | 3.5.1.98 |
6HUF | COPING WITH STRONG TRANSLATIONAL NON-CRYSTALLOGRAPHIC SYMMETRY AND EXTREME ANISOTROPY IN MOLECULAR REPLACEMENT WITH PHASER: HUMAN RAB27A | 3.6.5.2 |
6HUH | CRYSTAL STRUCTURE OF OXA-427 CLASS D BETA-LACTAMASE | 3.5.2.6 |
6HV0 | IRE1 KINASE/RNASE IN COMPLEX WITH IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE COMPOUND 33 | 2.7.11.1 3.1.26 |
6HV2 | MMP-13 IN COMPLEX WITH THE PEPTIDE IMISF | 3.4.24 |
6HV6 | CRYSTAL STRUCTURE OF PATOXP, A CYSTEINE PROTEASE-LIKE DOMAIN OF PHOTORHABDUS ASYMBIOTICA TOXIN PATOX | 2.4.1 3.5.1.44 |
6HV8 | CRYO-EM STRUCTURE OF S. CEREVISIAE POLYMERASE EPSILON DELTACAT MUTANT | 2.7.7.7 3.1.11 |
6HV9 | S. CEREVISIAE CMG-POL EPSILON-DNA | 3.6.4.12 |
6HVH | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 1 | 2.7.1.105 3.1.3.46 |
6HVI | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 2 | 2.7.1.105 3.1.3.46 |
6HVJ | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 3 | 2.7.1.105 3.1.3.46 |
6HW1 | ROOM TEMPERATURE STRUCTURE OF LIPASE FROM T. LANUGINOSA AT 2.5 A RESOLUTION IN CHIPX MICROFLUIDIC DEVICE | 3.1.1.3 |
6HWI | IMMATURE M-PMV CAPSID HEXAMER STRUCTURE IN INTACT VIRUS PARTICLES | 3.6.1.23 3.4.23 |
6HWM | STRUCTURE OF THERMUS THERMOPHILUS CLPP IN COMPLEX WITH BORTEZOMIB | 3.4.21.92 |
6HWN | STRUCTURE OF THERMUS THERMOPHILUS CLPP IN COMPLEX WITH A TRIPEPTIDE. | 3.4.21.92 |
6HWO | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-1335 | 3.1.4.53 |
6HWR | RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE | 3.1.3.2 |
6HX0 | CELL WALL BINDING DOMAIN OF ENDOLYSIN FROM LISTERIA PHAGE A500. | 3.4.24 |
6HX1 | IRE1 ALPHA IN COMPLEX WITH IMIDAZO[1,2-B]PYRIDAZIN-8-AMINE COMPOUND 2 | 2.7.11.1 3.1.26 |
6HXB | SERCA2A FROM PIG HEART | 3.6.3.8 7.2.2.10 |
6HXZ | VIRUS-LIKE PARTICLES BASED ON POTATO VIRUS Y | 2.7.7.48 3.4.22.44 3.4.22.45 |
6HY3 | THREE-DIMENSIONAL STRUCTURE OF AGAC FROM ZOBELLIA GALACTANIVORANS | 3.2.1.81 |
6HY4 | CO(II)-SUBSTITUTED WELLS-DAWSON BINDING TO HEN EGG-WHITE LYSOZYME (HEWL) | 3.2.1.17 |
6HY6 | NI(II)-SUBSTITUTED WELLS-DAWSON BINDING TO HEN EGG-WHITE LYSOZYME (HEWL) | 3.2.1.17 |
6HY8 | CU(II)-SUBSTITUTED WELLS-DAWSON BINDING TO HEN EGG-WHITE LYSOZYME (HEWL) | 3.2.1.17 |
6HYB | ZR(IV)-SUBSTITUTED WELLS-DAWSON BINDING TO HEN EGG-WHITE LYSOZYME (HEWL) | 3.2.1.17 |
6HYJ | PSPH HUMAN PHOSPHOSERINE PHOSPHATASE | 3.1.3.3 |
6HYT | CRYSTAL STRUCTURE OF DHX8 HELICASE DOMAIN BOUND TO ADP AT 2.3 ANGSTROM | 3.6.4.13 |
6HYY | HUMAN PHOSPHOSERINE PHOSPHATASE WITH SERINE AND PHOSPHATE | 3.1.3.3 |
6HZ4 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (ONE HALF OF THE FULL COMPLEX) | 3.1.21 |
6HZ5 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (CLASS 1) | 3.1.21 |
6HZ6 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (CLASS 2) | 3.1.21 |
6HZ7 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (CLASS 3) | 3.1.21 |
6HZ8 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (CLASS 4) | 3.1.21 |
6HZ9 | STRUCTURE OF MCRBC WITHOUT DNA BINDING DOMAINS (CLASS 5) | 3.1.21 |
6HZA | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC PEPTIDE C[GLUTARYL-ARG-ARG-LYS]-ARG-4-AMBA | 3.4.21.75 |
6HZB | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC INHIBITOR C[GLUTARYL-ARG-ARG-LYS]-LYS-4-AMBA | 3.4.21.75 |
6HZC | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC INHIBITOR C[GLUTARYL-BVK-LYS-ARG-ARG-TLE-LYS]-4-AMBA | 3.4.21.75 |
6HZD | X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE CYCLIC INHIBITOR C[GLUTARYL-ARG-ARG-ARG-LYS]-ARG-4-AMBA | 3.4.21.75 |
6HZI | APO STRUCTURE OF TP DOMAIN FROM BURKHOLDERIA PSEUDOMALLEI PENICILLIN-BINDING PROTEIN 3 | 3.4.16.4 |
6HZJ | APO STRUCTURE OF TP DOMAIN FROM CLINICAL PENICILLIN-RESISTANT MUTANT NEISSERIA GONORRHOEA STRAIN 6140 PENICILLIN-BINDING PROTEIN 2 (PBP2) | 3.4.16.4 |
6HZO | APO STRUCTURE OF TP DOMAIN FROM HAEMOPHILUS INFLUENZAE PENICILLIN-BINDING PROTEIN 3 | 3.4.16.4 |
6HZQ | APO STRUCTURE OF TP DOMAIN FROM ESCHERICHIA COLI PENICILLIN-BINDING PROTEIN 3 | 3.4.16.4 |
6HZR | APO STRUCTURE OF PSEUDOMONAS AERUGINOSA PENICILLIN-BINDING PROTEIN 3 | 3.4.16.4 |
6I00 | CRYO-EM INFORMED DIRECTED EVOLUTION OF NITRILASE 4 LEADS TO A CHANGE IN QUATERNARY STRUCTURE. | 3.5.5.1 3.5.5.4 4.2.1.65 |
6I0B | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE S ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR. | 3.1.1.8 |
6I0C | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THE R ENANTIOMER OF A CHLOROTACRINE-TRYPTOPHAN MULTI-TARGET INHIBITOR. | 3.1.1.8 |
6I0X | PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEMINASE (PPAD) MUTANT G231N/E232T/N235D IN COMPLEX WITH CL-AMIDINE. | 3.5.3 |
6I1D | STRUCTURE OF THE YSH1-MPE1 NUCLEASE COMPLEX FROM S.CEREVISIAE | 3.1.27 |
6I1E | CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PENICILLIN-BINDING PROTEIN 3 IN COMPLEX WITH AMOXICILLIN | 3.4.16.4 |
6I1I | CRYSTAL STRUCTURE OF TP DOMAIN FROM ESCHERICHIA COLI PENICILLIN-BINDING PROTEIN 3 IN COMPLEX WITH PENICILLIN | 3.4.16.4 |
6I1K | CRYSTAL STRUCTURE OF CATALYTICALLY INACTIVE FNCAS12A IN COMPLEX WITH A CRRNA GUIDE AND A DSDNA TARGET | 3.1.21.1 3.1.27.2 4.6.1.22 |
6I2K | STRUCTURE OF EV71 COMPLEXED WITH ITS RECEPTOR SCARB2 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6I2T | CRYOEM RECONSTRUCTION OF FULL-LENGTH, FULLY-GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE TETRAMER | 3.1.1.8 |
6I30 | CRYSTAL STRUCTURE OF THE AMPC FROM PSEUDOMONAS AERUGINOSA WITH 1C | 3.5.2.6 |
6I44 | ALLOSTERIC ACTIVATION OF HUMAN PREKALLIKREIN BY APPLE DOMAIN DISC ROTATION | 3.4.21.34 |
6I51 | THROMBIN IN COMPLEX WITH FRAGMENT J02 | 3.4.21.5 |
6I58 | ALLOSTERIC ACTIVATION OF HUMAN PREKALLIKREIN BY APPLE DOMAIN DISC ROTATION | 3.4.21.27 |
6I59 | LONG WAVELENGTH NATIVE-SAD PHASING OF SEN1 HELICASE | 3.6.4 |
6I5D | CRYSTAL STRUCTURE OF AN OXA-48 BETA-LACTAMASE SYNTHETIC MUTANT | 3.5.2.6 |
6I5E | X-RAY STRUCTURE OF APO HUMAN SOLUBLE EPOXIDE HYDROLASE C-TERMINAL DOMAIN (HSEH CTD) | 3.3.2.10 3.1.3.76 |
6I5G | X-RAY STRUCTURE OF HUMAN SOLUBLE EPOXIDE HYDROLASE C-TERMINAL DOMAIN (HSEH CTD)IN COMPLEX WITH 15D-PGJ2 | 3.3.2.10 3.1.3.76 |
6I5M | GAMMA SUBUNIT OF THE TRANSLATION INITIATION FACTOR 2 FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH GDP AND FORMATE ION | 3.6.5.3 |
6I5T | CRYO-EM INFORMED DIRECTED EVOLUTION OF NITRILASE 4 LEADS TO A CHANGE IN QUATERNARY STRUCTURE. | 3.5.5.1 3.5.5.4 4.2.1.65 |
6I5U | CRYO-EM INFORMED DIRECTED EVOLUTION OF NITRILASE 4 LEADS TO A CHANGE IN QUATERNARY STRUCTURE. | 3.5.5.1 3.5.5.4 4.2.1.65 |
6I6R | NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES | 3.2.1.76 |
6I6X | NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES | 3.2.1.76 |
6I6Z | CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE PHOSPHINIC INHIBITOR ACETYL-TYR-ALA-Y(PO2CH2)-HOMOPHE-OH | 3.4.17.1 |
6I7G | CRYSTAL STRUCTURE OF DIMERIC WILD TYPE FICD COMPLEXED WITH ATP | 2.7.7 3.1.4 |
6I7H | CRYSTAL STRUCTURE OF DIMERIC FICD MUTANT K256S | 2.7.7 3.1.4 |
6I7I | CRYSTAL STRUCTURE OF DIMERIC FICD MUTANT K256A COMPLEXED WITH MGATP | 2.7.7 3.1.4 |
6I7J | CRYSTAL STRUCTURE OF MONOMERIC FICD MUTANT L258D | 2.7.7 3.1.4 |
6I7K | CRYSTAL STRUCTURE OF MONOMERIC FICD MUTANT L258D COMPLEXED WITH MGATP | 2.7.7 3.1.4 |
6I7L | CRYSTAL STRUCTURE OF MONOMERIC FICD MUTANT L258D COMPLEXED WITH MGAMP-PNP | 2.7.7 3.1.4 |
6I8A | THE CRYSTAL STRUCTURE OF THE POL2 CATALYTIC DOMAIN OF DNA POLYMERASE EPSILON CARRYING A P301R SUBSTITUTION. | 2.7.7.7 3.1.11 |
6I8W | CRYSTAL STRUCTURE OF A MEMBRANE PHOSPHOLIPASE A, A NOVEL BACTERIAL VIRULENCE FACTOR | 3.1.1.3 |
6I9A | PORPHYROMONAS GINGIVALIS GINGIPAIN K (KGP) IN COMPLEX WITH INHIBITOR KYT-36 | 3.4.22.47 |
6I9C | STRUCTURE OF THE OTU DOMAIN OF OTULIN G281R MUTANT | 3.4.19.12 |
6I9L | JMJC DOMAIN-CONTAINING PROTEIN 5 (JMJD5) IN COMPLEX WITH MN AND PYRIDINE-2,4-DICARBOXYLIC ACID (2,4-PDCA) | 1.14.11.27 3.4 1.14.11 |
6I9M | JMJC DOMAIN-CONTAINING PROTEIN 5 (JMJD5) IN COMPLEX WITH MN AND R-2-HYDROXYGLUTARATE | 1.14.11.27 3.4 1.14.11 |
6I9N | JMJC DOMAIN-CONTAINING PROTEIN 5 (JMJD5) IN COMPLEX WITH MN AND L-2-HYDROXYGLUTARATE | 1.14.11.27 3.4 1.14.11 |
6I9Y | THE 2.14 A X-RAY CRYSTAL STRUCTURE OF SPOROSARCINA PASTEURII UREASE IN COMPLEX WITH AU(I) IONS | 3.5.1.5 |
6IAG | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-637 | 3.1.4.53 |
6IB7 | STRUCTURE OF WILD TYPE SUHB | 3.1.3.25 |
6IB8 | STRUCTURE OF A COMPLEX OF SUHB AND NUSA AR2 DOMAIN | 3.1.3.25 |
6IBD | THE PHOSPHATASE AND C2 DOMAINS OF HUMAN SHIP1 | 3.1.3.86 3.1.3.56 3.1.3.36 |
6IBF | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-417 | 3.1.4.53 |
6IBK | CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFAMIDATE ME763 | 3.2.1.22 3.2.1.47 |
6IBM | CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOSULFATE ME776 | 3.2.1.22 3.2.1.47 |
6IBR | CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOPHELLITOL EPOXIDE LWA481 | 3.2.1.22 3.2.1.47 |
6IBS | CRYSTAL STRUCTURE OF NDM-1 BETA-LACTAMASE IN COMPLEX WITH BORONIC INHIBITOR CPD 6 | 3.5.2.6 |
6IBT | CRYSTAL STRUCTURE OF HUMAN ALPHA-GALACTOSIDASE A IN COMPLEX WITH ALPHA-GALACTOSE CONFIGURED CYCLOPHELLITOL AZIRIDINE ME737 | 3.2.1.22 3.2.1.47 |
6IBU | APO CRH5 TRANSGLYCOSYLASE | 3.2 |
6IBV | CRYSTAL STRUCTURE OF NDM-1 BETA-LACTAMASE IN COMPLEX WITH BROAD SPECTRUM BORONIC INHIBITOR CPD 1 | 3.5.2.6 |
6IBW | CRH5 TRANSGLYCOSYLASE IN COMPLEX WITH NAG | 3.2 |
6IBX | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 5 | 2.7.1.105 3.1.3.46 |
6IBY | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 6 | 2.7.1.105 3.1.3.46 |
6IBZ | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 7 | 2.7.1.105 3.1.3.46 |
6IC0 | HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 4 | 2.7.1.105 3.1.3.46 |
6IC5 | HUMAN CATHEPSIN-C IN COMPLEX WITH DIPEPTIDYL CYCLOPROPYL NITRILE INHIBITOR 2 | 3.4.14.1 |
6IC6 | HUMAN CATHEPSIN-C IN COMPLEX WITH CYCLOPROPYL PEPTIDYL NITRILE INHIBITOR 1 | 3.4.14.1 |
6IC7 | HUMAN CATHEPSIN-C IN COMPLEX WITH DIPEPTIDYL CYCLOPROPYL NITRILE INHIBITOR 3 | 3.4.14.1 |
6ICC | THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 186 | 3.4.24 |
6ICF | THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 266 | 3.4.24 |
6IDI | CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 8.0. | 3.4.21.91 3.6.1.15 3.6.4.13 |
6IDL | CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS II PARTICLE) | 3.4.21.91 3.6.1.15 3.6.4.13 |
6IDW | GH6 ORPINOMYCES SP. Y102 ENZYME | 3.2.1 |
6IEG | CRYSTAL STRUCTURE OF HUMAN MTR4 | 3.6.4.13 |
6IEJ | THE C2 DOMAIN OF CYTOSOLIC PHOSPHOLIPASE A2 ALPHA BOUND TO PHOSPHATIDYLCHOLINE | 3.1.1.4 3.1.1.5 |
6IEO | CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS HTRA1 (RV1223) IN REGULATED CONFORMATION | 3.4.21.107 |
6IEY | CRYSTAL STRUCTURE OF CHLORAMPHENICOL-METABOLIZAING ENZYME ESTDL136-CHLORAMPHENICOL COMPLEX | 3.1.1.1 |
6IF8 | AEROMONAS HYDROPHILA MTAN-2 COMPLEXED WITH ADENINE | 3.2.2.9 |
6IFC | CRYSTAL STRUCTURE OF VAPBC FROM SALMONELLA TYPHIMURIUM | 3.1 |
6IFF | CRYSTAL STRUCTURE OF M1 ZINC METALLOPEPTIDASE E323A MUTANT FROM DEINOCOCCUS RADIODURANS | 3.4.11.2 |
6IFG | CRYSTAL STRUCTURE OF M1 ZINC METALLOPEPTIDASE E323A MUTANT BOUND TO TYR-SER-ALA SUBSTRATE FROM DEINOCOCCUS RADIODURANS | 3.4.11.2 |
6IFM | CRYSTAL STRUCTURE OF DNA BOUND VAPBC FROM SALMONELLA TYPHIMURIUM | 3.1 |
6IFQ | CRYSTAL STRUCTURE OF A STANDALONE VERSATILE EAL PROTEIN FROM VIBRIO CHOLERAE O395 - APO FORM | 3.1.4.52 |
6IG6 | CRYSTAL STRUCTURE OF LYSOZYME DELIVERED IN POLYACRYLAMIDE USING X-RAY FREE ELECTRON LASER | 3.2.1.17 |
6IG7 | CRYSTAL STRUCTURE OF THERMOLYSIN DELIVERED IN POLYACRYLAMIDE USING X-RAY FREE ELECTRON LASER | 3.4.24.27 |
6IGK | CRYSTAL STRUCTURE OF HUMAN ETB RECEPTOR IN COMPLEX WITH ENDOTHELIN-3 | 3.2.1.17 |
6IGL | CRYSTAL STRUCTURE OF HUMAN ETB RECEPTOR IN COMPLEX WITH IRL1620 | 3.2.1.17 |
6IGM | CRYO-EM STRUCTURE OF HUMAN SRCAP COMPLEX | 3.6.4.12 |
6IGY | CRYSTAL STRUCTURE OF ASPERGILLUS NIGER CHITINASE B | 3.2.1.14 |
6IH0 | AQUIFEX AEOLICUS LPXC COMPLEX WITH ACHN-975 | 3.5.1.108 |
6IH1 | CRYSTAL STRUCTURE OF A STANDALONE VERSATILE EAL PROTEIN FROM VIBRIO CHOLERAE O395 - C-DI-GMP BOUND FORM | 3.1.4.52 |
6IH7 | CRYSTAL STRUCTURE OF A STANDALONE VERSATILE EAL PROTEIN FROM VIBRIO CHOLERAE O395 - 3',3'-CGAMP BOUND FORM | 3.1.4.52 |
6IHG | N TERMINAL DOMAIN OF MYCOBACTERIUM AVIUM COMPLEX LON PROTEASE | 3.4.21.53 |
6IHL | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE | 3.1.3.16 |
6IHR | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE WITH HIS TAG | 3.1.3.16 |
6IHS | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE WITH HIS-TAG MUTATION | 3.1.3.16 |
6IHT | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE BOUND WITH PHOSPHORYLATED PEPTIDE | 3.1.3.16 |
6IHU | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE BEARING R161A MUTATION | 3.1.3.16 |
6IHV | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE BEARING R161E MUTATION | 3.1.3.16 |
6IHW | CRYSTAL STRUCTURE OF BACTERIAL SERINE PHOSPHATASE BEARING R161K MUTATION | 3.1.3.16 |
6IHZ | THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT | 3.1.3.48 |
6II7 | CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM ADENOSINE DEAMINASE C27Q+L227I MUTANT CO-COMPLEXED WITH ZN ION, HYPOXANTHINE AND INOSINE | 3.5.4.4 |
6IID | HUMAN EXOG-H140A IN COMPLEX WITH RNA-DNA CHIMERIC DUPLEX | 3.1.30 |
6IIH | CRYSTAL STRUCTURE OF MITOCHONDRIAL CALCIUM UPTAKE 2(MICU2) | 3.2.1.17 |
6IIK | USP14 CATALYTIC DOMAIN WITH IU1 | 3.4.19.12 |
6IIL | USP14 CATALYTIC DOMAIN BIND TO IU1-47 | 3.4.19.12 |
6IIM | USP14 CATALYTIC DOMAIN WITH IU1-206 | 3.4.19.12 |
6IIN | USP14 CATALYTIC DOMAIN WITH IU1-248 | 3.4.19.12 |
6IJ3 | CRYSTAL STRUCTURE OF PETASE S121D, D186H MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6IJ4 | CRYSTAL STRUCTURE OF PETASE S121E, D186H MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6IJ5 | CRYSTAL STRUCTURE OF PETASE P181A MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6IJ6 | CRYSTAL STRUCTURE OF PETASE S121E, D186H, R280A MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6IJH | CRYSTAL STRUCTURE OF PDE10 IN COMPLEX WITH INHIBITOR AF-399/14387019 | 3.1.4.17 3.1.4.35 |
6IJI | CRYSTAL STRUCTURE OF PDE10 IN COMPLEX WITH INHIBITOR 2B | 3.1.4.17 3.1.4.35 |
6IJM | APO STRUCTURE OF THE N6-METHYL-AMP DEAMINASE FROM ARABIDOPSIS THALIANA | 3.5.4 |
6IJN | THE D295N MUTANT OF THE N6-METHYL-AMP DEAMINASE FROM ARABIDOPSIS THALIANA COMPLEXED WITH N6M-AMP | 3.5.4 |
6IJP | THE STRUCTURE OF THE ADAL-IMP COMPLEX | 3.5.4 |
6IJY | CRYSTAL STRUCTURE OF HUMAN MTH1(G2K/C87A/C104S MUTANT) IN COMPLEX WITH 8-OXO-DGTP DETERMINED USING A CRYSTAL OBTAINED UNDER MICROGRAVITY | 3.6.1.55 3.6.1.56 |
6IK5 | CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
6IK6 | CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 WITH BETA-1,4-GALACTOBIOSE | 3.2.1.23 |
6IK7 | CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,3-GALACTOBIOSE | 3.2.1.23 |
6IK8 | CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE | 3.2.1.23 |
6IKT | K1U COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
6IKY | K2U COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
6IL0 | K3U COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
6IL2 | K4U COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV. ORYZAE | 3.5.1.88 |
6ILI | CRYSTAL STRUCTURE OF HUMAN MTH1(G2K/D120N MUTANT) IN COMPLEX WITH 8-OXO-DGTP AT PH 6.5 | 3.6.1.55 3.6.1.56 |
6ILU | ENDOLYSIN LYSPBC5 CBD | 3.2.1.17 |
6ILW | CRYSTAL STRUCTURE OF PETASE FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6ILX | CRYSTAL STRUCTURE OF PETASE W159F MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6IM6 | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMB | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMD | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMI | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMO | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMR | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMT | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6IMU | THE APO-STRUCTURE OF ENDO-BETA-1,2-GLUCANASE FROM TALAROMYCES FUNICULOSUS | 3.2.1.71 |
6IMV | THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE FROM TALAROMYCES FUNICULOSUS WITH SOPHOROSE | 3.2.1.71 |
6IMW | THE COMPLEX STRUCTURE OF ENDO-BETA-1,2-GLUCANASE MUTANT (E262Q) FROM TALAROMYCES FUNICULOSUS WITH BETA-1,2-GLUCAN | 3.2.1.71 |
6IMZ | CRYSTAL STRUCTURE OF MTH1 IN COMPLEX WITH 18-CROWN-6 | 3.6.1.55 3.6.1.56 |
6IND | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6INK | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6INM | CRYSTAL STRUCTURE OF PDE4D COMPLEXED WITH A NOVEL INHIBITOR | 3.1.4.53 |
6INX | STRUCTURAL INSIGHTS INTO A NOVEL GLYCOSIDE HYDROLASE FAMILY 18 N-ACETYLGLUCOSAMINIDASE FROM PAENIBACILLUS BARENGOLTZII | 3.2.1.96 3.2.1.52 |
6IO9 | THE STRUCTURE OF APO-UDGX | 3.2.2.27 |
6IOA | THE STRUCTURE OF UDGX IN COMPLEX WITH URACIL | 3.2.2.27 |
6IOB | THE STRUCTURE OF THE H109A MUTANT OF UDGX IN COMPLEX WITH URACIL | 2.7.7.7 3.2.2.27 |
6IOC | THE STRUCTURE OF THE H109Q MUTANT OF UDGX IN COMPLEX WITH URACIL | 2.7.7.7 3.2.2.27 |
6IOD | THE STRUCTURE OF UDGX IN COMPLEX WITH SINGLE-STRANDED DNA | 2.7.7.7 3.2.2.27 |
6IOZ | STRUCTURAL INSIGHTS OF IDURSULFASE BETA | 3.1.6.13 |
6IP2 | NSF-D1D2 PART IN THE WHOLE 20S COMPLEX | 3.6.4.6 |
6IQR | CRYSTAL STRUCTURE OF PRC WITH S452I AND L252Y MUTATIONS | 3.4.21.102 |
6IQW | CRYO-EM STRUCTURE OF CSM EFFECTOR COMPLEX | 3.1 2.7.7 |
6IRC | C-TERMINAL DOMAIN OF DROSOPHILA PHOSPHOLIPASE B NORPA, METHYLATED | 3.1.4.11 |
6IRE | COMPLEX STRUCTURE OF INAD PDZ45 AND NORPA CC-PBM | 3.1.4.11 |
6IRJ | CRYSTAL STRUCTURE OF LYSOZYME BY FIXED-TARGET SERIAL FEMTOSECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6ISO | HUMAN SIRT3 RECOGNIZING H3K4CR | 3.5.1 2.3.1.286 |
6ISP | STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT | 3.1.1.3 |
6ISQ | STRUCTURE OF LIPASE MUTANT WITH OXIDED CYS-HIS-ASP CATALYTIC TRIAD | 3.1.1.3 |
6ISR | STRUCTURE OF LIPASE MUTANT WITH CYS-HIS-ASP CATALYTIC TRIAD | 3.1.1.3 |
6ISU | CRYSTAL STRUCTURE OF LYS27-LINKED DI-UBIQUITIN IN COMPLEX WITH ITS SELECTIVE INTERACTING PROTEIN UCHL3 | 3.4.19.12 |
6ITB | ICOSAHEDRAL ASYMMETRIC UNIT (IASU) MODEL OF THE WELL-REFINED PART OF FHV ELUTED PARTICLE | 3.4.23.44 |
6ITF | ICOSAHEDRAL ASYMMETRIC UNIT (IASU) MODEL OF THE LESS REFINED, COARSE PART OF FHV ELUTED PARTICLE | 3.4.23.44 |
6ITY | CTX-M-64 SULBACTAM COMPLEX | 3.5.2.6 |
6IUX | CRYSTAL STRUCTURE OF A HYDROLASE PROTEIN | 3.2.2.19 |
6IV5 | CRYSTAL STRUCTURE OF ARABIDOPSIS N6-MAMP DEAMINASE MAPDA | 3.5.4 |
6IVC | THE FULL LENGTH OF TGEV NSP1 | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6IVD | TGEV NSP1 MUTANT - 91-95SG | 3.4.19.12 3.4.22 |
6IVV | STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII WITH MULTIPLE SURFACE BINDING REGIONS AT 1.26A RESOLUTION | 3.1.1.29 |
6IW0 | CRYSTAL STRUCTURE OF 5A SCFV IN COMPLEX WITH YFV-17D SE IN POSTFUSION STATE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6IW1 | CRYSTAL STRUCTURE OF YFV-17D SE IN POSTFUSION STATE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6IW2 | CRYSTAL STRUCTURE OF 5A SCFV IN COMPLEX WITH YFV-17D SE IN PREFUSION STATE | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6IWD | THE PTP DOMAIN OF HUMAN PTPN14 IN A COMPLEX WITH THE CR3 DOMAIN OF HPV18 E7 | 3.1.3.48 |
6IWI | CRYSTAL STRUCTURE OF PDE5A IN COMPLEX WITH A NOVEL INHIBITOR | 3.1.4.35 |
6IWK | THE STRUCTURE OF MALTOOLIGOSACCHARIDE-FORMING AMYLASE FROM PSEUDOMONAS SACCHAROPHILA STB07 | 3.2.1.60 |
6IX2 | STRUCTURE OF THE A214C/A250I MUTANT OF AN EPOXIDE HYDROLASE FROM ASPERGILLUS USAMII E001 (AUEH2) AT 1.48 ANGSTROMS RESOLUTION | 3.3.2.9 |
6IX4 | STRUCTURE OF AN EPOXIDE HYDROLASE FROM ASPERGILLUS USAMII E001 (AUEH2) AT 1.51 ANGSTROMS RESOLUTION | 3.3.2.9 |
6IX6 | CRYSTAL STRUCTURE OF THE COMPLEX OF PEPTIDYL-TRNA HYDROLASE WITH N-PROPANOL AT 1.43 A RESOLUTION | 3.1.1.29 |
6IXD | X-RAY CRYSTAL STRUCTURE OF BPI-11 HIV-1 PROTEASE COMPLEX | 3.4.23.16 |
6IYE | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII WITH 12% PEG 1500 AT 1.55 A RESOLUTION. | 3.1.1.29 |
6IYG | THE STRUCTURE OF MALTOOLIGOSACCHARIDE-FORMING AMYLASE FROM PSEUDOMONAS SACCHAROPHILA STB07 WITH MALTOTETRAOSE | 3.2.1.60 |
6IZ7 | E. COLI METHIONINE AMINOPEPTIDASE CRYSTAL STRUCTURE FITTED INTO THE CRYO-EM DENSITY MAP OF E. COLI 70S RIBOSOME IN COMPLEX WITH METHIONINE AMINOPEPTIDASE | 3.4.11.18 |
6IZC | CRYSTAL STRUCTURE OF THE CHROMOSOME-ENCODED BETA-LACTAMASE OF VIBRIO PARAHAEMOLYTICUS | 3.5.2.6 |
6IZD | CRYSTAL STRUCTURE OF THE CHROMOSOME-ENCODED BETA-LACTAMASE MUTANT R168H/M221I OF VIBRIO PARAHAEMOLYTICUS | 3.5.2.6 |
6IZH | CRYSTAL STRUCTURE OF DEAMINASE AMNE FROM PSEUDOMONAS SP. AP-3 | 3.5.99.5 |
6IZI | CRYSTAL STRUCTURE OF E. COLI PEPTIDE DEFORMYLASE AND METHIONINE AMINOPEPTIDASE FITTED INTO THE CRYO-EM DENSITY MAP OF THE COMPLEX | 3.5.1.88 |
6IZW | MYXOCOCCUS XANTHUS MGLA BOUND TO GTP-GAMMA-S AND MGLB | 3.6.5.2 |
6IZX | THE RNA-DEPENDENT RNA POLYMERASE DOMAIN OF DENGUE 2 NS5, BOUND WITH RK-0404678 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6IZY | THE RNA-DEPENDENT RNA POLYMERASE DOMAIN OF DENGUE 2 NS5 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6IZZ | THE RNA-DEPENDENT RNA POLYMERASE DOMAIN OF DENGUE 3 NS5, BOUND WITH RK-0404678 | 3.4.21.91 3.6.1.15 3.6.4.13 |
6J00 | THE RNA-DEPENDENT RNA POLYMERASE DOMAIN OF DENGUE 3 NS5 | 3.4.21.91 3.6.1.15 3.6.4.13 |
6J0A | CRYSTAL STRUCTURE OF E. COLI METHIONINE AMINOPEPTIDASE ENZYME AND CHAPERONE TRIGGER FACTOR FITTED INTO THE CRYO-EM DENSITY MAP OF THE COMPLEX | 3.4.11.18 |
6J1P | CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT - SR | 3.1.1.3 |
6J1Q | CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT - RS | 3.1.1.3 |
6J1R | CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT - RR | 3.1.1.3 |
6J1S | CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT - SS | 3.1.1.3 |
6J1T | CRYSTAL STRUCTURE OF CANDIDA ANTARCTICA LIPASE B MUTANT SR WITH PRODUCT ANALOGUE | 3.1.1.3 |
6J20 | CRYSTAL STRUCTURE OF THE HUMAN NK1 SUBSTANCE P RECEPTOR | 3.2.1.17 |
6J21 | CRYSTAL STRUCTURE OF THE HUMAN NK1 SUBSTANCE P RECEPTOR | 3.2.1.17 |
6J22 | CRYSTAL STRUCTURE OF BI-FUNCTIONAL ENZYME | 3.5.4.19 3.6.1.31 |
6J23 | CRYSTAL STRUCTURE OF ARABIDOPSIS ADAL COMPLEXED WITH GMP | 3.5.4 |
6J25 | CTX-M-64 BETA-LACTAMASE MUTANT-S130T | 3.5.2.6 |
6J2B | CTX-M-64 BETA-LACTAMASE S130T SULBACTAM COMPLEX | 3.5.2.6 |
6J2K | CTX-M-64 BETA-LACTAMASE S130T CLAVULANIC ACID COMPLEX | 3.5.2.6 |
6J2L | CRYSTAL STRUCTURE OF BI-FUNCTIONAL ENZYME | 3.5.4.19 3.6.1.31 |
6J2O | CRYSTAL STRUCTURE OF CTX-M-64 CLAVULANIC ACID COMPLEX | 3.5.2.6 |
6J34 | CRYSTAL STRUCTURE OF MALTOTRIOSE-COMPLEX OF PULA FROM KLEBSIELLA PNEUMONIAE | 3.2.1.41 |
6J35 | CRYSTAL STRUCTURE OF LIGAND-FREE OF PULA-G680L MUTANT FROM KLEBSIELLA PNEUMONIAE | 3.2.1.41 |
6J3X | THE STRUCTURE OF MALTOOLIGOSACCHARIDE-FORMING AMYLASE FROM PSEUDOMONAS SACCHAROPHILA STB07 WITH MALTOTRIOSE | 3.2.1.60 |
6J43 | PROTEINASE K DETERMINED BY PAL-XFEL | 3.4.21.64 |
6J4H | CRYSTAL STRUCTURE OF MALTOTRIOSE-COMPLEX OF PULA-G680L MUTANT FROM KLEBSIELLA PNEUMONIAE | 3.2.1.41 |
6J4O | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J4P | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J4Q | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J4S | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J4T | CRYSTAL STRUCTURE OF ARABIDOPSIS ADAL COMPLEXED WITH IMP | 3.5.4 |
6J4U | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J4V | STRUCTURAL BASIS OF TUBULIN DETYROSINATION BY VASOHIBINS-SVBP ENZYME COMPLEX AND FUNCTIONAL IMPLICATIONS | 3.4.17.17 |
6J53 | CRYSTAL STRUCTURE OF HUMAN HINT1 COMPLEXING WITH ATP | 3 |
6J58 | CRYSTAL STRUCTURE OF HUMAN HINT1 COMPLEXING WITH AP4A | 3 |
6J5C | LOUPING ILL VIRUS ENVELOPE PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6J5G | COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6J5S | CRYSTAL STRUCTURE OF HUMAN HINT1 MUTANT COMPLEXING WITH AP5A | 3 |
6J5Z | CRYSTAL STRUCTURE OF HUMAN HINT1 MUTANT COMPLEXING WITH AP3A | 3 |
6J64 | CRYSTAL STRUCTURE OF HUMAN HINT1 MUTANT COMPLEXING WITH AP4A | 3 |
6J65 | CRYSTAL STRUCTURE OF HUMAN HINT1 MUTANT COMPLEXING WITH AP4A II | 3 |
6J66 | CHONDROITIN SULFATE/DERMATAN SULFATE ENDOLYTIC 4-O-SULFATASE | 3.1.6.12 |
6J6T | CRYSTAL STRUCTURE OF HDA15 HD DOMAIN | 3.5.1.98 |
6J6U | RAT PTPRZ D1-D2 DOMAIN | 3.1.3.48 |
6J7B | CRYSTAL STRUCTURE OF VASH1-SVBP IN COMPLEX WITH EPOY | 3.4.17.17 |
6J7Y | HUMAN MITOCHONDRIAL OLIGORIBONUCLEASE IN COMPLEX WITH DNA | 3.1 |
6J7Z | HUMAN MITOCHONDRIAL OLIGORIBONUCLEASE IN COMPLEX WITH RNA | 3.1 |
6J80 | HUMAN MITOCHONDRIAL OLIGORIBONUCLEASE IN COMPLEX WITH POLY-DT DNA | 3.1 |
6J8Q | SERINE BETA-LACTAMASE KPC-2 IN COMPLEX WITH DUAL MBL/SBL INHIBITOR WL-001 | 3.5.2.6 |
6J8Y | CRYSTAL STRUCTURE OF THE HUMAN RAD9-HUS1-RAD1-RHINO COMPLEX | 3.1.11.2 |
6J93 | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 0.95 A RESOLUTION | 3.1.1.29 |
6J9M | NMEBH+ACRIIC2 | 3.1 |
6J9N | NMEHNH+ACRIIC3 | 3.1 |
6JAV | CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 1 IN COMPLEX WITH A PIPERIDINE-THIENOPYRIDINE DERIVATIVE | 3.2.1.14 |
6JAW | CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 1 IN COMPLEX WITH A NAPTHALIMIDE DERIVATIVE | 3.2.1.14 |
6JAX | CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 1 IN COMPLEX WITH CHITOOCTAOSE [(GLCN)8] | 3.2.1.14 |
6JAY | CRYSTAL STRUCTURE OF OSTRINIA FURNACALIS GROUP II CHITINASE CATALYTIC DOMAIN 1 IN COMPLEX WITH A DIPYRIDO-PYRIMIDINE DERIVATIVE | 3.2.1.14 |
6JCF | CRYOGENIC STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE DOMAIN BY SYNCHROTRON | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6JCG | ROOM TEMPERATURE STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE DOMAIN BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY. | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6JCI | CRYSTAL STRUCTURE OF PROLYL ENDOPEPTIDASE FROM HALIOTIS DISCUS HANNAI WITH SUAM-14746 | 3.4.21.26 |
6JD0 | STRUCTURE OF MUTANT HUMAN CATHEPSIN L, ENGINEERED FOR GAG BINDING | 3.4.22.15 |
6JD8 | STRUCTURE OF A PROLINE SPECIFIC MUTANT OF HUMAN CATHEPSIN L | 3.4.22.15 |
6JD9 | PROTEUS MIRABILIS LIPASE MUTANT - I118V/E130G | 3.1.1.3 |
6JDE | CRYSTAL STRUCTURE OF A DNA REPAIR PROTEIN | 3.6.4.12 |
6JDQ | CRYSTAL STRUCTURE OF NME1CAS9 IN COMPLEX WITH SGRNA | 3.1 |
6JDR | CRYSTAL STRUCTURE OF METHYLATED PRRSV NSP10 (HELICASE) | 3.6.4.13 |
6JDS | CRYSTAL STRUCTURE OF TRUNCATED PRRSV NSP10 (HELICASE) | 3.6.4.13 |
6JDT | CRYSTAL STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1 FROM ASPERGILLUS FUMIGATUS Z5 | 3.2.1.8 |
6JDU | CRYSTAL STRUCTURE OF PRRSV NSP10 (HELICASE) | 3.6.4.13 |
6JDV | CRYSTAL STRUCTURE OF NME1CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (ATATGATT PAM) IN CATALYTIC STATE | 3.1 |
6JDY | LIGAND COMPLEX STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1, SOAKING FOR 120 MINUTES | 3.2.1.8 |
6JDZ | LIGAND COMPLEX STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1, SOAKING FOR 20 MINUTES | 3.2.1.8 |
6JE0 | LIGAND COMPLEX STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1, SOAKING FOR 30 MINUTES | 3.2.1.8 |
6JE1 | LIGAND COMPLEX STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1, SOAKING FOR 40 MINUTES | 3.2.1.8 |
6JE2 | LIGAND COMPLEX STRUCTURE OF GH10 FAMILY XYLANASE XYNAF1, SOAKING FOR 80 MINUTES | 3.2.1.8 |
6JE3 | CRYSTAL STRUCTURE OF NME2CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (AGGCCC PAM) WITH 5 NT OVERHANG | 3.1 |
6JE8 | CRYSTAL STRUCTURE OF A BETA-N-ACETYLHEXOSAMINIDASE | 3.2.1.52 |
6JEA | CRYSTAL STRUCTURE OF A BETA-N-ACETYLHEXOSAMINIDASE | 3.2.1.52 |
6JEB | CRYSTAL STRUCTURE OF A BETA-N-ACETYLHEXOSAMINIDASE | 3.2.1.52 |
6JED | CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE IN A COMPLEX WITH MCR | 3.5.2.6 |
6JEP | STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III | 3.4.21.91 3.6.1.15 3.6.4.13 |
6JEQ | CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH BETA-CYCLODEXTRIN | 3.2.1.41 |
6JER | APO CRYSTAL STRUCTURE OF CLASS I TYPE A PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JES | APO CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JET | ACTINONIN BOUND CRYSTAL STRUCTURE OF CLASS I TYPE A PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JEU | K1U BOUND CRYSTAL PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANII | 3.5.1.88 |
6JEV | K2U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE A PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANII | 3.5.1.88 |
6JEW | K3U BOUND CRYSTAL PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANII | 3.5.1.88 |
6JEX | K4U BOUND CRYSTAL PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANII | 3.5.1.88 |
6JF3 | ACTINONIN BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF4 | K1U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF5 | K2U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF6 | MET-ALA-SER BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF7 | K3U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF8 | K4U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM ACINETOBACTER BAUMANNII | 3.5.1.88 |
6JF9 | APO CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFA | MET-ALA-SER BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFC | ACTINONIN BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFD | K1U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFE | K2U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFF | K3U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFG | K1U BOUND CRYSTAL STRUCTURE OF CLASS II PEPTIDE DEFORMYLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | 3.5.1.88 |
6JFH | THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6JFI | THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6JFJ | CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH MALTOHEXAOSE AND ALPHA-CYCLODEXTRIN | 3.2.1.41 |
6JFK | GDP BOUND MITOFUSIN2 (MFN2) | 3.6.5 |
6JFL | NUCLEOTIDE-FREE MITOFUSIN2 (MFN2) | 3.6.5 |
6JFM | MITOFUSIN2 (MFN2)_T111D | 3.6.5 |
6JFN | K4U BOUND CRYSTAL STRUCTURE OF CLASS I TYPE B PEPTIDE DEFORMYLASE FROM PSEUDOMONAS AERUGINOSA | 3.5.1.88 |
6JFO | FORMYL-MET-ALA-SER BOUND CRYSTAL STRUCTURE OF CLASS II PEPTIDE DEFORMYLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | 3.5.1.88 |
6JFP | CRYSTAL STRUCTURE OF THE BETA-GLUCOSIDASE BGL15 | 3.2.1.21 |
6JFQ | K2U BOUND CRYSTAL STRUCTURE OF CLASS II PEPTIDE DEFORMYLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | 3.5.1.88 |
6JFR | K3U BOUND CRYSTAL STRUCTURE OF CLASS II PEPTIDE DEFORMYLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | 3.5.1.88 |
6JFS | K4U BOUND CRYSTAL STRUCTURE OF CLASS II PEPTIDE DEFORMYLASE FROM METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS | 3.5.1.88 |
6JFU | CRYSTAL STRUCTURE OF NME2CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (AGGCCC PAM) | 3.1 |
6JFX | CRYSTAL STRUCTURE OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEX WITH MALTOPENTAOSE | 3.2.1.41 |
6JG0 | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN SINGLE MUTANT (S92E) OF THE HUMAN MITOCHONDRIAL CALCIUM UNIPORTER FUSED WITH T4 LYSOZYME | 3.2.1.17 |
6JGU | CRYSTAL STRUCTURE AT ATOMIC RESOLUTION REVEALS THE CATALYTIC MECHANISM IN PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII. | 3.1.1.29 |
6JHF | CRYSTAL STRUCTURE OF APO PULLULANASE FROM PAENIBACILLUS BARENGOLTZII | 3.2.1.41 |
6JHG | CRYSTAL STRUCTURE OF APO PULLULANASE FROM PAENIBACILLUS BARENGOLTZII IN SPACE GROUP P212121 | 3.2.1.41 |
6JHH | CRYSTAL STRUCTURE OF MUTANT D350A OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH MALTOTRIOSE | 3.2.1.41 |
6JHI | CRYSTAL STRUCTURE OF MUTANT D470A OF PULLULANASE FROM PAENIBACILLUS BARENGOLTZII COMPLEXED WITH MALTOTETRAOSE | 3.2.1.41 |
6JHP | CRYSTAL STRUCTURE OF THE GLYCOSIDE HYDROLASE FAMILY 36 ALPHA-GALACTOSIDASE FROM PAECILOMYCES THERMOPHILA | 3.2.1.22 |
6JHQ | THE CRYO-EM STRUCTURE OF HAV BOUND TO A NEUTRALIZING ANTIBODY-F4 | 3.6.1.15 3.4.22.28 2.7.7.48 |
6JHR | THE CRYO-EM STRUCTURE OF HAV BOUND TO A NEUTRALIZING ANTIBODY-F6 | 3.6.1.15 3.4.22.28 2.7.7.48 |
6JHZ | CRYSTAL STRUCTURE OF CAS2 | 3.1 |
6JIB | HUMAN MTHFD2 IN COMPLEX WITH DS44960156 | 1.5.1.15 3.5.4.9 |
6JID | HUMAN MTHFD2 IN COMPLEX WITH COMPOUND 1 | 1.5.1.15 3.5.4.9 |
6JIJ | THE CRYSTAL STRUCTURE OF MAIN PROTEASE FROM MOUSE HEPATITIS VIRUS A59 IN COMPLEX WITH AN INHIBITOR | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6JIM | VIRAL HELICASE PROTEIN | 2.7.7.19 3.1.3.33 3.1.3.84 3.6.1.15 3.6.4.13 |
6JJ1 | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 0.97 A RESOLUTION WITH DISORDERED FIVE N-TERMINAL RESIDUES | 3.1.1.29 |
6JJL | CRYSTAL STRUCTURE OF THE DEGP DODECAMER WITH A MODULATOR | 3.4.21.107 |
6JJQ | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 0.99 A RESOLUTION. | 3.1.1.29 |
6JJR | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 (HCHIT1) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 2-8-14 | 3.2.1.14 |
6JK6 | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE-1 (HCHIT) CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND 2-8-S2 | 3.2.1.14 |
6JK9 | CRYSTAL STRUCTURE OF SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH COMPOUND 2-8-14 | 3.2.1.14 |
6JKA | CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMSE, IMP-1, IN COMPLEX WITH A THIAZOLE-BEARING INHIBITOR | 3.5.2.6 |
6JKB | CRYSTAL STRUCTURE OF METALLO-BETA-LACTAMSE, NDM-1, IN COMPLEX WITH HYDROLYZED AMPICILLIN | 3.5.2.6 |
6JKF | CRYSTAL STRUCTURE OF SERRATIA MARCESCENS CHITINASE B COMPLEXED WITH COMPOUND 2-8-S2 | 3.2.1.14 |
6JKX | CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE WITH MULTIPLE SODIUM AND CHLORIDE IONS AT 1.08 A RESOLUTION. | 3.1.1.29 |
6JLQ | CRYSTAL STRUCTURE OF HUMAN USP46-WDR48-WDR20 COMPLEX | 3.4.19.12 |
6JMS | CJP38, A BETA-1,3-GLUCANASE AND ALLERGEN OF CRYPTOMERIA JAPONICA POLLEN | 3.2.1.39 |
6JN3 | SERINE BETA-LACTAMASE KPC-2 IN COMPLEX WITH DUAL MBL/SBL INHIBITOR MS05 | 3.5.2.6 |
6JN4 | SERINE BETA-LACTAMASE KPC-2 IN COMPLEX WITH DUAL MBL/SBL INHIBITOR WL-001 | 3.5.2.6 |
6JN5 | SERINE BETA-LACTAMASE KPC-2 IN COMPLEX WITH DUAL MBL/SBL INHIBITOR MS23 | 3.5.2.6 |
6JO8 | THE COMPLEX STRUCTURE OF CHIKV ENVELOPE GLYCOPROTEIN BOUND TO HUMAN MXRA8 | 3.4.21.90 |
6JOO | CRYSTAL STRUCTURE OF CORYNEBACTERIUM DIPHTHERIAE CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA | 3.1 |
6JPW | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 1C | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6JQB | THE STRUCTURE OF MALTOOLIGOSACCHARIDE-FORMING AMYLASE FROM PSEUDOMONAS SACCHAROPHILA STB07 WITH PSEUDO-MALTOHEPTAOSE | 3.2.1.60 |
6JQF | CRYSTALLIZATION ANALYSIS OF A BETA-N-ACETYLHEXOSAMINIDASE (AM2136) FROM AKKERMANSIA MUCINIPHILA | 3.2.1.52 |
6JQL | STRUCTURE OF PAAZ, A BIFUNCTIONAL ENZYME | 3.3.2.12 1.2.1.91 |
6JQM | STRUCTURE OF PAAZ WITH NADPH | 3.3.2.12 1.2.1.91 |
6JQN | STRUCTURE OF PAAZ, A BIFUNCTIONAL ENZYME IN COMPLEX WITH NADP+ AND OCOA | 3.3.2.12 1.2.1.91 |
6JQO | STRUCTURE OF PAAZ, A BIFUNCTIONAL ENZYME IN COMPLEX WITH NADP+ AND CCOA | 3.3.2.12 1.2.1.91 |
6JQT | CRYSTAL STRUCTURE OF ORDERED ASN70 AND ASN116 IN NATIVE PEPTIDYL T-RNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.80 ANGSTROM RESOLUTION. | 3.1.1.29 |
6JR7 | FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, COMPLEXED WITH GLUCOSE | 3.2.1.20 |
6JR8 | FLAVOBACTERIUM JOHNSONIAE GH31 DEXTRANASE, FJDEX31A, MUTANT D412A COMPLEXED WITH ISOMALTOTRIOSE | 3.2.1.20 |
6JSE | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-(3-((4S,5R)-2-AMINO-4-METHYL-5-PHENYL-5,6-DIHYDRO-4H-1,3-THIAZIN-4-YL)-4-FLUOROPHENYL)-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6JSF | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-(3-((4S,5S)-2-AMINO-4-METHYL-5-PHENYL-5,6-DIHYDRO-4H-1,3-THIAZIN-4-YL)-4-FLUOROPHENYL)-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6JSG | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-{3-[(4S)-2-AMINO-4-METHYL-5,6-DIHYDRO-4H-1,3-THIAZIN-4-YL]-4-FLUOROPHENYL}-5-CHLOROPYRIDINE-2-CARBOXAMIDE | 3.4.23.46 |
6JSN | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-{3-[(5R)-3-AMINO-5-METHYL-9,9-DIOXO-2,9LAMBDA6-DITHIA-4-AZASPIRO[5.5]UNDEC-3-EN-5-YL]-4-FLUOROPHENYL}-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6JSS | STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, Y99P MUTANT | 3.5 |
6JST | STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, Y99P/D266N DOUBLE MUTANT WITH BOUND 3-OXO-C8-HSL | 3.5 |
6JSU | STRUCTURE OF GEOBACILLUS KAUSTOPHILUS LACTONASE, Y99C/D266N DOUBLE MUTANT | 3.5 |
6JSZ | BACE2 XAPERONE COMPLEX WITH N-{3-[(5R)-3-AMINO-5-METHYL-9,9-DIOXO-2,9LAMBDA6-DITHIA-4-AZASPIRO[5.5]UNDEC-3-EN-5-YL]-4-FLUOROPHENYL}-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.45 |
6JT3 | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-{3-[(4R,5R,6R)-2-AMINO-5-FLUORO-4,6-DIMETHYL-5,6-DIHYDRO-4H-1,3-THIAZIN-4-YL]-4-FLUOROPHENYL}-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6JT4 | CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH N-{3-[(4S,6S)-2-AMINO-4-METHYL-6-(TRIFLUOROMETHYL)-5,6-DIHYDRO-4H-1,3-THIAZIN-4-YL]-4-FLUOROPHENYL}-5-(FLUOROMETHOXY)PYRAZINE-2-CARBOXAMIDE | 3.4.23.46 |
6JTB | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) WITH CITRATE FROM PORPHYROMONAS GINGIVALIS (SPACE) | 3.4.14 |
6JTC | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE 11 (DPP11) WITH SH-5 FROM PORPHYROMONAS GINGIVALIS (SPACE) | 3.4.14 |
6JTG | STRUCTURAL INSIGHTS INTO G DOMAIN DIMERIZATION AND PATHOGENIC MUTATIONS OF OPA1 | 3.6.5.5 |
6JTI | CRYSTAL STRUCTURE OF NATIVE NAGZ FROM NEISSERIA GONORRHOEAE | 3.2.1.52 |
6JTJ | CRYSTAL STRUCTURE OF NAGZ FROM NEISSERIA GONORRHOEAE IN COMPLEX WITH N-ACETYLGLUCOSAMINE | 3.2.1.52 |
6JTK | CRYSTAL STRUCTURE OF NAGZ FROM NEISSERIA GONORRHOEAE IN COMPLEX WITH N-TRIFLUOROACETYL-D-GLUCOSAMINE | 3.2.1.52 |
6JTL | CRYSTAL STRUCTURE OF NAGZ FROM NEISSERIA GONORRHOEAE IN COMPLEX WITH ZINC ION | 3.2.1.52 |
6JTT | MHETASE IN COMPLEX WITH BHET | 3.1.1.102 |
6JTU | CRYSTAL STRUCTURE OF MHETASE FROM IDEONELLA SAKAIENSIS | 3.1.1.102 |
6JTZ | CRYSTAL STRUCTURE OF HRECQ1_D2-ZN-WH CONTAINING MUTATION ON BETA-HAIRPIN | 3.6.4.12 |
6JUG | CRYSTAL STRUCTURES OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6JVF | CRYSTAL STRUCTURE OF HUMAN APO MTH1 | 3.6.1.55 3.6.1.56 |
6JVG | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI0639 | 3.6.1.55 3.6.1.56 |
6JVH | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI0320 | 3.6.1.55 3.6.1.56 |
6JVI | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI0861 | 3.6.1.55 3.6.1.56 |
6JVJ | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1006 | 3.6.1.55 3.6.1.56 |
6JVK | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1012 | 3.6.1.55 3.6.1.56 |
6JVL | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1014 | 3.6.1.55 3.6.1.56 |
6JVM | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1016 | 3.6.1.55 3.6.1.56 |
6JVN | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1020 | 3.6.1.55 3.6.1.56 |
6JVO | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1022 | 3.6.1.55 3.6.1.56 |
6JVP | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1024 | 3.6.1.55 3.6.1.56 |
6JVQ | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1025 | 3.6.1.55 3.6.1.56 |
6JVR | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1026 | 3.6.1.55 3.6.1.56 |
6JVS | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1029 | 3.6.1.55 3.6.1.56 |
6JVT | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH COMPOUND MI1030 | 3.6.1.55 3.6.1.56 |
6JW9 | CRYSTAL STRUCTURE OF E-64 INHIBITED FALCIPAIN 2 FROM PLASMODIUM FALCIPARUM, STRAIN 3D7 | 3.4.22 |
6JWB | CRYSTAL STRUCTURES OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6JXG | CRYSTASL STRUCTURE OF BETA-GLUCOSIDASE D2-BGL FROM CHAETOMELLA RAPHIGERA | 3.2.1.21 |
6JXL | CRYSTAL STRUCTURES OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6JXP | ROOM TEMPERATURE STRUCTURE OF LYSOZYME DELIVERED IN LCP BY SERIAL MILLISECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6JXQ | ROOM TEMPERATURE STRUCTURE OF LYSOZYME DELIVERED IN POLYACRYLAMIDE BY SERIAL MILLISECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6JYM | CRYSTAL STRUCTURE OF PROLYL ENDOPEPTIDASE FROM HALIOTIS DISCUS HANNAI | 3.4.21.26 |
6JYP | CRYSTAL STRUCTURE OF UPA_H99Y IN COMPLEX WITH 3-AZANYL-5-(AZEPAN-1-YL)-N-[BIS(AZANYL)METHYLIDENE]-6-CHLORANYL-PYRAZINE-2-CARBOXAMIDE | 3.4.21.73 |
6JYQ | CRYSTAL STRUCTURE OF UPA_H99Y IN COMPLEX WITH 3-AZANYL-5-(AZEPAN-1-YL)-N-CARBAMIMIDOYL-6-(FURAN-2-YL)PYRAZINE-2-CARBOXAMIDE | 3.4.21.73 |
6JYT | DELICATE STRUCTURAL COORDINATION OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS NSP13 UPON ATP HYDROLYSIS | 3.6.4.12 3.6.4.13 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 2.1.1 3.1.13 3.1 |
6JZ1 | APO STRUCTURE OF B-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS AT 1.7 ANGSTROM RESOLUTION | 3.2.1.23 |
6JZ2 | B-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH URONIC ISOFAGOMINE AT 1.3 ANGSTROMS RESOLUTION | 3.2.1.23 |
6JZ3 | B-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS IN COMPLEX WITH URONIC DEOXYNOJIRIMYCIN | 3.2.1.23 |
6JZC | STRUCTURAL BASIS OF TUBULIN DETYROSINATION | 3.4.17.17 |
6JZD | CRYSTAL STRUCTURE OF PEPTIDE-BOUND VASH2-SVBP COMPLEX | 3.4.17.17 |
6JZE | CRYSTAL STRUCTURE OF VASH2-SVBP COMPLEX WITH THE MAGIC TRIANGLE I3C | 3.4.17.17 |
6JZI | STRUCTURE OF HEN EGG-WHITE LYSOZYME OBTAINED FROM SFX EXPERIMENTS UNDER ATMOSPHERIC PRESSURE | 3.2.1.17 |
6JZL | S-FORMYLGLUTATHIONE HYDROLASE HOMOLOG FROM A PSYCHROPHILIC BACTERIUM OF SHEWANELLA FRIGIDIMARINA | 3.1.2.12 |
6JZP | CRYSTAL STRUCTURES OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6K0A | CRYO-EM STRUCTURE OF AN ARCHAEAL RIBONUCLEASE P | 3.1.26.5 |
6K0B | CRYO-EM STRUCTURE OF ARCHAEAL RIBONUCLEASE P WITH MATURE TRNA | 3.1.26.5 |
6K17 | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN | 3.1.11.1 3.1.13 |
6K18 | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MN | 3.1.11.1 3.1.13 |
6K19 | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MG | 3.1.11.1 3.1.13 |
6K1A | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MN AND MG | 3.1.11.1 3.1.13 |
6K1B | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MN AND DGMP | 3.1.11.1 3.1.13 |
6K1C | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MG AND DGMP | 3.1.11.1 3.1.13 |
6K1D | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MN AND GMP | 3.1.11.1 3.1.13 |
6K1E | CRYSTAL STRUCTURE OF EXD2 EXONUCLEASE DOMAIN SOAKED IN MG AND GMP | 3.1.11.1 3.1.13 |
6K1Q | HUMAN ENDOTHELIN RECEPTOR TYPE-B IN COMPLEX WITH INVERSE AGONIST IRL2500 | 3.2.1.17 |
6K1Z | CRYSTAL STRUCTURE OF FARNESYLATED HGBP1 | 3.6.5 |
6K21 | PYROPHOSPHATASE FROM ACINETOBACTER BAUMANNII | 3.6.1.1 |
6K26 | CRYSTAL STRUCTURE OF VIBRIO CHOLERAE METHIONINE AMINOPEPTIDASE | 3.4.11.18 |
6K27 | PYROPHOSPHATASE WITH PPI FROM ACINETOBACTER BAUMANNII | 3.6.1.1 |
6K2P | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2Q | AEROMONAS HYDROPHILA MTAN-2 COMPLEXED WITH ADENINE | 3.2.2.9 |
6K2R | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2S | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2T | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2V | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2W | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K2X | CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUM | 3.4.21.64 |
6K35 | CRYSTAL STRUCTURE OF GH20 EXO BETA-N-ACETYLGLUCOSAMINIDASE FROM VIBRIO HARVEYI IN COMPLEX WITH NAG-THIAZOLINE | 3.2.1.52 |
6K3J | SOLUTION STRUCTURE OF APOBEC3G-CD2 WITH SSDNA, PRODUCT A | 3.5.4 |
6K3K | SOLUTION STRUCTURE OF APOBEC3G-CD2 WITH SSDNA, PRODUCT B | 3.5.4 |
6K4T | CRYSTAL STRUCTURE OF SMB-1 METALLO-BETA-LACTAMASE IN A COMPLEX WITH TSA | 3.5.2.6 |
6K4X | CRYSTAL STRUCTURE OF SMB-1 METALLO-BETA-LACTAMASE IN A COMPLEX WITH ASB | 3.5.2.6 |
6K52 | HYPERTHERMOPHILIC GH6 CELLOBIOHYDROLASE (HMCEL6A) FROM THE MICROBIAL FLORA OF A JAPANESE HOT SPRING | 3.2.1.91 |
6K53 | A VARIANT OF METAGENOME-DERIVED GH6 CELLOBIOHYDROLASE, HMCEL6A (P88S/L230F/F414S) | 3.2.1.91 |
6K54 | HYPERTHERMOPHILIC GH6 CELLOBIOHYDROLASE II (HMCEL6A) IN COMPLEX WITH TRISACCHARIDE | 3.2.1.91 |
6K55 | INACTIVATED MUTANT (D140A) OF HYPERTHERMOPHILIC GH6 CELLOBIOHYDROLASE II (HMCEL6A) IN COMPLEX WITH HEXASACCHARIDE | 3.2.1 |
6K5E | CRYSTAL STRUCTURE OF BIOH FROM KLEBSIELLA PNEUMONIA | 3.1.1.85 |
6K5J | STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-N-ACETYLGLUCOSAMINIDASE FROM PAENIBACILLUS SP. STR. FPU-7 | 3.2.1.52 |
6K5L | THE CRYSTAL STRUCTURE OF ISOCITRATE DEHYDROGENASE KINASE/PHOSPHATASE WTIH TWO MN2+ FROM E. COLI | 3.1.3 2.7.11.5 |
6K5Q | CRYSTAL STRUCTURE OF LYSOZYME COMPLEXED WITH A BIOACTIVE COMPOUND FROM JATROPHA GOSSYPIIFOLIA | 3.2.1.17 |
6K6S | STRUCTURE OF RNASE J1 FROM STAPHYLOCOCCUS EPIDERMIDIS | 3.1 |
6K6T | CRYSTAL STRUCTURE OF A STANDALONE VERSATILE EAL PROTEIN FROM VIBRIO CHOLERAE O395 - C-DI-IMP BOUND FORM | 3.1.4.1 |
6K6U | CRYSTAL STRUCTURE OF THE HUMAN YTHDC2 YTH DOMAIN | 3.6.4.13 |
6K6W | STRUCTURE OF RNASE J2 FROM STAPHYLOCOCCUS EPIDERMIDIS | 3.1 |
6K7W | SOLUTION STRUCTURE OF THE CS1 DOMAIN OF USP19 | 3.4.19.12 |
6K7Z | CRYSTAL STRUCTURE OF A GH18 CHITINASE FROM PSEUDOALTEROMONAS AURANTIA | 3.2.1.14 |
6K81 | CRYSTAL STRUCTURE OF HUMAN VASH1-SVBP COMPLEX | 3.4.17.17 |
6K8G | H/D EXCHANGED HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
6K8M | HIGH RESOLUTION CRYSTAL STRUCTURE OF PROTEINASE K WITH THIOUREA | 3.4.21.64 |
6K8X | CRYSTAL STRUCTURE OF A CLASS C BETA LACTAMASE | 3.5.2.6 |
6K98 | SUBSTRATES PROMISCUITY OF XYLOGLUCANASES AND ENDOGLUCANASES OF GLYCOSIDE HYDROLASE 12 FAMILY | 3.2.1.4 |
6K9D | GLYCOSIDE HYDROLASE FAMILY 12 (GH12) ENGLUCANASE | 3.2.1.4 |
6K9N | RICE_OTUB_LIKE_CATALYTIC DOMAIN | 3.4.19.12 |
6K9O | CRYSTAL STRUCTURE ANALYSIS OF PROTEIN | 3.2.1.8 |
6K9P | STRUCTURE OF DEUBIQUITINASE | 3.4.19.12 |
6K9R | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6K9T | CRYSTAL STRUCTURE OF A CLASS C BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME | 3.5.2.6 |
6K9U | DISCOVERY OF PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVE AS A HIGHLY SELECTIVE PDE10A INHIBITOR | 3.1.4.17 3.1.4.35 |
6K9W | CRYSTAL STRUCTURES OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6KA5 | CRYSTAL STRUCTURE OF A CLASS C BETA-LACTAMASE IN COMPLEX WITH CEFOXITIN | 3.5.2.6 |
6KBD | FUSED TO-MTBCSM1 WITH 2DATP | 3.1 2.7.7 |
6KBE | STRUCTURE OF DEUBIQUITINASE | 3.4.19.12 |
6KBR | CRYSTAL STRUCTURE OF HUMAN KLK4 AND SPINK2 DERIVED KLK4 INHIBITOR COMPLEX | 3.4.21 |
6KBS | CRYSTAL STRUCTURE OF YEDK IN COMPLEX WITH SSDNA | 3.4 |
6KBU | CRYSTAL STRUCTURE OF YEDK | 3.4 |
6KBY | CRYSTAL STRUCTURE OF A CLASS C BETA LACTAMASE IN COMPLEX WITH AMP | 3.5.2.6 |
6KC0 | FUSED TO-MTBCSM1 WITH 2ATP | 3.1 2.7.7 |
6KC7 | CRYSTAL STRUCTURE OF NME1CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (ATATGATT PAM) IN SEED-BASE PARING STATE | 3.1 |
6KC8 | CRYSTAL STRUCTURE OF WT NME1CAS9 IN COMPLEX WITH SGRNA AND TARGET DNA (ATATGATT PAM) IN POST-CLEAVAGE STATE | 3.1 |
6KCB | ROOM TEMPERATURE STRUCTURE OF LYSOZYME DELIVERED IN SHORTENING A BY SERIAL MILLISECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6KCD | ROOM TEMPERATURE STRUCTURE OF LYSOZYME DELIVERED IN SHORTENING B BY SERIAL MILLISECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6KCS | CRYSTAL STRUCTURE OF HIRAN DOMAIN OF HLTF IN COMPLEX WITH DUPLEX DNA | 2.3.2.27 3.6.4 |
6KCZ | SOLUTION STRUCTURE OF THE ZNF-UBP DOMAIN OF USP20/VDU2 | 3.4.19.12 |
6KD1 | ROOM TEMPERATURE STRUCTURE OF LYSOZYME DELIVERED IN AGAROSE BY SERIAL MILLISECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6KD5 | CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MSPL/TMPRSS13 IN COMPLEX WITH DEC-RVKR-CMK INHIBITOR | 3.4.21 |
6KDV | CRYSTAL STRUCTURE OF TTCAS1-DNA COMPLEX | 3.1 |
6KDX | CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH A TRIAZOLOPYRIMIDINE INHIBITOR | 3.1.4.17 3.1.4.35 |
6KDZ | CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH A TRIAZOLOPYRIMIDINE INHIBITOR | 3.1.4.17 3.1.4.35 |
6KE0 | CRYSTAL STRUCTURE OF PDE10A IN COMPLEX WITH A TRIAZOLOPYRIMIDINE INHIBITOR | 3.1.4.17 3.1.4.35 |
6KE1 | CRYSTAL STRUCTURE OF TTCAS1 | 3.1 |
6KG2 | HUMAN MTHFD2 IN COMPLEX WITH COMPOUND 18 | 1.5.1.15 3.5.4.9 |
6KGJ | M1Q-HNTAQ1 C28S | 3.5.1.122 |
6KHV | SOLUTION STRUCTURE OF THE CS2 DOMAIN OF USP19 | 3.4.19.12 |
6KHW | INTRACELLULAR SUBTILISIN FROM B. PUMILLUS | 3.4.21 |
6KHY | THE CRYSTAL STRUCTURE OF ASFVAP:AG | 3.1.21 |
6KI3 | THE CRYSTAL STRUCTURE OF ASFVAP:DF COMMPLEX | 3.1.21 |
6KI7 | PYROPHOSPHATASE MUTANT K30R FROM ACINETOBACTER BAUMANNII | 3.6.1.1 |
6KI8 | PYROPHOSPHATASE MUTANT K149R FROM ACINETOBACTER BAUMANNII | 3.6.1.1 |
6KIP | CRYSTAL STRUCTURE OF PTPRD PHOSPHATASE DOMAIN IN COMPLEX WITH LIPRIN-ALPHA3 TANDEM SAM DOMAINS | 3.1.3.48 |
6KJC | LOVASTATIN ESTERASE PCEST, WILD TYPE | 3.1.1 |
6KJD | LOVASTATIN ESTERASE PCEST INACTIVE MUTANT S57A IN COMPLEX WITH LOVASTATIN | 3.1.1 |
6KJE | LOVASTATIN ESTERASE PCEST IN COMPLEX WITH MONACOLIN J | 3.1.1 |
6KJF | LOVASTATIN ESTERASE PCEST IN COMPLEX WITH SIMVASTATIN | 3.1.1 |
6KJL | XYLANASE J FROM BACILLUS SP. STRAIN 41M-1 | 3.2.1.8 |
6KJV | STRUCTURE OF THERMAL-STABILISED(M9) HUMAN GLP-1 RECEPTOR TRANSMEMBRANE DOMAIN | 3.2.1.17 |
6KJZ | CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN COMPLEXED WITH COMPOUND 1 | 3.1.4.53 |
6KK0 | CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN COMPLEXED WITH COMPOUND 4E | 3.1.4.53 |
6KK1 | STRUCTURE OF THERMAL-STABILISED(M8) HUMAN GLP-1 RECEPTOR TRANSMEMBRANE DOMAIN | 3.2.1.17 |
6KK2 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 2 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KK3 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 4 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KK4 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 9 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KK5 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 15 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KK6 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 16 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KK7 | STRUCTURE OF THERMAL-STABILISED(M6) HUMAN GLP-1 RECEPTOR TRANSMEMBRANE DOMAIN | 3.2.1.17 |
6KKA | XYLANASE J MUTANT FROM BACILLUS SP. 41M-1 | 3.2.1.8 |
6KKF | CRYSTAL STRUCTURE OF PROTEINASE K COMPLEXED WITH A TRIGLYCINE | 3.4.21.64 |
6KL8 | CRYSTAL STRUCTURE OF PIPTIDYL T-RNA HYDROLASE FROM ACINETOBACTER BAUMANNII WITH BOUND NACL AT THE SUBSTRATE BINDING SITE | 3.1.1.29 |
6KLC | STRUCTURE OF APO LASSA VIRUS POLYMERASE | 2.7.7.48 3.1 |
6KLD | STRUCTURE OF APO MACHUPO VIRUS POLYMERASE | 2.7.7.48 3.1 |
6KLE | MONOMERIC STRUCTURE OF MACHUPO VIRUS POLYMERASE BOUND TO VRNA PROMOTER | 2.7.7.48 3.1 |
6KLH | DIMERIC STRUCTURE OF MACHUPO VIRUS POLYMERASE BOUND TO VRNA PROMOTER | 2.7.7.48 3.1 |
6KLK | CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA DIHYDROPYRIMIDINASE COMPLEXED WITH 5-FU | 3.5.2.2 |
6KMB | CRYSTAL STRUCTURE OF STH1 BROMODOMAIN | 3.6.4.12 |
6KMJ | CRYSTAL STRUCTURE OF STH1 BROMODOMAIN IN COMPLEX WITH H3K14AC | 3.6.4.12 |
6KMP | 100K X-RAY STRUCTURE OF HIV-1 PROTEASE TRIPLE MUTANT (V32I,I47V,V82I) WITH TETRAHEDRAL INTERMEDIATE MIMIC KVS-1 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6KMQ | 2.3 ANGSTROM RESOLUTION STRUCTURE OF DIMERIC HIGBA TOXIN-ANTITOXIN COMPLEX FROM E. COLI | 3.1 |
6KMT | P32 OF CASPASE-11 MUTANT C254A | 3.4.22.64 |
6KMU | P22/P10 COMPLEX OF CASPASE-11 MUTANT C254A | 3.4.22.64 |
6KMZ | CASPASE-4 P22/P10 C258A IN COMPLEX WITH HUMAN GSDMD-C DOMAIN | 3.4.22.57 |
6KN0 | CASPASE-1 P20/P10 C285A IN COMPLEX WITH HUMAN GSDMD-C DOMAIN | 3.4.22.36 |
6KN1 | P20/P12 OF CASPASE-11 MUTANT C254A | 3.4.22.64 |
6KN9 | CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN 18 RECEPTOR BETA EXTRACELLULAR DOMAIN IN COMPLEX WITH AN ANTAGONISTIC SCFV | 3.2.2.6 |
6KNB | POLD-PCNA-DNA (FORM A) | 2.7.7.7 3.1.11.1 |
6KNC | POLD-PCNA-DNA (FORM B) | 2.7.7.7 3.1.11.1 |
6KO0 | THE CRYSTAL STRUCTUE OF PDE10A COMPLEXED WITH 1I | 3.1.4.17 3.1.4.35 |
6KO1 | THE CRYSTAL STRUCTUE OF PDE10A COMPLEXED WITH 2D | 3.1.4.17 3.1.4.35 |
6KOY | CRYSTAL STRUCTURE OF TWO DOMAIN M1 ZINC METALLOPEPTIDASE E323A MUTANT BOUND TO L-TRYPTOPHAN AMINO ACID | 3.4.11.2 |
6KOZ | CRYSTAL STRUCTURE OF TWO DOMAIN M1 ZINC METALLOPEPTIDASE E323 MUTANT BOUND TO L-LEUCINE AMINO ACID | 3.4.11.2 |
6KP0 | CRYSTAL STRUCTURE OF TWO DOMAIN M1 ZINC METALLOPEPTIDASE E323A MUTANT BOUND TO L-ARGININE | 3.4.11.2 |
6KP1 | CRYSTAL STRUCTURE OF TWO DOMAIN M1 ZINC METALLOPEPTIDASE E323A MUTANT BOUND TO L-METHIONINE AMINO ACID | 3.4.11.2 |
6KPC | CRYSTAL STRUCTURE OF AN AGONIST BOUND GPCR | 3.2.1.17 |
6KPL | CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS IN APO FORM | 3.2.1.14 |
6KPM | CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS IN COMPLEX WITH L-FUCOSE | 3.2.1.14 |
6KPN | CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS D154N/E156Q MUTANT IN COMPLEX WITH FUCOSYL-N-ACETYLGLUCOSAMINE | 3.2.1.14 |
6KPO | CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM CORDYCEPS MILITARIS D154N/E156Q MUTANT IN COMPLEX WITH FUCOSYL-N-ACETYLGLUCOSAMINE-ASN | 3.2.1.14 |
6KPQ | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 8 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6KQU | CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 | 3.1.1.4 |
6KQV | SOLUTION STRUCTURE OF THE UBL DOMAIN OF USP19 | 3.4.19.12 |
6KR1 | ATP DEPENDENT PROTEASE HSLV FROM STAPHYLOCOCCUS AUREUS | 3.4.25.2 |
6KR2 | CRYSTAL STRUCTURE OF DENGUE VIRUS NONSTRUCTURAL PROTEIN NS5 (FORM 1) | 3.4.21.91 3.6.1.15 3.6.4.13 |
6KR3 | CRYSTAL STRUCTURE OF DENGUE VIRUS NONSTRUCTURAL PROTEIN NS5 (FORM 2) | 3.4.21.91 3.6.1.15 3.6.4.13 |
6KR6 | CRYSTAL STRUCTURE OF DROSOPHILA PIWI | 3.1.26 |
6KRB | HIGH RESOLUTION CRYSTAL STRUCTURE OF AN ACYLPHOSPHATASE PROTEIN CAGE | 3.6.1.7 |
6KRW | CRYSTAL STRUCTURE OF ATPTP1 AT 1.4 ANGSTROM | 3.1.3.48 |
6KRX | CRYSTAL STRUCTURE OF ATPTP1 AT 1.7 ANGSTROM | 3.1.3.48 |
6KSG | VIBRIO CHOLERAE METHIONINE AMINOPEPTIDASE IN HOLO FORM | 3.4.11.18 |
6KSI | STAPHYLOCOCCUS AUREUS LIPASE - NATIVE | 3.1.1.3 |
6KSL | STAPHYLOCOCCUS AUREUS LIPASE - S116A INACTIVE MUTANT | 3.1.1.3 |
6KSM | STAPHYLOCOCCUS AUREUS LIPASE -ORLISTAT COMPLEX | 3.1.1.3 |
6KU7 | STRUCTURE OF HRV-C 3C PROTEIN | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6KU8 | STRUCTURE OF HRV-C 3C PROTEIN WITH RUPINTRIVIR | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6KUA | CRYSTAL STRUCTURE OF THE NICOTINAMIDASE SAPNCA FROM STAPHYLOCOCCUS AUREUS | 3.5.1 3.5.1.19 3.5.1.110 |
6KUI | ACTIVE CONFORMATION OF HSLV FROM STAPHYLOCOCCUS AUREUS. | 3.4.25.2 |
6KUO | CRYSTAL STRCUTURE OF PETASE N246D MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6KUQ | CRYSTAL STRCUTURE OF PETASE A248D, R280K MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6KUS | CRYSTAL STRCUTURE OF PETASE S121E, D186H, S242T, N246D MUTANT FROM IDEONELLA SAKAIENSIS | 3.1.1.101 |
6KUZ | E.COLI BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH FLUORESCENT PROBE KSL01 | 3.2.1.23 |
6KVX | CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN SINGLE MUTANT (D119A) OF THE HUMAN MITOCHONDRIAL CALCIUM UNIPORTER FUSED WITH T4 LYSOZYME | 3.2.1.17 |
6KW9 | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6KWC | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II | 3.2.1.8 |
6KWD | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6KWF | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6KWG | CRYSTAL STRUCTURE ANALYSIS OF ENDO-BETA-1,4-XYLANASE II COMPLEXED WITH XYLOTRIOSE | 3.2.1.8 |
6KWQ | CRYSTAL STRUCTURE OF ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (NATIVE FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6KWR | CRYSTAL STRUCTURE OF ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (DDCTP FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6KWY | HUMAN PA200-20S COMPLEX | 3.4.25.1 |
6KX2 | CRYSTAL STRUCTURE OF GDP BOUND RHOA PROTEIN | 3.6.5.2 |
6KX3 | CRYSTAL STRUCTURE OF RHOA PROTEIN WITH COVALENT INHIBITOR DC-RHOIN | 3.6.5.2 |
6KXH | ALP1U_Y247F MUTANT IN COMPLEX WITH FLUOSTATIN C | 3.3.2.3 |
6KXR | CRYSTAL STRUCTURE OF WILD TYPE ALP1U FROM THE BIOSYNTHESIS OF KINAMYCINS | 3.3.2.3 |
6KY5 | CRYSTAL STRUCTURE OF A HYDROLASE MUTANT | 3.1.1.101 |
6KY8 | CRYSTAL STRUCTURE OF ASFV DUTPASE | 3.6.1.23 |
6KY9 | CRYSTAL STRUCTURE OF ASFV DUTPASE AND UMP COMPLEX | 3.6.1.23 |
6KYS | THE STRUCTURE OF THE M. TB TOXIN MAZF-MT1 | 3.1 |
6KYT | THE STRUCTURE OF THE M. TB TOXIN MAZEF-MT1 COMPLEX | 3.1 |
6KYZ | HRV14 3C IN COMPLEX WITH SINGLE CHAIN ANTIBODY YDF | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6KZ0 | HRV14 3C IN COMPLEX WITH SINGLE CHAIN ANTIBODY GGVV | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6KZ6 | CRYSTAL STRUCTURE OF ASFV DUTPASE | 3.6.1.23 |
6KZ8 | CRYSTAL STRUCTURE OF PLANT PHOSPHOLIPASE D ALPHA COMPLEX WITH PHOSPHATIDIC ACID | 3.1.4.4 |
6KZ9 | CRYSTAL STRUCTURE OF PLANT PHOSPHOLIPASE D ALPHA | 3.1.4.4 |
6KZA | CRYSTAL STRUCTURE OF THE COMPLEX OF THE INTERACTION DOMAINS OF E. COLI DNAB HELICASE AND DNAC HELICASE LOADER | 3.6.4.12 |
6KZE | THE CRYSTAL STRUCTUE OF PDE10A COMPLEXED WITH 4D | 3.1.4.17 3.1.4.35 |
6KZQ | STRUCTURE OF PTP-MEG2 AND NSF-PY83 PEPTIDE COMPLEX | 3.1.3.48 |
6L03 | STRUCTURE OF PTP-MEG2 AND MUNC18-1-PY145 PEPTIDE COMPLEX | 3.1.3.48 |
6L04 | CRYSTAL STRUCTURE OF UPA_H99Y IN COMPLEX WITH 31F | 3.4.21.73 |
6L05 | CRYSTAL STRUCTURE OF UPA_H99Y IN COMPLEX WITH 50F | 3.4.21.73 |
6L08 | CRYSTAL STRUCTURE OF ARABIDOPSIS CYTIDINE DEAMINASE | 3.5.4.5 |
6L0A | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH7 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0B | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH FLUOROURACIL FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0F | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH 5-AMINOURACIL FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0G | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH6 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0H | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH7 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0I | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH6.5 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0J | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH7.5 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0K | CRYSTAL STRUCTURE OF DIHYDROOROTASE IN COMPLEX WITH MALATE AT PH9 FROM SACCHAROMYCES CEREVISIAE | 3.5.2.3 |
6L0O | WH DOMAIN OF HUMAN MCM8 | 3.6.4.12 |
6L0T | CRYSTAL STRUCTURE OF SENECAVIRUS A 3C PROTEASE | 3.6.4.13 3.4.19.12 3.4.22.28 2.7.7.48 |
6L1S | CRYSTAL STRUCTURE OF DUSP22 MUTANT_C88S | 3.1.3.16 3.1.3.48 |
6L25 | DEOXYRIBONUCLEASE FROM STAPHYLOCOCCUS AUREUS | 3.1.21 |
6L29 | THE STRUCTURE OF THE MAZF-MT1 MUTANT | 3.1 |
6L2A | THE STRUCTURE OF THE M. TB TOXIN MAZEF-MT1 COMPLEX | 3.1 |
6L40 | DISCOVERY OF NOVEL PEPTIDOMIMETIC BORONATE CLPP INHIBITORS WITH NONCANONICAL ENZYME MECHANISM AS POTENT VIRULENCE BLOCKERS IN VITRO AND IN VIVO | 3.4.21.92 |
6L4R | CRYSTAL STRUCTURE OF ENTEROVIRUS D68 RDRP | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6L4V | TURNING AN ASPARAGINYL ENDOPEPTIDASE INTO A PEPTIDE LIGASE | 3.4.22.34 |
6L4W | TURNING AN ASPARAGINYL ENDOPEPTIDASE INTO A PEPTIDE LIGASE | 3.4.22.34 |
6L4X | TURNING AN ASPARAGINYL ENDOPEPTIDASE INTO A PEPTIDE LIGASE | 3.4.22.34 |
6L4Y | TURNING AN ASPARAGINYL ENDOPEPTIDASE INTO A PEPTIDE LIGASE | 3.4.22.34 |
6L4Z | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 6 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6L50 | CRYSTAL STRUCTURE OF ZIKA NS2B-NS3 PROTEASE WITH COMPOUND 16 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6L5A | THE STRUCTURE OF THE UDGX MUTANT H109E AT A PRE-EXCISION STATE | 3.2.2.27 |
6L5B | THE STRUCTURE OF THE UDGX MUTANT H109E AT A POST-EXCISION STATE | 3.2.2.27 |
6L5L | CRYSTAL STRUCTURE OF HUMAN DEAD-BOX RNA HELICASE DDX21 AT APO STATE | 3.6.4.13 |
6L5N | CRYSTAL STRUCTURE OF HUMAN DEAD-BOX RNA HELICASE DDX21 AT POST-UNWOUND STATE | 3.6.4.13 |
6L5O | CRYSTAL STRUCTURE OF HUMAN DEAD-BOX RNA HELICASE DDX21 AT POST-HYDROLYSIS STATE | 3.6.4.13 |
6L5T | THE CRYSTAL STRUCTURE OF SADS-COV PAPAIN LIKE PROTEASE | 2.7.7.48 3.4.19.12 3.6.4.12 3.6.4.13 |
6L63 | HUMAN COAGULATION FACTOR XIIA (FXIIA) BOUND WITH THE MACROCYCLIC PEPTIDE F3 CONTAINING TWO (1S,2S)-2-ACHC RESIDUES | 3.4.21.38 |
6L6E | HUMAN PDE5 CATALYTIC CORE IN COMPLEX WITH AVANAFIL | 3.1.4.35 |
6L6S | THE STRUCTURE OF THE UDGX MUTANT H109E CROSSLINKED TO SINGLE-STRANDED DNA | 2.7.7.7 3.2.2.27 |
6L70 | COMPLEX STRUCTURE OF PEDV 3CLPRO WITH GC376 | 2.7.7.48 3.4.19.12 3.6.4.12 3.6.4.13 |
6L7V | CRYSTAL STRUCTURE OF CET1 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH TRIPOLYPHOSPHATE, MANGANESE AND IODIDE IONS. | 3.1.3.33 |
6L7W | CRYSTAL STRUCTURE OF CET1 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH MANGANESE ION. | 3.1.3.33 |
6L7X | CRYSTAL STRUCTURE OF CET1 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH #951 LIGAND | 3.1.3.33 |
6L7Y | CRYSTAL STRUCTURE OF CET1 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH #466 LIGAND. | 3.1.3.33 |
6L8A | TETRATHIONATE HYDROLASE FROM ACIDITHIOBACILLUS FERROOXIDANS | 3.12.1 |
6L8N | CRYSTAL STRUCTURE OF THE K. LACTIS RAD5 | 3.6.4 |
6L8O | CRYSTAL STRUCTURE OF THE K. LACTIS RAD5 (HG-DERIVATIVE) | 3.6.4 |
6LAR | STRUCTURE OF ESX-3 COMPLEX | 3.6 |
6LB8 | CRYSTAL STRUCTURE OF THE CA2+-FREE T4L-MICU1-MICU2 COMPLEX | 3.2.1.17 |
6LBL | CRYSTAL STRUCTURE OF IMP-1 METALLO-BETA-LACTAMASE IN COMPLEX WITH NO9 INHIBITOR | 3.5.2.6 |
6LC7 | CRYSTAL STRUCTURE OF AMPC ENT385 FREE FORM | 3.5.2.6 |
6LC8 | CRYSTAL STRUCTURE OF AMPC ENT385 COMPLEX FORM WITH AVIBACTAM | 3.5.2.6 |
6LC9 | CRYSTAL STRUCTURE OF AMPC ENT385 COMPLEX FORM WITH CEFTAZIDIME | 3.5.2.6 |
6LD1 | ZIKA NS5 POLYMERASE DOMAIN | 2.1.1.56 2.1.1.57 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 |
6LD2 | ZIKA NS5 POLYMERASE DOMAIN | 2.1.1.56 2.1.1.57 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 |
6LD3 | ZIKA NS5 POLYMERASE DOMAIN | 2.1.1.56 2.1.1.57 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 |
6LD4 | ZIKA NS5 POLYMERASE DOMAIN | 2.1.1.56 2.1.1.57 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 |
6LD5 | ZIKA NS5 POLYMERASE DOMAIN | 2.1.1.56 2.1.1.57 2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 |
6LD6 | STRUCTURE OF BIFIDOBACTERIUM DENTIUM BETA-GLUCURONIDASE | 3.2.1.23 |
6LEG | STRUCTURE OF E. COLI BETA-GLUCURONIDASE COMPLEX WITH URONIC ISOFAGOMINE | 3.2.1.31 |
6LEH | CRYSTAL STRUCTURE OF AUTOTAXIN IN COMPLEX WITH AN INHIBITOR | 3.1.4.39 |
6LEJ | STRUCTURE OF E. COLI BETA-GLUCURONIDASE COMPLEX WITH C6-PROPYL URONIC ISOFAGOMINE | 3.2.1.31 |
6LEL | STRUCTURE OF E. COLI BETA-GLUCURONIDASE COMPLEX WITH C6-HEXYL URONIC ISOFAGOMINE | 3.2.1.31 |
6LEM | STRUCTURE OF E. COLI BETA-GLUCURONIDASE COMPLEX WITH C6-NONYL URONIC ISOFAGOMINE | 3.2.1.31 |
6LFB | E. COLI THIOESTERASE I MUTANT DG | 3.1.2.2 3.1.1.2 3.1.1.5 3.1.2.14 3.4.21 |
6LFC | E. COLI THIOESTERASE I MUTANT DG | 3.1.2.2 3.1.1.2 3.1.1.5 3.1.2.14 3.4.21 |
6LFH | X-RAY CRYSTAL STRUCTURE OF CHEMICALLY SYNTHESIZED HUMAN LYSOZYME | 3.2.1.17 |
6LFQ | CRYSTAL STRUCTURE OF POA1P IN APO FORM | 3.1.3.84 3.2.2 |
6LFR | POA1P IN COMPLEX WITH ADP-RIBOSE | 3.1.3.84 3.2.2 |
6LFS | POA1P H23A MUTANT IN COMPLEX WITH ADP-RIBOSE | 3.1.3.84 3.2.2 |
6LFT | POA1P S30A MUTANT IN COMPLEX WITH ADP-RIBOSE | 3.1.3.84 3.2.2 |
6LFU | POA1P F152A MUTANT IN COMPLEX WITH ADP-RIBOSE | 3.1.3.84 3.2.2 |
6LH4 | CRYSTAL STRUCTURAL OF MACROD1-ADPR COMPLEX | 3.1.1.106 3.2.2 |
6LH7 | CRYSTAL STRUCTURE OF VIBRIO CHOLERAE METHIONINE AMINOPEPTIDASE WITH PARTIALLY OCCUPIED METALS | 3.4.11.18 |
6LHA | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 MATURE VIRION | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHB | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 A-PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHC | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 EMPTY PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHE | CRYSTAL STRUCTURE OF GOLD-BOUND NDM-1 | 3.5.2.6 |
6LHK | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 MATURE VIRION IN COMPLEX WITH FAB 18A7 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHP | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 MATURE VIRION IN COMPLEX WITH FAB 14B10 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHQ | THE CRYO-EM STRUCTURE OF COXSACKIEVIRUS A16 MATURE VIRION IN COMPLEX WITH FAB NA9D7 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LHT | LOCALIZED RECONSTRUCTION OF COXSACKIEVIRUS A16 MATURE VIRION IN COMPLEX WITH FAB 18A7 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LIP | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS0218 | 3.5.2.6 |
6LIS | ASFV DUTPASE IN COMPLEX WITH DUMP | 3.6.1.23 |
6LIZ | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS02120 | 3.5.2.6 |
6LJ0 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS02122 | 3.5.2.6 |
6LJ1 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS02127 MONOMER | 3.5.2.6 |
6LJ2 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH HETERODIMER OF D-CAPTOPRIL DERIVATIVE WSS02127 STEREOISOMER | 3.5.2.6 |
6LJ3 | FULL LENGTH ASFV DUTPASE IN COMPLEX WITH ALPHA,BETA-IMINODUTP AND MAGNESIUM ION | 3.6.1.23 |
6LJ4 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS04146 | 3.5.2.6 |
6LJ5 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS04145 | 3.5.2.6 |
6LJ6 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS05008 | 3.5.2.6 |
6LJ7 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS05010 | 3.5.2.6 |
6LJ8 | CRYSTAL STRUCTURE OF NDM-1 IN COMPLEX WITH D-CAPTOPRIL DERIVATIVE WSS04134 | 3.5.2.6 |
6LJ9 | CRYSTAL STRUCTURE OF SE-MET ASFV PS273R PROTEASE | 3.4.22 |
6LJB | CRYSTAL STRUCTURE OF ASFV PS273R PROTEASE | 3.4.22 |
6LJJ | SWINE DUTPASE IN COMPLEX WITH ALPHA,BETA-IMINODUTP AND MAGNESIUM ION | 3.6.1.23 |
6LJO | AFRICAN SWINE FEVER VIRUS DUTPASE | 3.6.1.23 |
6LKA | CRYSTAL STRUCTURE OF EV71-3C PROTEASE WITH A NOVEL MACROCYCLIC COMPOUNDS | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LKO | TURNING AN ASPARAGINYL ENDOPEPTIDASE INTO A PEPTIDE LIGASE | 3.4.22.34 |
6LKX | THE STRUCTURE OF PRRSV HELICASE | 3.6.4.13 |
6LL3 | CRYSTAL STRUCTURE OF LYSOZYME BY FIXED-TARGET SERIAL FEMTOSECOND CRYSTALLOGRAPHY | 3.2.1.17 |
6LL7 | TYPE II INORGANIC PYROPHOSPHATASE (PPASE) FROM THE PSYCHROPHILIC BACTERIUM SHEWANELLA SP. AS-11, MN-ACTIVATED FORM | 3.6.1.1 |
6LL8 | TYPE II INORGANIC PYROPHOSPHATASE (PPASE) FROM THE PSYCHROPHILIC BACTERIUM SHEWANELLA SP. AS-11, MG-PNP FORM | 3.6.1.1 |
6LLB | CRYSTAL STRUCTURE OF MPY-RNASE J (MUTANT S247A), AN ARCHAEAL RNASE J FROM METHANOLOBUS PSYCHROPHILUS R15, IN COMPLEX WITH 6 NT RNA | 3.1 |
6LMI | CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE DOMAIN IN COMPLEX WITH 2-(TERT-BUTOXY)-2-[3-(3,4-DIHYDRO-2H-1-BENZOPYRAN-6-YL)-6-METHANESULFONAMIDO-2,3',4',5-TETRAMETHYL-[1,1'-BIPHENYL]-4-YL]ACETIC ACID | 2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1 |
6LMQ | CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE DOMAIN IN COMPLEX WITH 2-(TERT-BUTOXY)-2-[3-(3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)-6-METHANESULFONAMIDO-2,3',4',5-TETRAMETHYL-[1,1'-BIPHENYL]-4-YL]ACETIC ACID | 2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1 |
6LMY | CRYSTAL STRUCTURE OF DUSP22 MUTANT_C88S/S93A | 3.1.3.16 3.1.3.48 |
6LNQ | THE CO-CRYSTAL STRUCTURE OF SARS-COV 3C LIKE PROTEASE WITH ALDEHYDE INHIBITOR M7 | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6LNT | CRYO-EM STRUCTURE OF IMMATURE ZIKA VIRUS IN COMPLEX WITH HUMAN ANTIBODY DV62.5 FAB | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6LNU | CRYO-EM STRUCTURE OF IMMATURE ZIKA VIRUS | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6LNY | THE CO-CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 3C-LIKE PROTEASE WITH ALDEHYDE M15 | 3.4.19.12 3.4.22.69 3.4.22 |
6LO0 | THE CO-CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 3C LIKE PROTEASE WITH ALDEHYDE M14 | 3.4.19.12 3.4.22.69 3.4.22 |
6LOQ | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH CAMP | 3.2.2.22 |
6LOR | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH ADP | 3.2.2.22 |
6LOT | CRYSTAL STRUCTURE OF DUSP22 MUTANT_N128D | 3.1.3.16 3.1.3.48 |
6LOU | CRYSTAL STRUCTURE OF DUSP22 MUTANT_C88S/S93N | 3.1.3.16 3.1.3.48 |
6LOV | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH XANTHOSINE | 3.2.2.22 |
6LOW | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH GMP | 3.2.2.22 |
6LOX | CRYSTAL STRUCTURE OF HUMAN GLUTAMINASE WITH MACROCYCLIC INHIBITOR | 3.5.1.2 |
6LOY | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH DAMP | 3.2.2.22 |
6LOZ | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH ADENINE | 3.2.2.22 |
6LP0 | CRYSTAL STRUCTURE OF ALPHA-MOMORCHARIN IN COMPLEX WITH AMP | 3.2.2.22 |
6LP9 | THE PROTEIN OF CAT VIRUS | 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6LPA | THE NSP1 PROTEIN OF A NEW PORCINE CORONAVIRUS | 2.7.7.48 3.4.19.12 3.6.4.12 3.6.4.13 |
6LPG | HUMAN VASH1-SVBP COMPLEX | 3.4.17.17 |
6LPM | CRYSTAL STRUCTURE OF AP ENDONUCLEASE FROM DEINOCOCCUS RADIODURAN | 3.1.11.2 |
6LPR | STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS | 3.4.21.12 |
6LPS | CRYSTAL STRUCTURE OF FAMILY 10 XYLANASE FROM BACILLUS HALODURANS | 3.2.1.8 |
6LQD | STRUCTURE OF ENTEROVIRUS 71 IN COMPLEX WITH NLD-22 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LRY | CRYSTAL STRUCTURE OF HUMAN ENDOTHELIN ETB RECEPTOR IN COMPLEX WITH SARAFOTOXIN S6B | 3.2.1.17 |
6LS5 | STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED WITH COVALENT ALLOSTERIC INHIBITOR | 3.1.3.11 |
6LSE | CRYSTAL STRUCTURE OF THE ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (C3S6A/C3S6B FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6LSF | CRYSTAL STRUCTURE OF THE ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (C2S6RA/C2S6RB FORM) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6LSG | CRYSTAL STRUCTURE OF THE ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (C0S6M FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6LSH | CRYSTAL STRUCTURE OF THE ENTEROVIRUS 71 POLYMERASE ELONGATION COMPLEX (C2S6M FORM) | 2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28 |
6LSO | CRYSTAL STRUCTURE OF A DIMERIC INHIBITED OF PEPTIDYL TRNA HYDROLASE AT 1.76A RESOLUTION | 3.1.1.29 |
6LSP | CRYSTAL STRUCTURE OF A DIMERIC PIPTIDYL T-RNA HYDROLASE FROM ACINETOBACTER BAUMANNII AT 1.50 A RESOLUTION REVEALS AN INHIBITED FORM. | 3.1.1.29 |
6LT5 | LYSOZYME PROTECTED BY ALGINATE GEL | 3.2.1.17 |
6LT7 | CRYSTAL STRUCTURE OF HUMAN RPP20-RPP25 PROTEINS IN COMPLEX WITH THE P3 DOMAIN OF LNCRNA RMRP | 3.1.26.5 |
6LTH | STRUCTURE OF HUMAN BAF BASE MODULE | 3.6.4 |
6LU7 | THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR N3 | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6LUG | CRYSTAL STRUCTURE OF N(OMEGA)-HYDROXY-L-ARGININE HYDROLASE | 3.5.3.25 |
6LUH | HIGH RESOLUTION STRUCTURE OF N(OMEGA)-HYDROXY-L-ARGININE HYDROLASE | 3.5.3.25 |
6LUQ | HALOPERIDOL BOUND D2 DOPAMINE RECEPTOR STRUCTURE INSPIRED DISCOVERY OF SUBTYPE SELECTIVE LIGANDS | 3.2.1.17 |
6LVB | STRUCTURE OF DIMETHYLFORMAMIDASE, TETRAMER | 3.5.1.56 |
6LVC | STRUCTURE OF DIMETHYLFORMAMIDASE, DIMER | 3.5.1.56 |
6LVD | STRUCTURE OF DIMETHYLFORMAMIDASE, TETRAMER, Y440A MUTANT | 3.5.1.56 |
6LVE | STRUCTURE OF DIMETHYLFORMAMIDASE, TETRAMER, E521A MUTANT | 3.5.1.56 |
6LVJ | IMP-6 METALLO-BETA-LACTAMASE | 3.5.2.6 |
6LVQ | CRYSTAL STRUCTURE OF DUSP22_VO4 | 3.1.3.16 3.1.3.48 |
6LVR | CRYSTAL STRUCTURE OF THE PPR DOMAIN OF ARABIDOPSIS THALIANA PROTEIN-ONLY RNASE P 1 (PRORP1) IN COMPLEX WITH TRNA | 3.1.26.5 |
6LVV | N, N-DIMETHYLFORMAMIDASE | 3.5.1.56 |
6LVW | POLYEXTREMOPHILIC BETA-GALACTOSIDASE FROM THE ANTARCTIC HALOARCHAEON HALORUBRUM LACUSPROFUNDI | 3.2.1.23 |
6LW2 | THE N-ARYLSULFONYL-INDOLE-2-CARBOXAMIDE-BASED INHIBITORS AGAINST FRUCTOSE-1,6-BISPHOSPHATASE | 3.1.3.11 |
6LW3 | CRYSTAL STRUCTURE OF RUVC FROM PSEUDOMONAS AERUGINOSA | 3.1.22.4 |
6LXD | PRI-MIRNA BOUND DROSHA-DGCR8 COMPLEX | 3.1.26.3 |
6LXE | DROSHA-DGCR8 COMPLEX | 3.1.26.3 |
6LXI | CRYSTAL STRUCTURE OF Z2B3 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/BREVIG MISSION/1/1918 (H1N1) | 3.2.1.18 |
6LXK | CRYSTAL STRUCTURE OF Z2B3 D102R FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/SERBIA/NS-601/2014 (H1N1) | 3.2.1.18 |
6LYD | CRYSTAL STRUCTURE OF MIMIVIRUS UNG Y322L IN COMPLEX WITH UGI | 3.2.2 |
6LYE | CRYSTAL STRUCTURE OF MIMIVIRUS UNG Y322F IN COMPLEX WITH UGI | 3.2.2 |
6LYF | CRYSTAL STRUCTURE OF THE MOUSE ENDONUCLEASE ENDOG(H138A/SE-MET) | 3.1.30 |
6LYJ | THE CRYSTAL STRUCTURE OF SAUGI/EBVUDG COMPLEX | 3.2.2.27 |
6LYT | COMPARISON OF RADIATION-INDUCED DECAY AND STRUCTURE REFINEMENT FROM X-RAY DATA COLLECTED FROM LYSOZYME CRYSTALS AT LOW AND AMBIENT TEMPERATURES | 3.2.1.17 |
6LYZ | REAL-SPACE REFINEMENT OF THE STRUCTURE OF HEN EGG-WHITE LYSOZYME | 3.2.1.17 |
6LZ1 | STRUCTURE OF S.POMBE ALPHA-MANNOSIDASE AMS1 | 3.2.1.24 |
6LZE | THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR 11A | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6LZG | STRUCTURE OF NOVEL CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN COMPLEXED WITH ITS RECEPTOR ACE2 | 3.4.17.23 3.4.17 |
6LZM | COMPARISON OF THE CRYSTAL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME AT LOW, MEDIUM, AND HIGH IONIC STRENGTHS | 3.2.1.17 |
6LZN | THERMOLYSIN | 3.4.24.27 |
6LZO | THERMOLYSIN WITH 1,10-PHENANTHROLINE | 3.4.24.27 |
6M03 | THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN APO FORM | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M06 | CRYSTAL STRUCTURE OF LP-PLA2 IN COMPLEX WITH A NOVEL COVALENT INHIBITOR | 3.1.1.47 |
6M07 | CRYSTAL STRUCTURE OF LP-PLA2 IN COMPLEX WITH A NOVEL COVALENT INHIBITOR | 3.1.1.47 |
6M08 | CRYSTAL STRUCTURE OF LP-PLA2 IN COMPLEX WITH A NOVEL COVALENT INHIBITOR. | 3.1.1.47 |
6M0J | CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN BOUND WITH ACE2 | 3.4.17.23 3.4.17 |
6M0K | THE CRYSTAL STRUCTURE OF COVID-19 MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR 11B | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M0V | CRSYTAL STRUCTURE OF STREPTOCOCCUS THERMOPHILUS CAS9 IN COMPLEX WITH THE GGAA PAM | 3.1 |
6M0W | CRYSTAL STRUCTURE OF STREPTOCOCCUS THERMOPHILUS CAS9 IN COMPLEX WITH THE AGAA PAM | 3.1 |
6M0X | CRYSTAL STRUCTURE OF STREPTOCOCCUS THERMOPHILUS CAS9 IN COMPLEX WITH AGGA PAM | 3.1 |
6M2N | SARS-COV-2 3CL PROTEASE (3CL PRO) IN COMPLEX WITH A NOVEL INHIBITOR | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M2Q | SARS-COV-2 3CL PROTEASE (3CL PRO) APO STRUCTURE (SPACE GROUP C21) | 3.4.22.69 3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M3B | HAPC-C25K23 FAB COMPLEX | 3.4.21.69 |
6M3F | CRYSTAL STRUCTURE OF THE MOUSE ENDONUCLEASE ENDOG(H138A/C110A), SPACE GROUP P212121 | 3.1.30 |
6M3T | CRYSTAL STRUCTURE OF THE MOUSE ENDONUCLEASE ENDOG(H138A/C110A), SPACE GROUP P41212 | 3.1.30 |
6M40 | CRYSTAL STRUCTURE OF THE NS3-LIKE HELICASE FROM ALONGSHAN VIRUS | 3.6.4.13 |
6M4B | 1510-N MEMBRANE-BOUND STOMATIN-SPECIFIC PROTEASE S97A MUTANT | 3.4.21 |
6M4K | X-RAY CRYSTAL STRUCTURE OF WILD TYPE ALPHA-AMYLASE I FROM EISENIA FETIDA | 3.2.1.1 |
6M4L | X-RAY CRYSTAL STRUCTURE OF THE E249Q MUTANT OF ALPHA-AMYLASE I FROM EISENIA FETIDA | 3.2.1.1 |
6M4M | X-RAY CRYSTAL STRUCTURE OF THE E249Q MUTAN OF ALPHA-AMYLASE I AND MALTOHEXAOSE COMPLEX FROM EISENIA FETIDA | 3.2.1.1 |
6M5A | CRYSTAL STRUCTURE OF GH121 BETA-L-ARABINOBIOSIDASE HYPBA2 FROM BIFIDOBACTERIUM LONGUM | 3.2.1.187 |
6M5H | A CLASS C BETA-LACTAMASE MUTANT - Y150F | 3.5.2.6 |
6M5I | CRYSTAL STRUCTURE OF 2019-NCOV NSP7-NSP8C COMPLEX | 3.4.19.12 3.4.22 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M5P | A CLASS C BETA-LACTAMASE | 3.5.2.6 |
6M5Q | A CLASS C BETA-LACTAMASE MUTANT - Y150F | 3.5.2.6 |
6M5R | THE COORDINATES OF THE APO MONOMERIC TERMINASE COMPLEX | 3.1 |
6M5S | THE COORDINATES OF THE APO HEXAMERIC TERMINASE COMPLEX | 3.1 |
6M5T | THE COORDINATE OF THE NUCLEASE DOMAIN OF THE APO TERMINASE COMPLEX | 3.1 |
6M5U | THE COORDINATES OF THE MONOMERIC TERMINASE COMPLEX IN THE PRESENCE OF THE ADP-BEF3 | 3.1 |
6M5V | THE COORDINATE OF THE HEXAMERIC TERMINASE COMPLEX IN THE PRESENCE OF THE ADP-BEF3 | 3.1 |
6M65 | CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS MUTT1 IN COMPLEX WITH GMPPNP (GDP) | 3.6.1.69 3.6.1.58 3.6.1.61 |
6M69 | CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS MUTT1 IN COMPLEX WITH GMPPCP (GDP) | 3.6.1.69 3.6.1.58 3.6.1.61 |
6M6Y | CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS MUTT1 IN COMPLEX WITH 8-OXO-DGTP | 3.6.1.69 3.6.1.58 3.6.1.61 |
6M71 | SARS-COV-2 RNA-DEPENDENT RNA POLYMERASE IN COMPLEX WITH COFACTORS | 3.4.19.12 3.4.22 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1 |
6M72 | CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS MUTT1 IN COMPLEX WITH 8-OXO-DGDP | 3.6.1.69 3.6.1.58 3.6.1.61 |
6M7I | CRYSTAL STRUCTURE OF KPC-2 WITH COMPOUND 3 | 3.5.2.6 |
6M8Q | CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR SUBUNIT 3 (CPSF3) IN COMPLEX WITH NVP-LTM531 | 3.1.27 |
6M8W | PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR AIAF | 3.4.21.100 |
6M8Y | PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR AIPF | 3.4.21.100 |
6M8Z | CRYSTAL STRUCTURE OF HUMAN DJ-1 WITHOUT A MODIFICATION ON CYS-106 | 3.1.2 3.5.1 3.5.1.124 |
6M9C | PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR PSEUDOTYROSTATIN | 3.4.21.100 |
6M9D | PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR CHYMOSTATIN | 3.4.21.100 |
6M9F | PSEUDOMONAS SERINE-CARBOXYL PROTEINASE (SEDOLISIN) COMPLEXED WITH THE INHIBITOR TYROSTATIN | 3.4.21.100 |
6M9K | CRYSTAL STRUCTURE OF LAMBDA EXONUCLEASE IN COMPLEX WITH THE RED BETA C-TERMINAL DOMAIN | 3.1.11.3 |
6M9T | CRYSTAL STRUCTURE OF EP3 RECEPTOR BOUND TO MISOPROSTOL-FA | 3.2.1.17 |
6M9W | STRUCTURE OF MG-FREE KRAS4B (2-169) BOUND TO GDP WITH THE SWITCH-I IN FULLY OPEN CONFORMATION | 3.6.5.2 |
6MAE | CHAIN A. UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE DEACETYLASE PA-LPXC COMPLEXED WITH (R)-3-((S)-3-(4-(CYCLOPROPYLETHYNYL)PHENYL)-2-OXOOXAZOLIDIN-5-YL)-N-HYDROXY-2-METHYL-2-(METHYLSULFONYL)PROPENAMIDE | 3.5.1.108 |
6MAI | CRYSTAL STRUCTURE OF DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE FROM LEGIONELLA PNEUMOPHILA PHILADELPHIA 1 | 3.6.1.23 |
6MAL | STRUCTURE OF HUMAN NOCTURNIN C-TERMINAL DOMAIN | 3.1.13.4 3.1.3 |
6MAO | CRYSTAL STRUCTURE OF DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE FROM LEGIONELLA PNEUMOPHILA PHILADELPHIA 1 IN COMPLEX WITH DUMP (DEOXYURIDINE 5'-MONOPHOSPHATE) | 3.6.1.23 |
6MAV | COMPLEX OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) MUTANT L34G WITH MATRIX METALLOPROTEINASE-3 CATALYTIC DOMAIN (MMP-3CD) | 3.4.24.17 |
6MAX | CRYSTAL STRUCTURE OF RIBONUCLEASE P PROTEIN FROM THERMOTOGA MARITIMA IN COMPLEX WITH PURPURIN | 3.1.26.5 |
6MBQ | CRYSTAL STRUCTURE OF MG-FREE WILD-TYPE KRAS (2-166) BOUND TO GMPPNP IN THE STATE 1 CONFORMATION | 3.6.5.2 |
6MBT | CRYSTAL STRUCTURE OF WILD-TYPE KRAS BOUND TO GDP AND MG (SPACE GROUP C2) | 3.6.5.2 |
6MCB | CRYOEM STRUCTURE OF ACRIIA2 IN COMPLEX WITH CRISPR-CAS9 | 3.1 |
6MCC | CRYOEM STRUCTURE OF ACRIIA2 HOMOLOG IN COMPLEX WITH CRISPR-CAS9 | 3.1 |
6MCR | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-001 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6MCS | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-003 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6MCX | INFLUENZA VIRUS NEURAMINIDASE SUBTYPE N9 (TERN) RECOMBINANT HEAD DOMAIN | 3.2.1.18 |
6MD7 | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR PYRIMIDINONE 7 | 3.1.3.48 |
6MD8 | CRYSTAL STRUCTURE OF CTX-M-14 WITH COMPOUND 3 | 3.5.2.6 |
6MD9 | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR ISOXAZOLO-PYRIDINONE 3 | 3.1.3.48 |
6MDA | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR PYRAZOLO-PYRIDINE 4 | 3.1.3.48 |
6MDB | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR PYRAZOLO-PYRIMIDINONE 5 | 3.1.3.48 |
6MDC | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR PYRAZOLO-PYRIMIDINONE 1 SHP389 | 3.1.3.48 |
6MDD | NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR IMIDAZO-PYRIDINE 24 | 3.1.3.48 |
6MDM | THE 20S SUPERCOMPLEX ENGAGING THE SNAP-25 N-TERMINUS (CLASS 1) | 3.6.4.6 |
6MDN | THE 20S SUPERCOMPLEX ENGAGING THE SNAP-25 N-TERMINUS (CLASS 2) | 3.6.4.6 |
6MDO | THE D1 AND D2 DOMAIN RINGS OF NSF ENGAGING THE SNAP-25 N-TERMINUS WITHIN THE 20S SUPERCOMPLEX (FOCUSED REFINEMENT ON D1/D2 RINGS, CLASS 1) | 3.6.4.6 |
6MDP | THE D1 AND D2 DOMAIN RINGS OF NSF ENGAGING THE SNAP-25 N-TERMINUS WITHIN THE 20S SUPERCOMPLEX (FOCUSED REFINEMENT ON D1/D2 RINGS, CLASS 2) | 3.6.4.6 |
6MDU | CRYSTAL STRUCTURE OF NDM-1 WITH COMPOUND 7 | 3.5.2.6 |
6MDW | MECHANISM OF PROTEASE DEPENDENT DPC REPAIR | 3.4.24 |
6MDX | MECHANISM OF PROTEASE DEPENDENT DPC REPAIR | 3.4.24 |
6MDZ | HUMAN ARGONAUTE2-MIR-122 BOUND TO A TARGET RNA WITH TWO CENTRAL MISMATCHES (BU2) | 3.1.26 |
6MEA | CRYSTAL STRUCTURE OF A TYLONYCTERIS BAT CORONAVIRUS HKU4 MACRODOMAIN IN COMPLEX WITH ADENOSINE DIPHOSPHATE RIBOSE (ADP-RIBOSE) | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6MEB | CRYSTAL STRUCTURE OF TYLONYCTERIS BAT CORONAVIRUS HKU4 MACRODOMAIN IN COMPLEX WITH NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6MEN | CRYSTAL STRUCTURE OF A TYLONYCTERIS BAT CORONAVIRUS HKU4 MACRODOMAIN IN COMPLEX WITH ADENOSINE DIPHOSPHATE GLUCOSE (ADP-GLUCOSE) | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6MEY | CRYSTAL STRUCTURE OF KPC-2 WITH COMPOUND 9 | 3.5.2.6 |
6MFN | HUMAN ARGONAUTE2-MIR-27A BOUND TO HSUR1 TARGET RNA | 3.1.26 |
6MFQ | CRYSTAL STRUCTURE OF A PMS2 VARIANT | 3.1 |
6MFR | HUMAN ARGONAUTE2-MIR-122 BOUND TO A TARGET RNA WITH THREE CENTRAL MISMATCHES (BU3) | 3.1.26 |
6MGF | UNTAGGED, WILD-TYPE LPTB IN COMPLEX WITH ADP | 3.6.3 7.5.2 |
6MGQ | ERAP1 IN THE OPEN CONFORMATION BOUND TO 10MER PHOSPHINIC INHIBITOR DG014 | 3.4.11 |
6MGY | CRYSTAL STRUCTURE OF THE NEW DELI METALLO BETA LACTAMASE VARIANT 5 FROM KLEBSIELLA PNEUMONIAE | 3.5.2.6 |
6MGZ | CRYSTAL STRUCTURE OF THE NEW DELI METALLO BETA LACTAMASE VARIANT 4 FROM KLEBSIELLA PNEUMONIAE | 3.5.2.6 |
6MH3 | THE CRYSTAL STRUCTURE OF ZIKA VIRUS NS3 HELICASE DOMAIN | 3.6.4.13 3.4.21.91 3.6.1.15 2.1.1.56 2.1.1.57 2.7.7.48 |
6MH6 | HIGH-VISCOSITY INJECTOR-BASED PINK BEAM SERIAL CRYSTALLOGRAPHY OF MICRO-CRYSTALS AT A SYNCHROTRON RADIATION SOURCE. | 3.4.21.64 |
6MHJ | STRUCTURE OF BONT MUTANT | 3.4.24.69 |
6MHM | CRYSTAL STRUCTURE OF HUMAN ACID CERAMIDASE IN COVALENT COMPLEX WITH CARMOFUR | 3.5.1.23 3.5.1 |
6MHU | NUCLEOTIDE-FREE CRYO-EM STRUCTURE OF E.COLI LPTB2FG TRANSPORTER | 3.6.3 7.5.2 |
6MHZ | VANADATE TRAPPED CRYO-EM STRUCTURE OF E.COLI LPTB2FG TRANSPORTER | 3.6.3 7.5.2 |
6MI7 | NUCLEOTIDE-FREE CRYO-EM STRUCTURE OF E.COLI LPTB2FGC | 3.6.3 7.5.2 |
6MI8 | CRYO-EM STRUCTURE OF VANADATE-TRAPPED E.COLI LPTB2FGC | 3.6.3 7.5.2 |
6MIA | CRYSTAL STRUCTURE OF CTX-M-14 WITH COMPOUND 6 | 3.5.2.6 |
6MID | CRYO-EM STRUCTURE OF THE ZIKV VIRION IN COMPLEX WITH FAB FRAGMENTS OF THE POTENTLY NEUTRALIZING HUMAN MONOCLONAL ANTIBODY ZIKV-195 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6MIG | CRYSTAL STRUCTURE OF HOST-GUEST COMPLEX WITH PB HACHIMOJI DNA | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6MIH | CRYSTAL STRUCTURE OF HOST-GUEST COMPLEX WITH PC HACHIMOJI DNA | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6MII | CRYSTAL STRUCTURE OF MINICHROMOSOME MAINTENANCE PROTEIN MCM/DNA COMPLEX | 3.6.4.12 |
6MIK | CRYSTAL STRUCTURE OF HOST-GUEST COMPLEX WITH PP HACHIMOJI DNA | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6MIS | NATIVE ANANAIN IN COMPLEX WITH E-64 | 3.4.22.31 |
6MJ5 | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ519 | 3.1.4 |
6MJK | CRYSTAL STRUCTURE OF DUTP PYROPHOSPHATASE PROTEIN, FROM NAEGLERIA FOWLERI IN COMPLEX WITH DEOXYURIDINE | 3.6.1.23 |
6MJP | LPTB(E163Q)FGC FROM VIBRIO CHOLERAE | 3.6.3 |
6MK3 | CRYSTALLOGRAPHIC SOLVENT MAPPING ANALYSIS OF DMSO BOUND TO APE1 | 3.1 4.2.99.18 |
6MK6 | CARBAPENEMASE VCC-1 FROM VIBRIO CHOLERAE N14-02106 | 3.5.2.6 |
6MKK | CRYSTALLOGRAPHIC SOLVENT MAPPING ANALYSIS OF DMSO/MG BOUND TO APE1 | 3.1 4.2.99.18 |
6MKM | CRYSTALLOGRAPHIC SOLVENT MAPPING ANALYSIS OF DMSO/TRIS BOUND TO APE1 | 3.1 4.2.99.18 |
6MKO | CRYSTALLOGRAPHIC SOLVENT MAPPING ANALYSIS OF GLYCEROL BOUND TO APE1 | 3.1 4.2.99.18 |
6MKQ | CARBAPENEMASE VCC-1 BOUND TO AVIBACTAM | 3.5.2.6 |
6ML1 | STRUCTURE OF THE USP15 DEUBIQUITINASE DOMAIN IN COMPLEX WITH AN AFFINITY-MATURED INHIBITORY UBV | 3.4.19.12 |
6MLL | CRYSTAL STRUCTURE OF KPC-2 WITH COMPOUND 7 | 3.5.2.6 |
6MLY | BIFUNCTIONAL GH43-CE BACTEROIDES EGGERTHII, BACEGG_01304 | 3.2.1.37 |
6MNP | CRYSTAL STRUCTURE OF KPC-2 WITH COMPOUND 6 | 3.5.2.6 |
6MNX | STRUCTURAL BASIS OF IMPAIRED HYDROLYSIS IN KRAS Q61H MUTANT | 3.6.5.2 |
6MO0 | STRUCTURE OF DENGUE VIRUS PROTEASE WITH AN ALLOSTERIC INHIBITOR THAT BLOCKS REPLICATION | 3.4.21.91 3.6.1.15 3.6.4.13 |
6MO1 | STRUCTURE OF DENGUE VIRUS PROTEASE WITH AN ALLOSTERIC INHIBITOR THAT BLOCKS REPLICATION | 3.4.21.91 3.6.1.15 3.6.4.13 |
6MO2 | STRUCTURE OF DENGUE VIRUS PROTEASE WITH AN ALLOSTERIC INHIBITOR THAT BLOCKS REPLICATION | 3.4.21.91 3.6.1.15 3.6.4.13 |
6MO4 | CO-CRYSTAL STRUCTURE OF P. AERUGINOSA LPXC-50067 COMPLEX | 3.5.1.108 |
6MO5 | CO-CRYSTAL STRUCTURE OF P. AERUGINOSA LPXC-50228 COMPLEX | 3.5.1.108 |
6MOD | CO-CRYSTAL STRUCTURE OF P. AERUGINOSA LPXC-50432 COMPLEX | 3.5.1.108 |
6MOO | CO-CRYSTAL STRUCTURE OF P. AERUGINOSA LPXC-ACHN975 COMPLEX | 3.5.1.108 |
6MOZ | STRUCTURE OF ACID-BETA-GLUCOSIDASE IN COMPLEX WITH AN AROMATIC PYRROLIDINE IMINOSUGAR INHIBITOR | 3.2.1.45 2.4.1 3.2.1 |
6MPQ | 1.95 ANG CRYSTAL STRUCTURE OF OXA-24/40 BETA-LACTAMASE IN COMPLEX THE INHIBITOR ETX2514 | 3.5.2.6 |
6MQ3 | STRUCTURE OF CYSTEINE-FREE HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH SUBSTRATE-SELECTIVE MACROCYCLE INHIBITOR 63 | 3.4.24.56 |
6MQG | CRYSTAL STRUCTURE OF KRAS V14I-GDP DEMONSTRATING OPEN SWITCH 1 CONFORMATION - FORM 1 | 3.6.5.2 |
6MQN | CRYSTAL STRUCTURE OF KRAS V14I-GDP DEMONSTRATING DISORDER SWITCH 1 CONFORMATION - FORM 2 | 3.6.5.2 |
6MQT | HRAS G12S IN COMPLEX WITH GDP | 3.6.5.2 |
6MQV | STRUCTURE OF HEWL FROM LCP INJECTOR USING SYNCHROTRON RADIATION | 3.2.1.17 |
6MR4 | CRYSTAL STRUCTURE OF THE STH1 BROMODOMAIN FROM S.CEREVISIAE | 3.6.4.12 |
6MRD | ADP-BOUND HUMAN MITOCHONDRIAL HSP60-HSP10 HALF-FOOTBALL COMPLEX | 3.6.4.9 5.6.1.7 |
6MRF | CRYSTAL STRUCTURE OF A METHIONINE AMINOPEPTIDASE METAP FROM ACINETOBACTER BAUMANNII | 3.4.11.18 |
6MRG | FAAH BOUND TO NON COVALENT INHIBITOR | 3.5.1.99 3.1.1 |
6MRN | CRYSTAL STRUCTURE OF CHLADUB2 DUB DOMAIN | 3.4.22 |
6MRQ | STRUCTURE OF TOPI1 INHIBITOR FROM TITYUS OBSCURUS SCORPION VENOM IN COMPLEX WITH TRYPSIN | 3.4.21.4 |
6MS9 | GDP-BOUND KRAS P34R MUTANT | 3.6.5.2 |
6MSA | NOVEL, POTENT, SELECTIVE AND BRAIN PENETRANT PHOSPHODIESTERASE 10A INHIBITORS | 3.1.4.17 3.1.4.35 |
6MSC | NOVEL, POTENT, SELECTIVE AND BRAIN PENETRANT PHOSPHODIESTERASE 10A INHIBITORS | 3.1.4.17 3.1.4.35 |
6MSM | PHOSPHORYLATED, ATP-BOUND HUMAN CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) | 3.6.3.49 5.6.1.6 |
6MT1 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MEDICAGO TRUNCATULA (R3 CRYSTAL FORM) | 3.6.1.1 |
6MT2 | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM MEDICAGO TRUNCATULA (I23 CRYSTAL FORM) | 3.6.1.1 |
6MTA | KRAS P34R MUTANT STRUCTURE IN COMPLEX WITH GTP ANALOGUE | 3.6.5.2 |
6MTW | LYSOSOMAL PHOSPHOLIPASE A2 IN COMPLEX WITH ZINC | 2.3.1 3.1.1.5 3.1.1.32 3.1.1.4 |
6MU9 | BETA-LACTAMASE PENICILLINASE FROM BACILLUS MEGATERIUM | 3.5.2.6 |
6MUA | CRYSTAL STRUCTURE OF CSM1-CSM4 SUBCOMPLEX IN THE TYPE III-A CRISPR-CSM INTERFERENCE COMPLEX | 3.1 2.7.7 |
6MUH | FLUOROACETATE DEHALOGENASE, ROOM TEMPERATURE STRUCTURE SOLVED BY SERIAL 1 DEGREE OSCILLATION CRYSTALLOGRAPHY | 3.8.1.3 |
6MUI | CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY | 3.4.21.90 |
6MUR | CRYO-EM STRUCTURE OF CSM-CRRNA-TARGET RNA TERNARY COMPLEX IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6MUS | CRYO-EM STRUCTURE OF LARGER CSM-CRRNA-TARGET RNA TERNARY COMPLEX IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6MUT | CRYO-EM STRUCTURE OF TERNARY CSM-CRRNA-TARGET RNA WITH ANTI-TAG SEQUENCE COMPLEX IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6MUU | CRYO-EM STRUCTURE OF CSM-CRRNA BINARY COMPLEX IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6MUV | THE STRUCTURE OF THE PLASMODIUM FALCIPARUM 20S PROTEASOME IN COMPLEX WITH TWO PA28 ACTIVATORS | 3.4.25.1 |
6MUW | THE STRUCTURE OF THE PLASMODIUM FALCIPARUM 20S PROTEASOME. | 3.4.25.1 |
6MUX | THE STRUCTURE OF THE PLASMODIUM FALCIPARUM 20S PROTEASOME IN COMPLEX WITH ONE PA28 ACTIVATOR | 3.4.25.1 |
6MUY | FLUOROACETATE DEHALOGENASE, ROOM TEMPERATURE STRUCTURE SOLVED BY SERIAL 3 DEGREE OSCILLATION CRYSTALLOGRAPHY | 3.8.1.3 |
6MUZ | LYSOZYME, ROOM TEMPERATURE STRUCTURE SOLVED BY SERIAL 3 DEGREE OSCILLATION CRYSTALLOGRAPHY | 3.2.1.17 |
6MV4 | CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR IXA | 3.4.21.22 |
6MV6 | CRYSTAL STRUCTURE OF RNASE 6 | 3.1.27 |
6MV7 | CRYSTAL STRUCTURE OF RNASE 6 | 3.1.27 |
6MVD | CRYSTAL STRUCTURE OF LECITHIN:CHOLESTEROL ACYLTRANSFERASE (LCAT) IN COMPLEX WITH ISOPROPYL DODEC-11-ENYLFLUOROPHOSPHONATE (IDFP) AND A SMALL MOLECULE ACTIVATOR | 2.3.1.43 3.1.1.47 |
6MVF | CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 | 3.2.1.23 |
6MVH | CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS | 3.2.1.23 |
6MVI | APO CEL45A FROM NEUROSPORA CRASSA OR74A | 3.2.1.4 |
6MVJ | CELLOBIOSE COMPLEX CEL45A FROM NEUROSPORA CRASSA OR74A | 3.2.1.4 |
6MVK | HCV NS5B 1B N316 BOUND TO COMPOUND 18 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6MVO | HCV NS5B 1A Y316 BOUND TO COMPOUND 49 | 2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 |
6MVP | HCV NS5B 1B N316 BOUND TO COMPOUND 18 | 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6MVQ | HCV NS5B 1B N316 BOUND TO COMPOUND 31 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6MW7 | CRYSTAL STRUCTURE OF ATPASE MODULE OF SMCHD1 BOUND TO ATP | 3.6.1 |
6MWC | CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY | 3.4.21.90 |
6MWM | BAT CORONAVIRUS HKU4 SUD-C | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6MWV | CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY | 3.4.21.90 |
6MX7 | CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS: GENOME-BINDING CAPSID N-TERMINAL DOMAIN | 3.4.21.90 |
6MX9 | LYSOZYME BOUND TO 3-AMINOPHENOL | 3.2.1.17 |
6MXT | CRYSTAL STRUCTURE OF HUMAN BETA2 ADRENERGIC RECEPTOR BOUND TO SALMETEROL AND NB71 | 3.2.1.17 |
6MZ1 | CTX-M-14 CLASS A BETA-LACTAMASE IN COMPLEX WITH AVIBACTAM AT PH 5.3 | 3.5.2.6 |
6MZ2 | CTX-M-14 CLASS A BETA-LACTAMASE IN COMPLEX WITH AVIBACTAM AT PH 7.9 | 3.5.2.6 |
6MZB | CRYO-EM STRUCTURE OF PHOSPHODIESTERASE 6 | 3.1.4.35 |
6MZI | CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EXPANDED 1 PARTICLE (PH 6.5, 4 DEGREES CELSIUS, 3 MIN) | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6MZZ | FLUOROACETATE DEHALOGENASE, ROOM TEMPERATURE STRUCTURE, USING FIRST 1 DEGREE OF TOTAL 3 DEGREE OSCILLATION | 3.8.1.3 |
6N00 | FLUOROACETATE DEHALOGENASE, ROOM TEMPERATURE STRUCTURE, USING LAST 1 DEGREE OF TOTAL 3 DEGREE OSCILLATION AND 144 KGY DOSE | 3.8.1.3 |
6N0N | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ574 | 3.1.4 |
6N0O | CRYSTAL STRUCTURE OF TDP1 CATALYTIC DOMAIN IN COMPLEX WITH COMPOUND XZ523 | 3.1.4 |
6N14 | PHOSPHOSERINE BLAC, CLASS A SERINE BETA-LACTAMASE FROM MYCOBACTERIUM TUBERCULOSIS | 3.5.2.6 |
6N1C | CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM LEGIONELLA PNEUMOPHILA PHILADELPHIA 1 | 3.6.1.1 |
6N1N | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE FROM SEBALDELLA TERMITIDIS ATCC 33386 | 3.5.2.6 |
6N2I | LON PROTEASE AAA+ DOMAIN | 3.4.21.53 |
6N2J | TETRAHYDROPYRIDOPYRIMIDINES AS COVALENT INHIBITORS OF KRAS-G12C | 3.6.5.2 |
6N2K | TETRAHYDROPYRIDOPYRIMIDINES AS COVALENT INHIBITORS OF KRAS-G12C | 3.6.5.2 |
6N36 | BETA-LACTAMASE FROM CHITINOPHAGA PINENSIS | 3.5.2.6 |
6N3S | CRYSTAL STRUCTURE OF APO-CRUZAIN | 3.4.22.51 |
6N3V | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HINT1) WITH BOUND 5'-O-[1-ETHYL]CARBAMOYL GUANOSINE | 3 |
6N3W | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HINT1) WITH BOUND 5'-O-[3-PHENYL-1-ETHYL]CARBAMOYL GUANOSINE | 3 |
6N3X | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HINT1) WITH BOUND 5'-O-[1-BENZYL]CARBAMOYL GUANOSINE | 3 |
6N3Y | HUMAN HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1 (HINT1) WITH BOUND 5'-O-[(3-INDOLYL)-1-ETHYL]CARBAMOYL GUANOSINE | 3 |
6N48 | STRUCTURE OF BETA2 ADRENERGIC RECEPTOR BOUND TO BI167107, NANOBODY 6B9, AND A POSITIVE ALLOSTERIC MODULATOR | 3.2.1.17 |
6N4D | THE CRYSTAL STRUCTURE OF NEURAMINDASE FROM A/CANINE/IL/11613/2015 (H3N2) INFLUENZA VIRUS. | 3.2.1.18 |
6N4N | CRYSTAL STRUCTURE OF THE DESIGNED PROTEIN DNCR2/DANOPREVIR/NS3A COMPLEX | 3.4.21 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48 |
6N4O | HUMAN ARGONAUTE2-MIR-122 BOUND TO A SEED AND SUPPLEMENTARY PAIRED TARGET | 3.1.26 |
6N4T | CRYSTAL STRUCTURE OF MATRIPTASE1 IN COMPLEX WITH A PEPTIDOMIMETIC BENZOTHIAZOLE | 3.4.21.109 |
6N4W | TETRAGONAL THERMOLYSIN (WITH 50% XYLOSE) CRYOCOOLED IN A NITROGEN GAS STREAM TO 100 K | 3.4.24.27 |
6N4Z | TETRAGONAL THERMOLYSIN (WITH 50% XYLOSE) PLUNGE COOLED IN LIQUID NITROGEN TO 77 K | 3.4.24.27 |
6N64 | CRYSTAL STRUCTURE OF MOUSE SMCHD1 HINGE DOMAIN | 3.6.1 |
6N6A | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PGG | 3.1 |
6N6B | THE COMPLEX CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/MINNESOTA/11/2010 WITH B10 ANTIBODY. | 3.2.1.18 |
6N6C | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PAA | 3.1 |
6N6D | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PAG | 3.1 |
6N6E | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PGA | 3.1 |
6N6F | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PGC | 3.1 |
6N6G | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PCG | 3.1 |
6N6H | VIBRIO CHOLERAE OLIGORIBONUCLEASE BOUND TO PCPU | 3.1 |
6N6I | HUMAN REXO2 BOUND TO PGG | 3.1 |
6N6J | HUMAN REXO2 BOUND TO PAA | 3.1 |
6N6K | HUMAN REXO2 BOUND TO PAG | 3.1 |
6N6T | OXA-23 MUTANT F110A/M221A LOW PH FORM | 3.5.2.6 |
6N6U | OXA-23 MUTANT F110A/M221A LOW PH FORM IMIPENEM COMPLEX | 3.5.2.6 |
6N6V | OXA-23 MUTANT F110A/M221A LOW PH FORM MEROPENEM COMPLEX | 3.5.2.6 |
6N6W | OXA-23 MUTANT F110A/M221A NEUTRAL PH FORM | 3.5.2.6 |
6N6X | OXA-23 MUTANT F110A/M221A NEUTRAL PH FORM IMIPENEM COMPLEX | 3.5.2.6 |
6N6Y | OXA-23 MUTANT F110A/M221A NEUTRAL PH FORM MEROPENEM COMPLEX | 3.5.2.6 |
6N7I | STRUCTURE OF BACTERIOPHAGE T7 E343Q MUTANT GP4 HELICASE-PRIMASE IN COMPLEX WITH SSDNA, DTTP, AC DINUCLEOTIDE AND CTP (GP4(5)-DNA) | 2.7.7 3.6.4.12 |
6N7N | STRUCTURE OF BACTERIOPHAGE T7 E343Q MUTANT GP4 HELICASE-PRIMASE IN COMPLEX WITH SSDNA, DTTP, AC DINUCLEOTIDE AND CTP (FORM I) | 2.7.7 3.6.4.12 |
6N7S | STRUCTURE OF BACTERIOPHAGE T7 E343Q MUTANT GP4 HELICASE-PRIMASE IN COMPLEX WITH SSDNA, DTTP, AC DINUCLEOTIDE AND CTP (FORM II) | 2.7.7 3.6.4.12 |
6N7T | STRUCTURE OF BACTERIOPHAGE T7 E343Q MUTANT GP4 HELICASE-PRIMASE IN COMPLEX WITH SSDNA, DTTP, AC DINUCLEOTIDE AND CTP (FORM III) | 2.7.7 3.6.4.12 |
6N7V | STRUCTURE OF BACTERIOPHAGE T7 GP4 (HELICASE-PRIMASE, E343Q MUTANT) IN COMPLEX WITH SSDNA, DTTP, AC DINUCLEOTIDE, AND CTP (FROM MULTIPLE LEAD COMPLEXES) | 2.7.7 3.6.4.12 |
6N7W | STRUCTURE OF BACTERIOPHAGE T7 LEADING-STRAND DNA POLYMERASE (D5A/E7A)/TRX IN COMPLEX WITH A DNA FORK AND INCOMING DTTP (FROM MULTIPLE LEAD COMPLEXES) | 2.7.7.7 3.1.11 |
6N80 | S. AUREUS CLPP BOUND TO ANTI-4A | 3.4.21.92 |
6N91 | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM VIBRIO CHOLERAE COMPLEXED WITH PENTOSTATIN (DEOXYCOFORMYCIN) | 3.5.4.4 |
6N9D | COMPLEX OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 (TIMP-1) MUTANT (L34G/L133P/L151C/G154A) WITH MATRIX METALLOPROTEINASE-3 CATALYTIC DOMAIN (MMP-3CD) | 3.4.24.17 |
6N9K | BETA-LACTAMASE FROM ESCHERICHIA COLI STR. SAKAI | 3.5.2.6 |
6N9M | CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM SALMONELLA TYPHIMURIUM WITH PENTOSTATIN (DEOXYCOFORMYCIN) | 3.5.4.4 |
6N9U | STRUCTURE OF BACTERIOPHAGE T7 LAGGING-STRAND DNA POLYMERASE (D5A/E7A) INTERACTING WITH PRIMASE DOMAINS OF TWO GP4 SUBUNITS BOUND TO AN RNA/DNA HYBRID AND DTTP (FROM LAGS1) | 2.7.7 3.6.4.12 |
6N9V | STRUCTURE OF BACTERIOPHAGE T7 LAGGING-STRAND DNA POLYMERASE (D5A/E7A) AND GP4 (HELICASE/PRIMASE) BOUND TO DNA INCLUDING RNA/DNA HYBRID, AND AN INCOMING DTTP (LAGS1) | 2.7.7 3.6.4.12 |
6N9W | STRUCTURE OF BACTERIOPHAGE T7 LAGGING-STRAND DNA POLYMERASE (D5A/E7A) AND GP4 (HELICASE/PRIMASE) BOUND TO DNA INCLUDING RNA/DNA HYBRID, AND AN INCOMING DTTP (LAGS2) | 2.7.7 3.6.4.12 |
6N9X | STRUCTURE OF BACTERIOPHAGE T7 LAGGING-STRAND DNA POLYMERASE (D5A/E7A) AND GP4 (HELICASE/PRIMASE) BOUND TO DNA INCLUDING RNA/DNA HYBRID, AND AN INCOMING DTTP (LAGS3) | 2.7.7 3.6.4.12 |
6NAQ | CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS CLPP PROTEASE IN APO FORM | 3.4.21.92 |
6NAY | CRYSTAL STRUCTURE OF NEISSERIA MENINGITIDIS CLPP PROTEASE E31A+E58A ACTIVATED DOUBLE MUTANT | 3.4.21.92 |
6NB1 | CRYSTAL STRUCTURE OF ESCHERICHIA COLI CLPP PROTEASE COMPLEXED WITH SMALL MOLECULE ACTIVATOR, ACP1-06 | 3.4.21.92 |
6NBG | 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN KP1_5497 FROM KLEBSIELLA PNEUMONIAE. | 3.5.99.6 |
6NBK | CRYSTAL STRUCTURE OF ARGINASE FROM BACILLUS CEREUS | 3.5.3.1 |
6NBO | CRYSTAL STRUCTURE OF N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE FROM BURKHOLDERIA MULTIVORANS ATCC 17616 | 3.5.4.42 |
6NCY | CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS | 3.2.1.31 3.2.1.23 |
6NCZ | CRYSTAL STRUCTURE OF HYBRID BETA-GLUCURONIDASE/BETA-GALACTURONIDASE FROM FUSICATENIBACTER SACCHARIVORANS BOUND TO PHENYL-THIO-BETA-D-GLUCURONIDE | 3.2.1.31 3.2.1.23 |
6NEA | HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH REACTIVATOR, HLO7 | 3.1.1.7 |
6NF0 | NOCTURNIN WITH BOUND NADPH SUBSTRATE | 3.1.13.4 3.1.3 |
6NFD | BETA-LACTAMASE SHV-11 FROM KLEBSIELLA PNEUMONIAE STRAIN NTUH-K2044 | 3.5.2.6 |
6NFF | STRUCTURE OF X-PROLYL DIPEPTIDYL AMINOPEPTIDASE FROM LACTOBACILLUS HELVETICUS | 3.4.14.11 |
6NFK | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B WITH LOOP 7 FROM APOBEC3G BOUND TO IODIDE | 3.5.4.38 3.5.4 |
6NFL | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B WITH LOOP 7 FROM APOBEC3G COMPLEXED WITH 2-HP | 3.5.4.38 |
6NFM | CRYSTAL STRUCTURE OF THE CANCER GENOMIC DNA MUTATOR APOBEC3B WITH LOOP 7 FROM APOBEC3G | 3.5.4.38 |
6NFP | 1.7 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF ARGINASE FROM BACILLUS SUBTILIS SUBSP. SUBTILIS STR. 168 | 3.5.3.1 |
6NFT | STRUCTURE OF USP5 ZINC-FINGER UBIQUITIN BINDING DOMAIN CO-CRYSTALLIZED WITH (4-OXOQUINAZOLIN-3(4H)-YL)ACETIC ACID | 3.4.19.12 |
6NHU | CRYSTAL STRUCTURE OF THE BETA LACTAMASE CLASS D YBXI FROM AGROBACTERIUM FABRUM | 3.5.2.6 |
6NI0 | CRYSTAL STRUCTURE OF THE BETA LACTAMASE CLASS D YBXI FROM BURKHOLDERIA THAILANDENSIS | 3.5.2.6 |
6NI1 | CRYSTAL STRUCTURE OF THE BETA LACTAMASE CLASS A PENP FROM BACILLUS SUBTILIS | 3.5.2.6 |
6NIB | CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA AGMATINE IMINOHYDROLASE (DEIMINASE) | 3.5.3.12 |
6NIC | CRYSTAL STRUCTURE OF MEDICAGO TRUNCATULA AGMATINE IMINOHYDROLASE (DEIMINASE) IN COMPLEX WITH 6-AMINOHEXANAMIDE | 3.5.3.12 |
6NIH | CRYSTAL STRUCTURE OF HUMAN TLR1 | 3.2.2.6 |
6NIL | CRYOEM STRUCTURE OF THE TRUNCATED HIV-1 VIF/CBFBETA/A3F COMPLEX | 3.5.4.38 |
6NIQ | CRYSTAL STRUCTURE OF THE PUTATIVE CLASS A BETA-LACTAMASE PENP FROM RHODOPSEUDOMONAS PALUSTRIS | 3.5.2.6 |
6NIT | HUMAN ARGONAUTE2-MIR-122 BOUND TO A TARGET RNA WITH FOUR CENTRAL MISMATCHES (BU4) | 3.1.26 |
6NIU | CRYSTAL STRUCTURE OF A HUMAN ANTI-ZIKV-DENV NEUTRALIZING ANTIBODY MZ4 IN COMPLEX WITH ZIKV E GLYCOPROTEIN | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6NJ1 | CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE FROM CLOSTRIDIUM KLUYVERI DSM 555 | 3.5.2.6 |
6NJH | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN AND UCR2 REGULATORY HELIX WITH T-48 | 3.1.4.53 |
6NJI | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN AND UCR2 REGULATORY HELIX WITH T-49 | 3.1.4.53 |
6NJJ | CRYSTAL STRUCTURE OF THE PDE4D CATALYTIC DOMAIN AND UCR2 REGULATORY HELIX WITH BPN14770 | 3.1.4.53 |
6NJK | CRYSTAL STRUCTURE OF BETA-LACTAMASE FROM SULFITOBACTER SP. EE-36 | 3.5.2.6 |
6NJT | MOUSE ENDONUCLEASE G MUTANT - H97A | 3.1.30 |
6NJU | MOUSE ENDONUCLEASE G MUTANT H97A BOUND TO A-DNA | 3.1.30 |
6NK6 | ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH MOUSE MXRA8 RECEPTOR | 3.4.21.90 |
6NKC | CRYSTAL STRUCTURE OF THE LIPASE LIP_VUT1 FROM GOAT RUMEN METAGENOME. | 3.1.1.3 |
6NKD | CRYSTAL STRUCTURE OF THE LIPASE LIP_VUT3 FROM GOAT RUMEN METAGENOME. | 3 |
6NKL | 2.2 A RESOLUTION STRUCTURE OF VAPBC-1 FROM NONTYPEABLE HAEMOPHILUS INFLUENZAE | 3.1 |
6NLR | CRYSTAL STRUCTURE OF THE PUTATIVE HISTIDINOL PHOSPHATASE HISK FROM LISTERIA MONOCYTOGENES WITH TRINUCLEAR METALS DETERMINED BY PIXE REVEALING SULPHATE ION IN ACTIVE SITE. BASED ON PIXE ANALYSIS AND ORIGINAL DATE FROM 3DCP | 3.1.3.15 |
6NLW | THE CRYSTAL STRUCTURE OF CLASS D CARBAPENEM-HYDROLYZING BETA-LACTAMASE BLAA FROM SHEWANELLA ONEIDENSIS MR-1 | 3.5.2.6 |
6NMB | TRANEXAMIC ACID IS AN ACTIVE SITE INHIBITOR OF UROKINASE PLASMINOGEN ACTIVATOR | 3.4.21.73 |
6NMI | CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX | 3.6.4.12 |
6NN9 | REFINED ATOMIC STRUCTURES OF N9 SUBTYPE INFLUENZA VIRUS NEURAMINIDASE AND ESCAPE MUTANTS | 3.2.1.18 |
6NNA | HUMAN FATTY ACID SYNTHASE PSI/KR TRI-DOMAIN WITH NADPH AND COMPOUND 22 | 2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14 |
6NNQ | NON-COVALENT STRUCTURE OF SENP1 IN COMPLEX WITH SUMO2 | 3.4.22 |
6NOZ | X-RAY STRUCTURE OF PEDV PAPAIN-LIKE PROTEASE 2 | 2.7.7.48 3.4.19.12 3.6.4.12 3.6.4.13 |
6NQ6 | STRUCTURE & FUNCTION OF A NEW ASPARTYLGLUCOSAMINURIA VARIANT | 3.5.1.26 |
6NR0 | SIRT2(56-356) WITH COVALENT INTERMEDIATE BETWEEN MECHANISM-BASED INHIBITOR GLUCOSE-TM-1BETA AND 1'-SH ADP-RIBOSE | 3.5.1 2.3.1.286 |
6NRU | CRYSTAL STRUCTURE OF THE ALPHA-RIBAZOLE PHOSPHATASE FROM SHIGELLA FLEXNERI | 3.1.3.73 |
6NRY | CRYSTAL STRUCTURE OF HUMAN CASPASE-4 | 3.4.22.57 |
6NS7 | CRYSTAL STRUCTURE OF MURINE CASPASE-11 | 3.4.22.64 |
6NTC | CRYSTAL STRUCTURE OF G12V HRAS-GPPNHP BOUND IN COMPLEX WITH THE ENGINEERED RBD VARIANT 1 OF CRAF KINASE PROTEIN | 3.6.5.2 |
6NTD | CRYSTAL STRUCTURE OF G12V HRAS-GPPNHP BOUND IN COMPLEX WITH THE ENGINEERED RBD VARIANT 12 OF CRAF KINASE PROTEIN | 3.6.5.2 |
6NTG | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234 IN COMPLEX WITH REACTIVATOR, HI-6 | 3.1.1.7 |
6NTH | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY (S) STEREOISOMER OF A-232 | 3.1.1.7 |
6NTK | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232 | 3.1.1.7 |
6NTL | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-234 | 3.1.1.7 |
6NTM | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-232 IN COMPLEX WITH THE REACTIVATOR, HI-6 | 3.1.1.7 |
6NTN | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230 IN COMPLEX WITH THE REACTIVATOR, HI-6 | 3.1.1.7 |
6NTO | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN ACETYLCHOLINESTERASE INHIBITED BY A-230 | 3.1.1.7 |
6NTP | PTP1B DOMAIN OF PTP1B-LOV2 CHIMERA | 3.1.3.48 |
6NTZ | CRYSTAL STRUCTURE OF E. COLI PBP5-MEROPENEM | 3.4.16.4 3.5.2.6 |
6NU7 | STRUCTURE OF SUCROSE-6-PHOSPHATE HYDROLASE FROM LACTOBACILLUS GASSERI | 3.2.1.26 |
6NU8 | STRUCTURE OF SUCROSE-6-PHOSPHATE HYDROLASE FROM LACTOBACILLUS GASSERI IN COMPLEX WITH FRUCTOSE | 3.2.1.26 |
6NUA | DNA-PROTEIN CROSSLINK BETWEEN E. COLI YEDK AND SSDNA CONTAINING AN ABASIC SITE | 3.4 |
6NUC | STRUCTURE OF CALCINEURIN IN COMPLEX WITH NHE1 PEPTIDE | 3.1.3.16 |
6NUF | STRUCTURE OF CALCINEURIN IN COMPLEX WITH NHE1 PEPTIDE | 3.1.3.16 |
6NUH | NON-COVALENT DNA-PROTEIN COMPLEX BETWEEN E. COLI YEDK AND SSDNA CONTAINING AN ABASIC SITE ANALOG | 3.4 |
6NUR | SARS-CORONAVIRUS NSP12 BOUND TO NSP7 AND NSP8 CO-FACTORS | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6NUS | SARS-CORONAVIRUS NSP12 BOUND TO NSP8 CO-FACTOR | 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1 |
6NUU | STRUCTURE OF CALCINEURIN MUTANT IN COMPLEX WITH NHE1 PEPTIDE | 3.1.3.16 |
6NV7 | BACE1 IN COMPLEX WITH A MACROCYCLIC INHIBITOR | 3.4.23.46 |
6NV9 | BACE1 IN COMPLEX WITH A MACROCYCLIC INHIBITOR | 3.4.23.46 |
6NVB | CRYSTAL STRUCTURE OF THE INHIBITOR-FREE FORM OF THE SERINE PROTEASE KALLIKREIN-4 | 3.4.21 |
6NVT | CRYSTAL STRUCTURE OF TLA-1 EXTENDED SPECTRUM BETA-LACTAMASE | 3.5.2.6 |
6NVU | CRYSTAL STRUCTURE OF TLA-1 EXTENDED SPECTRUM BETA-LACTAMASE IN COMPLEX WITH CLAVULANIC ACID | 3.5.2.6 |
6NVW | CRYSTAL STRUCTURE OF PENICILLIN G ACYLASE FROM BACILLUS MEGATERIUM | 3.5.1.11 |
6NW3 | BACE1 IN COMPLEX WITH A MACROCYCLIC INHIBITOR | 3.4.23.46 |
6NX6 | ECAII(D90T,K162T) MUTANT IN COMPLEX WITH CITRATE AT PH 5 | 3.5.1.1 |
6NX7 | ECAII(D90T,K162T) MUTANT IN COMPLEX WITH CITRATE AT PH 5.6 | 3.5.1.1 |
6NX8 | ECAII(D90T,K162T) MUTANT IN COMPLEX WITH CITRATE AT PH 6.2 | 3.5.1.1 |
6NX9 | ECAII(D90T,K162T) MUTANT IN COMPLEX WITH CITRATE AT PH 7 | 3.5.1.1 |
6NXA | ECAII(D90T,K162T) MUTANT AT PH 7 | 3.5.1.1 |
6NXB | ECAII IN COMPLEX WITH CITRATE AT PH 7 | 3.5.1.1 |
6NXC | ECAI(T162A) MUTANT IN COMPLEX WITH CITRATE AT PH 4 | 3.5.1.1 |
6NXD | TYPE I L-ASPARAGINASE FROM ESCHERICHIA COLI IN COMPLEX WITH CITRATE AT PH 4 | 3.5.1.1 |
6NY7 | CRYSTAL STRUCTURE OF NDM-1 D199N WITH COMPOUND 16 | 3.5.2.6 |
6NY9 | ALPHA/BETA HYDROLASE DOMAIN-CONTAINING PROTEIN 10 FROM MOUSE | 3.1.1.93 3.1.2.22 |
6NYY | HUMAN M-AAA PROTEASE AFG3L2, SUBSTRATE-BOUND | 3.4.24 |
6NZS | DEXTRANASE AODEX KQ11 | 3.2.1.11 |
6NZT | CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH VOXILAPREVIR | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6NZV | CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH COMPOUND 12 | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6O06 | EXTRACELLULAR FACTORS PRIME ENTEROVIRUS PARTICLES FOR UNCOATING | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6O0Q | CRYSTAL STRUCTURE OF THE TIR DOMAIN FROM HUMAN SARM1 IN COMPLEX WITH RIBOSE | 3.2.2.6 3.2.2 |
6O0R | CRYSTAL STRUCTURE OF THE TIR DOMAIN FROM HUMAN SARM1 IN COMPLEX WITH GLYCEROL | 3.2.2.6 3.2.2 |
6O0S | CRYSTAL STRUCTURE OF THE TANDEM SAM DOMAINS FROM HUMAN SARM1 | 3.2.2.6 3.2.2 |
6O0T | CRYSTAL STRUCTURE OF SELENOMETHIONINE LABELLED TANDEM SAM DOMAINS (L446M:L505M:L523M MUTANT) FROM HUMAN SARM1 | 3.2.2.6 3.2.2 |
6O0U | CRYSTAL STRUCTURE OF THE TIR DOMAIN H685A MUTANT FROM HUMAN SARM1 | 3.2.2.6 3.2.2 |
6O0V | CRYSTAL STRUCTURE OF THE TIR DOMAIN G601P MUTANT FROM HUMAN SARM1, CRYSTAL FORM 2 | 3.2.2.6 3.2.2 |
6O0W | CRYSTAL STRUCTURE OF THE TIR DOMAIN FROM THE GRAPEVINE DISEASE RESISTANCE PROTEIN RUN1 IN COMPLEX WITH NADP+ AND BIS-TRIS | 3.2.2.6 3.2.2 |
6O0X | CONFORMATIONAL STATES OF CAS9-SGRNA-DNA TERNARY COMPLEX IN THE PRESENCE OF MAGNESIUM | 3.1 |
6O0Y | CONFORMATIONAL STATES OF CAS9-SGRNA-DNA TERNARY COMPLEX IN THE PRESENCE OF MAGNESIUM | 3.1 |
6O0Z | CONFORMATIONAL STATES OF CAS9-SGRNA-DNA TERNARY COMPLEX IN THE PRESENCE OF MAGNESIUM | 3.1 |
6O1B | CRYSTAL STRUCTURE OF THE TIR DOMAIN G601P MUTANT FROM HUMAN SARM1, CRYSTAL FORM 1 | 3.2.2.6 3.2.2 |
6O1F | COMPLEX BETWEEN SOYBEAN TRYPSIN INHIBITOR BETA1-TRYPTASE AND A HUMANIZED FAB | 3.4.21.59 |
6O1G | FULL LENGTH HUMAN PLASMA KALLIKREIN WITH INHIBITOR | 3.4.21.34 |
6O1I | ALPHA-L-FUCOSIDASE ALFC FUCOSYLTRANSFERASE MUTANT E274A | 3.2.1.51 |
6O1J | ALPHA-L-FUCOSIDASE ALFC FUCOSYLTRANSFERASE MUTANT N243A | 3.2.1.51 |
6O1K | ARCHITECTURAL PRINCIPLES FOR HFQ/CRC-MEDIATED REGULATION OF GENE EXPRESSION. HFQ-CRC-AMIE 2:2:2 COMPLEX (CORE COMPLEX) | 3.1.11.2 |
6O1L | ARCHITECTURAL PRINCIPLES FOR HFQ/CRC-MEDIATED REGULATION OF GENE EXPRESSION HFQ-CRC-AMIE 2:3:2 COMPLEX | 3.1.11.2 |
6O1M | ARCHITECTURAL PRINCIPLES FOR HFQ/CRC-MEDIATED REGULATION OF GENE EXPRESSION. HFQ-CRC-AMIE 2:4:2 COMPLEX | 3.1.11.2 |
6O1S | STRUCTURE OF HUMAN PLASMA KALLIKREIN PROTEASE DOMAIN WITH INHIBITOR | 3.4.21.34 |
6O1V | COMPLEX OF HUMAN CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) AND GLPG1837 | 3.6.3.49 5.6.1.6 |
6O21 | CRYSTAL STRUCTURE OF HUMAN KLK4 IN COMPLEX WITH CLEAVED SFTI-FCQR(ASN14)[1,14] INHIBITOR | 3.4.21 |
6O2H | HEN LYSOZYME IN TRICLINIC SPACE GROUP AT AMBIENT TEMPERATURE - DIFFUSE SCATTERING DATASET | 3.2.1.17 |
6O2P | COMPLEX OF IVACAFTOR WITH CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) | 3.6.3.49 5.6.1.6 |
6O2X | STRUCTURE OF CRUZAIN BOUND TO MMTS INHIBITOR | 3.4.22.51 |
6O36 | CRYSTAL STRUCTURE OF HUMAN KRAS P34R MUTANT IN COMPLEX WITH GNP | 3 3.6.5.2 |
6O3P | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MOUSE NUDT12 IN COMPLEX WITH AMP AND 3 MG2+ IONS | 3.6.1.22 3.6.1 |
6O3R | CRYSTAL STRUCTURE OF NDM-1 D199N WITH COMPOUND 7 | 3.5.2.6 |
6O3S | NMR SOLUTION STRUCTURE OF VICILIN-BURIED PEPTIDE-8 (VBP-8) | 3.2.2.22 |
6O44 | INSIGHT INTO SUBTILISIN E-S7 CLEAVAGE PATTERN BASED ON CRYSTAL STRUCTURE AND HYDROLYSATES PEPTIDE ANALYSIS | 3.4.21.62 |
6O46 | CRYSTAL STRUCTURE OF HUMAN KRAS P34R MUTANT IN COMPLEX WITH GNP AND PHOSPHATE | 3 3.6.5.2 |
6O48 | WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH A SUBSTRATE ANALOG CA-P2 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6O4W | BINARY COMPLEX OF NATIVE HACHE WITH DONEPEZIL | 3.1.1.7 |
6O4X | BINARY COMPLEX OF NATIVE HACHE WITH 9-AMINOACRIDINE | 3.1.1.7 |
6O50 | BINARY COMPLEX OF NATIVE HACHE WITH BW284C51 | 3.1.1.7 |
6O52 | ROOM TEMPERATURE STRUCTURE OF BINARY COMPLEX OF NATIVE HACHE WITH BW284C51 | 3.1.1.7 |
6O56 | HNH NUCLEASE FROM S. PYOGENES CAS9 | 3.1 |
6O5F | CRYSTAL STRUCTURE OF DEAD-BOX RNA HELICASE DDX3X AT PRE-UNWOUND STATE | 3.6.4.13 |
6O5J | CRYSTAL STRUCTURE OF DAD2 BOUND TO QUINAZOLINONE DERIVATIVE | 3.1 |
6O5R | ROOM TEMPERATURE STRUCTURE OF BINARY COMPLEX OF NATIVE HACHE WITH OXIME REACTIVATOR RS-170B | 3.1.1.7 |
6O5S | ROOM TEMPERATURE STRUCTURE OF VX-PHOSPHONYLATED HACHE IN COMPLEX WITH OXIME REACTIVATOR RS-170B | 3.1.1.7 |
6O5V | BINARY COMPLEX OF NATIVE HACHE WITH OXIME REACTIVATOR RS-170B | 3.1.1.7 |
6O66 | STRUCTURE OF VX-PHOSPHONYLATED HACHE IN COMPLEX WITH OXIME REACTIVATOR RS-170B | 3.1.1.7 |
6O69 | CRYSTAL STRUCTURE OF DOUBLE MUTANT L380R/F535K OF HUMAN ACETYLCHOLINESTERASE | 3.1.1.7 |
6O6B | ROTAVIRUS A-VP3 (RVA-VP3) | 3.1.4 2.7.7.50 2.1.1.56 |
6O73 | CRYSTAL STRUCTURE OF APO CSM1-CSM4 CASSETTE | 3.1 2.7.7 |
6O74 | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH AMPPNP | 3.1 2.7.7 |
6O75 | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH PPPAPA | 3.1 2.7.7 |
6O78 | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH PPPAPAPA | 3.1 2.7.7 |
6O79 | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH CA3 | 3.1 2.7.7 |
6O7B | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH CA4 | 3.1 2.7.7 |
6O7D | CRYSTAL STRUCTURE OF CSM1-CSM4 CASSETTE IN COMPLEX WITH ONE ATP | 3.1 2.7.7 |
6O7E | CRYO-EM STRUCTURE OF CSM-CRRNA-TARGET RNA TERNARY COMPLEX IN COMPLEX WITH AMPPNP IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6O7H | CRYO-EM STRUCTURE OF CSM-CRRNA-TARGET RNA TERNARY COMPLEX IN COMPLEX WITH CA4 IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6O7I | CRYO-EM STRUCTURE OF CSM-CRRNA-TARGET RNA TERNARY BIGGER COMPLEX IN COMPLEX WITH CA4 IN TYPE III-A CRISPR-CAS SYSTEM | 3.1 2.7.7 |
6O9E | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA AND INDOPY-1 | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6O9L | HUMAN HOLO-PIC IN THE CLOSED STATE | 3.6.4.12 |
6O9M | STRUCTURE OF THE HUMAN APO TFIIH | 3.6.4.12 |
6O9X | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2-4 | 3.2.1.143 |
6O9Y | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2-8 | 3.2.1.143 |
6OA0 | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2-9 | 3.2.1.143 |
6OA1 | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2120 | 3.2.1.143 |
6OA3 | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2131 | 3.2.1.143 |
6OA9 | CDC48-NPL4 COMPLEX PROCESSING POLY-UBIQUITINATED SUBSTRATE IN THE PRESENCE OF ATP | 3.6.4.6 |
6OAA | CDC48-NPL4 COMPLEX PROCESSING POLY-UBIQUITINATED SUBSTRATE IN THE PRESENCE OF ADP-BEFX, STATE 1 | 3.6.4.6 |
6OAB | CDC48-NPL4 COMPLEX PROCESSING POLY-UBIQUITINATED SUBSTRATE IN THE PRESENCE OF ADP-BEFX, STATE 2 | 3.6.4.6 |
6OAD | 2.05 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF AMINOPEPTIDASE B FROM ESCHERICHIA COLI STR. K-12 SUBSTR. MG1655. | 3.4.11.23 |
6OAK | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2131 | 3.2.1.143 |
6OAL | STRUCTURE OF HUMAN PARG COMPLEXED WITH JA2120 | 3.2.1.143 |
6OAM | CRYSTAL STRUCTURE OF CHLADUB2 DUB DOMAIN | 3.4.22 |
6OAU | APO STRUCTURE OF WT LIPOPROTEIN LIPASE IN COMPLEX WITH GPIHBP1 MUTANT N78D N82D PRODUCED IN GNTI-DEFICIENT HEK293-F CELLS | 3.1.1.34 3.1.1.32 |
6OAZ | APO STRUCTURE OF WT LIPOPROTEIN LIPASE IN COMPLEX WITH GPIHBP1 MUTANT N78D N82D PRODUCED IN HEK293-F CELLS | 3.1.1.34 3.1.1.32 |
6OB0 | COMPOUND 2 BOUND STRUCTURE OF WT LIPOPROTEIN LIPASE IN COMPLEX WITH GPIHBP1 MUTANT N78D N82D PRODUCED IN HEK293-F CELLS | 3.1.1.34 3.1.1.32 |
6OB2 | CRYSTAL STRUCTURE OF WILD-TYPE KRAS (GMPPNP-BOUND) IN COMPLEX WITH GAP-RELATED DOMAIN (GRD) OF NEUROFIBROMIN (NF1) | 3.6.5.2 |
6OB3 | CRYSTAL STRUCTURE OF G13D-KRAS (GMPPNP-BOUND) IN COMPLEX WITH GAP-RELATED DOMAIN (GRD) OF NEUROFIBROMIN (NF1) | 3.6.5.2 |
6OBA | THE BETA2 ADRENERGIC RECEPTOR BOUND TO A NEGATIVE ALLOSTERIC MODULATOR | 3.2.1.17 |
6OBC | RICIN A CHAIN BOUND TO CAMELID | 3.2.2.22 |
6OBE | RICIN A CHAIN BOUND TO VHH ANTIBODY V6H8 | 3.2.2.22 |
6OBG | RICIN A CHAIN BOUND TO VHH ANTIBODY V8E6 | 3.2.2.22 |
6OBJ | STRUCTURE OF A DNA-BOUND DIMER EXTRACTED FROM FILAMENTOUS SGRAI ENDONUCLEASE IN ITS ACTIVATED FORM | 3.1.21 |
6OBM | RICIN A CHAIN BOUND TO VHH ANTIBODY V6A7 | 3.2.2.22 |
6OBN | THE CRYSTAL STRUCTURE OF COEXPRESSED SDS22:PP1 COMPLEX | 3.1.3.16 |
6OBO | RICIN A CHAIN BOUND TO VHH ANTIBODY V6A6 | 3.2.2.22 |
6OBP | RECONSTITUTED PP1 HOLOENZYME | 3.1.3.16 |
6OBQ | PP1 H66K IN COMPLEX WITH MICROCYSTIN LR | 3.1.3.16 |
6OBR | PP1 Y134A IN COMPLEX WITH MICROCYSTIN LR | 3.1.3.16 |
6OBS | PP1 Y134K | 3.1.3.16 |
6OBU | PP1 Y134K IN COMPLEX WITH MICROCYSTIN LR | 3.1.3.16 |
6OBX | MONTBRETIN A ANALOGUE M10-MBA IN COMPLEX WITH HUMAN PANCREATIC ALPHA-AMYLASE | 3.2.1.1 |
6OCA | RICIN A CHAIN BOUND TO VHH ANTIBODY V2G10 | 3.2.2.22 |
6OCD | RICIN A CHAIN BOUND TO VHH ANTIBODY V6D4 | 3.2.2.22 |
6OCF | THE CRYSTAL STRUCTURE OF VASH1-SVBP COMPLEX | 3.4.17.17 |
6OCG | CRYSTAL STRUCTURE OF VASH1-SVBP COMPLEX BOUND WITH EPOY | 3.4.17.17 |
6OCH | CRYSTAL STRUCTURE OF VASH1-SVBP COMPLEX BOUND WITH PARTHENOLIDE | 3.4.17.17 |
6OCN | MONTBRETIN A ANALOGUE M06-MBA IN COMPLEX WITH HUMAN PANCREATIC ALPHA-AMYLASE | 3.2.1.1 |
6OE2 | X-RAY STRUCTURE OF THE C-TERMINAL DOMAIN (277-440) OF PUTATIVE CHITOBIASE FROM BACTEROIDES THETAIOTAOMICRON. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR324A. RE-REFINEMENT OF 3GGL WITH CORRECT METAL MN REPLACING ZN. NEW METAL CONFIRMED WITH PIXE ANALYSIS OF ORIGINAL SAMPLE. | 3.2.1.169 |
6OE3 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2-(2-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-7-FLUORO-2-NAPHTHONITRILE (JLJ635), A NON-NUCLEOSIDE INHIBITOR | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6OE7 | CRYSTAL STRUCTURE OF HMCES CROSS-LINKED TO DNA ABASIC SITE | 3.4 |
6OEA | CRYSTAL STRUCTURE OF HMCES SRAP DOMAIN IN COMPLEX WITH LONGER 3' OVERHANG DNA | 3.4 |
6OEB | CRYSTAL STRUCTURE OF HMCES SRAP DOMAIN IN COMPLEX WITH 3' OVERHANG DNA | 3.4 |
6OEM | CRYO-EM STRUCTURE OF MOUSE RAG1/2 PRC COMPLEX (DNA0) | 3.1 2.3.2.27 |
6OEN | CRYO-EM STRUCTURE OF MOUSE RAG1/2 PRC COMPLEX (DNA1) | 3.1 2.3.2.27 |
6OEO | CRYO-EM STRUCTURE OF MOUSE RAG1/2 NFC COMPLEX (DNA1) | 3.1 2.3.2.27 |
6OEP | CRYO-EM STRUCTURE OF MOUSE RAG1/2 12RSS-NFC/23RSS-PRC COMPLEX (DNA1) | 3.1 2.3.2.27 |
6OEQ | CRYO-EM STRUCTURE OF MOUSE RAG1/2 12RSS-PRC/23RSS-NFC COMPLEX (DNA1) | 3.1 2.3.2.27 |
6OER | CRYO-EM STRUCTURE OF MOUSE RAG1/2 NFC COMPLEX (DNA2) | 3.1 2.3.2.27 |
6OES | CRYO-EM STRUCTURE OF MOUSE RAG1/2 STC COMPLEX (WITHOUT NBD DOMAIN) | 3.1 2.3.2.27 |
6OET | CRYO-EM STRUCTURE OF MOUSE RAG1/2 STC COMPLEX | 3.1 2.3.2.27 |
6OF5 | THE CRYSTAL STRUCTURE OF DODECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE | 3.1.3.2 |
6OFD | THE CRYSTAL STRUCTURE OF OCTADECYLOXY(NAPHTHALEN-1-YL)METHYLPHOSPHONIC ACID IN COMPLEX WITH RED KIDNEY BEAN PURPLE ACID PHOSPHATASE | 3.1.3.2 |
6OFS | THE CRYSTAL STRUCTURE OF THE PERIPLASMIC PROTEASE PQQL FROM ESCHERICHIA COLI | 3.4.24 |
6OFT | THE CRYSTAL STRUCTURE OF THE FIRST HALF OF THE PERIPLASMIC PROTEASE PQQL FROM ESCHERICHIA COLI | 3.4.24 |
6OG4 | PLASMINOGEN BINDING GROUP A STREPTOCOCCAL M PROTEIN | 3.4.21.7 |
6OH1 | IGA1 PROTEASE G5 DOMAIN STRUCTURE | 3.4.24.13 |
6OH9 | YEAST GUANINE DEAMINASE | 3.5.4.3 |
6OHA | YEAST GUANINE DEAMINASE | 3.5.4.3 |
6OHB | E. COLI GUANINE DEAMINASE | 3.5.4.3 |
6OHM | STRUCTURE OF TUNGSTATE BOUND HUMAN PHOSPHOLIPASE D2 CATALYTIC DOMAIN | 3.1.4.4 |
6OHO | STRUCTURE OF HUMAN PHOSPHOLIPASE D2 CATALYTIC DOMAIN | 3.1.4.4 |
6OHP | STRUCTURE OF COMPOUND 1 (HALOPEMIDE) BOUND HUMAN PHOSPHOLIPASE D2 CATALYTIC DOMAIN | 3.1.4.4 |
6OHQ | STRUCTURE OF COMPOUND 4 BOUND HUMAN PHOSPHOLIPASE D2 CATALYTIC DOMAIN | 3.1.4.4 |
6OHR | STRUCTURE OF COMPOUND 5 BOUND HUMAN PHOSPHOLIPASE D1 CATALYTIC DOMAIN | 3.1.4.4 |
6OHS | STRUCTURE OF COMPOUND 3 (ML299) BOUND HUMAN PHOSPHOLIPASE D2 CATALYTIC DOMAIN | 3.1.4.4 |
6OI7 | SE-MET STRUCTURE OF APO- ESCHERICHIA COLI DGTPASE | 3.1.5.1 |
6OIM | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO AMG 510 | 3.6.5.2 |
6OIV | XFEL STRUCTURE OF ESCHERICHIA COLI DGTPASE | 3.1.5.1 |
6OIW | STRUCTURE OF ESCHERICHIA COLI DGTPASE BOUND TO DGTP-1-THIOL | 3.1.5.1 |
6OIX | STRUCTURE OF ESCHERICHIA COLI DGTPASE BOUND TO GTP | 3.1.5.1 |
6OIY | STRUCTURE OF ESCHERICHIA COLI BOUND TO DGTP | 3.1.5.1 |
6OJ1 | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 | 3.2.1.22 |
6OJB | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS EGA3 COMPLEX WITH GALACTOSAMINE | 3.2.1.22 |
6OJE | DIMERIC STRUCTURE OF LRRK2 GTPASE DOMAIN | 2.7.11.1 3.6.5 |
6OJF | DIMERIC STRUCTURE OF LRRK2 GTPASE DOMAIN | 2.7.11.1 3.6.5 |
6OK0 | CRYSTAL STRUCTURE OF SEL1 REPEAT PROTEIN FROM OXALOBACTER FORMIGENES | 3.5.2.6 |
6OK3 | CRYSTAL STRUCTURE OF SEL1 REPEAT PROTEIN FROM OXALOBACTER FORMIGENES | 3.5.2.6 |
6OK8 | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS K127L AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6OKJ | NATIVE ANANAIN FROM ANANAS COMOSUS | 3.4.22.31 |
6OL4 | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), F182A MUTANT, APO STATE | 3.1.3.48 |
6OLQ | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P188A MUTANT, APO STATE | 3.1.3.48 |
6OLV | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P185A MUTANT, APO STATE | 3.1.3.48 |
6OMB | CDC48 HEXAMER (SUBUNITS A TO E) WITH SUBSTRATE BOUND TO THE CENTRAL PORE | 3.6.4.6 |
6OME | CRYSTAL STRUCTURE OF A PROBABLE CYTOSOL AMINOPEPTIDASE (LEUCINE AMINOPEPTIDASE, LAP) FROM CHLAMYDIA TRACHOMATIS D/UW-3/CX | 3.4.11.1 3.4.11.10 |
6OMY | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P180A MUTANT, APO STATE | 3.1.3.48 |
6ON2 | LON PROTEASE FROM YERSINIA PESTIS WITH Y2853 SUBSTRATE | 3.4.21.53 |
6ONW | CRYSTAL STRUCTURE OF SEL1 REPEAT PROTEIN FROM OXALOBACTER FORMIGENES | 3.5.2.6 |
6OOE | CTX-M-27 BETA LACTAMASE WITH COMPOUND 20 | 3.5.2.6 |
6OOF | CTX-M-14 BETA LACTAMASE WITH COMPOUND 20 | 3.5.2.6 |
6OOH | CTX-M-27 BETA LACTAMASE WITH COMPOUND 14 | 3.5.2.6 |
6OOJ | CTX-M-14 BETA LACTAMASE WITH COMPOUND 14 | 3.5.2.6 |
6OOK | CTX-M-14 BETA LACTAMASE WITH COMPOUND 3 | 3.5.2.6 |
6OOS | HIV-1 PROTEASE NL4-3 L90M MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OOT | HIV-1 PROTEASE NL4-3 L89V, L90M MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OOU | CRYSTAL STRUCTURE OF HIV-1 PROTEASE NL4-3 L89V MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OOV | CRYSTAL STRUCTURE OF HMCES SRAP DOMAIN IN COMPLEX WITH PALINDROMIC 3' OVERHANG DNA | 3.4 |
6OPC | CDC48 HEXAMER IN A COMPLEX WITH SUBSTRATE AND SHP1(UBX DOMAIN) | 3.6.4.6 |
6OPM | CASPOSASE BOUND TO INTEGRATION PRODUCT | 3.1 |
6OPW | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OPY | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OPZ | HIV-1 PROTEASE NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, I54L, A71V, L76V, V82F, I84V MUTANT IN COMPLEX WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OQ6 | STRUCTURE OF THE PORE FORMING FRAGMENT OF CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH VHH 5D | 3.4.22 2.4.1 |
6OQ8 | STRUCTURE OF THE GTD DOMAIN OF CLOSTRIDIUM DIFFICILE TOXIN B IN COMPLEX WITH VHH 7F | 3.4.22 2.4.1 |
6OQJ | SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH1/AA] AND PLASMINOGEN KRINGLE 2 | 3.4.21.7 |
6OQK | SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH2/AA] AND PLASMINOGEN KRINGLE 2 | 3.4.21.7 |
6OR3 | STRUCTURE OF AN ACYL INTERMEDIATE OF THERMOMYCES LANUGINOSA LIPASE WITH PALMITIC ACID IN AN ORTHORHOMBIC CRYSTAL | 3.1.1.3 |
6OR7 | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DNA AND (-)FTC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6ORK | CRYSTAL STRUCTURE OF SEL1 REPEAT PROTEIN FROM OXALOBACTER FORMIGENES | 3.5.2.6 |
6ORM | CRYSTAL STRUCTURE OF PERUVIANIN-I (CYSTEINE PEPTIDASE FROM THEVETIA PERUVIANA LATEX) | 3.4.22.2 |
6ORS | STRUCTURE OF PLASMEPSIN X (PM10, PMX) FROM PLASMODIUM FALCIPARUM 3D7 | 3.4.23.1 |
6OSU | CRYSTAL STRUCTURE OF THE D-ALANYL-D-ALANINE CARBOXYPEPTIDASE DACD FROM FRANCISELLA TULARENSIS | 3.4.16.4 |
6OTZ | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DSDNA AND (+)FTC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6OUN | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DSDNA AND (-)3TC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6OV1 | STRUCTURE OF STAPHYLOCOCCUS AUREUS RNASE P PROTEIN MUTANT WITH DEFECTIVE MRNA DEGRADATION ACTIVITY | 3.1.26.5 |
6OV8 | 2.6 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF AMINOPEPTIDASE B FROM ESCHERICHIA COLI STR. K-12 SUBSTR. MG1655 | 3.4.11.23 |
6OW2 | X-RAY STRUCTURE OF POLYPEPTIDE DEFORMYLASE | 3.5.1.88 |
6OW7 | X-RAY STRUCTURE OF POLYPEPTIDE DEFORMYLASE WITH A PIPERAZIC ACID | 3.5.1.88 |
6OWN | CRYSTAL STRUCTURE OF MSM DNAB1 INTEIN SPLICING DOMAIN BOUND WITH ZINC | 3.6.4.12 |
6OX6 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE TYPE VI EFFECTOR TAS1 AND ITS IMMUNITY PROTEIN | 3.2.2.5 |
6OXO | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-91 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXP | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH UMASS3 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXQ | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH UMASS8 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXR | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-82 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXS | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-76 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXT | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-84 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXU | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-99 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXV | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-85 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXW | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR-100 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXX | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-18 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXY | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-19 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OXZ | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-20 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OY0 | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-21 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OY1 | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-26 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OY2 | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-25 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OYD | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-004 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OYR | X-RAY CRYSTAL STRUCTURE OF WILD TYPE HIV-1 PROTEASE IN COMPLEX WITH GRL-002 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6OZE | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ENDONUCLEASE V (C140S/C225S/C226A/C228S) | 3.1.26 |
6OZF | CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA (TM) ENDONUCLEASE V (D110N) IN COMPLEX WITH A 12MER DNA CONTAINING AN INOSINE FOLLOWED BY A RIBO-ADENOSINE | 3.1.21.7 |
6OZG | CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA (TM) ENDONUCLEASE V (E89Q) IN COMPLEX WITH A 12MER DNA CONTAINING AN INOSINE FOLLOWED BY A RIBO-ADENOSINE | 3.1.21.7 |
6OZJ | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE IN THE ABSENCE OF DIVALENT CATION | 3.1.26 |
6OZK | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER 68H SOAK IN CA2+ | 3.1.26 |
6OZL | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 2 MIN SOAK IN MN2+ | 3.1.26 |
6OZM | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 10 MIN SOAK IN 10 MM MN2+ | 3.1.26 |
6OZN | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 15 MIN SOAK IN 10 MM MN2+ | 3.1.26 |
6OZO | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 30 MIN SOAK IN 10 MM MN2+ | 3.1.26 |
6OZP | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 180 MIN SOAK IN 10 MM MN2+ | 3.1.26 |
6OZQ | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V (K155M) IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 100 MIN SOAK IN 10 MM MN2+ AND K+ | 3.1.26 |
6OZR | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 15 MIN SOAK IN 10 MM MG2+ | 3.1.26 |
6OZS | CRYSTAL STRUCTURE OF MUS MUSCULUS (MM) ENDONUCLEASE V IN COMPLEX WITH A 23MER RNA OLIGO CONTAINING AN INOSINE AFTER A 90 MIN SOAK IN 10 MM MG2+ | 3.1.26 |
6P0I | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA IN A COVALENT COMPLEX WITH ARYL SULFONYL FLUORIDE COMPOUNDS. | 3.6.5.2 |
6P0J | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA | 3.6.5 3.6.5.2 |
6P0K | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA IN A COVALENT COMPLEX WITH ARYL SULFONYL FLUORIDE COMPOUNDS. | 3.6.5.2 |
6P0L | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA IN A COVALENT COMPLEX WITH ARYL SULFONYL FLUORIDE COMPOUNDS. | 3.6.5.2 |
6P0M | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA IN A COVALENT COMPLEX WITH ARYL SULFONYL FLUORIDE COMPOUNDS. | 3.6.5.2 |
6P0N | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA IN A COVALENT COMPLEX WITH ARYL SULFONYL FLUORIDE COMPOUNDS. | 3.6.5.2 |
6P0O | CRYSTAL STRUCTURE OF GDP-BOUND HUMAN RALA | 3.6.5.2 |
6P0P | HUMAN BETA-TRYPTASE CO-CRYSTAL STRUCTURE WITH 5-{4-[3-(AMINOMETHYL)PHENYL]PIPERIDINE-1-CARBONYL}-2-(3'-{4-[3-(AMINOMETHYL)PHENYL]PIPERIDINE-1-CARBONYL}-[1,1'-BIPHENYL]-3-YL)-2-HYDROXY-2H-1,3,2-BENZODIOXABOROL-2-UIDE | 3.4.21.59 |
6P0Z | CRYSTAL STRUCTURE OF N-ACETYLATED KRAS (2-169) BOUND TO GDP AND MG | 3.6.5.2 |
6P1H | CRYO-EM STRUCTURE OF DNA POLYMERASE DELTA HOLOENZYME | 2.7.7.7 3.1.11 |
6P1I | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DSDNA AND DCTP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6P1X | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DSDNA AND L-DDCTP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6P1Z | BACTERIOPHAGE PHIKZ GP163.1 PAAR REPEAT PROTEIN IN COMPLEX WITH THE C-TERMINAL PART OF THE T4 GP5 BETA-HELICAL DOMAIN | 3.2.1.17 |
6P22 | PHOTORHABDUS VIRULENCE CASSETTE (PVC) PAAR REPEAT PROTEIN PVC10 IN COMPLEX WITH A T4 GP5 BETA-HELIX FRAGMENT MODIFIED TO MIMIC PVC8, THE CENTRAL SPIKE PROTEIN OF PVC | 3.2.1.17 |
6P2A | CHIMERA OF BACTERIOPHAGE OBP GP146 CENTRAL SPIKE PROTEIN AND A T4 GP5 BETA-HELIX FRAGMENT | 3.2.1.17 |
6P2G | STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DSDNA AND D-DDCTP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6P2T | BSHB FROM BACILLUS SUBTILIS COMPLEXED WITH CITRATE | 3.5.1 |
6P3Q | CALPAIN-5 (CAPN5) PROTEASE CORE (PC) | 3.4.22 |
6P3X | CRYSTAL STRUCTURE OF FULL LENGTH APOBEC3G E/Q (PH 7.0) | 3.5.4 |
6P3Y | CRYSTAL STRUCTURE OF FULL LENGTH APOBEC3G E/Q (PH 7.4) | 3.5.4 |
6P3Z | CRYSTAL STRUCTURE OF FULL LENGTH APOBEC3G E/Q (PH 5.2) | 3.5.4 |
6P40 | CRYSTAL STRUCTURE OF FULL LENGTH APOBEC3G FKL | 3.5.4 |
6P4A | HYHEL10 FAB COMPLEXED WITH HEN EGG LYSOZYME CARRYING TWO MUTATIONS (HEL2X-RIGID): R21Q AND R73E | 3.2.1.17 |
6P4D | HEN EGG LYSOZYME (HEL) CONTAINING THREE POINT MUTATIONS (HEL3X): R21Q, R73E, AND D101R | 3.2.1.17 |
6P4E | LEISHMANIA MEXICANA CPB IN COMPLEX WITH AN AZA-NITRILE INHIBITOR | 3.4.22 |
6P52 | CRYSTAL STRUCTURE OF TRANSPEPTIDASE DOMAIN OF PBP2 FROM NEISSERIA GONORRHOEAE WITH A BOUND PHOSPHATE AT THE ACTIVE SITE | 3.4.16.4 |
6P53 | CRYSTAL STRUCTURE OF THE TRANSPEPTIDASE DOMAIN OF PBP2 FROM NEISSERIA GONORRHOEAE IN APO FORM | 3.4.16.4 |
6P54 | CRYSTAL STRUCTURE OF TRANSPEPTIDASE DOMAIN OF PBP2 FROM NEISSERIA GONORRHOEAE ACYLATED BY CEFTRIAXONE | 3.4.16.4 |
6P55 | CRYSTAL STRUCTURE OF TRANSPEPTIDASE DOMAIN OF PBP2 FROM NEISSERIA GONORRHOEAE ACYLATED BY CEFIXIME | 3.4.16.4 |
6P56 | CRYSTAL STRUCTURE OF THE TRANSPEPTIDASE DOMAIN OF A T498A MUTANT OF PBP2 FROM NEISSERIA GONORRHOEAE | 3.4.16.4 |
6P5L | CRYSTAL STRUCTURE OF UBL123 WITH AN EZH2 PEPTIDE | 3.4.19.12 |
6P5V | STRUCTURE OF DCN1 BOUND TO N-((4S,5S)-7-ETHYL-4-(4-FLUOROPHENYL)-3-METHYL-6-OXO-1-PHENYL-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)-3-METHYLBENZAMIDE | 3.2.1.17 |
6P5W | STRUCTURE OF DCN1 BOUND TO 3-METHYL-N-((4S,5S)-3-METHYL-6-OXO-1-PHENYL-4-(P-TOLYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)BENZAMIDE | 3.2.1.17 |
6P66 | THE CRYSTAL STRUCTURE OF THE XPB COMPLEX WITH BAX1 FROM ARCHAEOGLOBUS FULGIDUS AT 3.0 ANGSTROM RESOLUTION | 3.6.4.12 |
6P6L | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 1A IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6M | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 1A C159 IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6O | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 1A D168E IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6Q | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 1A3A CHIMERA IN COMPLEX WITH GRAZOPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6R | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 1A3A CHIMERA IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6S | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 3A IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6T | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 4A IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6V | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 5A IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P6Z | HCV NS3/4A PROTEASE DOMAIN OF GENOTYPE 4A WITH AN EXTENDED LINKER IN COMPLEX WITH GLECAPREVIR | 3.4.21.98 3.6.1.15 3.6.4.13 3.4.22 2.7.7.48 |
6P7A | CRYSTAL STRUCTURE OF THE FOWLPOX VIRUS HOLLIDAY JUNCTION RESOLVASE | 3.1 |
6P7B | CRYSTAL STRUCTURE OF FOWLPOX VIRUS RESOLVASE AND SUBSTRATE HOLLIDAY JUNCTION DNA COMPLEX | 3.1 |
6P8W | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO AN ACRYLOYLAZETIDINE ACETAMIDE INHIBITOR. | 3.6.5.2 |
6P8X | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO AN ACRYLOYLAZETIDINE ACETAMIDE INHIBITOR. | 3.6.5.2 |
6P8Y | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO AN ACRYLOYLAZETIDINE ACETAMIDE INHIBITOR. | 3.6.5.2 |
6P8Z | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO AN ACRYLOYLAZETIDINE ACETAMIDE INHIBITOR | 3.6.5.2 |
6P93 | HUMAN APE1 K98A AP-ENDONUCLEASE PRODUCT COMPLEX | 3.1 4.2.99.18 |
6P94 | HUMAN APE1 C65A AP-ENDONUCLEASE PRODUCT COMPLEX | 3.1 4.2.99.18 |
6P96 | OXA-48 CARBAPANEMASE, APO FORM | 3.5.2.6 |
6P97 | OXA-48 CARBAPANEMASE, IMIPENEM COMPLEX | 3.5.2.6 |
6P98 | OXA-48 CARBAPANEMASE, MEROPENEM COMPLEX | 3.5.2.6 |
6P99 | OXA-48 CARBAPANEMASE, ERTAPENEM COMPLEX | 3.5.2.6 |
6P9A | HIV-1 PROTEASE MULTIPLE MUTANT PRS5B WITH DARUNAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6P9B | HIV-1 PROTEASE MULTIPLE DRUG RESISTANT MUTANT PRS5B WITH AMPRENAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6P9C | OXA-48 CARBAPANEMASE, DORIPENEM COMPLEX | 3.5.2.6 |
6P9G | STRUCTURE OF USP5 ZINC-FINGER UBIQUITIN BINDING DOMAIN CO-CRYSTALLIZED WITH 2-(4-OXOQUINAZOLIN-3(4H)-YL)PROPANOIC ACID | 3.4.19.12 |
6P9O | POLIOVIRUS 135S-LIKE EXPANDED PARTICLE IN COMPLEX WITH A MONOCLONAL ANTIBODY DIRECTED AGAINST THE N-TERMINAL EXTENSION OF CAPSID PROTEIN VP1 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6P9U | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT W215A | 3.4.21.5 |
6P9W | POLIOVIRUS (TYPE 1 MAHONEY), RECEPTOR CATALYSED 135S PARTICLE MAP | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6PA2 | E. COLI L-ASPARAGINASE II MUTANT (K162M) IN COMPLEX WITH L-ASP AT PH 5.6 | 3.5.1.1 |
6PA3 | E. COLI L-ASPARAGINASE II DOUBLE MUTANT (T89V,K162T) IN COMPLEX WITH L-ASN AT PH 7.0 | 3.5.1.1 |
6PA4 | E. COLI L-ASPARAGINASE II DOUBLE MUTANT (T89V,K162T) IN COMPLEX WITH L-ASP AT PH 7.0 | 3.5.1.1 |
6PA5 | ECAII(T89V,K162T) MUTANT IN COMPLEX WITH L-ASN AT PH 8.3 IN SPACE GROUP P2(1) | 3.5.1.1 |
6PA6 | ECAII(T89V,K162T) MUTANT IN COMPLEX WITH L-ASN AT PH 8.3 IN SPACE GROUP C2 | 3.5.1.1 |
6PA8 | ECAII(T89V,K162T) MUTANT IN COMPLEX WITH L-ASN AT PH 7.0 | 3.5.1.1 |
6PA9 | E. COLI L-ASPARAGINASE II MUTANT (T12V) IN COMPLEX WITH L-ASN AT PH 7.0 | 3.5.1.1 |
6PAA | E. COLI L-ASPARAGINASE II MUTANT (T12V) IN COMPLEX WITH L-ASP AT PH 5.5 | 3.5.1.1 |
6PAB | E. COLI L-ASPARAGINASE II IN COMPLEX WITH L-ASP AT PH 7.0 | 3.5.1.1 |
6PAC | E. COLI L-ASPARAGINASE II IN COMPLEX WITH L-ASP AT PH 5.6 | 3.5.1.1 |
6PAD | BINDING OF CHLOROMETHYL KETONE SUBSTRATE ANALOGUES TO CRYSTALLINE PAPAIN | 3.4.22.2 |
6PAE | DICKEYA CHRYSANTHEMI COMPLEX WITH L-ASP AT PH 5.6 | 3.5.1.1 |
6PAK | INSIGHT INTO SUBTILISIN E-S7 CLEAVAGE PATTERN BASED ON CRYSTAL STRUCTURE AND HYDROLYSATES PEPTIDE ANALYSIS | 3.4.21.62 |
6PBB | CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME IN COMPLEX WITH I3C | 3.2.1.17 |
6PBC | STRUCTURAL BASIS FOR THE ACTIVATION OF PLC-GAMMA ISOZYMES BY PHOSPHORYLATION AND CANCER-ASSOCIATED MUTATIONS | 3.1.4.11 |
6PBU | CLPP1 FROM MYCOBACTERIUM SMEGMATIS | 3.4.21.92 |
6PBZ | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GPPA | 3.6.1.40 |
6PCK | CRYSTAL STRUCTURE OF HUMAN DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE 1 IN COMPLEX WITH 1-IP7 | 3.6.1.52 3.6.1 |
6PCL | CRYSTAL STRUCTURE OF HUMAN DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE 1 IN COMPLEX WITH 5-IP7 | 3.6.1.52 3.6.1 |
6PFW | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), T177A MUTANT, APO STATE | 3.1.3.48 |
6PG0 | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P188A MUTANT, VANADATE BOUND STATE | 3.1.3.48 |
6PGO | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO A PHTHALAZINE INHIBITOR | 3.6.5.2 |
6PGP | CRYSTAL STRUCTURE OF HUMAN KRAS G12C COVALENTLY BOUND TO A QUINAZOLINONE INHIBITOR | 3.6.5.2 |
6PGT | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), T177A MUTANT, VANADATE BOUND STATE | 3.1.3.48 |
6PGV | HUMAN JOSEPHIN-2 IN COMPLEX WITH UBIQUITIN | 3.4.19.12 |
6PGY | MTSL LABELLED T4 LYSOZYME PSEUDO-WILD TYPE K65C MUTANT | 3.2.1.17 |
6PGZ | MTSL LABELLED T4 LYSOZYME PSEUDO-WILD TYPE V75C MUTANT | 3.2.1.17 |
6PH0 | T4 LYSOZYME PSEUDO-WILD TYPE SOAKED IN TEMPO | 3.2.1.17 |
6PH1 | T4 LYSOZYME PSEUDO-WILD TYPE SOAKED IN TEMPOL | 3.2.1.17 |
6PH9 | CRYSTAL STRUCTURE OF THE KLEBSIELLA PNEUMONIAE LPXH-LIPID X COMPLEX | 3.6.1.54 |
6PHA | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), F182A MUTANT, VANADATE BOUND STATE | 3.1.3.48 |
6PHS | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P185A MUTANT, VANADATE BOUND STATE | 3.1.3.48 |
6PHU | SPAGA WILD TYPE APO STRUCTURE | 3.2.1.22 |
6PHV | SPAGA GALACTOSE PRODUCT COMPLEX STRUCTURE | 3.2.1.22 |
6PHW | SPAGA D472N STRUCTURE IN COMPLEX WITH MELIBIOSE | 3.2.1.22 |
6PHX | SPAGA D472N STRUCTURE IN COMPLEX WITH RAFFINOSE | 3.2.1.22 |
6PHY | SPAGA D472N STRUCTURE IN COMPLEX ALPHA 1,3 GALACTOBIOSE | 3.2.1.22 |
6PI0 | AGAD472N-LINEAR BLOOD GROUP B TYPE 2 TRISACCHARIDE COMPLEX STRUCTURE | 3.2.1.22 |
6PIB | STRUCTURE OF THE KLEBSIELLA PNEUMONIAE LPXH-AZ1 COMPLEX | 3.6.1.54 |
6PJ3 | CRYSTAL STRUCTURE OF THE KLEBSIELLA PNEUMONIAE LPXH/JH-LPH-33 COMPLEX | 3.6.1.54 |
6PJ4 | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJ5 | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJ7 | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJ8 | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJ9 | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJA | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJB | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LOPINAVIR | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJC | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR4-41 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJD | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-32 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJE | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-43 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJF | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-44 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJG | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR3-97 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJH | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR3-28 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJI | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR3-43 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJK | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR3-29 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJL | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR3-95 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJM | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-35 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJN | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-41 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJO | HIV-1 PROTEASE NL4-3 WT IN COMPLEX WITH LR2-42 | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PJP | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJQ | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJR | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PJU | TIME-RESOLVED STRUCTURAL SNAPSHOT OF PROTEOLYSIS BY GLPG INSIDE THE MEMBRANE | 3.4.21.105 |
6PK0 | CRYSTAL STRUCTURE OF OXA-48 WITH HYDROLYZED IMIPENEM | 3.5.2.6 |
6PKA | STRUCTURE OF CLPP FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH UREADEPSIPEPTIDE | 3.4.21.92 |
6PL9 | ADDUCT FORMED AFTER 1 MONTH IN THE REACTION OF DICHLORIDO(1,3-DIMETHYLBENZIMIDAZ OL-2-YLIDENE)(ETA5-PENTAMETHYLCYCLOPENTADIENYL)RHODIUM(III) WITH HEWL | 3.2.1.17 |
6PLA | ADDUCTS FORMED AFTER 1 MONTH IN THE REACTION OF DICHLORIDO(1,3-DIMETHYLBENZIMIDAZOL-2-YLIDENE)(ETA6-P-CYMENE)OSMIUM(II) WITH HEWL | 3.2.1.17 |
6PLB | ADDUCTS FORMED AFTER 1 MONTH IN THE REACTION OF DICHLORIDO(1,3-DIMETHYLBENZIMIDA ZOL-2-YLIDENE)(ETA5-PENTAMETHYLCYCLOPENTADIENYL)IRIDIUM(III) WITH HEWL | 3.2.1.17 |
6PLK | CRYSTAL STRUCTURE OF ZIKV-116 FAB IN COMPLEX WITH ZIKV ENVELOPE DIII | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6PM8 | PROTEIN TYROSINE PHOSPHATASE 1B (1-301), P180A MUTANT, VANADATE BOUND STATE | 3.1.3.48 |
6PMD | STRUCTURE OF CLPP FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH ACYLDEPSIPEPTIDE | 3.4.21.92 |
6PMP | CRYSTAL STRUCTURE OF A FRAGMENT OF RAT PHOSPHOLIPASE CEPSILON EF3-RA1 | 3.1.4.11 |
6PNR | A GH31 FAMILY SULFOQUINOVOSIDASE FROM E. RECTALE IN COMPLEX WITH AZA-SUGAR INHIBITOR IFGSQ | 3.2.1.20 |
6PO4 | 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE (MTNN) FROM HAEMOPHILUS INFLUENZAE PITTII. | 3.2.2.9 |
6PPJ | CRYO-EM STRUCTURE OF ADNA(D934A)-ADNB(D1014A) IN COMPLEX WITH AMPPNP | 3.6.4.12 |
6PPM | ANCESTRAL CASPASE 6 | 3.4.22.59 |
6PPO | RHINOVIRUS C15 COMPLEXED WITH DOMAIN I OF RECEPTOR CDHR3 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6PPR | CRYO-EM STRUCTURE OF ADNA(D934A)-ADNB(D1014A) IN COMPLEX WITH AMPPNP AND DNA | 3.6.4.12 |
6PPT | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PPU | CRYO-EM STRUCTURE OF ADNAB-AMPPNP-DNA COMPLEX | 3.6.4.12 |
6PQ2 | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PQ3 | CRYSTAL STRUCTURE OF GDP-BOUND KRAS WITH TEN RESIDUES LONG INTERNAL TANDEM DUPLICATION IN THE SWITCH II REGION | 3.6.5.2 |
6PQ8 | CRYSTAL STRUCTURE OF TLA-1 S70G EXTENDED SPECTRUM BETA-LACTAMASE IN COMPLEX WITH CLAVULANIC ACID | 3.5.2.6 |
6PQ9 | CRYSTAL STRUCTURE OF TLA-1 S70G EXTENDED SPECTRUM BETA-LACTAMASE | 3.5.2.6 |
6PQC | STRUCTURE OF CEFOTAXIME-CDD-1 BETA-LACTAMASE COMPLEX | 3.5.2.6 |
6PQE | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PQI | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE OXA-48 WITH CEFOTAXIME | 3.5.2.6 |
6PQK | CRYOGENIC CRYSTAL STRUCTURE OF BARNASE A43C/S80C BOUND TO BARSTAR C40A/S59C/A67C/C82A | 3.1.27 |
6PQM | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PRF | HIV-1 PROTEASE MULTIPLE DRUG RESISTANT CLINICAL ISOLATE MUTANT PR20 WITH GRL-14213A | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PRI | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PRJ | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PRP | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PRQ | STRUCTURAL BASIS FOR CLIENT RECOGNITION AND ACTIVITY OF HSP40 CHAPERONES | 3.1.3.1 |
6PRZ | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM ALPRENOLOL TO ALPRENOLOL. | 3.2.1.17 |
6PS0 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM ALPRENOLOL TO CARAZOLOL. | 3.2.1.17 |
6PS1 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM ALPRENOLOL TO TIMOLOL. | 3.2.1.17 |
6PS2 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO ALPRENOLOL. | 3.2.1.17 |
6PS3 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO CARVEDILOL. | 3.2.1.17 |
6PS4 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO ICI-118551. | 3.2.1.17 |
6PS5 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO PROPRANOLOL. | 3.2.1.17 |
6PS6 | XFEL BETA2 AR STRUCTURE BY LIGAND EXCHANGE FROM TIMOLOL TO TIMOLOL. | 3.2.1.17 |
6PSF | RHINOVIRUS C15 COMPLEXED WITH DOMAINS I AND II OF RECEPTOR CDHR3 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6PSG | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE OXA-48 WITH FAROPENEM | 3.5.2.6 |
6PSZ | POLIOVIRUS (TYPE 1 MAHONEY), HEAT-CATALYSED 135S PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6PT1 | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE OXA-48 WITH MEROPENEM | 3.5.2.6 |
6PT5 | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE OXA-48 WITH CEFOXITIN | 3.5.2.6 |
6PTD | PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT H32L | 3.1.4.10 4.6.1.13 |
6PTJ | STRUCTURE OF CTF4 TRIMER IN COMPLEX WITH ONE CMG HELICASE | 3.6.4.12 |
6PTN | STRUCTURE OF CTF4 TRIMER IN COMPLEX WITH TWO CMG HELICASES | 3.6.4.12 |
6PTU | CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE OXA-48 WITH IMIPENEM | 3.5.2.6 |
6PUT | STRUCTURE OF HIV CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME BOUND WITH CALCIUM | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PUW | STRUCTURE OF HIV CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME BOUND WITH MAGNESIUM AND BICTEGRAVIR (BIC) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PUY | STRUCTURE OF HIV CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME BOUND WITH MAGNESIUM AND INSTI XZ426 (COMPOUND 4D) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PUZ | STRUCTURE OF HIV CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME BOUND WITH MAGNESIUM AND INSTI XZ446 (COMPOUND 4F) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6PV4 | STRUCTURE OF CPGH84A | 3.2.1.35 |
6PWL | ADC-7 IN COMPLEX WITH BORONIC ACID TRANSITION STATE INHIBITOR LP06 | 3.5.2.6 |
6PWM | ADC-7 IN COMPLEX WITH BETA-LACTAM ANTIBIOTIC CEFTAZIDIME | 3.5.2.6 |
6PX5 | CRYSTAL STRUCTURE OF HUMAN MEIZOTHROMBIN DESF1 MUTANT S195A BOUND WITH PPACK | 3.4.21.5 |
6PX9 | CRYSTAL STRUCTURE OF PROCASPASE-8 IN COMPLEX WITH COVALENT SMALL MOLECULE INHIBITOR 63-R | 3.4.22.61 |
6PXF | STRUCTURE OF HUMAN CATHEPSIN K WITH AN ECTOSTERIC INHIBITOR AT 1.85 ANGSTROM RESOLUTION | 3.4.22.38 |
6PXI | THE CRYSTAL STRUCTURE OF A SINGLY CAPPED HSLUV COMPLEX WITH AN AXIAL PORE PLUG AND A HSLU E257Q MUTATION | 3.4.25.2 |
6PXJ | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT I16T | 3.4.21.5 |
6PXQ | CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT D194A | 3.4.21.5 |
6PXX | CLASS D BETA-LACTAMASE IN COMPLEX WITH BETA-LACTAM ANTIBIOTIC | 3.5.2.6 |
6PY9 | CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIPHOSPHATE METAVANADATE | 3.1.3.2 |
6PYM | STRUCTURE OF ACTIVE-SITE SERINE MUTANT OF ESP, SERINE PROTEASE FROM STAPHYLOCOCCUS EPIDERMIDIS | 3.4.21.19 |
6PYO | CALCIUM ACTIVATED CHLORIDE CHANNEL REGULATOR 1 (CLCA1) VWA DOMAIN | 3.4 |
6PYX | CALCIUM ACTIVATED CHLORIDE CHANNEL REGULATOR 1 (CLCA1) VWA DOMAIN | 3.4 |
6PZ4 | CO-CRYSTAL STRUCTURE OF BACE WITH INHIBITOR AM-6494 | 3.4.23.46 |
6PZD | CRYSTAL STRUCTURE OF THE NEURAMINIDASE STABILIZATION MUTANT Y169AH FROM A/SHANGHAI/2/2013 (H7N9) | 3.2.1.18 |
6PZE | CRYSTAL STRUCTURE OF HUMAN NA-45 FAB IN COMPLEX WITH NEURAMINIDASE Y169AH MUTANT FROM A/SHANGHAI/2/2013 (H7N9) | 3.2.1.18 |
6PZF | CRYSTAL STRUCTURE OF HUMAN NA-63 FAB IN COMPLEX WITH NEURAMINIDASE FROM A/HUNAN/02650/2016(H7N9) | 3.2.1.18 |
6PZO | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 COMPLEXED WITH YX-153 | 3.5.1.98 |
6PZP | CRYSTAL STRUCTURE OF CASPASE-1 IN COMPLEX WITH VX-765 | 3.4.22.36 |
6PZR | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 COMPLEXED WITH RESMINOSTAT | 3.5.1.98 |
6PZS | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 COMPLEXED WITH JR005 | 3.5.1.98 |
6PZW | CRYOEM DERIVED MODEL OF NA-22 FAB IN COMPLEX WITH N9 SHANGHAI2 | 3.2.1.18 |
6PZY | CRYOEM DERIVED MODEL OF NA-73 FAB IN COMPLEX WITH N9 SHANGHAI2 | 3.2.1.18 |
6PZZ | CRYOEM DERIVED MODEL OF NA-80 FAB IN COMPLEX WITH N9 SHANGHAI2 | 3.2.1.18 |
6Q0B | POLIOVIRUS (TYPE 1 MAHONEY), RECEPTOR-CATALYSED 135S PARTICLE INCUBATED WITH ANTI-VP1 MAB AT RT FOR 1 HR | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6Q0C | MUTY ADENINE GLYCOSYLASE BOUND TO DNA CONTAINING A TRANSITION STATE ANALOG (1N) PAIRED WITH UNDAMAGED DG | 3.2.2.31 |
6Q12 | STRUCTURE OF PRO-ESP MUTANT- S66V | 3.4.21.19 |
6Q1I | GH5-4 BROAD SPECIFICITY ENDOGLUCANASE FROM CLOSTRDIUM LONGISPORUM | 3.2.1.4 |
6Q1M | CRYSTAL STRUCTURE OF THE WHEAT DWARF VIRUS REP DOMAIN | 3.1.21 2.7.7 |
6Q1N | GLUCOCEREBROSIDASE IN COMPLEX WITH PHARMACOLOGICAL CHAPERONE IMX8 | 3.2.1.45 2.4.1 3.2.1 |
6Q1P | GLUCOCEREBROSIDASE IN COMPLEX WITH PHARMACOLOGICAL CHAPERONE NORIMX8 | 3.2.1.45 2.4.1 3.2.1 |
6Q1U | STRUCTURE OF PLASMIN AND PEPTIDE COMPLEX | 3.4.21.7 |
6Q20 | CRYSTAL STRUCTURE OF HUMAN 1E01 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/JAPAN/305/1957 (H2N2) | 3.2.1.18 |
6Q21 | MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS OF PROTOONCOGENIC RAS PROTEINS | 3.6.5.2 |
6Q23 | CRYSTAL STRUCTURE OF HUMAN 1G01 FAB IN COMPLEX WITH INFLUENZA VIRUS NEURAMINIDASE FROM A/CALIFORNIA/04/2009 (H1N1) | 3.2.1.18 |
6Q24 | STRUCTURE OF PRO-ESP MUTANT- S235A | 3.4.21.19 |
6Q2Y | CRYSTAL STRUCTURE OF NDM-1 BETA-LACTAMASE IN COMPLEX WITH BROAD SPECTRUM BORONIC INHIBITOR CPD3 | 3.5.2.6 |
6Q30 | CRYSTAL STRUCTURE OF NDM-1 BETA-LACTAMASE IN COMPLEX WITH BORONIC INHIBITOR CPD 5 | 3.5.2.6 |
6Q35 | CRYSTAL STRUCTURE OF GES-5 BETA-LACTAMASE IN COMPLEX WITH BORONIC INHIBITOR CPD 3 | 3.5.2.6 |
6Q37 | COMPLEX OF ARGINASE 2 WITH EXAMPLE 23 | 3.5.3.1 |
6Q39 | COMPLEX OF ARGINASE 2 WITH EXAMPLE 49 | 3.5.3.1 |
6Q3M | STRUCTURE OF CHD4 PHD2 - TANDEM CHROMODOMAINS | 3.6.4.12 |
6Q3R | ASPERGILLUS ACULEATUS GALACTANASE | 3.2.1.89 |
6Q3T | STRUCTURE OF PROTEASE1 FROM PYROCOCCUS HORIKOSHII AT ROOM TEMPERATURE IN CHIPX MICROFLUIDIC DEVICE | 3.5.1.124 3.4.22 |
6Q42 | CRYSTAL STRUCTURE OF HUMAN PANCREATIC PHOSPHOLIPASE A2 | 3.1.1.4 |
6Q4L | CARBOXYPEPTIDASE T MUTANT L254N WITH WITH N-SULFAMOYL-L-GLUTAMIC ACID | 3.4.17.18 |
6Q4R | HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERAP1 WITH BOUND PHOSPHINIC TRANSITION-STATE ANALOGUE INHIBITOR | 3.4.11 |
6Q4T | KOD DNA POL IN A CLOSED TERNARY COMPLEX WITH 7-DEAZA-7-(2-(2-HYDROXYETHOXY)-N-(PROP-2-YN-1-YL)ACETAMIDE)-2-DATP | 2.7.7.7 3.1 |
6Q5B | OXA-48_P68A-AVI. EVOLUTIONARY TRADE-OFFS OF OXA-48 MEDIATED CEFTAZIDIME-AVIBACTAM RESISTANCE | 3.5.2.6 |
6Q5F | OXA-48_P68A-CAZ. EVOLUTIONARY TRADE-OFFS OF OXA-48 MEDIATED CEFTAZIDIME-AVIBACTAM RESISTANCE | 3.5.2.6 |
6Q5T | CRYSTAL STRUCTURE OF MYCOLICIBACTERIUM HASSIACUM GLUCOSYLGLYCERATE HYDROLASE (MHGGH) - APO FORM | 3.2.1.208 |
6Q63 | BT0459 | 3.2.1.52 |
6Q6J | HUMAN PHOSPHOSERINE PHOSPHATASE WITH SUBSTRATE ANALOGUE HOMO-CYSTEIC ACID | 3.1.3.3 |
6Q6K | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BETA-GLUCOCEREBROSIDASE IN COMPLEX WITH CYCLOPHELLITOL ACTIVITY BASED PROBE WITH CY5 TAG (ME569) | 3.2.1.45 2.4.1 3.2.1 |
6Q6L | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BETA-GLUCOCEREBROSIDASE IN COMPLEX WITH ADAMANTYL-CYCLOPHELLITOL INHIBITOR (ME656) | 3.2.1.45 2.4.1 3.2.1 |
6Q6N | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN BETA-GLUCOCEREBROSIDASE IN COMPLEX WITH BIPHENYL-CYCLOPHELLITOL INHIBITOR (ME655) | 3.2.1.45 2.4.1 3.2.1 |
6Q78 | THE STRUCTURE OF GH26C FROM MURICAUDA SP. MAR_2010_75 | 3.2.1.78 |
6Q7I | GH3 EXO-BETA-XYLOSIDASE (XLND) | 3.2.1.37 |
6Q7J | GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE | 3.2.1.37 |
6Q88 | RT STRUCTURE OF HEWL AT 5 KGY | 3.2.1.17 |
6Q8M | GH10 ENDO-XYLANASE | 3.2.1.8 |
6Q8N | GH10 ENDO-XYLANASE IN COMPLEX WITH XYLOBIOSE EPOXIDE INHIBITOR | 3.2.1.8 |
6Q8R | HEW LYSOZYME UNDER 2 KBAR OF ARGON | 3.2.1.17 |
6Q8S | ELASTASE (PPE) UNDER 2 KBAR OF ARGON | 3.4.21.36 |
6Q8T | CRYO STRUCTURE OF HEWL AT 81 KGY | 3.2.1.17 |
6Q92 | CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 AT PH 7.0 IN COMPLEX WITH ABH | 3.5.3.1 |
6Q9P | CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 AT PH 9.0 IN COMPLEX WITH ABH | 3.5.3.1 |
6QAA | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(2-CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE | 3.1.1.8 |
6QAB | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N-(1-((2-CYCLOHEPTYLETHYL)AMINO)-3-(1H-INDOL-3-YL)-1-OXOPROPAN-2-YL)-N,N-DIMETHYLBUTAN-1-AMINIUM | 3.1.1.8 |
6QAC | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-2-(BUTYLAMINO)-N-(3-CYCLOHEPTYLPROPYL)-3-(1H-INDOL-3-YL)PROPANAMIDE | 3.1.1.8 |
6QAD | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ((S)-2-(BUTYLAMINO)-N-(2-(4-(DIMETHYLAMINO)CYCLOHEXYL)ETHYL)-3-(1H-INDOL-3-YL)PROPANAMIDE | 3.1.1.8 |
6QAE | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH (S)-N2-BUTYL-N1-(2-CYCLOHEPTYLETHYL)-3-(1H-INDOL-3-YL)-N1,N2-DIMETHYLPROPANE-1,2-DIAMINE | 3.1.1.8 |
6QAF | CRYSTAL STRUCTURE OF HUMAN ARGINASE-1 AT PH 9.0 IN COMPLEX WITH CB-1158/INCB001158 | 3.5.3.1 |
6QAJ | STRUCTURE OF THE TRIPARTITE MOTIF OF KAP1/TRIM28 | 3.2.1.17 2.3.2.27 |
6QAR | THERMOLYSINE UNDER 2 KBAR OF ARGON | 3.4.24.27 |
6QBG | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN D IN COMPLEX WITH MACROCYCLIC INHIBITOR 14 | 3.4.23.5 |
6QBH | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN D IN COMPLEX WITH MACROCYCLIC INHIBITOR 33 | 3.4.23.5 |
6QBS | THE ALKYNE MOIETY AS A LATENT ELECTROPHILE IN IRREVERSIBLE COVALENT SMALL MOLECULE INHIBITORS OF CATHEPSIN K | 3.4.22.38 |
6QBT | STRUCTURE OF THE HTLV-2 INTEGRASE CATALYTIC CORE DOMAIN IN COMPLEX WITH MAGNESIUM (TRIMERIC FORM) | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6QBU | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE (PPE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC188 | 3.4.21.36 |
6QBV | STRUCTURE OF THE HTLV-2 INTEGRASE CATALYTIC CORE DOMAIN IN COMPLEX WITH MAGNESIUM (DIMERIC FORM) | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6QBW | STRUCTURE OF THE HTLV-2 INTEGRASE CATALYTIC CORE DOMAIN IN COMPLEX WITH CALCIUM | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6QBY | CRYSTAL STRUCTURE OF VASH 2 IN COMPLEX WITH SVBP | 3.4.17.17 |
6QCB | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN D IN COMPLEX WITH MACROCYCLIC INHIBITOR 9 | 3.4.23.5 |
6QCD | HUMAN SIRT6 IN COMPLEX WITH ADP-RIBOSE AND THE ACTIVATOR QUERCETIN | 3.5.1 2.3.1.286 |
6QCE | HUMAN SIRT6 IN COMPLEX WITH ADP-RIBOSE AND THE ACTIVATOR ISOQUERCETIN | 3.5.1 2.3.1.286 |
6QCH | HUMAN SIRT6 IN COMPLEX WITH ADP-RIBOSE AND THE ACTIVATOR CYANIDIN | 3.5.1 2.3.1.286 |
6QCJ | HUMAN SIRT6 IN COMPLEX WITH ADP-RIBOSE AND THE INHIBITOR CATECHIN GALLATE | 3.5.1 2.3.1.286 |
6QCN | HUMAN SIRT2 IN COMPLEX WITH ADP-RIBOSE AND THE INHIBITOR QUERCETIN | 3.5.1 2.3.1.286 |
6QCS | INFLUENZA B POLYMERASE PRE-INITIATION COMPLEX | 3.1 |
6QCT | INFLUENZA B POLYMERASE ELONGATION COMPLEX | 3.1 |
6QCV | CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE INITIATION STATE WITH CAPPED 14-MER RNA PRIMER AND CTP | 3.1 |
6QCW | CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE INITIATION STATE WITH CAPPED 14-MER RNA PRIMER | 3.1 |
6QCX | CRYSTAL STRUCTURE OF INFLUENZA B POLYMERASE INITIATION STATE WITH CAPPED 15-MER RNA PRIMER | 3.1 |
6QDY | THE CRYSTAL STRUCTURE OF SPOROSARCINA PASTEURII UREASE IN COMPLEX WITH ITS SUBSTRATE UREA | 3.5.1.5 |
6QE2 | CRYSTAL STRUCTURE OF PALEOCOCCUS FERROPHILUS MONOACYLGLYCEROL LIPASE. | 3.1.1.23 |
6QE8 | CRYSTAL STRUCTURE OF ASPERGILLUS NIGER GH11 ENDOXYLANASE XYNA IN COMPLEX WITH XYLOBIOSE EPOXIDE ACTIVITY BASED PROBE | 3.2.1.8 |
6QE9 | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN BOVINE PANCREATIC RIBONUCLEASE AND COMPLEX I, A PENTACOORDINATE PT(II) COMPOUND CONTAINING 2,9-DIMETHYL-1,10-PHENANTHROLINE, DIMETHYLFUMARATE, METHYL AND IODINE AS LIGANDS | 3.1.27.5 4.6.1.18 |
6QEA | THE X-RAY STRUCTURE OF THE ADDUCT FORMED IN THE REACTION BETWEEN HEN EGG WHITE LYSOZYME AND COMPLEX I, A PENTACOORDINATE PT(II) COMPOUND CONTAINING 2,9-DIMETHYL-1,10-PHENANTHROLINE, DIMETHYLFUMARATE, METHYL AND IODINE AS LIGANDS | 3.2.1.17 |
6QED | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX; WITH AN INHIBITOR (S)-3-HYDROXY-2-OXO-1-(2-OXO-1,2,3,4-TETRAHYDRO-QUINOLIN-6-YL)-PYRROLIDINE-3-CARBOXYLIC ACID 3-CHLORO-5-FLUORO-BENZYLAMIDE | 3.4.11.18 |
6QEF | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR (S)-3-HYDROXY-2-OXO-1-PHENYL-PYRROLIDINE-3-CARBOXYLIC ACID 3-CHLORO-5-FLUORO-BENZYLAMIDE | 3.4.11.18 |
6QEG | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 2-OXO-1-PHENYL-PYRROLIDINE-3-CARBOXYLIC ACID (2-THIOPHEN-2-YL-ETHYL)-AMIDE | 3.4.11.18 |
6QEH | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 5-CHLORO-QUINOLIN-8-OL | 3.4.11.18 |
6QEI | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR 5,6-DIFLUORO-3-(2-ISOPROPOXY-4-PIPERAZIN-1-YL-PHENYL)-1H-INDOLE-2-CARBOXYLIC ACID AMIDE | 3.4.11.18 |
6QEJ | CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE-2 IN COMPLEX WITH AN INHIBITOR THIOPHENE-2-SULFONIC ACID (4-FLUORO-BENZYL)-(4H-[1,2,4]TRIAZOL-3-YLMETHYL)-AMIDE | 3.4.11.18 |
6QEL | E. COLI DNABC APO COMPLEX | 3.6.4.12 |
6QEM | E. COLI DNABC COMPLEX BOUND TO SSDNA | 3.6.4.12 |
6QEN | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE (PPE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC240 | 3.4.21.36 |
6QEO | CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE (PPE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC269 | 3.4.21.36 |
6QF1 | X-RAY STRUCTURE OF PROTEINASE K CRYSTALLIZED ON A SILICON CHIP | 3.4.21.64 |
6QF2 | X-RAY STRUCTURE OF THERMOLYSIN CRYSTALLIZED ON A SILICON CHIP | 3.4.24.27 |
6QF3 | X-RAY STRUCTURE OF THERMOLYSIN SOAKED WITH SODIUM ASPARTATE ON A SILICON CHIP | 3.4.24.27 |
6QFE | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH GSK144 | 3.4.21 |
6QFF | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 IN COMPLEX WITH GSK144 | 3.4.21 |
6QFG | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (I218Y) IN COMPLEX WITH GSK144 | 3.4.21 |
6QFH | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (N217D/I218Y/K224R) IN COMPLEX WITH GSK144. | 3.4.21 |
6QFS | CHARGELESS VARIANT OF THE CELLULOSE-BINDING DOMAIN FROM CELLULOMONAS FIMI | 3.2.1.91 3.2.1.8 |
6QGC | PETASE FROM IDEONELLA SAKAIENSIS WITHOUT LIGAND | 3.1.1.101 |
6QGN | CRYSTAL STRUCTURE OF APT1 BOUND TO 2-BROMOPALMITATE | 3.1.2 |
6QGO | CRYSTAL STRUCTURE OF APT1 S119A MUTANT BOUND TO PALMITIC ACID. | 3.1.2 |
6QGP | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-0769 | 3.1.4 |
6QGQ | CRYSTAL STRUCTURE OF APT1 C2S MUTANT BOUND TO PALMITIC ACID. | 3.1.2 |
6QGS | CRYSTAL STRUCTURE OF APT1 BOUND TO PALMITIC ACID. | 3.1.2 |
6QGU | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1361 | 3.1.4 |
6QH9 | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 IN COMPLEX WITH GSK3239861A | 3.4.21 |
6QHA | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 IN COMPLEX WITH GSK3205388B | 3.4.21 |
6QHB | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 IN COMPLEX WITH GSK578724A | 3.4.21 |
6QHC | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 IN COMPLEX WITH GSK358180B | 3.4.21 |
6QHP | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 2256 MS COVALENT INTERMEDIATE 1 | 3.8.1.3 |
6QHQ | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 1128 MS | 3.8.1.3 |
6QHS | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 564 MS | 3.8.1.3 |
6QHT | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 376 MS | 3.8.1.3 |
6QHU | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 100 MS | 3.8.1.3 |
6QHV | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 100 MS | 3.8.1.3 |
6QHW | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 4512 MS | 3.8.1.3 |
6QHX | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 6156 MS | 3.8.1.3 |
6QHY | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 100 MS | 3.8.1.3 |
6QHZ | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 6788 MS | 3.8.1.3 |
6QI0 | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 9024 MS | 3.8.1.3 |
6QI1 | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 12312 MS | 3.8.1.3 |
6QI2 | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 13536 MS | 3.8.1.3 |
6QI3 | TIME RESOLVED STRUCTURAL ANALYSIS OF THE FULL TURNOVER OF AN ENZYME - 27072 MS | 3.8.1.3 |
6QI8 | TRUNCATED HUMAN R2TP COMPLEX, STRUCTURE 3 (ADP-FILLED) | 3.6.4.12 |
6QI9 | TRUNCATED HUMAN R2TP COMPLEX, STRUCTURE 4 (ADP-EMPTY) | 3.6.4.12 |
6QIB | THE CRYSTAL STRUCTURE OF POL2CORE IN COMPLEX WITH DNA AND AN INCOMING NUCLEOTIDE, CARRYING AN FE-S CLUSTER | 2.7.7.7 3.1.11 |
6QIG | METALLOPROTEINASE | 3.4.24.87 |
6QIH | PANCREATIC BOVINE TRYPSIN WITH A BORONIC ACID INHIBITOR | 3.4.21.4 |
6QIN | CRYSTAL STRUCTURE OF THE PMGL2 ESTERASE FROM PERMAFROST METAGENOMIC LIBRARY | 3.1.1.3 |
6QJ6 | THE STRUCTURE OF TREHALOSE-6-PHOSPHATASE FROM BURKHOLDERIA PSEUDOMALLEI | 3.1.3.12 |
6QKS | CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - TYR219PHE - APO | 3.8.1.3 |
6QKT | CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - TYR219PHE - FLUOROACETATE SOAKED 24HR - GLYCOLATE BOUND | 3.8.1.3 |
6QKU | CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - TYR219PHE - CHLOROACETATE SOAKED 2HR | 3.8.1.3 |
6QKW | CRYSTAL STRUCTURE OF THE FLUOROACETATE DEHALOGENASE RPA1163 - TYR219PHE - FLUOROACETATE SOAKED 2HR | 3.8.1.3 |
6QL0 | CATIONIC TRYPSIN IN COMPLEX WITH A D-PHE-PRO-P-AMINOPYRIDINE DERIVATIVE | 3.4.21.4 |
6QL8 | CATHEPSIN-K IN COMPLEX WITH MIV-711 | 3.4.22.38 |
6QLA | CRYSTAL STRUCTURE OF THE PMGL2 ESTERASE (POINT MUTANT 1) FROM PERMAFROST METAGENOMIC LIBRARY | 3.1.1.3 |
6QLM | CATHEPSIN-K IN COMPLEX WITH MIV-701 | 3.4.22.38 |
6QLW | CATHEPSIN-K IN COMPLEX WITH MIV-710 | 3.4.22.38 |
6QLX | CATHEPSIN-K IN COMPLEX WITH FLUORO-OXA-AZABICYCLO[3.3.0]OCTANYL CONTAINING INHIBITOR | 3.4.22.38 |
6QM0 | CATHEPSIN-K IN COMPLEX WITH AMINO-OXAAZABICYCLO[3.3.0]OCTANYL CONTAINING INHIBITOR | 3.4.22.38 |
6QM2 | NLAIV RESTRICTION ENDONUCLEASE | 3.1.21.4 |
6QML | UCHL3 IN COMPLEX WITH SYNTHETIC, K27-LINKED DIUBIQUITIN | 3.4.19.12 |
6QMN | CRYSTAL STRUCTURE OF A RIBONUCLEASE A-ONCONASE CHIMERA | 3.1.27.5 4.6.1.18 |
6QMR | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR (S)-2-(2-((3'-(1-AMINO-2-HYDROXYETHYL)-[1,1'-BIPHENYL]-3-YL)METHOXY)PHENYL)ACETIC ACID | 3.4.21.46 |
6QMT | COMPLEMENT FACTOR D IN COMPLEX WITH THE INHIBITOR 2-(2-(3'-(AMINOMETHYL)-[1,1'-BIPHENYL]-3-CARBOXAMIDO)PHENYL)ACETIC ACID | 3.4.21.46 |
6QNB | LIQUID APPLICATION METHOD FOR TIME-RESOLVED ANALYSES (LAMA) BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY, LYSOZYME WITH GLCNAC3 | 3.2.1.17 |
6QNS | CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B MUTANT I1248W/V1249W IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1 AND GD1A RECEPTORS | 3.4.24.69 |
6QPP | RHIZOMUCOR MIEHEI LIPASE PROPEPTIDE COMPLEX, NATIVE | 3.1.1.3 |
6QPR | RHIZOMUCOR MIEHEI LIPASE PROPEPTIDE COMPLEX, SER95/ILE96 DELETION MUTANT | 3.1.1.3 |
6QQ3 | THE ROOM TEMPERATURE STRUCTURE OF LYSOZYME VIA THE ACOUSTIC LEVITATION OF A DROPLET | 3.2.1.17 |
6QQC | CRYOGENIC TEMPERATURE STRUCTURE OF HEN EGG WHITE LYSOZYME RECORDED AFTER AN ACCUMULATED DOSE OF 110 KGY | 3.2.1.17 |
6QQD | CRYOGENIC TEMPERATURE STRUCTURE OF HEN EGG WHITE LYSOZYME RECORDED AFTER AN ACCUMULATED DOSE OF 10 MGY | 3.2.1.17 |
6QQE | ROOM TEMPERATURE STRUCTURE OF HEN EGG WHITE LYSOZYME RECORDED AFTER AN ACCUMULATED DOSE OF 20 KGY | 3.2.1.17 |
6QQF | ROOM TEMPERATURE STRUCTURE OF HEN EGG WHITE LYSOZYME RECORDED AFTER AN ACCUMULATED DOSE OF 100 KGY | 3.2.1.17 |
6QRO | CRYSTAL STRUCTURE OF TANNERELLA FORSYTHIA GLUTAMINYL CYCLASE | 3.4 |
6QS1 | CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH BPPB | 3.2.1 3.4.15.1 |
6QSB | CRYSTAL STRUCTURE OF ARG470HIS MUTANT OF HUMAN PROLIDASE WITH MN IONS | 3.4.13.9 |
6QSC | CRYSTAL STRUCTURE OF ARG470HIS MUTANT OF HUMAN PROLIDASE WITH MN IONS AND GLYPRO LIGAND | 3.4.13.9 |
6QSN | CRYSTAL STRUCTURE OF YELLOW FEVER VIRUS POLYMERASE NS5A | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6QSU | HELICOBACTER PYLORI UREASE WITH BME BOUND IN THE ACTIVE SITE | 3.5.1.5 |
6QUB | TRUNCATED BETA-GALACTOSIDASE III FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
6QUC | TRUNCATED BETA-GALACTOSIDASE III FROM BIFIDOBACTERIUM BIFIDUM | 3.2.1.23 |
6QUD | 2-DEOXY-GALACTOSE REACTION INTERMEDIATE OF A TRUNCATED BETA-GALACTOSIDASE III FROM BIFIDOBACTERIUM BIFIDUM | 3.2.1.23 |
6QUU | CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH GMP-PCP | 3.6.5.2 |
6QUV | CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH GMP-PCP AND COMPOUND 15R | 3.6.5.2 |
6QUW | CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH NATURAL PRODUCT-LIKE COMPOUND 9B | 3.6.5.2 |
6QUX | CRYSTAL STRUCTURE OF KRAS-G12D IN COMPLEX WITH NATURAL PRODUCT-LIKE COMPOUND 15 | 3.6.5.2 |
6QVO | CRYSTAL STRUCTURE OF HUMAN MTH1 IN COMPLEX WITH N6-METHYL-DAMP | 3.6.1.55 3.6.1.56 |
6QW7 | CRYSTAL STRUCTURE OF L2 COMPLEXED WITH RELEBACTAM (16 HOUR SOAK) | 3.5.2.6 |
6QW8 | CRYSTAL STRUCTURE OF CTX-M-15 COMPLEXED WITH RELEBACTAM (16 HOUR SOAK) | 3.5.2.6 |
6QW9 | CRYSTAL STRUCTURE OF KPC-2 COMPLEXED WITH RELEBACTAM (16 HOUR SOAK) | 3.5.2.6 |
6QWA | CRYSTAL STRUCTURE OF KPC-3 COMPLEXED WITH RELEBACTAM (16 HOUR SOAK) | 3.5.2.6 |
6QWB | CRYSTAL STRUCTURE OF KPC-4 COMPLEXED WITH RELEBACTAM (16 HOUR SOAK) | 3.5.2.6 |
6QWC | CRYSTAL STRUCTURE OF KPC-4 COMPLEXED WITH RELEBACTAM (1 HOUR SOAK) | 3.5.2.6 |
6QWD | CRYSTAL STRUCTURE OF KPC-3 | 3.5.2.6 |
6QWE | CRYSTAL STRUCTURE OF KPC-4 | 3.5.2.6 |
6QWI | STRUCTURE OF BETA-GLUCOSIDASE A FROM PAENIBACILLUS POLYMYXA COMPLEXED WITH MULTIVALENT INHIBITORS. | 3.2.1.21 |
6QWL | INFLUENZA B VIRUS (B/PANAMA/45) POLYMERASE HETERMOTRIMER IN COMPLEX WITH 3'5' CRNA PROMOTER | 3.1 |
6QWV | SARM1 SAM1-2 DOMAINS | 3.2.2.6 3.2.2 |
6QWW | HEWL LYSOZYME, CRYSTALLIZED FROM CUCL2 SOLUTION | 3.2.1.17 |
6QWX | HEWL LYSOZYME, CRYSTALLIZED FROM NICL2 SOLUTION | 3.2.1.17 |
6QWY | HEWL LYSOZYME, CRYSTALLIZED FROM NACL SOLUTION | 3.2.1.17 |
6QWZ | HEWL LYSOZYME, CRYSTALLIZED FROM KCL SOLUTION | 3.2.1.17 |
6QX0 | HEWL LYSOZYME, CRYSTALLIZED FROM LICL SOLUTION | 3.2.1.17 |
6QX3 | INFLUENZA A VIRUS (A/NT/60/1968) POLYMERASE HETERMOTRIMER IN COMPLEX WITH 3'5' CRNA PROMOTER AND NB8205 | 3.1 |
6QXV | PINK BEAM SERIAL CRYSTALLOGRAPHY: PROTEINASE K, 1 US EXPOSURE, 1585 PATTERNS MERGED (2 CHIPS) | 3.4.21.64 |
6QXW | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 24344 PATTERNS MERGED (3 CHIPS) | 3.2.1.17 |
6QXX | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 14793 PATTERNS MERGED | 3.2.1.17 |
6QXY | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 8813 PATTERNS MERGED (1 CHIP) | 3.2.1.17 |
6QY0 | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 3000 PATTERNS MERGED | 3.2.1.17 |
6QY1 | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 1500 PATTERNS MERGED | 3.2.1.17 |
6QY2 | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 5 US EXPOSURE, 750 PATTERNS MERGED | 3.2.1.17 |
6QY4 | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 1 US EXPOSURE, 14793 PATTERNS MERGED | 3.2.1.17 |
6QY5 | PINK BEAM SERIAL CRYSTALLOGRAPHY: LYSOZYME, 1 US EXPOSURE, 4448 PATTERNS MERGED (1 CHIP) | 3.2.1.17 |
6QZ1 | STRUCTURE OF MHETASE FROM IDEONELLA SAKAIENSIS | 3.1.1.102 |
6QZ3 | STRUCTURE OF MHETASE FROM IDEONELLA SAKAIENSIS | 3.1.1.102 |
6QZ4 | STRUCTURE OF MHETASE FROM IDEONELLA SAKAIENSIS | 3.1.1.102 |
6QZH | STRUCTURE OF THE HUMAN CC CHEMOKINE RECEPTOR 7 IN COMPLEX WITH THE INTRACELLULAR ALLOSTERIC ANTAGONIST CMP2105 AND THE INSERTION PROTEIN SIALIDASE NANA | 3.2.1.18 |
6QZU | GETAH VIRUS MACRO DOMAIN | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R0F | GETAH VIRUS MACRO DOMAIN IN COMPLEX WITH ADPR, POSE 1 | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R0G | GETAH VIRUS MACRO DOMAIN IN COMPLEX WITH ADPR, POSE 2 | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R0J | THE N-TERMINAL DOMAIN OF RHOMBOID PROTEASE YQGP | 3.4.21.105 |
6R0P | GETAH VIRUS MACRO DOMAIN IN COMPLEX WITH ADPR IN DOUBLE OPEN CONFORMATION | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R0R | GETAH VIRUS MACRO DOMAIN IN COMPLEX WITH ADPR COVALENTLY BOND TO CYS34 | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R0T | GETAH VIRUS MACRO DOMAIN IN COMPLEX WITH ADPR IN OPEN CONFORMATION | 2.1.1 2.7.7 3.1.3.33 3.4.22 3.6.1.15 3.6.4.13 3.1.3.84 2.7.7.19 2.7.7.48 |
6R1V | SOLUTION STRUCTURE OF SORTASE A FROM S. AUREUS IN COMPLEX WITH 2-(AMINOMETHYL)-3-HYDROXY-4H-PYRAN-4-ONE BASED PRODRUG | 3.4.22.70 |
6R22 | THE STRUCTURE OF A TY3 RETROTRANSPOSON CAPSID N-TERMINAL DOMAIN DIMER | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 |
6R23 | THE STRUCTURE OF A TY3 RETROTRANSPOSON CAPSID C-TERMINAL DOMAIN DIMER | 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 |
6R2W | CRYSTAL STRUCTURE OF THE SUPER-ACTIVE FVIIA VARIANT VYT IN COMPLEX WITH TISSUE FACTOR | 3.4.21.21 |
6R31 | FAMILY 11 CARBOHYDRATE-BINDING MODULE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH BETA-1,3-1,4-MIXED-LINKED TETRASACCHARIDE | 3.2.1.4 |
6R3M | FAMILY 11 CARBOHYDRATE-BINDING MODULE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH BETA-1,3-1,4-MIXED-LINKED TETRASACCHARIDE | 3.2.1.4 |
6R3X | STRUCTURE OF PSEUDOMONAS AERUGINOSA PENICILLIN-BINDING PROTEIN 3 (PBP3) IN COMPLEX WITH PIPERACILLIN | 3.4.16.4 |
6R40 | APO STRUCTURE OF R504C MUTANT OF PSEUDOMONAS AERUGINOSA PENICILLIN-BINDING PROTEIN 3 (PBP3) | 3.4.16.4 |
6R42 | STRUCTURE OF R504C MUTANT OF PSEUDOMONAS AERUGINOSA PENICILLIN-BINDING PROTEIN 3 (PBP3) IN COMPLEX WITH PIPERACILLIN | 3.4.16.4 |
6R45 | CRYSTAL STRUCTURE OF EUKARYOTIC O-GLCNACASE HAT-LIKE DOMAIN | 3.2.1.169 |
6R4K | STRUCTURE OF BETA-GLUCOSIDASE A FROM PAENIBACILLUS POLYMYXA COMPLEXED WITH A MONOVALENT INHIBITOR | 3.2.1.21 |
6R4W | CRYSTAL STRUCTURE OF APO PPEP-1(E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNAPVP-CONH2 | 3.4.24.89 |
6R4X | CRYSTAL STRUCTURE OF PPEP-1(E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNPAVP-CONH2 | 3.4.24.89 |
6R4Y | CRYSTAL STRUCTURE OF HOLO PPEP-1(E143A/Y178F) IN COMPLEX WITH PRODUCT PEPTIDE AC-EVNP-CO2 (SUBSTRATE PEPTIDE: AC-EVNPAVP-CONH2) | 3.4.24.89 |
6R4Z | CRYSTAL STRUCTURE OF HOLO PPEP-1(E143A/Y178F) IN COMPLEX WITH PRODUCT PEPTIDE AC-EVNP-CO2 (SUBSTRATE PEPTIDE: AC-EVNPPVP-CONH2) | 3.4.24.89 |
6R50 | CRYSTAL STRUCTURE OF HOLO PPEP-1(E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNAPVP-CONH2 | 3.4.24.89 |
6R51 | CRYSTAL STRUCTURE OF APO PPEP-1(E143A/Y178F) IN COMPLEX WITH FIBRINOGEN-DERIVED SUBSTRATE PEPTIDE AC-SLRPAPP-CONH2 | 3.4.24.89 |
6R52 | CRYSTAL STRUCTURE OF PPEP-1(K101A) | 3.4.24.89 |
6R53 | CRYSTAL STRUCTURE OF PPEP-1(K101R) | 3.4.24.89 |
6R54 | CRYSTAL STRUCTURE OF PPEP-1(E184A) | 3.4.24.89 |
6R55 | CRYSTAL STRUCTURE OF PPEP-1(E184K) | 3.4.24.89 |
6R56 | CRYSTAL STRUCTURE OF PPEP-1(K101E/E184K) | 3.4.24.89 |
6R57 | CRYSTAL STRUCTURE OF PPEP-1(E143A/Y178F/E184A) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNPPVP-CONH2 | 3.4.24.89 |
6R58 | CRYSTAL STRUCTURE OF PPEP-1(E143A/Y178F/E184A) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNAPVP-CONH2 | 3.4.24.89 |
6R59 | CRYSTAL STRUCTURE OF PPEP-1(E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVAPPVP-NH2 | 3.4.24.89 |
6R5A | CRYSTAL STRUCTURE OF PPEP-1(W103F) | 3.4.24.89 |
6R5B | CRYSTAL STRUCTURE OF PPEP-1(W103H/E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNPPVP-CONH2 | 3.4.24.89 |
6R5C | CRYSTAL STRUCTURE OF PPEP-1(W103F/E143A/Y178F) IN COMPLEX WITH SUBSTRATE PEPTIDE AC-EVNPPVP-CONH2 | 3.4.24.89 |
6R5G | C-SH2 DOMAIN OF SHP-2 IN COMPLEX WITH PHOSPHO-ITSM OF PD-1 | 3.1.3.48 |
6R5K | CRYO-EM STRUCTURE OF A POLY(A) RNP BOUND TO THE PAN2-PAN3 DEADENYLASE | 3.1.13.4 |
6R64 | N-TERMINAL DOMAIN OF MODIFICATION DEPENDENT ECOKMCRA RESTRICTION ENDONUCLEASE (NECO) IN COMPLEX WITH C5MCGG TARGET SEQUENCE | 3.1.21 |
6R6V | STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT COUMARIN-BASED PROBE | 3.1.1.8 |
6R6W | STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A FLUORESCENT NBD-BASED PROBE | 3.1.1.8 |
6R70 | ENDOGENEOUS NATIVE HUMAN 20S PROTEASOME | 3.4.25.1 |
6R73 | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE COMPLEXED WITH HYDROLYSED MEROPENEM | 3.5.2.6 |
6R78 | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE IN APO FORM (LOOP CLOSED) | 3.5.2.6 |
6R79 | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE IN APO FORM (LOOP OPEN) | 3.5.2.6 |
6R8F | CRYO-EM STRUCTURE OF THE HUMAN BRISC-SHMT2 COMPLEX | 3.4.19 |
6R8N | STRUCTURE DETERMINATION OF THE TETRAHEDRAL AMINOPEPTIDASE TET2 FROM P. HORIKOSHII BY USE OF COMBINED SOLID-STATE NMR, SOLUTION-STATE NMR AND EM DATA 4.1 A, FOLLOWED BY REAL_SPACE_REFINEMENT AT 4.1 A | 3.4.11 |
6R8P | NOTUM FRAGMENT 723 | 3.1.1.98 |
6R8Q | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A BENZOTRIAZOLE FRAGMENT | 3.1.1.98 |
6R8R | STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH ISOQUINOLINE 45 | 3.1.1.98 |
6R8S | CRYSTAL STRUCTURE OF AIF2GAMMA SUBUNIT I181K FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
6R8T | CRYSTAL STRUCTURE OF AIF2GAMMA SUBUNIT I181T FROM ARCHAEON SULFOLOBUS SOLFATARICUS COMPLEXED WITH GDPCP | 3.6.5.3 |
6R8X | COAGULATION FACTOR XI CATALYTIC DOMAIN IN COMPLEX WITH FAB-PORTION OF MAA868 | 3.4.21.27 |
6R9I | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE | 3.1.13.4 |
6R9J | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE IN COMPLEX WITH A7 RNA | 3.1.13.4 |
6R9M | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE IN COMPLEX WITH AAGGAA RNA | 3.1.13.4 |
6R9O | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE IN COMPLEX WITH AAGGA RNA | 3.1.13.4 |
6R9P | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE IN COMPLEX WITH AAUUAA RNA | 3.1.13.4 |
6R9Q | STRUCTURE OF SACCHAROMYCES CEREVISIAE APO PAN2 PSEUDOUBIQUITIN HYDROLASE-RNA EXONUCLEASE (UCH-EXO) MODULE IN COMPLEX WITH AACCAA RNA | 3.1.13.4 |
6RA4 | HUMAN ARGONAUTE-2 PAZ DOMAIN (214-347) IN COMPLEX WITH CGUGACUCU | 3.1.26 |
6RAT | EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K | 3.1.27.5 4.6.1.18 |
6RAW | D. MELANOGASTER CMG-DNA, STATE 1A | 3.6.4.12 |
6RAX | D. MELANOGASTER CMG-DNA, STATE 1B | 3.6.4.12 |
6RAY | D. MELANOGASTER CMG-DNA, STATE 2A | 3.6.4.12 |
6RAZ | D. MELANOGASTER CMG-DNA, STATE 2B | 3.6.4.12 |
6RBC | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH A INHIBITOR KB1157 | 3.4.17.21 |
6RCI | CRYSTAL STRUCTURE OF REXO2 | 3.1 |
6RCL | CRYSTAL STRUCTURE OF REXO2-D199A-AA | 3.1 |
6RCN | CRYSTAL STRUCTURE OF REXO2-D199A-DADA | 3.1 |
6RCW | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D2 CATALYTIC DOMAIN WITH INHIBITOR NPD-053 | 3.1.4.53 |
6RCZ | THE STRUCTURE OF BURKHOLDERIA PSEUDOMALLEI TREHALOSE-6-PHOSPHATASE | 3.1.3.12 |
6RD0 | HUMAN MMP12 CATALYTIC DOMAIN IN COMPLEX WITH AP280 | 3.4.24.65 |
6RFK | CRYSTAL STRUCTURE OF EGRCK-INHIBITED GLA-DOMAINLESS FIXA (K148Q, R150Q VARIANT) | 3.4.21.22 |
6RFN | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1018 | 3.1.4 |
6RFW | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-1039 | 3.1.4 |
6RGK | CRYSTAL STRUCTURE OF T. BRUCEI PDE-B1 CATALYTIC DOMAIN WITH INHIBITOR NPD-055 | 3.1.4 |
6RHE | CPOGA D298N IN COMPLEX WITH HOGA-DERIVED S-GLCNAC PEPTIDE | 3.2.1.169 |
6RHN | HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN (HINT) FROM RABBIT WITHOUT NUCLEOTIDE | 3 |
6RIX | CRYSTAL STRUCTURE OF MCHDNAB-1 INTEIN | 3.6.4.12 |
6RIY | CRYSTAL STRUCTURE OF MCHDNAB-1 INTEIN (N145AA) | 3.6.4.12 |
6RJ7 | CRYSTAL STRUCTURE OF THE 19F LABELLED OXA-48 | 3.5.2.6 |
6RJD | CRYO-EM STRUCTURE OF ST1CAS9-SGRNA-TDNA59-NTPAM COMPLEX. | 3.1 |
6RJE | LYSOSTAPHIN SH3B P4-G5 COMPLEX, HOMESOURCE DATASET | 3.4.24.75 |
6RJF | ECHOVIRUS 1 INTACT PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6RJK | STRUCTURE OF VIRULENCE FACTOR SGHA FROM AGROBACTERIUM TUMEFACIENS | 3.2.1.21 |
6RJM | COMPLEX STRUCTURE OF VIRULENCE FACTOR SGHA AND ITS HYDROLYSIS PRODUCT GLUCOSE | 3.2.1.21 |
6RJO | COMPLEX STRUCTURE OF VIRULENCE FACTOR SGHA WITH ITS SUBSTRATE ANALOG SALICIN | 3.2.1.21 |
6RK2 | COMPLEX STRUCTURE OF VIRULENCE FACTOR SGHA MUTANT WITH ITS SUBSTRATE SAG | 3.2.1.21 |
6RK4 | LYSOSTAPHIN SH3B P4-G5 COMPLEX, SYNCHROTRON DATASET | 3.4.24.75 |
6RK6 | CHARACTERIZATION OF AN INTERTIDAL ZONE METAGENOME OLIGORIBONUCLEASE AND THE ROLE OF THE INTERMOLECULAR DISULFIDE BOND FOR HOMODIMER FORMATION AND NUCLEASE ACTIVITY. | 3.1.13.3 |
6RKG | 1.32 A RESOLUTION OF SPOROSARCINA PASTEURII UREASE INHIBITED IN THE PRESENCE OF NBPTO AT PH 7.5 | 3.5.1.5 |
6RLY | HUMAN MMP12 (CATALYTIC DOMAIN) IN COMPLEX WITH AP316 | 3.4.24.65 |
6RME | STRUCTURE OF IMP BOUND PLASMODIUM FALCIPARUM IMP-NUCLEOTIDASE MUTANT D172N | 3.1.3.5 3.1.3.99 |
6RMF | CRYSTAL STRUCTURE OF NDM-1 WITH VNRX-5133 | 3.5.2.6 |
6RMO | STRUCTURE OF PLASMODIUM FALCIPARUM IMP-NUCLEOTIDASE | 3.1.3.5 3.1.3.99 |
6RMR | CRYSTAL STRUCTURE OF ESCHERICHIA COLI PERIPLASMIC GLUCOSE-1-PHOSPHATASE H18D MUTANT | 3.1.3.10 |
6RMW | STRUCTURE OF N-TERMINAL TRUNCATED IMP BOUND PLASMODIUM FALCIPARUM IMP-NUCLEOTIDASE | 3.1.3.5 3.1.3.99 |
6RN1 | STRUCTURE OF N-TERMINAL TRUNCATED PLASMODIUM FALCIPARUM IMP-NUCLEOTIDASE | 3.1.3.5 3.1.3.99 |
6RN6 | DPP1 IN COMPLEX WITH INHIBITOR | 3.4.14.1 |
6RN7 | DPP1 IN COMPLEX WITH INHIBITOR | 3.4.14.1 |
6RN9 | DPP1 IN COMPLEX WITH INHIBITOR | 3.4.14.1 |
6RNB | LIQUID APPLICATION METHOD FOR TIME-RESOLVED ANALYSES (LAMA) BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY, LYSOZYME WITH GLCNAC3 50MS DIFFUSION TIME | 3.2.1.17 |
6RNC | LIQUID APPLICATION METHOD FOR TIME-RESOLVED ANALYSES (LAMA) BY SERIAL SYNCHROTRON CRYSTALLOGRAPHY, LYSOZYME WITH GLCNAC3 - 100MS DIFFUSION TIME. | 3.2.1.17 |
6RNE | DPP1 IN COMPLEX WITH INHIBITOR | 3.4.14.1 |
6RNH | STRUCTURE OF C-TERMINAL TRUNCATED PLASMODIUM FALCIPARUM IMP-NUCLEOTIDASE | 3.1.3.5 3.1.3.99 |
6RNI | DPP1 IN COMPLEX WITH INHIBITOR | 3.4.14.1 |
6RNM | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RNO | CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RNR | THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RNT | CRYSTAL STRUCTURE OF RIBONUCLEASE T1 COMPLEXED WITH ADENOSINE 2'-MONOPHOSPHATE AT 1.8-ANGSTROMS RESOLUTION | 3.1.27.3 4.6.1.24 |
6RO2 | THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RO3 | 2YR-X: LYSOZYME WITH RE CLUSTER 2 YEAR ON SHELF | 3.2.1.17 |
6RO4 | STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX | 3.6.4.12 |
6RO5 | 1YR-Y: LYSOZYME WITH RE CLUSTER 1 YEAR ON SHELF | 3.2.1.17 |
6ROK | THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RON | ENDOTHIAPEPSIN IN COMPLEX WITH COMPOUND 046 | 3.4.23.22 |
6ROP | KS-MAT DI-DOMAIN OF MOUSE FAS WITH OCTANOYL COA | 2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14 |
6ROY | STRUCTURE OF THE N-SH2 DOMAIN OF THE HUMAN TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11 IN COMPLEX WITH THE PHOSPHORYLATED IMMUNE RECEPTOR TYROSINE-BASED INHIBITORY MOTIF | 3.1.3.48 |
6ROZ | STRUCTURE OF THE N-SH2 DOMAIN OF THE HUMAN TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11 IN COMPLEX WITH THE PHOSPHORYLATED IMMUNE RECEPTOR TYROSINE-BASED SWITCH MOTIF | 3.1.3.48 |
6RP0 | THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RP1 | 1.49 A RESOLUTION OF SPOROSARCINA PASTEURII UREASE INHIBITED IN THE PRESENCE OF NBPTO AT PH 6.5 | 3.5.1.5 |
6RP4 | CDT OF SIDD, DEAMPYLASE FROM LEGIONELLA PNEUMOPHILA | 3.1.4 |
6RP7 | THE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE LLFPG PROTEIN, A THF-DNA AND AN INHIBITOR | 3.2.2.23 4.2.99.18 |
6RPC | GOLGI ALPHA-MANNOSIDASE II | 3.2.1.114 |
6RPP | CRYSTAL STRUCTURE OF PABCDC21-1 INTEIN | 3.6.4.12 |
6RPQ | CRYSTAL STRUCTURE OF PHOCDC21-1 INTEIN | 3.6.4.12 |
6RQX | HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERAP1 IN COMPLEX WITH 10MER PHOSPHINIC PEPTIDE | 3.4.11 |
6RQZ | GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH MANNO-EPI-CYCLOPHELLITOL AZIRIDINE | 3.2.1.114 |
6RR7 | INFLUENZA A VIRUS (A/NT/60/1968) POLYMERASE HETEROTRIMER BOUND TO 3'5' VRNA PROMOTER AND CAPPED RNA PRIMER | 3.1 |
6RRH | GOLGI ALPHA-MANNOSIDASE II | 3.2.1.114 |
6RRJ | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH 5-(ADAMANTAN-1YL-METHOXY)-PENTYL 2,5-DIDEOXY-2,5-IMINO-D-TALO-HEXONAMIDE | 3.2.1.114 |
6RRN | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH PENTYL 2,5-DIDEOXY-2,5-IMINO-D-TALO-HEXONAMIDE | 3.2.1.114 |
6RRU | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH (5R,6R,7S,8S)-5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)-3-(3-PHENYLPROPYL)IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | 3.2.1.114 |
6RRW | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH (2R,3R,4R,5S)-1-(5-{[4-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)BENZYL]OXY}PENTYL)-2-(HYDROXYMETHYL)-3,4,5-PIPERIDINETRIOL | 3.2.1.114 |
6RRX | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH (2S,3R)-2-(HYDROXYMETHYL)-3-PIPERIDINOL | 3.2.1.114 |
6RRY | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH (2S,3R)-2-(HYDROXYMETHYL)-1,2,3,6-TETRAHYDRO-3-PYRIDINOL | 3.2.1.114 |
6RS0 | GOLGI ALPHA-MANNOSIDASE II IN COMPLEX WITH (2S,3S,4R,5R)-1-(2-(BENZYLOXY)ETHYL)-2-(HYDROXYMETHYL)PIPERIDINE-3,4,5-TRIOL | 3.2.1.114 |
6RSA | NUCLEAR MAGNETIC RESONANCE AND NEUTRON DIFFRACTION STUDIES OF THE COMPLEX OF RIBONUCLEASE*A WITH URIDINE VANADATE, A TRANSITION-STATE ANALOGUE | 3.1.27.5 4.6.1.18 |
6RSV | ENDOTHIAPEPSIN IN COMPLEX WITH 017 | 3.4.23.22 |
6RT1 | NATIVE TETRAGONAL LYSOZYME - HOME SOURCE DATA | 3.2.1.17 |
6RT3 | NATIVE TETRAGONAL LYSOZYME - SYNCHROTRON DATA | 3.2.1.17 |
6RT9 | ORTHORHOMBIC LYSOZYME GROWN WITH 300G/L SUCROSE | 3.2.1.17 |
6RTA | TETRAGONAL LYSOZYME GROWN WITH 300G/L FICOLL | 3.2.1.17 |
6RTI | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH APTAMER A9G | 3.4.17.21 |
6RTN | CRYSTAL STRUCTURE OF OXA-10 WITH VNRX-5133 | 3.5.2.6 |
6RTV | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR INACTIVE S270A VARIANT | 3.1.1 |
6RU1 | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR INACTIVE S270A VARIANT IN COMPLEX WITH THE ALDOURONIC ACID UM4X | 3.1.1 |
6RU2 | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR | 3.1.1 |
6RUA | STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR. | 3.1.1.8 |
6RUD | WOLINELLA SUCCINOGENES L-ASPARAGINASE P1 | 3.5.1.1 |
6RUE | WOLINELLA SUCCINOGENES L-ASPARAGINASE MUTANT V23Q,K24T WITH L-ASP | 3.5.1.1 |
6RUF | WOLINELLA SUCCINOGENES L-ASPARAGINASE MUTANT V23Q,K24T WITH L-GLU | 3.5.1.1 |
6RUG | CO-SUBSTITUTED ALPHA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RUH | NI-SUBSTITUTED ALPHA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RUK | CU-SUBSTITUTED ALPHA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RUN | CO-SUBSTITUTED ALPHA-KEGGIN BOUND TO PROTEINASE K SOLVED BY EP | 3.4.21.64 |
6RUW | ZN-SUBSTITUTED ALPHA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RV7 | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR INACTIVE S270A VARIANT IN COMPLEX WITH THE ALDOURONIC ACID UXXR | 3.1.1 |
6RV8 | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR COVALENT COMPLEX WITH THE ALDOURONIC ACID UXXR | 3.1.1 |
6RV9 | CRYSTAL STRUCTURE OF GLUCURONOYL ESTERASE FROM CERRENA UNICOLOR INACTIVE S270A VARIANT IN COMPLEX WITH THE ALDOURONIC ACID XUXXR | 3.1.1 |
6RVE | CO-SUBSTITUTED BETA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RVG | CO-SUBSTITUTED BETA-KEGGIN BOUND TO PROTEINASE K SOLVED BY MR | 3.4.21.64 |
6RWF | THE DISSOCIATION MECHANISM OF PROCESSIVE CELLULASES | 3.2.1 |
6RWL | SIVRCM INTASOME | 2.7.7.49 3.1.13.2 3.1.26.13 |
6RWM | SIVRCM INTASOME IN COMPLEX WITH BICTEGRAVIR | 2.7.7.49 3.1.13.2 3.1.26.13 |
6RWN | SIVRCM INTASOME IN COMPLEX WITH DOLUTEGRAVIR | 2.7.7.49 3.1.13.2 3.1.26.13 |
6RWO | SIVRCM INTASOME (Q148H/G140S) IN COMPLEX WITH BICTEGRAVIR | 2.7.7.49 3.1.13.2 3.1.26.13 |
6RWZ | STRUCTURE OF ZIKA VIRUS NS3 HELICASE IN COMPLEX WITH ADP-BEF3 | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6RX7 | STRUCTURE OF THE KIV TYPE 2 (KIV-2) DOMAIN OF LIPOPROTEIN (A) | 3.4.21 |
6RXI | IN-FLOW SERIAL SYNCHROTRON CRYSTALLOGRAPHY USING A 3D-PRINTED MICROFLUIDIC DEVICE (3D-MIXD): LYSOZYME | 3.2.1.17 |
6RXJ | CRYSTAL STRUCTURE OF COBB WT IN COMPLEX WITH H4K16-ACETYL PEPTIDE | 3.5.1 2.3.1.286 |
6RXK | CRYSTAL STRUCTURE OF COBB WT IN COMPLEX WITH H4K16-BUTYRYL PEPTIDE | 3.5.1 2.3.1.286 |
6RXL | CRYSTAL STRUCTURE OF COBB WT IN COMPLEX WITH H4K16-CROTONYL PEPTIDE | 3.5.1 2.3.1.286 |
6RXO | CRYSTAL STRUCTURE OF COBB AC2 (A76G, I131C, V162A) IN COMPLEX WITH H4K16-BUTURYL PEPTIDE | 3.5.1 2.3.1.286 |
6RXP | CRYSTAL STRUCTURE OF COBB AC2 (A76G,I131C,V162A) IN COMPLEX WITH H4K16-CROTONYL PEPTIDE | 3.5.1 2.3.1.286 |
6RXQ | CRYSTAL STRUCTURE OF COBB AC2 (A76G,I131C,V162A) IN COMPLEX WITH H4K16CR-2'OH-ADPR PEPTIDE INTERMEDIATE AFTER SOAKING | 3.5.1 2.3.1.286 |
6RXR | CRYSTAL STRUCTURE OF COBB AC2 (A76G, I131C, V162G) IN COMPLEX WITH H4K16CR-2'OH-ADPR PEPTIDE INTERMEDIATE AFTER CO-CRYSTALLISATION | 3.5.1 2.3.1.286 |
6RXS | CRYSTAL STRUCTURE OF COBB AC3(A76G,Y92A, I131L, V187Y) IN COMPLEX WITH H4K16-ACETYL PEPTIDE | 3.5.1 2.3.1.286 |
6RY0 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM | 3.2.1.101 |
6RY1 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH MANNOSE | 3.2.1.101 |
6RY2 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH ALPHA-1,2-MANNOBIOSE | 3.2.1.101 |
6RY5 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH ALPHA-1,6-MANNOBIOSE | 3.2.1.101 |
6RY6 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH GLUCOSAMINE | 3.2.1.101 |
6RY7 | CRYSTAL STRUCTURE OF DFG5 FROM CHAETOMIUM THERMOPHILUM IN COMPLEX WITH LAMINARIBIOSE | 3.2.1.101 |
6RYF | HIGH-RESOLUTION CRYSTAL STRUCTURE OF ERAP1 IN COMPLEX WITH 15MER PHOSPHINIC PEPTIDE | 3.4.11 |
6RYO | BACTERIAL MEMBRANE ENZYME STRUCTURE BY THE IN MESO METHOD AT 1.9 A RESOLUTION | 3.4.23.36 |
6RYP | BACTERIAL MEMBRANE ENZYME STRUCTURE BY THE IN MESO METHOD AT 2.3 A RESOLUTION | 3.4.23.36 |
6RZ0 | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GLYOXALASE II | 3.1.2.6 |
6RZD | CRYSTAL STRUCTURE OF AN INVERTING FAMILY GH156 EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7 | 3.2.1.18 |
6RZN | CRYSTAL STRUCTURE OF THE N-TERMINAL CARBOHYDRATE BINDING MODULE FAMILY 48 AND FERULIC ACID ESTERASE FROM THE MULTI-ENZYME CE1-GH62-GH10 | 3.1.1.73 |
6RZO | CRYSTAL STRUCTURE OF THE N-TERMINAL CARBOHYDRATE BINDING MODULE FAMILY 48 AND FERULIC ACID ESTERASE FROM THE MULTI-ENZYME CE1-GH62-GH10 | 3.1.1.73 |
6RZP | MULTICRYSTAL STRUCTURE OF PROTEINASE K AT ROOM TEMPERATURE USING A MULTILAYER MONOCHROMATOR. | 3.4.21.64 |
6RZR | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE COMPLEXED WITH HYDROLYSED IMIPENEM | 3.5.2.6 |
6RZS | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE COMPLEXED WITH HYDROLYSED ERTAPENEM | 3.5.2.6 |
6S00 | CRYSTAL STRUCTURE OF AN INVERTING FAMILY GH156 EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7 IN COMPLEX WITH N-ACETYLNEURAMINIC ACID | 3.2.1.18 |
6S04 | CRYSTAL STRUCTURE OF AN INVERTING FAMILY GH156 EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7 IN COMPLEX WITH N-GLYCOLYLNEURAMINIC ACID | 3.2.1.18 |
6S06 | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE LINB D147C+L177C MUTANT (LINB73) FROM SPHINGOBIUM JAPONICUM UT26 | 3.8.1.5 |
6S0E | CRYSTAL STRUCTURE OF AN INVERTING FAMILY GH156 EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7 IN COMPLEX WITH N-ACETYL-2,3-DEHYDRO-2-DEOXYNEURAMINIC ACID | 3.2.1.18 |
6S0F | CRYSTAL STRUCTURE OF AN INVERTING FAMILY GH156 EXOSIALIDASE FROM UNCULTURED BACTERIUM PG7 IN COMPLEX WITH 3-DEOXY-D-GLYCERO-D-GALACTO-2-NONULOSONIC ACID | 3.2.1.18 |
6S0H | STRUCTURE OF IMP-13 METALLO-BETA-LACTAMASE COMPLEXED WITH HYDROLYSED DORIPENEM | 3.5.2.6 |
6S0I | CRYSTAL STRUCTURE OF ESCHERICHIA COLI GLYOXALASE II WITH L-TARTRATE IN THE ACTIVE SITE | 3.1.2.6 |
6S0J | STRUCTURE OF ZIKA VIRUS NS3 HELICASE IN COMPLEX WITH ADP-MGF3(H2O)- | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6S0M | STRUCTURAL AND DYNAMIC STUDIES PROVIDE INSIGHTS INTO SPECIFICITY AND ALLOSTERIC REGULATION OF RIBONUCLEASE AS, A KEY ENZYME IN MYCOBACTERIAL VIRULENCE | 3.1.13 |
6S16 | T. THERMOPHILUS RUVC IN COMPLEX WITH HOLLIDAY JUNCTION SUBSTRATE | 3.1.22.4 |
6S1C | P3221 CRYSTAL FORM OF THE CTF18-1-8/POL2(1-528) COMPLEX | 2.7.7.7 3.1.11 |
6S1M | HUMAN POLYMERASE DELTA HOLOENZYME CONFORMER 1 | 2.7.7.7 3.1.11 |
6S1N | HUMAN POLYMERASE DELTA HOLOENZYME CONFORMER 2 | 2.7.7.7 3.1.11 |
6S1O | HUMAN POLYMERASE DELTA HOLOENZYME CONFORMER 3 | 2.7.7.7 3.1.11 |
6S1S | CRYSTAL STRUCTURE OF AMPC FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH [3-(2-CARBOXYVINYL)PHENYL]BORONIC ACID] INHIBITOR | 3.5.2.6 |
6S1U | CRYSTAL STRUCTURE OF DIMERIC M-PMV PROTEASE C7A/D26N/C106A MUTANT IN COMPLEX WITH INHIBITOR | 3.6.1.23 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6S1V | CRYSTAL STRUCTURE OF DIMERIC M-PMV PROTEASE D26N MUTANT IN COMPLEX WITH INHIBITOR | 3.6.1.23 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6S1W | CRYSTAL STRUCTURE OF DIMERIC M-PMV PROTEASE D26N MUTANT | 3.6.1.23 3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1 |
6S1X | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII)-E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR KB1160 | 3.4.17.21 |
6S1Y | CRYSTAL STRUCTURE OF ANOPHELES GAMBIAE ANOACE2 IN COMPLEX WITH GAMMA-POLYGLUTAMIC ACID. | 3.4 |
6S1Z | CRYSTAL STRUCTURE OF ANOPHELES GAMBIAE ANOACE2 IN COMPLEX WITH FOSINOPRILAT | 3.4 |
6S20 | METABOLISM OF MULTIPLE GLYCOSAMINOGLYCANS BY BACTEROIDES THETAIOTAOMICRON IS ORCHESTRATED BY A VERSATILE CORE GENETIC LOCUS (BT33336S-SULF) | 3.1.6 |
6S21 | METABOLISM OF MULTIPLE GLYCOSAMINOGLYCANS BY BACTEROIDES THETAIOTAOMICRON IS ORCHESTRATED BY A VERSATILE CORE GENETIC LOCUS (BT33494S-SULF) | 3.1.6 |
6S2E | CRYO-EM STRUCTURE OF CTF18-1-8 IN COMPLEX WITH THE CATALYTIC DOMAIN OF DNA POLYMERASE EPSILON | 2.7.7.7 3.1.11 |
6S2F | CRYO-EM STRUCTURE OF CTF18-1-8 IN COMPLEX WITH THE CATALYTIC DOMAIN OF DNA POLYMERASE EPSILON (CLASS 2) | 2.7.7.7 3.1.11 |
6S2L | FMDV 3D POLYMERASE CRYSTALLIZED IN PRESENCE OF (F)URIDYLYLATED VPG PEPTIDE | 3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48 |
6S2Q | MYCOBACTERIAL HYDROLASE 1 | 3.1.3.85 3.1.3.70 |
6S2R | MYCOBACTERIAL HYDROLASE 2 | 3.1.3.85 3.1.3.70 |
6S3A | COXSACKIE B3 2C PROTEIN IN COMPLEX WITH S-FLUOXETINE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6S3G | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 VARIANT A187C/F291C | 3.1.1.3 |
6S3J | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 VARIANT E134C/F149C | 3.1.1.3 |
6S3V | CRYSTAL STRUCTURE OF LIPASE FROM GEOBACILLUS STEAROTHERMOPHILUS T6 METHANOL STABLE VARIANT E251C/G332C | 3.1.1.3 |
6S42 | THE DOUBLE MUTANT(ILE44LEU+GLN102HIS) OF HALOALKANE DEHALOGENASE DBEA FROM BRADYRHIZOBIUM ELKANII USDA94 WITH AN ELIMINATED HALIDE-BINDING SITE | 3.8.1.5 |
6S55 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH N-(4-BROMO-3-((3-METHYLPIPERIDIN-1-YL)SULFONYL)PHENYL)-2-(2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETAMIDE | 3.6.1.3 3.6.1 |
6S56 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITH N-(4-CHLORO-3-(N,N-DIMETHYLSULFAMOYL)PHENYL)-2-(2,5-DIOXO-3',4'-DIHYDRO-2'H-SPIRO[IMIDAZOLIDINE-4,1'-NAPHTHALEN]-1-YL)ACETAMIDE | 3.6.1.3 3.6.1 |
6S57 | CRYSTAL STRUCTURE OF HUMAN ATAD2 BROMODOMAIN IN COMPLEX WITHN-(3-(AZEPAN-1-YLSULFONYL)-4-METHYLPHENYL)-2-(4,4-DIMETHYL-2,5-DIOXOIMIDAZOLIDIN-1-YL)ACETAMIDE | 3.6.1.3 3.6.1 |
6S6A | CRYSTAL STRUCTURE OF RAGA-Q66L/RAGC-T90N GTPASE HETERODIMER COMPLEX | 3.6.5 |
6S6D | CRYSTAL STRUCTURE OF RAGA-Q66L-GTP/RAGC-S75N-GDP GTPASE HETERODIMER COMPLEX | 3.6.5 |
6S7F | HUMAN CD73 (5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12379 (AN AOPCP DERIVATIVE) IN THE CLOSED STATE | 3.1.3.5 |
6S7H | HUMAN CD73 (5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12489 (AN AOPCP DERIVATIVE) IN THE CLOSED STATE | 3.1.3.5 |
6S7N | CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME GROWN AT PH 5.5 WITH A 26% OF SOLVENT CONTENT | 3.2.1.17 |
6S8C | POST-FUSION CONFORMATION OF THE ENVELOPE PROTEIN OF TICK-BORNE ENCEPHALITIS VIRUS WITH LONGER STEM | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6S8O | HUMAN BRR2 HELICASE REGION M641C/A1582C | 3.6.4.13 |
6S8Q | HUMAN BRR2 HELICASE REGION IN COMPLEX WITH C-TAIL DELETED JAB1 | 3.6.4.13 |
6S8R | D. MELANOGASTER RNA HELICASE ME31B IN COMPLEX WITH GIGYF | 3.6.4.13 |
6S8S | EXTENDED STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3 FDF PEPTIDE | 3.6.4.13 |
6S92 | CRYSTAL STRUCTURE OF GROUP A OF USUTU VIRUS ENVELOPE PROTEIN DOMAIN III | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6S93 | CRYSTAL STRUCTURE OF GROUP B OF USUTU VIRUS ENVELOPE PROTEIN DOMAIN III | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6S94 | CRYSTAL STRUCTURE OF GROUP D OF USUTU VIRUS ENVELOPE PROTEIN DOMAIN III | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6S95 | CRYSTAL STRUCTURE OF GROUP I OF USUTU VIRUS ENVELOPE PROTEIN DOMAIN III | 3.4.21.91 3.6.1.15 3.6.4.13 |
6S9A | ARTIFICIAL GTPASE-BSE DIMER OF HUMAN DYNAMIN1 | 3.6.5.5 |
6S9I | HUMAN BRR2 HELICASE REGION D534C/N1866C IN COMPLEX WITH C-TAIL DELETED JAB1 | 3.6.4.13 |
6SA9 | ENDOGENOUS RETROVIRUS HML2 CAPSID NTD | 3.4.23.50 2.7.7.49 2.7.7.7 3.1.26.4 |
6SAK | STRUCTURE OF THE OTULINCAT C129A - SNX27 PDZ DOMAIN COMPLEX. | 3.4.19.12 |
6SAM | STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 1-(2,3-DIHYDRO-1H-INDEN2-YL)PIPERIDIN-3-YL N-PHENYL CARBAMATE | 3.1.1.8 |
6SAR | E COLI BEPA/YFGC | 3.4 |
6SAV | STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF THREE NOVEL FUNGAL AMYLASES WITH ENHANCED STABILITY AND PH TOLERANCE | 3.2.1.1 |
6SAZ | CLEAVED HUMAN FETUIN-B IN COMPLEX WITH CRAYFISH ASTACIN | 3.4.24.21 |
6SB9 | THERMOLYSIN IN COMPLEX WITH J28 | 3.4.24.27 |
6SBI | X-RAY STRUCTURE OF MURINE FUMARYLACETOACETATE HYDROLASE DOMAIN CONTAINING PROTEIN 1 (FAHD1) IN COMPLEX WITH INHIBITOR OXALATE | 3.7.1.5 4.1.1.112 |
6SBJ | X-RAY STRUCTURE OF MUS MUSCULUS FUMARYLACETOACETATE HYDROLASE DOMAIN CONTAINING PROTEIN 1 (FAHD1) APO-FORM UUNCOMPLEXED | 3.7.1.5 4.1.1.112 |
6SBK | THERMOLYSIN IN COMPLEX WITH FRAGMENT J13 | 3.4.24.27 |
6SBQ | THE CRYSTAL STRUCTURE OF PFA-M1 IN COMPLEX WITH 7-AMINO-4-PHENYL-5,7,8,9-TETRAHYDROBENZOCYCLOHEPTEN-6-ONE | 3.4.11.2 |
6SBR | THE CRYSTAL STRUCTURE OF PFA-M1 IN COMPLEX WITH 7-AMINO-1,4-DIBROMO-5,7,8,9-TETRAHYDROBENZOCYCLOHEPTEN-6-ONE | 3.4.11.2 |
6SC0 | THERMOLYSIN IN COMPLEX WITH FRAGMENT J22 | 3.4.24.27 |
6SC1 | THERMOLYSIN IN COMPLEX WITH FRAGMENT J96 | 3.4.24.27 |
6SC3 | THERMOLYSIN IN COMPLEX WITH FRAGMENT J62 | 3.4.24.27 |
6SCK | THERMOLYSIN IN COMPLEX WITH FRAGMENT J77 | 3.4.24.27 |
6SCU | THERMOLYSIN IN COMPLEX WITH FRAGMENT J88 | 3.4.24.27 |
6SCV | ENDOTHIAPEPSIN IN COMPLEX WITH LIGAND 69 | 3.4.23.22 |
6SCX | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN NUDT12 IN COMPLEX WITH 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE | 3.6.1.22 3.6.1 |
6SE8 | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB MUTANT E441Q | 3.2.1.23 |
6SE9 | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB MUTANT E441Q IN COMPLEX WITH LACTOSE BOUND IN SHALLOW MODE | 3.2.1.23 |
6SEA | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB MUTANT E441Q IN COMPLEX WITH LACTOSE BOUND IN DEEP MODE | 3.2.1.23 |
6SEB | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB IN COMPLEX WITH IPTG | 3.2.1.23 |
6SEC | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CBON COMPLEX WITH ONPG | 3.2.1.23 |
6SED | COLD-ADAPTED BETA-D-GALACTOSIDASE FROM ARTHROBACTER SP. 32CB IN COMPLEX WITH GALACTOSE | 3.2.1.23 |
6SEH | RECOGNITION AND PROCESSING OF BRANCHED DNA SUBSTRATES BY SLX1-SLX4 NUCLEASE | 3.1 |
6SEI | RECOGNITION AND PROCESSING OF BRANCHED DNA SUBSTRATES BY SLX1-SLX4 NUCLEASE | 3.1 |
6SEL | MULTICRYSTAL STRUCTURE OF THERMOLYSIN AT ROOM TEMPERATURE USING A MULTILAYER MONOCHROMATOR. | 3.4.24.27 |
6SET | X-RAY STRUCTURE OF THE GOLD/LYSOZYME ADDUCT FORMED UPON 3 DAYS EXPOSURE OF PROTEIN CRYSTALS TO COMPOUND 1 | 3.2.1.17 |
6SEU | X-RAY STRUCTURE OF THE GOLD/LYSOZYME ADDUCT FORMED UPON 21H EXPOSURE OF PROTEIN CRYSTALS TO COMPOUND 2 | 3.2.1.17 |
6SEW | X-RAY STRUCTURE OF THE GOLD/LYSOZYME ADDUCT FORMED UPON 24H EXPOSURE OF PROTEIN CRYSTALS TO COMPOUND 2 | 3.2.1.17 |
6SEX | X-RAY STRUCTURE OF THE GOLD/LYSOZYME ADDUCT FORMED UPON 21H EXPOSURE OF PROTEIN CRYSTALS TO COMPOUND 1 | 3.2.1.17 |
6SEZ | X-RAY STRUCTURE OF THE GOLD/LYSOZYME ADDUCT FORMED UPON 24H EXPOSURE OF PROTEIN CRYSTALS TO COMPOUND 1 | 3.2.1.17 |
6SFX | CRYO-EM STRUCTURE OF CLPP1/2 IN THE LMCLPXP1/2 COMPLEX | 3.4.21.92 |
6SGF | MOLECULAR INSIGHT INTO A NEW LOW AFFINITY XYLAN BINDING MODULE CBM86, FROM THE XYLANOLYTIC GUT SYMBIONT ROSEBURIA INTESTINALIS. | 3.2.1.8 |
6SGP | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A SULFAMIDE INHIBITOR GLUGLU | 3.4.17.21 |
6SGW | STRUCTURE OF THE ESX-3 CORE COMPLEX | 3.6 |
6SGX | STRUCTURE OF PROTOMER 1 OF THE ESX-3 CORE COMPLEX | 3.6 |
6SGY | STRUCTURE OF ECCB3 DIMER FROM THE ESX-3 CORE COMPLEX | 3.6 |
6SH6 | CRYSTAL STRUCTURE OF THE HUMAN DEAH-HELICASE DHX15 IN COMPLEX WITH THE NKRF G-PATCH BOUND TO ADP | 3.6.4.13 |
6SH7 | CRYSTAL STRUCTURE OF THE HUMAN DEAH-HELICASE DHX15 IN COMPLEX WITH THE NKRF G-PATCH | 3.6.4.13 |
6SH9 | ENGBF DARPIN FUSION 4B D12 | 3.2.1.97 |
6SHC | CRYSTAL STRUCTURE OF HUMAN IRE1 LUMINAL DOMAIN Q105C | 2.7.11.1 3.1.26 |
6SHH | HUMAN KALLIKREIN 7 WITH AROMATIC COUMARINIC ESTER COMPOUND 1 COVALENTLY BOUND TO H57 | 3.4.21.117 |
6SHI | HUMAN KALLIKREIN 7 WITH AROMATIC COUMARINIC ESTER COMPOUND 2 COVALENTLY BOUND TO H57 | 3.4.21.117 |
6SHK | HIGH RESOLUTION STRUCTURE OF THE ANTIMICROBIAL PEPTIDE DERMCIDIN FROM HUMAN | 3.4 |
6SHW | N-TERMINAL DOMAIN OF DROSOPHILA X VIRUS VP3 | 3.4.21 |
6SHY | STRUCTURE OF L320A/H321S DOUBLE MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS | 3.2.1.156 |
6SI6 | N-TERMINAL DOMAIN OF DROSOPHILA X VIRUS VP3 | 3.4.21 |
6SIJ | SAD STRUCTURE OF HEN EGG WHITE LYSOZYME RECOVERED BY CONTINUOUS ROTATION DATA COLLECTION AND MULTIVARIATE ANALYSIS OF FRIEDEL PAIRS | 3.2.1.17 |
6SIK | SAD STRUCTURE OF HEN EGG WHITE LYSOZYME RECOVERED BY CONTINUOUS ROTATION DATA COLLECTION AND UNIVARIATE ANALYSIS | 3.2.1.17 |
6SIL | SAD STRUCTURE OF HEN EGG WHITE LYSOZYME RECOVERED BY INVERSE BEAM GEOMETRY DATA COLLECTION AND MULTIVARIATE ANALYSIS OF FRIEDEL PAIRS | 3.2.1.17 |
6SIM | SAD STRUCTURE OF HEN EGG WHITE LYSOZYME RECOVERED BY INVERSE BEAM GEOMETRY DATA COLLECTION AND UNIVARIATE ANALYSIS | 3.2.1.17 |
6SIU | CRYSTAL STRUCTURE OF IBPAFIC2 COVALENTLY TETHERED TO CDC42 | 2.7.7 3.4.22 |
6SJB | CRYO-EM STRUCTURE OF THE RECBCD CHI RECOGNISED COMPLEX | 3.1.11.5 |
6SJD | ZC3H12B-RIBONUCLEASE DOMAIN BOUND TO RNA | 3.1 |
6SJE | CRYO-EM STRUCTURE OF THE RECBCD CHI PARTIALLY-RECOGNISED COMPLEX | 3.1.11.5 |
6SJF | CRYO-EM STRUCTURE OF THE RECBCD CHI UNRECOGNISED COMPLEX | 3.1.11.5 |
6SJG | CRYO-EM STRUCTURE OF THE RECBCD NO CHI NEGATIVE CONTROL COMPLEX | 3.1.11.5 |
6SJU | HUMAN KALLIKREIN 7 WITH AROMATIC COUMARINIC ESTER COMPOUND 3 COVALENTLY BOUND TO H57 | 3.4.21.117 |
6SK7 | CRYO-EM STRUCTURE OF RHINOVIRUS-A89 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6SKB | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (N217D/I218Y/K224R) IN COMPLEX WITH GSK3496783A | 3.4.21 |
6SKC | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (I218Y) IN COMPLEX WITH GSK3448330A | 3.4.21 |
6SKD | CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 6 (I218Y) IN COMPLEX WITH GSK3397892A | 3.4.21 |
6SKH | X-RAY STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) - THE E424M INACTIVE MUTANT, IN COMPLEX WITH A INHIBITOR SULFAMIDE INHIBITOR GLUASP | 3.4.17.21 |
6SKK | STRUCTURE OF THE NATIVE FULL-LENGTH HIV-1 CAPSID PROTEIN IN HELICAL ASSEMBLY (-13,8) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6SKM | STRUCTURE OF THE NATIVE FULL-LENGTH HIV-1 CAPSID PROTEIN A92E IN HELICAL ASSEMBLY (-13,12) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6SKO | CRYO-EM STRUCTURE OF THE FORK PROTECTION COMPLEX BOUND TO CMG AT A REPLICATION FORK - CONFORMATION 2 MCM CTD:SSDNA | 3.6.4.12 |
6SKP | OXA-10_IPM. STRUCTURAL INSIGHT TO THE ENHANCED CARBAPENEM EFFICIENCY OF OXA-655 COMPARED TO OXA-10. | 3.5.2.6 |
6SKQ | OXA-655_MEM. STRUCTURAL INSIGHTS INTO THE ENHANCED CARBAPENEMASE EFFICIENCY OF OXA-655 COMPARED TO OXA-10. | 3.5.2.6 |
6SKR | OXA-10_ETP. STRUCTURAL INSIGHT TO THE ENHANCED CARBAPENEM EFFICIENCY OF OXA-655 COMPARED TO OXA-10. | 3.5.2.6 |
6SLF | NALPHA-ACYLGLUTAMINE AMINOACYLASE FROM CORYNEBACTERIUM SP.RELEASING HUMAN AXILLA ODORANTS CO-CRYSTALLISED WITH HIGH AFFINITY INHIBITOR | 3.5.1.133 |
6SLQ | STRUCTURE OF THE NATIVE FULL-LENGTH HIV-1 CAPSID PROTEIN A92E IN HELICAL ASSEMBLY (-12,11) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6SLU | STRUCTURE OF THE NATIVE FULL-LENGTH HIV-1 CAPSID PROTEIN A92E IN HELICAL ASSEMBLY (-13,11) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6SM5 | MBC/SHP1-C-SH2 COMPLEX | 3.1.3.48 |
6SMA | CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (HNE) IN COMPLEX WITH THE 3-OXO-BETA-SULTAM INHIBITOR LMC249 | 3.4.21.37 |
6SMG | STRUCTURE OF COXSACKIEVIRUS A10 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6SMU | STRUCTURE OF THE NATIVE FULL-LENGTH HIV-1 CAPSID PROTEIN IN HELICAL ASSEMBLY (-13,12) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6SN6 | CARBOXYPEPTIDASE T WITH N-SULFAMOYL-L-GLUTAMIC ACID | 3.4.17.18 |
6SNB | STRUCTURE OF COXSACKIEVIRUS A10 A-PARTICLE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6SNW | STRUCTURE OF COXSACKIEVIRUS A10 COMPLEXED WITH ITS RECEPTOR KREMEN1 | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6SO0 | NMR SOLUTION STRUCTURE OF THE FAMILY 14 CARBOHYDRATE BINDING MODULE (CBM14) FROM HUMAN CHITOTRIOSIDASE | 3.2.1.14 |
6SO5 | HOMO SAPIENS WRB/CAML HETEROTETRAMER IN COMPLEX WITH A TRC40 DIMER | 3.6 |
6SP5 | STRUCTURE OF HYPERSTABLE HALOALKANE DEHALOGENASE VARIANT DHAA115 | 3.8.1.5 |
6SP6 | ULTRA-HIGH RESOLUTION CRYSTAL STRUCTURE OF THE CTX-M-15 EXTENDED-SPECTRUM BETA-LACTAMASE IN COMPLEX WITH TANIBORBACTAM (VNRX-5133) | 3.5.2.6 |
6SP8 | STRUCTURE OF HYPERSTABLE HALOALKANE DEHALOGENASE VARIANT DHAA115 PREPARED BY THE 'SOAK-AND-FREEZE' METHOD UNDER 150 BAR OF KRYPTON PRESSURE | 3.8.1.5 |
6SQU | CRYSTAL STRUCTURE OF HUMAN SHIP2 CATALYTIC DOMAIN IN COMPLEX WITH 1,2,4 DIMER | 3.1.3.86 |
6SQW | MOUSE DCTPASE IN COMPLEX WITH 5-ME-DCMP | 3.6.1.12 |
6SQY | MOUSE DCTPASE IN COMPLEX WITH DCMP | 3.6.1.12 |
6SQZ | MOUSE DCTPASE IN COMPLEX WITH DCMPNPP | 3.6.1.12 |
6SR0 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: SINGLE COLOUR REFERENCE DATA | 3.2.1.17 |
6SR1 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: 35 FS TIME DELAY | 3.2.1.17 |
6SR2 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: 37 FS TIME DELAY | 3.2.1.17 |
6SR3 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: 62 FS TIME DELAY | 3.2.1.17 |
6SR4 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: 112 FS TIME DELAY | 3.2.1.17 |
6SR5 | X-RAY PUMP X-RAY PROBE ON LYSOZYME.GD NANOCRYSTALS: 102 FS TIME DELAY | 3.2.1.17 |
6SRD | STRUCTURE OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH XYLOSE. | 3.2.1.156 |
6SRE | CRYSTAL STRUCTURE OF HUMAN PROLIDASE S202F VARIANT EXPRESSED IN THE PRESENCE OF CHAPERONES | 3.4.13.9 |
6SRF | CRYSTAL STRUCTURE OF HUMAN PROLIDASE G278N VARIANT EXPRESSED IN THE PRESENCE OF CHAPERONES | 3.4.13.9 |
6SRG | CRYSTAL STRUCTURE OF HUMAN PROLIDASE G448R VARIANT EXPRESSED IN THE PRESENCE OF CHAPERONES | 3.4.13.9 |
6SRR | CRYSTAL STRUCTURE OF HUMAN SHIP2 CATALYTIC DOMAIN | 3.1.3.86 |
6SSZ | STRUCTURE OF THE PLASMODIUM FALCIPARUM FALCIPAIN 2 PROTEASE IN COMPLEX WITH AN (E)-CHALCONE INHIBITOR. | 3.4.22 |
6STY | HUMAN REXO2 EXONUCLEASE IN COMPLEX WITH RNA. | 3.1 |
6SUB | HUMAN PTPRU D1 DOMAIN, REDUCED FORM | 3.1.3.48 |
6SUC | HUMAN PTPRU D1 DOMAIN, OXIDISED FORM | 3.1.3.48 |
6SUD | STRUCTURE OF L320A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH XYLOSE. | 3.2.1.156 |
6SUK | CRYSTAL STRUCTURE OF NEPRILYSIN IN COMPLEX WITH OMAPATRILAT. | 3.4.24.11 |
6SUP | CRYSTAL STRUCTURE OF TCDB2-TCCC3-CDC42 | 3.6.5.2 |
6SUQ | CRYSTAL STRUCTURE OF TCDB2-TCCC3-TEV | 3.4 3.4.22.45 3.6.4 3.4.22.44 2.7.7.48 |
6SUX | TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X37) | 3.4.21.4 |
6SV0 | NON-TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X37) | 3.4.21.4 |
6SV6 | NON-TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X38) | 3.4.21.4 |
6SV8 | TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X38) | 3.4.21.4 |
6SV9 | NON-TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X40) | 3.4.21.4 |
6SVB | TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X40) | 3.4.21.4 |
6SVD | NON-TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X41) | 3.4.21.4 |
6SVG | TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X41) | 3.4.21.4 |
6SVI | NON-TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X42) | 3.4.21.4 |
6SVJ | TERAHERTZ IRRADIATED STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X42) | 3.4.21.4 |
6SVN | REFERENCE STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X28) | 3.4.21.4 |
6SVR | REFERENCE STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X28) | 3.4.21.4 |
6SVU | REFERENCE STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X30) | 3.4.21.4 |
6SVV | REFERENCE STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X30) | 3.4.21.4 |
6SVW | REFERENCE STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X33) | 3.4.21.4 |
6SVX | REFERENCE STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X33) | 3.4.21.4 |
6SVY | CRYSTAL STRUCTURE OF NEPRILYSIN IN COMPLEX WITH SAMPATRILAT-ASP. | 3.4.24.11 |
6SVZ | REFERENCE STRUCTURE OF BOVINE TRYPSIN (EVEN FRAMES OF CRYSTAL X34) | 3.4.21.4 |
6SW0 | REFERENCE STRUCTURE OF BOVINE TRYPSIN (ODD FRAMES OF CRYSTAL X34) | 3.4.21.4 |
6SXA | XPF-ERCC1 CRYO-EM STRUCTURE, APO-FORM | 3.1 |
6SXR | E221Q MUTANT OF GH54 A-L-ARABINOFURANOSIDASE SOAKED WITH 4-NITROPHENYL A-L-ARABINOFURANOSIDE | 3.2.1.55 |
6SXT | GH54 A-L-ARABINOFURANOSIDASE SOAKED WITH AZIRIDINE INHIBITOR | 3.2.1.55 |
6SXV | GH51 A-L-ARABINOFURANOSIDASE SOAKED WITH AZIRIDINE INHIBITOR | 3.2.1.55 |
6SY2 | STRUCTURE OF THE BRK DOMAIN OF THE SWI/SNF CHROMATIN REMODELLING COMPLEX SUBUNIT BRG1 REVEALS A POTENTIAL ROLE IN PROTEIN-PROTEIN INTERACTIONS | 3.6.4 |
6SY3 | CATIONIC TRYPSIN IN COMPLEX WITH A D-DIPHE-PRO-PYRIDINE DERIVATIVE | 3.4.21.4 |
6SYC | CRYSTAL STRUCTURE OF THE LYSOZYME IN PRESENCE OF BROMOPHENOL BLUE AT PH 6.5 | 3.2.1.17 |
6SYD | CRYSTAL STRUCTURE OF THE LYSOZYME IN PRESENCE OF BROMOPHENOL BLUE AT PH 5.5 | 3.2.1.17 |
6SYE | CRYSTAL STRUCTURE OF ORTHORHOMBIC LYSOZYME IN PRESENCE OF THE DYE BROMOPHENOL BLUE AT PH 7.0 | 3.2.1.17 |
6SYH | WOLINELLA SUCCINOGENES L-ASPARAGINASE MUTANT V23Q,K24T IN P 22121 | 3.5.1.1 |
6SYI | C-TERMINAL DOMAIN OF INFLUENZA POLYMERASE PA SUBUNIT AND OPTIMIZED SMALL PEPTIDE INHIBITOR | 3.1 |
6SYN | CRYSTAL STRUCTURE OF Y. PESTIS PENICILLIN-BINDING PROTEIN 3 | 3.4.16.4 |
6SZA | MOXR AAA-ATPASE RAVA, C2-SYMMETRIC CLOSED RING CONFORMATION | 3.6.3 |
6SZB | MOXR AAA-ATPASE RAVA, SPIRAL OPEN RING CONFORMATION | 3.6.3 |
6SZP | HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN DDAH-1 IN COMPLEX WITH N-(4-AMINOBUTYL)-N'-(2-METHOXYETHYL)GUANIDINE | 3.5.3.18 |
6SZQ | CRYSTAL STRUCTURE OF HUMAN DDAH-1 | 3.5.3.18 |
6T0I | THE WILD TYPE GLUCURONOYL ESTERASE OTCE15A FROM OPITUTUS TERRAE IN COMPLEX WITH THE ALDOTETRAURONIC ACID XUX | 3.1.1 |
6T0M | CATIONIC TRYPSIN IN COMPLEX WITH A D-PHE-PRO-DIAMINOPYRIDINE DERIVATIVE | 3.4.21.4 |
6T0P | CATIONIC TRYPSIN IN COMPLEX WITH A D-PHE-PRO-2-AMINOPYRIDINE DERIVATIVE | 3.4.21.4 |
6T0W | HUMAN INFLUENZA B POLYMERASE RECYCLING COMPLEX | 3.1 |
6T0Y | CRYSTAL STRUCTURE OF YLMD FROM GEOBACILLUS STEAROTHERMOPHILUS | 2.4.2.1 3.5.4.4 2.4.2.28 |
6T13 | CRYSTAL STRUCTURE OF GLUCOCEREBROSIDASE IN COMPLEX WITH A PYRROLOPYRAZINE | 3.2.1.45 |
6T1B | CRYSTAL STRUCTURE OF YLMD FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH INOSINE | 2.4.2.1 3.5.4.4 2.4.2.28 |
6T1Q | 3C-LIKE PROTEASE FROM SOUTHAMPTON NOROVIRUS. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T21 | N-TERMINAL DOMAIN OF ECOKMCRA RESTRICTION ENDONUCLEASE (NECO) IN COMPLEX WITH T5MCGA TARGET SEQUENCE | 3.1.21 |
6T22 | N-TERMINAL DOMAIN OF ECOKMCRA RESTRICTION ENDONUCLEASE (NECO) IN COMPLEX WITH T5HMCGA TARGET SEQUENCE | 3.1.21 |
6T2B | GLYCOSIDE HYDROLASE FAMILY 109 FROM AKKERMANSIA MUCINIPHILA IN COMPLEX WITH GALNAC AND NAD+. | 3.2.1 |
6T2H | FURANO[2,3-D]PRYMIDINE AMIDES AS NOTUM INHIBITORS | 3.1.1.98 |
6T2I | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000157A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T2K | FURANO[2,3-D]PRYMIDINE AMIDES AS NOTUM INHIBITORS | 3.1.1.98 |
6T2U | CRYO-EM STRUCTURE OF THE RECBCD IN COMPLEX WITH CHI-MINUS2 SUBSTRATE | 3.1.11.5 |
6T2V | CRYO-EM STRUCTURE OF THE RECBCD IN COMPLEX WITH CHI-PLUS2 SUBSTRATE | 3.1.11.5 |
6T2X | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000004A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T35 | CRYSTAL STRUCTURE OF AMPC FROM E.COLI WITH ENMETAZOBACTAM (AAI-101) | 3.5.2.6 |
6T36 | CRYSTAL STRUCTURE OF THE PTPN3 PDZ DOMAIN BOUND TO THE HBV CORE PROTEIN C-TERMINAL PEPTIDE | 3.1.3.48 |
6T3D | CRYSTAL STRUCTURE OF AMPC FROM E.COLI | 3.5.2.6 |
6T3G | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000324A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T3M | THROMBIN IN COMPLEX WITH A D-PHE-PRO-P-PHENOL DERIVATIVE | 3.4.21.5 |
6T3Q | THROMBIN IN COMPLEX WITH A D-PHE-PRO-2-AMINOPYRIDINE DERIVATIVE | 3.4.21.5 |
6T3W | COXSACKIE B3 2C PROTEIN IN COMPLEX WITH S-FLUOXETINE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6T40 | BOVINE ENTEROVIRUS F3 IN COMPLEX WITH A CYSTEINYLGLYCINE DIPEPTIDE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6T48 | BOVINE ENTEROVIRUS F3 IN COMPLEX WITH GLUTATHIONE AND A CYSTEINYLGLYCINE DIPEPTIDE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6T49 | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000582A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T4A | THROMBIN IN COMPLEX WITH A D-PHE-PRO-P-AMINOPYRIDINE DERIVATIVE | 3.4.21.5 |
6T4C | BOVINE ENTEROVIRUS F3 IN COMPLEX WITH GLUTATHIONE | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6T4E | NATIVE C3-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000287A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T4S | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000013A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T52 | THROMBIN IN COMPLEX WITH A D-PHE-PRO-IMIDAZOLE DERIVATIVE | 3.4.21.5 |
6T53 | THROMBIN IN COMPLEX WITH A D-PHE-PRO-P-BENZYLAMINE DERIVATIVE | 3.4.21.5 |
6T54 | THROMBIN IN COMPLEX WITH A D-PHE-PRO-2-BROMOTHIOPHENE DERIVATIVE | 3.4.21.5 |
6T55 | THROMBIN IN COMPLEX WITH METHYLBENZYLAMINE | 3.4.21.5 |
6T56 | THROMBIN IN COMPLEX WITH BENZYLAMINE | 3.4.21.5 |
6T57 | THROMBIN IN COMPLEX WITH A D-PHE-PRO-N-AMIDINOPIPERIDINE DERIVATIVE | 3.4.21.5 |
6T5B | KRASG12C LIGAND COMPLEX | 3.6.5.2 |
6T5D | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000014A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T5J | STRUCTURE OF NUDT15 IN COMPLEX WITH INHIBITOR TH1760 | 3.6.1.9 |
6T5K | ECV-1 FROM ECHINICOLA VIETNAMENSIS. ENVIRONMENTAL METALLO-BETA-LACTAMASES EXHIBIT HIGH ENZYMATIC ACTIVITY UNDER ZINC DEPRIVATION | 3.5.2.6 |
6T5R | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000091A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T5S | APO FORM OF C-TYPE LYSOZYME FROM THE UPPER GASTROINTESTINAL TRACT OF OPISTHOCOMUS HOATZIN | 3.2.1.17 |
6T5V | KRASG12C LIGAND COMPLEX | 3.6.5.2 |
6T5W | CATIONIC TRYPSIN IN COMPLEX WITH A D-PHE-PRO-P-AMINOPYRIDINE DERIVATIVE (COCRYSTALLIZATON AT 291 K) | 3.4.21.4 |
6T5Y | CRYSTAL STRUCTURE OF AMPC FROM E.COLI WITH ZIDEBACTAM (WCK 5107) | 3.5.2.6 |
6T6C | COMPLEX WITH CHITIN OLIGOMER OF C-TYPE LYSOZYME FROM THE UPPER GASTROINTESTINAL TRACT OF OPISTHOCOMUS HOATZIN | 3.2.1.17 |
6T6E | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HIV-1 INTEGRASE (PNL4-3) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6T6I | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HIV-1 INTEGRASE (SUBTYPE A2) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6T6J | CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF THE HIV-1 INTEGRASE (SUBTYPE A2, MUTANT N254K, K340Q) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6T6R | HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 (ERAP1) IN COMPLEX WITH (4AR,5S,6R,8S,8AR)-5-(2-(FURAN-3-YL)ETHYL)-8-HYDROXY-5,6,8A-TRIMETHYL-3,4,4A,5,6,7,8,8A-OCTAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | 3.4.11 |
6T6W | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH XST00000692B. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T71 | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH XST00000375B. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T7H | CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH MACROCYCLE N14-PR4-A | 3.4.21.5 |
6T7L | CRYSTAL STRUCTURE OF AMPC FROM E.COLI WITH NACUBACTAM (OP0595) | 3.5.2.6 |
6T7P | HUMAN PLASMAKALLIKREIN PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE DIRECTED INHIBITOR | 3.4.21.34 |
6T82 | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000542A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T89 | THROMBIN IN COMPLEX WITH (S)-N-(TERT-BUTYL)-4-(3-(3-CARBAMIMIDOYLPHENYL)-2-((2',4'-DIMETHOXY-[1,1'-BIPHENYL])-3-SULFONAMIDO)PROPANOYL)PIPERAZINE-1-CARBOXAMIDE (MI-498) | 3.4.21.5 |
6T8A | THROMBIN IN COMPLEX WITH DIPHENYL ((4-CARBAMIMIDOYLPHENYL)((S)-1-((R)-3-CYCLOHEXYL 2-((PHENYLMETHYL)SULFONAMIDO)PROPANOYL)PYRROLIDINE-2-CARBOXAMIDO)METHYL)PHOSPHONATE (MI-492) | 3.4.21.5 |
6T8H | CRYO-EM STRUCTURE OF THE DNA-BOUND POLD-PCNA PROCESSIVE COMPLEX FROM P. ABYSSI | 2.7.7.7 3.1.11.1 |
6T8R | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000605A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T8T | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000603A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6T9P | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N-[(1R)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1-YL}-1- PHENYLPROPYL]ACETAMIDE | 3.1.1.8 |
6T9S | HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-(N-HYDROXYIMINO)-N-[(1S)-3-{4-[(2-METHYL-1H-IMIDAZOL-1-YL)METHYL]-1H-1,2,3-TRIAZOL-1-YL}-1- PHENYLPROPYL]ACETAMIDE | 3.1.1.8 |
6T9T | MATRIPTASE IN COMPLEX WITH THE SYNTHETIC INHIBITOR (S)-3-(3-(4-(3-(TERT-BUTYL)UREIDO)PIPERIDIN-1-YL)-2-((3'-FLUORO-4'-(HYDROXYMETHYL)-[1,1'-BIPHENYL])-3-SULFONAMIDO)-3-OXOPROPYL)BENZIMIDAMIDE (MI-1904) | 3.4.21.109 |
6T9U | BOVINE TRYPSINE IN COMPLEX WITH THE SYNTHETIC INHIBITOR (S)-3'-(N-(1-(4-(3-(TERT-BUTYL)UREIDO)PIPERIDIN-1-YL)-3-(3-CARBAMIMIDOYLPHENYL)-1-OXOPROPAN-2-YL)SULFAMOYL)-[1,1'-BIPHENYL]-3-CARBOXIMIDAMIDE (MI-490) | 3.4.21.4 |
6T9V | BOVINE TRYPSIN IN COMPLEX WITH THE SYNTHETIC INHIBITOR (S)-3-(3-(4-(3-(TERT-BUTYL)UREIDO)PIPERIDIN-1-YL)-2-((3'-FLUORO-4'-(HYDROXYMETHYL)-[1,1'-BIPHENYL])-3-SULFONAMIDO)-3-OXOPROPYL)BENZIMIDAMIDE (MI-1904) | 3.4.21.4 |
6T9Y | CARBOXYPEPTIDASE T WITH N-SULFAMOYL-L-LYSIN | 3.4.17.18 |
6TAA | STRUCTURE AND MOLECULAR MODEL REFINEMENT OF ASPERGILLUS ORYZAE (TAKA) ALPHA-AMYLASE: AN APPLICATION OF THE SIMULATED-ANNEALING METHOD | 3.2.1.1 |
6TAL | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000227A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TAM | X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 3) | 3.6.5.2 |
6TAN | X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 17) | 3.6.5.2 |
6TAW | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000411A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TBF | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBG | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBH | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBI | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBJ | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBK | STRUCTURE OF A BETA GALACTOSIDASE WITH INHIBITOR | 3.2.1.23 |
6TBO | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000363A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TBP | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000490A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TBW | CRYSTAL STRUCTURE OF AMPC FROM E.COLI WITH AVIBACTAM | 3.5.2.6 |
6TC1 | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000283A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TC6 | CRYSTAL STRUCTURE OF MUTM FROM NEISSERIA MENINGITIDIS | 3.2.2.23 4.2.99.18 |
6TC9 | CRYSTAL STRUCTURE OF MUTM FROM NEISSERIA MENINGITIDIS | 3.2.2.23 4.2.99.18 |
6TCC | CRYSTAL STRUCTURE OF SALMO SALAR RIDA-1 | 3.5.99.10 |
6TCD | CRYSTAL STRUCTURE OF SALMO SALAR RIDA-2 | 3.5.99.10 |
6TCF | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH XST00000642B. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TD0 | CRYSTAL STRUCTURE OF VABORBACTAM BOUND TO KPC-2 | 3.5.2.6 |
6TD1 | CRYSTAL STRUCTURE OF VNRX-5133 (TANIBORBACTAM) BOUND TO KPC-2 | 3.5.2.6 |
6TD2 | MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH N-(2-(DIETHYLAMINO)ETHYL)-1-(4-(TRIFLUOROMETHYL)PHENYL)METHANESULFONAMIDE | 3.1.1.7 |
6TDT | THROMBIN IN COMPLEX WITH A D-DIPHE-PRO-P-PYRIDINE DERIVATIVE | 3.4.21.5 |
6TG6 | TOPRIM DOMAIN OF RNASE M5 | 3.1.26.8 |
6TGI | CRYSTAL STRUCTURE OF VIM-2 IN COMPLEX WITH TRIAZOLE-BASED INHIBITOR OP24 | 3.5.2.6 |
6TGJ | RNA-BINDING DOMAIN OF RNASE M5 | 3.1.26.8 |
6TGL | 3C-LIKE PROTEASE FROM SOUTHAMPTON VIRUS COMPLEXED WITH FMOPL000644A. | 3.6.1.15 3.4.22.66 2.7.7.48 |
6TH7 | STRUCTURE OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH TUTUILAMIDE | 3.4.21.36 |
6THD | MULTIPLE GENOMIC RNA-COAT PROTEIN CONTACTS PLAY VITAL ROLES IN THE ASSEMBLY OF INFECTIOUS ENTEROVIRUS-E | 3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48 |
6THP | NEPRILYSIN IN COMPLEX WITH THE INHIBITOR (R)-4-(1-CARBOXY-3-(3'-CHLOROBIPHENYL-4-YL)PROPAN-2-YLAMINO)-4-OXOBUTANOIC ACID | 3.4.24.11 |
6THS | HIGH RESOLUTION CRYSTAL STRUCTURE OF LEAF-BRANCH CUTINASE S165A VARIANT | 3.1.1.74 3.1.1.101 |
6THT | HIGH RESOLUTION CRYSTAL STRUCTURE OF A LEAF-BRANCH COMPOST CUTINASE QUINTUPLE VARIANT | 3.1.1.74 3.1.1.101 |
6TKG | TSETSE THROMBIN INHIBITOR IN COMPLEX WITH HUMAN ALPHA-THROMBIN - ORTHORHOMBIC FORM AT 12KEV | 3.4.21.5 |
6TKH | TSETSE THROMBIN INHIBITOR IN COMPLEX WITH HUMAN ALPHA-THROMBIN - ORTHORHOMBIC FORM AT 7KEV | 3.4.21.5 |
6TKI | TSETSE THROMBIN INHIBITOR IN COMPLEX WITH HUMAN ALPHA-THROMBIN - TETRAGONAL FORM AT 12.7KEV | 3.4.21.5 |
6TKJ | TSETSE THROMBIN INHIBITOR IN COMPLEX WITH HUMAN ALPHA-THROMBIN - TETRAGONAL FORM AT 7KEV | 3.4.21.5 |
6TKL | NON-CLEAVABLE TSETSE THROMBIN INHIBITOR IN COMPLEX WITH HUMAN ALPHA-THROMBIN | 3.4.21.5 |
6TLI | THERMOLYSIN (60% ISOPROPANOL SOAKED CRYSTALS) | 3.4.24.27 |
6TM1 | CRYSTAL STRUCTURE OF THE DHR2 DOMAIN OF DOCK10 IN COMPLEX WITH RAC3 | 3.6.5.2 |
6TMN | STRUCTURES OF TWO THERMOLYSIN-INHIBITOR COMPLEXES THAT DIFFER BY A SINGLE HYDROGEN BOND | 3.4.24.27 |
6TMY | CRYSTAL STRUCTURE OF ISOFORM CBD OF THE BASIC PHOSPHOLIPASE A2 SUBUNIT OF CROTOXIN FROM CROTALUS DURISSUS TERRIFICUS | 3.1.1.4 |
6TN6 | X-RAY STRUCTURE OF THE ENDO-BETA-1,4-MANNANASE FROM THERMOTOGA PETROPHILA | 3.2.1.78 |
6TNK | CARBOXYPEPTIDASE T WITH N-SULFAMOYL-L-VALINE | 3.4.17.18 |
6TNN | MINI-RNASE III (MINI-III) BOUND TO 50S RIBOSOME WITH PRECURSOR 23S RRNA | 3.1.26 |
6TNY | PROCESSIVE HUMAN POLYMERASE DELTA HOLOENZYME | 2.7.7.7 3.1.11 |
6TNZ | HUMAN POLYMERASE DELTA-FEN1-PCNA TOOLBELT | 2.7.7.7 3.1.11 |
6TO0 | STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 2(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTRIOSE. | 3.2.1.156 |
6TOW | STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH XYLOTETRAOSE. | 3.2.1.156 |
6TOY | CRYSTAL STRUCTURE OF BACILLUS PARALICHENIFORMIS WILD-TYPE ALPHA-AMYLASE | 3.2.1.1 |
6TOZ | CRYSTAL STRUCTURE OF BACILLUS PARALICHENIFORMIS ALPHA-AMYLASE IN COMPLEX WITH ACARBOSE | 3.2.1.1 |
6TP0 | CRYSTAL STRUCTURE OF BACILLUS PARALICHENIFORMIS ALPHA-AMYLASE IN COMPLEX WITH MALTOSE | 3.2.1.1 |
6TP1 | CRYSTAL STRUCTURE OF BACILLUS PARALICHENIFORMIS ALPHA-AMYLASE IN COMPLEX WITH MALTOTETRAOSE | 3.2.1.1 |
6TP2 | CRYSTAL STRUCTURE OF BACILLUS PARALICHENIFORMIS ALPHA-AMYLASE IN COMPLEX WITH BETA-CYCLODEXTRIN | 3.2.1.1 |
6TP8 | SUBSTRATE PROTEIN INTERACTIONS IN THE LIMBUS REGION OF THE CATALYTIC SITE OF CANDIDA ANTARCTICA LIPASE B | 3.1.1.3 |
6TPM | CRYSTAL STRUCTURE OF AMPC FROM E.COLI WITH RELEBACTAM (MK-7655) | 3.5.2.6 |
6TPP | STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS. | 3.2.1.156 |
6TPQ | RNASE M5 BOUND TO 50S RIBOSOME WITH PRECURSOR 5S RRNA | 3.1.26.8 |
6TPT | CRYSTAL STRUCTURES OF FNIII DOMAIN THREE AND FOUR OF THE HUMAN LEUCOCYTE COMMON ANTIGEN-RELATED PROTEIN, LAR | 3.1.3.48 |
6TPU | CRYSTAL STRUCTURES OF FNIII DOMAIN THREE AND FOUR OF THE HUMAN LEUCOCYTE COMMON ANTIGEN-RELATED PROTEIN, LAR | 3.1.3.48 |
6TPV | CRYSTAL STRUCTURES OF FNIII DOMAIN ONE AND TWO OF THE HUMAN LEUCOCYTE COMMON ANTIGEN-RELATED PROTEIN, LAR | 3.1.3.48 |
6TR3 | RUMINOCOCCUS GNAVUS GH29 FUCOSIDASE E1_10125 IN COMPLEX WITH FUCOSE | 3.2.1.187 |
6TR4 | RUMINOCOCCUS GNAVUS GH29 FUCOSIDASE E1_10125 D221A MUTANT IN COMPLEX WITH FUCOSE | 3.2.1.187 |
6TR5 | MELATONIN-NOTUM COMPLEX | 3.1.1.98 |
6TR6 | N-ACETYLSEROTONIN-NOTUM COMPLEX | 3.1.1.98 |
6TR7 | N-[2-(5-FLUORO-1H-INDOL-3-YL)ETHYL]ACETAMIDE-NOTUM COMPLEX | 3.1.1.98 |
6TRH | STRUCTURE OF E70A MUTANT OF REX8A FROM PAENIBACILLUS BARCINONENSIS COMPLEXED WITH 3(3)-ALPHA-L-ARABINOFURANOSYL-XYLOTETRAOSE. | 3.2.1.156 |
6TRQ | S.C. SCAVENGER DECAPPING ENZYME DCPS IN COMPLEX WITH THE CAPPED RNA DINUCLEOTIDE M7G-GU | 3.6.1.59 |
6TRX | CRYSTAL STRUCTURE OF DPP8 IN COMPLEX WITH 1G244 | 3.4.14.5 |
6TS4 | COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR | 3.4.21.27 |
6TS5 | COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR | 3.4.21.27 |
6TS6 | COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR | 3.4.21.27 |
6TS7 | COAGULATION FACTOR XI PROTEASE DOMAIN IN COMPLEX WITH ACTIVE SITE INHIBITOR | 3.4.21.27 |
6TS9 | CRYSTAL STRUCTURE OF GES-5 CARBAPENEMASE | 3.5.2.6 |
6TSH | BETA-GALACTOSIDASE IN COMPLEX WITH DEOXYGALACTO-NOJIRIMYCIN | 3.2.1.23 |
6TT0 | CRYSTAL STRUCTURE OF A POTENT AND REVERSIBLE DUAL BINDING SITE ACETYLCHOLINESTERASE CHIRAL INHIBITOR | 3.1.1.7 |
6TT1 | CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH 33RE. | 3.2.1 3.4.15.1 |
6TT3 | CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH SG6. | 3.2.1 3.4.15.1 |
6TT4 | CRYSTAL STRUCTURE OF 'RES_S2 MUTANT HUMAN ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH OMAPATRILAT. | 3.2.1 3.4.15.1 |
6TTE | BETA-GALACTOSIDASE IN COMPLEX WITH PETG | 3.2.1.23 |
6TTJ | NEUTRAL INVERTASE 2 FROM ARABIDOPSIS THALIANA | 3.2.1.26 |
6TTY | STRUCTURE OF CLPP FROM STAPHYLOCOCCUS AUREUS (APO, CLOSED STATE) | 3.4.21.92 |
6TTZ | STRUCTURE OF THE CLPP:ADEP4-COMPLEX FROM STAPHYLOCOCCUS AUREUS (OPEN STATE) | 3.4.21.92 |
6TU3 | RAT 20S PROTEASOME | 3.4.25.1 |
6TUG | ENTEROCOCCUS ITALICUS CSM6 BOUND TO CYCLIC HEXA-2'-FLUORO-HEXA-DAMP | 3.1 |
6TUN | HELICASE DOMAIN COMPLEX | 3.6.4.12 |
6TUV | CRYSTAL STRUCTURE OF MINDY1 IN COMPLEX WITH LYS48 LINKED DI-UBIQUITIN | 3.4.19.12 |
6TUW | HUMAN XPG-DNA, COMPLEX 1 | 3.1 |
6TUX | HUMAN XPG-DNA, COMPLEX 2 | 3.1 |
6TUZ | THEOPHYLLINE-NOTUM COMPLEX | 3.1.1.98 |
6TV4 | CFF-NOTUM COMPLEX | 3.1.1.98 |
6TVE | UNLIGANDED HUMAN CD73 (5'-NUCLEOTIDASE) IN THE OPEN STATE | 3.1.3.5 |
6TVG | HUMAN CD73 (ECTO 5'-NUCLEOTIDASE) IN COMPLEX WITH AMPCP IN THE OPEN STATE | 3.1.3.5 |
6TVL | HEN EGG WHITE LYSOZYME IN COMPLEX WITH A HALF SANDWICH"-TYPE RU(II) COORDINATION COMPOUND" | 3.2.1.17 |
6TVX | HUMAN CD73 (ECTO 5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12676 (AN AOPCP DERIVATIVE, COMPOUND 9 IN PAPER) IN THE CLOSED STATE | 3.1.3.5 |
6TVY | STRUCTURE OF HEN EGG WHITE LYSOZYME CRYSTALLIZED IN THE PRESENCE OF TB-XO4 CRYSTALLOPHORE IN THE XTALCONTROLLER DEVICE | 3.2.1.17 |
6TW0 | HUMAN CD73 (ECTO 5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12690 (AN AOPCP DERIVATIVE, COMPOUND 10 IN PUBLICATION) IN THE CLOSED STATE | 3.1.3.5 |
6TWA | HUMAN CD73 (ECTO 5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12646 (AN AOPCP DERIVATIVE, COMPOUND 20 IN PUBLICATION) IN THE CLOSED STATE | 3.1.3.5 |
6TWB | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XIA IN COMPLEX WITH DOUBLE BRIDGED PEPTIDE F19 | 3.4.21.27 |
6TWC | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE COAGULATION FACTOR XIA IN COMPLEX WITH DOUBLE BRIDGED PEPTIDE F21 | 3.4.21.27 |
6TWF | HUMAN CD73 (ECTO 5'-NUCLEOTIDASE) IN COMPLEX WITH PSB12604 (AN AOPCP DERIVATIVE, COMPOUND 21 IN PUBLICATION) IN THE CLOSED STATE | 3.1.3.5 |
6TWJ | APO STRUCTURE OF THE ECTOINE UTILIZATION PROTEIN EUTD (DOEA) FROM HALOMONAS ELONGATA | 3.4 3.5.4.44 |
6TWK | SUBSTRATE BOUND STRUCTURE OF THE ECTOINE UTILIZATION PROTEIN EUTD (DOEA) FROM HALOMONAS ELONGATA | 3.4 3.5.4.44 |
6TWT | CRYSTAL STRUCTURE OF N-TERMINALLY TRUNCATED NDM-1 METALLO-BETA-LACTAMASE | 3.5.2.6 |
6TX0 | CRYSTAL STRUCTURE OF TETRAMERIC HUMAN D137N-SAMHD1 (RESIDUES 109-626) WITH XTP, DAMPNPP AND MG | 3.1.5 |
6TXB | CRYSTAL STRUCTURE OF MINDY1 MUTANT (P138A) IN COMPLEX WITH LYS48 LINKED DI-UBIQUITIN | 3.4.19.12 |
6TXF | CRYSTAL STRUCTURE OF TETRAMERIC HUMAN D137N-SAMHD1 (RESIDUES 109-626) WITH XTP, DAMPNPP AND MN | 3.1.5 |
6TXG | PROTEINASE K IN COMPLEX WITH A HALF SANDWICH"-TYPE RU(II) COORDINATION COMPOUND" | 3.4.21.64 |
6TY7 | CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE VARIANT DHAA115 DOMAIN-SWAPPED DIMER TYPE-1 | 3.8.1.5 |
6TYA | STRUCTURE OF N-TERMINUS LOCKED ESP WITH ONE PRO-PEPTIDE RESIDUE - V67C, D255C | 3.4.21.19 |
6TYT | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN S229A MUTANT COMPLEXED WITH APLF AND XLF KU BINDING MOTIF | 3.6.4 |
6TYU | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN COMPLEXED WITH MRI KU BINDING MOTIF | 3.6.4 |
6TYV | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN COMPLEXED WITH WRN KU BINDING MOTIF | 3.6.4 |
6TYW | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN S229A MUTANT COMPLEXED WITH APLF KU BINDING MOTIF | 3.6.4 |
6TYX | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN S229A MUTANT COMPLEXED WITH XLF KU BINDING MOTIF | 3.6.4 |
6TYZ | STRUCTURE OF KU80 VON WILLEBRAND DOMAIN COMPLEXED WITH APLF KU BINDING MOTIF | 3.6.4 |
6TZ6 | CRYSTAL STRUCTURE OF CANDIDA ALBICANS CALCINEURIN A, CALCINEURIN B, FKBP12 AND FK506 (TACROLIMUS) | 3.1.3.16 |
6TZ7 | CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CALCINEURIN A, CALCINEURIN B, FKBP12 AND FK506 (TACROLIMUS) | 3.1.3.16 |
6TZ8 | CRYSTAL STRUCTURE OF CRYPTOCOCCUS NEOFORMANS CALCEINEURIN A, CALCINEURIN B, AND FKBP12 WITH FK-506 | 3.1.3.16 |
6TZF | ADC-7 IN COMPLEX WITH BORONIC ACID TRANSITION STATE INHIBITOR S17079 | 3.5.2.6 |
6TZH | ADC-7 IN COMPLEX WITH BORONIC ACID TRANSITION STATE INHIBITOR S06015 | 3.5.2.6 |
6TZI | ADC-7 IN COMPLEX WITH BORONIC ACID TRANSITION STATE INHIBITOR PFC_001 | 3.5.2.6 |
6TZJ | ADC-7 IN COMPLEX WITH BORONIC ACID TRANSITION STATE INHIBITOR ME_096 | 3.5.2.6 |
6U02 | CRYOEM-DERIVED MODEL OF NA-63 FAB IN COMPLEX WITH N9 SHANGHAI2 | 3.2.1.18 |
6U0B | NEUTRON CRYSTAL STRUCTURE OF WTT4LD | 3.2.1.17 |
6U0C | NEUTRON CRYSTAL STRUCTURE OF WTT4LE | 3.2.1.17 |
6U0E | NEUTRON CRYSTAL STRUCTURE OF T4L M6AE | 3.2.1.17 |
6U0F | NEUTRON CRYSTAL STRUCTURE OF T4L L99AE | 3.2.1.17 |
6U0W | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS K133M AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6U0X | CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS Q123D AT CRYOGENIC TEMPERATURE | 3.1.31.1 |
6U0Y | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA | 3.5.2.6 |
6U0Z | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH THE HYDROLYZED PENICILLIN G | 3.5.2.6 |
6U10 | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH THE INHIBITOR CAPTOPRIL | 3.5.2.6 |
6U13 | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH THE HYDROLYZED ANTIBIOTIC MOXALACTAM | 3.5.2.6 |
6U15 | HUMAN THYMINE DNA GLYCOSYLASE N140A MUTANT BOUND TO DNA WITH 2'-F-5-CARBOXYL-DC SUBSTRATE ANALOG | 3.2.2.29 |
6U16 | HUMAN THYMINE DNA GLYCOSYLASE N140A MUTANT BOUND TO DNA WITH 5-CARBOXYL-DC SUBSTRATE | 3.2.2.29 |
6U17 | HUMAN THYMINE DNA GLYCOSYLASE BOUND TO DNA WITH 2'-F-5-CARBOXYL-DC SUBSTRATE ANALOG | 3.2.2.29 |
6U1B | STRUCTURE OF N-TERMINUS LOCKED ESP WITH EIGHT PRO-PEPTIDE RESIDUES - V67C, D255C | 3.4.21.19 |
6U1P | CRYSTAL STRUCTURE OF VPSU (VC0916) FROM VIBRIO CHOLERAE | 3.1.3.48 |
6U22 | CRYSTAL STRUCTURE OF SFTI-TRIAZOLE INHIBITOR IN COMPLEX WITH BETA-TRYPSIN | 3.4.21.4 |
6U26 | PCSK9 IN COMPLEX WITH COMPOUND 16 | 3.4.21 |
6U2A | SHYA ENDOPEPTIDASE FROM VIBRIO CHOLERA (OPEN FORM) | 3.4.24.75 |
6U2F | PCSK9-FAB 7G7 COMPLEX BOUND TO CIS-1-AMINO-4-PHENYLCYCLOHEXANEACYL-WNLK(HR)IGLLR - NH2 | 3.4.21 |
6U2N | PCSK9 IN COMPLEX WITH COMPOUND 4 | 3.4.21 |
6U2P | PCSK9 IN COMPLEX WITH COMPOUND 5 | 3.4.21 |
6U2Y | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH THE HYDROLYZED MOXALACTAM AND TWO NI IONS | 3.5.2.6 |
6U2Z | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH THE HYDROLYZED MOXALACTAM AND TWO COPPER IONS | 3.5.2.6 |
6U34 | BINARY COMPLEX OF NATIVE HACHE WITH OXIME REACTIVATOR RS194B | 3.1.1.7 |
6U36 | PCSK9 IN COMPLEX WITH A FAB AND COMPOUND 14 | 3.4.21 |
6U37 | STRUCTURE OF VX-PHOSPHONYLATED HACHE IN COMPLEX WITH OXIME REACTIVATOR RS194B | 3.1.1.7 |
6U38 | PCSK9 IN COMPLEX WITH A FAB AND COMPOUND 8 | 3.4.21 |
6U3I | DESIGN OF ORGANO-PEPTIDES AS BIPARTITE PCSK9 ANTAGONISTS | 3.4.21 |
6U3P | BINARY COMPLEX OF NATIVE HACHE WITH OXIME REACTIVATOR LG-703 | 3.1.1.7 |
6U3U | CRYSTAL STRUCTURE OF SHIGA TOXIN 2K | 3.2.2.22 |
6U3X | PCSK9 IN COMPLEX WITH COMPOUND 2 | 3.4.21 |
6U58 | TOHO1 BETA LACTAMASE GLU166GLN MUTANT | 3.5.2.6 |
6U5Z | CRYO-EM STRUCTURE OF E. COLI LONA S679A | 3.4.21.53 |
6U6X | HUMAN SAMHD1 BOUND TO DEOXYRIBO(C*G*C*C*T)-OLIGONUCLEOTIDE | 3.1.5 |
6U6Y | HUMAN SAMHD1 BOUND TO RIBO(CGCCU)-OLIGONUCLEOTIDE | 3.1.5 |
6U6Z | HUMAN SAMHD1 BOUND TO DEOXYRIBO(TG*TTCA)-OLIGONUCLEOTIDE | 3.1.5 |
6U7E | HCOV-229E RBD CLASS III IN COMPLEX WITH HUMAN APN | 3.4.11.2 |
6U7F | HCOV-229E RBD CLASS IV IN COMPLEX WITH HUMAN APN | 3.4.11.2 |
6U7G | HCOV-229E RBD CLASS V IN COMPLEX WITH HUMAN APN | 3.4.11.2 |
6U7J | UNCULTURED CLOSTRIDIUM SP. BETA-GLUCURONIDASE | 3.2.1.31 3.2.1.23 |
6U7T | MUTY ADENINE GLYCOSYLASE BOUND TO DNA CONTAINING A TRANSITION STATE ANALOG (1N) PAIRED WITH D(8-OXO-G) | 3.2.2.31 |
6U8Q | CRYOEM STRUCTURE OF HIV-1 CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME | 2.7.7 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.1 |
6U8Z | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PHOSPHOLIPASE D1 | 3.1.4.4 |
6UA1 | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE NO-METAL BOUND FORM | 3.5.2.6 |
6UAC | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH CADMIUM AND HYDROLYZED MOXOLACTAM | 3.5.2.6 |
6UAF | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH HYDROLYZED IMIPNEM | 3.5.2.6 |
6UAH | CRYSTAL STRUCTURE OF THE METALLO-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA IN THE COMPLEX WITH HYDROLYZED MEROPENEM | 3.5.2.6 |
6UC6 | CRYSTAL STRUCTURE OF BONT/B RECEPTOR-BINDING DOMAIN IN COMPLEX WITH VHH JLI-H11 | 3.4.24.69 |
6UE2 | 1.85 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF CLASS D BETA-LACTAMASE FROM CLOSTRIDIUM DIFFICILE 630 | 3.5.2.6 |
6UFN | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 7-[(3-AMINOPROPYL)AMINO]HEPTAN-2-ONE | 3.5.1.48 3.5.1.62 |
6UFO | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 7-[(3-AMINOPROPYL)AMINO]-1-METHOXYHEPTAN-2-ONE | 3.5.1.48 3.5.1.62 |
6UFT | CRYSTAL STRUCTURE OF BONT/B RECEPTOR-BINDING DOMAIN IN COMPLEX WITH VHH JLK-G12 | 3.4.24.69 |
6UFV | CRYSTAL STRUCTURE OF THE CBM3 FROM BACILLUS SUBTILIS AT 1.06 ANGSTROM RESOLUTION | 3.2.1.4 |
6UFW | CRYSTAL STRUCTURE OF THE CBM3 FROM BACILLUS SUBTILIS AT 1.28 ANGSTROM RESOLUTION | 3.2.1.4 |
6UH4 | B. THETA BILE SALT HYDROLASE WITH COVALENT INHIBITOR | 3.5.1.24 |
6UH8 | CRYSTAL STRUCTURE OF DAD2 N242I MUTANT | 3.1 |
6UH9 | CRYSTAL STRUCTURE OF DAD2 D166A MUTANT | 3.1 |
6UHT | CRYSTAL STRUCTURE OF BONT/B RECEPTOR-BINDING DOMAIN IN COMPLEX WITH VHH JLI-G10 | 3.4.24.69 |
6UHU | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 5-[(3-AMINOPROPYL)AMINO]PENTYLBORONIC ACID | 3.5.1.48 3.5.1.62 |
6UHV | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 6-[(3-AMINOPROPYL)AMINO]-N-HYDROXYHEXANAMIDE | 3.5.1.48 3.5.1.62 |
6UI1 | CRYSTAL STRUCTURE OF BONT/A-LCHN DOMAIN IN COMPLEX WITH VHH CIA-D12, CIA-B5, AND CIA-H7 | 3.4.24.69 |
6UI3 | GH5-4 BROAD SPECIFICITY ENDOGLUCANASE FROM CLOSTRIDUM CELLULOVORANS | 3.2.1 3.2.1.4 |
6UII | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 5-[(3-AMINOPROPYL)AMINO]PENTANE-1-THIOL | 3.5.1.48 3.5.1.62 |
6UIJ | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH S-{5-[(3-AMINOPROPYL)AMINO]PENTYL} THIOACETATE | 3.5.1.48 3.5.1.62 |
6UIL | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 7-[(3-AMINOPROPYL)AMINO]-1,1,1-TRIFLUOROHEPTAN-2-ONE | 3.5.1.48 3.5.1.62 |
6UIM | CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 10 IN COMPLEX WITH 7-{[(3-AMINOPROPYL)AMINO]-2-OXOHEPTYL} THIOACETATE | 3.5.1.48 3.5.1.62 |
6UIR | HIV-1 M184V REVERSE TRANSCRIPTASE-DNA COMPLEX WITH (-)-FTC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UIS | HIV-1 M184V REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DCTP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UIT | HIV-1 WILD-TYPE REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DCTP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UJ0 | UNBOUND BACE2 MUTANT STRUCTURE | 3.4.23.45 |
6UJE | CRYSTAL STRUCTURE OF THE CLOSTRIDIAL CELLULOSE SYNTHASE SUBUNIT Z (CCSZ) FROM CLOSTRIDIOIDES DIFFICILE | 3.2.1.4 |
6UJF | CRYSTAL STRUCTURE OF THE CLOSTRIDIAL CELLULOSE SYNTHASE SUBUNIT Z (CCSZ) FROM CLOSTRIDIOIDES DIFFICILE | 3.2.1.4 |
6UJG | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00012 | 3.5.1.2 |
6UJM | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00013 | 3.5.1.2 |
6UJX | HIV-1 WILD-TYPE REVERSE TRANSCRIPTASE-DNA COMPLEX WITH (-)-FTC-TP | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6UJY | HIV-1 WILD-TYPE REVERSE TRANSCRIPTASE-DNA COMPLEX WITH (-)-3TC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UJZ | HIV-1 WILD-TYPE REVERSE TRANSCRIPTASE-DNA COMPLEX WITH (+)-FTC-TP | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UK0 | HIV-1 M184V REVERSE TRANSCRIPTASE-DNA COMPLEX | 2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1 |
6UK3 | CRYSTAL STRUCTURE OF S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE FROM ACANTHAMOEBA CASTELLANII WITH BOUND NAD AND ADENOSINE | 3.3.1.1 |
6UK6 | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00018 | 3.5.1.2 |
6UKB | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00012 | 3.5.1.2 |
6UKC | CRYSTAL STRUCTURE OF A LYSOZYME FROM LITOPENAEUS VANNAMEI | 3.2.1.17 |
6UKD | CO-COMPLEX OF S. PYOGENES 10782 STREPTOPAIN BOUND WITH A NITRILE-BASED SPECIFIC COVALENT INHIBITOR | 3.4.22.10 |
6UL3 | CRYSTAL STRUCTURE OF A LYSOZYME FROM LITOPENAEUS VANNAMEI | 3.2.1.17 |
6UL4 | CRYSTAL STRUCTURE OF BONT/B RECEPTOR-BINDING DOMAIN IN COMPLEX WITH VHH JLO-G11 | 3.4.24.69 |
6UL5 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH 4-[(4-{4-[(E)-2-CYANOETHENYL]-2,6-DIMETHYLPHENOXY}THIENO[3,2-D]PYRIMIDIN-2-YL)AMINO]-2-FLUOROBENZONITRILE (24B), A NON-NUCLEOSIDE RT INHIBITOR | 2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6UL6 | CRYSTAL STRUCTURE OF BONT/A-LCHN DOMAIN IN COMPLEX WITH VNA CIA-D12/11/CIA-B5 AND VHH CIA-H7 | 3.4.24.69 |
6UL9 | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00023 | 3.5.1.2 |
6ULA | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00012 | 3.5.1.2 |
6ULJ | CRYSTAL STRUCTURE OF HUMAN GAC IN COMPLEX WITH INHIBITOR UPGL00012 | 3.5.1.2 |
6ULL | BSHB FROM BACILLUS SUBTILIS COMPLEXED WITH A SUBSTRATE ANALOGUE | 3.5.1 |
6UM3 | STRUCTURE OF ZIKA VIRUS NS2B-NS3 PROTEASE MUTANT STABILIZING THE SUPER-OPEN CONFORMATION | 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48 |
6UMQ | STRUCTURE OF DUF89 | 3.1.3 2.1.1 |
6UMR | STRUCTURE OF DUF89 - D291A MUTANT | 3.1.3 2.1.1 |
6UN1 | CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PBP3 IN COMPLEX WITH TEMOCILLIN | 3.4.16.4 |
6UN3 | CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA PBP3 IN COMPLEX WITH TICARCILLIN | 3.4.16.4 |
6UNB | CRYSTAL STRUCTURE OF CTX-M-14 IN COMPLEX WITH TEMOCILLIN | 3.5.2.6 |
6UNC | THE CRYSTAL STRUCTURE OF PHOSPHOPANTETHEINYL HYDROLASE (PPTH) FROM MYCOBACTERIUM TUBERCULOSIS | 3.1.4.14 |
6UOD | ASPARAGINASE II FROM ESCHERICHIA COLI | 3.5.1.1 |
6UOG | ASPARAGINASE II FROM ESCHERICHIA COLI | 3.5.1.1 |
6UOH | ASPARAGINASE II FROM ESCHERICHIA COLI | 3.5.1.1 |
6UP2 | CRYSTAL STRUCTURE OF THE MURINE DHX36 HELICASE | 3.6.4.13 |
6UP3 | CRYSTAL STRUCTURE OF THE MURINE DHX36 HELICASE IN COMPLEX WITH ANP | 3.6.4.13 |
6UP4 | CRYSTAL STRUCTURE OF THE MURINE DHX36 HELICASE IN COMPLEX WITH ADP | 3.6.4.13 |
6UPB | STRUCTURE OF APO TREHALOSE-6-PHOSPHATE PHOSPHATASE FROM SALMONELLA TYPHIMURIUM | 3.1.3.12 |
6UPC | STRUCTURE OF TREHALOSE-6-PHOSPHATE PHOSPHATASE FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH TREHALOSE 6-SULFATE | 3.1.3.12 |
6UPD | STRUCTURE OF TREHALOSE-6-PHOSPHATE PHOSPHATASE FROM SALMONELLA TYPHIMURIUM IN COMPLEX WITH TREHALOSE | 3.1.3.12 |
6UPE | STRUCTURE OF TREHALOSE-6-PHOSPHATE PHOSPHATASE FROM SALMONELLA TYPHIMURIUM INHIBITED BY 4-N-OCTYLPHENYL ALPHA-D-GLUCOPYRANOSIDE-6-SULFATE | 3.1.3.12 |
6UPJ | HIV-2 PROTEASE/U99294 COMPLEX | 3.4.23.16 3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6UPS | CRYSTAL STRUCTURE OF THE DEUBIQUITYLASE DOMAIN FROM THE ORIENTIA TSUTSUGAMUSHI PROTEIN OTT_1962 (OTDUB) | 3.4.22 |
6UQD | CO-COMPLEX OF S. PYOGENES 10782 STREPTOPAIN BOUND WITH A SUFEX-BASED OPTIMIZED SMALL MOLECULE INHIBITOR | 3.4.22.10 |
6UQO | CLPA/CLPP ENGAGED STATE BOUND TO REPA-GFP | 3.4.21.92 |
6UQS | SERENDIPITOUS DISCOVERY OF ARYL BORONIC ACIDS AS BETA-LACTAMASE INHIBITORS | 3.5.2.6 |
6UQT | SERENDIPITOUS DISCOVERY OF ARYL BORONIC ACIDS AS BETA-LACTAMASE INHIBITORS | 3.5.2.6 |
6UQU | SERENDIPITOUS DISCOVERY OF ARYL BORONIC ACIDS AS BETA-LACTAMASE INHIBITORS | 3.5.2.6 |
6UQV | CRYSTAL STRUCTURE OF CHOE, A BACTERIAL ACETYLCHOLINESTERASE FROM PSEUDOMONAS AERUGINOSA | 3.1 |
6UQW | CRYSTAL STRUCTURE OF CHOE IN COMPLEX WITH ACETATE AND THIOCHOLINE | 3.1 |
6UQX | CRYSTAL STRUCTURE OF CHOE IN COMPLEX WITH PROPIONYLTHIOCHOLINE | 3.1 |
6UQY | CRYSTAL STRUCTURE OF CHOE H288N MUTANT IN COMPLEX WITH ACETYLTHIOCHOLINE | 3.1 |
6UQZ | CRYSTAL STRUCTURE OF CHOE D285N MUTANT IN COMPLEX WITH ACETATE AND THIOCHOLINE | 3.1 |
6UR0 | CRYSTAL STRUCTURE OF CHOE D285N MUTANT ACYL-ENZYME | 3.1 |
6UR3 | SERENDIPITOUS DISCOVERY OF ARYL BORONIC ACIDS AS BETA-LACTAMASE INHIBITORS | 3.5.2.6 |
6URC | CRYSTAL STRUCTURE OF IRE1A IN COMPLEX WITH COMPOUND 18 | 2.7.11.1 3.1.26 |
6URV | CRYSTAL STRUCTURE OF YELLOW FEVER VIRUS NS2B-NS3 PROTEASE DOMAIN | 3.4.21.91 3.6.1.15 3.6.4.13 |
6URW | CRYSTAL STRUCTURE OF RICIN A CHAIN IN COMPLEX WITH INHIBITOR 4-(2-THIENYLMETHYL)BENZOIC ACID | 3.2.2.22 |
6URX | CRYSTAL STRUCTURE OF RICIN A CHAIN IN COMPLEX WITH INHIBITOR 5-PHENYL-2-THIOPHENECARBOXYLIC ACID | 3.2.2.22 |
6URY | CRYSTAL STRUCTURE OF RICIN A CHAIN IN COMPLEX WITH INHIBITOR 9-OXO-4-FLUORENECARBOXAMIDE | 3.2.2.22 |
6US2 | MTH1 IN COMPLEX WITH COMPOUND 5 | 3.6.1.55 3.6.1.56 |
6US3 | MTH1 IN COMPLEX WITH COMPOUND 4 | 3.6.1.55 3.6.1.56 |
6US4 | MTH1 IN COMPLEX WITH COMPOUND 32 | 3.6.1.55 3.6.1.56 |
6UST | GUT MICROBIAL SULFATASE FROM HUNGATELLA HATHEWAYI | 3.1.6.1 |
6USX | IDENTIFICATION OF THE CLINICAL DEVELOPMENT CANDIDATE MRTX849, A COVALENT KRASG12C INHIBITOR FOR THE TREATMENT OF CANCER | 3.6.5.2 |
6USY | COAGULATION FACTOR XI CATALYTIC DOMAIN (C123S) IN COMPLEX WITH NVP-XIV936 | 3.4.21.27 |
6USZ | IDENTIFICATION OF THE CLINICAL DEVELOPMENT CANDIDATE MRTX849, A COVALENT KRASG12C INHIBITOR FOR THE TREATMENT OF CANCER | 3.6.5.2 |
6UT0 | IDENTIFICATION OF THE CLINICAL DEVELOPMENT CANDIDATE MRTX849, A COVALENT KRASG12C INHIBITOR FOR THE TREATMENT OF CANCER | 3.6.5.2 |
6UT6 | CRYO-EM STRUCTURE OF THE ESCHERICHIA COLI MCRBC COMPLEX | 3.1.21 |
6UTF | ALLOSTERIC COUPLING BETWEEN ALPHA-RINGS OF THE 20S PROTEASOME, ARCHAEA 20S PROTEASOME SINGLY CAPPED WITH A PAN COMPLEX | 3.4.25.1 |
6UTG | ALLOSTERIC COUPLING BETWEEN ALPHA-RINGS OF THE 20S PROTEASOME, 20S SINGLY CAPPED WITH A PA26/V230F | 3.4.25.1 |
6UTI | ALLOSTERIC COUPLING BETWEEN ALPHA-RINGS OF 20S PROTEASOME, 20S PROTEASOME WITH SINGLY CAPPED PAN COMPLEX | 3.4.25.1 |
6UUK | CRYSTAL STRUCTURE OF MURAMOYLTETRAPEPTIDE CARBOXYPEPTIDASE FROM OXALOBACTER FORMIGENES | 3.4.17.13 |
6UV0 | CRYSTAL STRUCTURE OF APO CORE DOMAIN OF RNA HELICASE DDX17 | 3.6.4.13 |
6UV1 | CRYSTAL STRUCTURE OF RNA HELICASE DDX17 IN COMPLEX OF RU10 RNA | 3.6.4.13 |
6UV2 | CRYSTAL STRUCTURE OF THE CORE DOMAIN OF RNA HELICASE DDX17 WITH RNA PRI-125A-OLIGO1 | 3.6.4.13 |
6UV3 | CRYSTAL STRUCTURE OF THE CORE DOMAIN OF RNA HELICASE DDX17 WITH RNA PRI-125A-OLIGO2 | 3.6.4.13 |
6UV4 | CRYSTAL STRUCTURE OF THE CORE DOMAIN OF RNA HELICASE DDX17 WITH RNA PRI-18A-OLIGO1 | 3.6.4.13 |
6UVK | OXA-48 BOUND BY INHIBITOR CDD-97 | 3.5.2.6 |
6UVP | BACE-1 IN COMPLEX WITH COMPOUND #3 | 3.4.23.46 |
6UVV | BACE-1 IN COMPLEX WITH COMPOUND #17 | 3.4.23.46 |
6UVY | BACE-1 IN COMPLEX WITH COMPOUND #18 | 3.4.23.46 |
6UWP | BACE-1 IN COMPLEX WITH COMPOUND #32 | 3.4.23.46 |
6UWV | BACE-1 IN COMPLEX WITH COMPOUND #34 | 3.4.23.46 |
6UX6 | CRUZAIN COVALENTLY BOUND BY A VINYLSULFONE COMPOUND | 3.4.22.51 |
6UXV | SWI/SNF BODY MODULE | 3.6.4 |
6UXW | SWI/SNF NUCLEOSOME COMPLEX WITH ADP-BEFX | 3.6.4 |
6UY1 | CRYSTAL STRUCTURE OF THE STH1 BROMODOMAIN FROM SACCHAROMYCES CEREVISIAE AT 2.2 ANGSTROM RESOLUTION | 3.6.4.12 |
6UYF | STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2MC3-V1 REDESIGNED CORE FROM GENOTYPE 6A BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3B | 2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13 |
6UZ4 | SOLUTION STRUCTURE OF AGL55-KRINGLE 2 COMPLEX | 3.4.21.7 |
6UZ5 | SOLUTION STRUCTURE OF KTI55-KRINGLE 2 COMPLEX | 3.4.21.7 |
6UZT | CRYSTAL STRUCTURE OF RPTP ALPHA | 3.1.3.48 |
6V11 | LON PROTEASE FROM YERSINIA PESTIS | 3.4.21.53 |
6V1J | STRUCTURE OF KPC-2 BOUND TO QPX7728 AT 1.30 A | 3.5.2.6 |
6V1M | STRUCTURE OF NDM-1 BOUND TO QPX7728 AT 1.05 A | 3.5.2.6 |
6V1O | STRUCTURE OF OXA-48 BOUND TO QPX7728 AT 1.80 A | 3.5.2.6 |
6V1W | NMR STRUCTURE OF C-TERMINAL DOMAIN OF PHI29 ATPASE | 3.6.4 |
6V23 | LIGAND-FREE L-ASPRAGINASE II FROM E. COLI (ECAII) | 3.5.1.1 |
6V24 | COMPLEX OF MUTANT (K162M) OF E. COLI L-ASPARAGINASE II WITH L-ASP. COVALENT ACYL-ENZYME INTERMEDIATE. | 3.5.1.1 |
6V25 | COMPLEX OF MUTANT (K162M) OF E. COLI L-ASPARAGINASE II WITH L-ASP | 3.5.1.1 |
6V26 | COMPLEX OF MUTANT (K162M) OF E. COLI L-ASPARAGINASE II WITH L-ASP | 3.5.1.1 |
6V27 | COMPLEX OF DOUBLE MUTANT (T89V,K162T) OF E. COLI L-ASPARAGINASE II WITH L-ASP | 3.5.1.1 |
6V28 | COMPLEX OF DOUBLE MUTANT (T89V,K162T) OF E. COLI L-ASPARAGINASE II WITH L-ASP | 3.5.1.1 |
6V29 | COMPLEX OF DOUBLE MUTANT (T89V,K162T) OF E. COLI L-ASPARAGINASE II WITH L-ASP | 3.5.1.1 |
6V2A | COMPLEX OF DOUBLE MUTANT (T89V,K162T) OF E. COLI L-ASPARAGINASE II WITH L-ASN | 3.5.1.1 |
6V2B | COMPLEX OF DOUBLE MUTANT (T89V,K162T) OF E. COLI L-ASPARAGINASE II WITH L-ASN | 3.5.1.1 |
6V2C | COMPLEX OF MUTANT (K162M) OF E. COLI L-ASPARAGINASE II WITH L-ASP. COVALENT ACYL-ENZYME INTERMEDIATE AND TETRAHEDRAL INTERMEDIATE | 3.5.1.1 |
6V2G | COMPLEX OF MUTANT (K162M) OF E. COLI L-ASPARAGINASE II WITH L-ASP. COVALENT ACYL-ENZYME INTERMEDIATE AND TETRAHEDRAL INTERMEDIATE. | 3.5.1.1 |
6V3K | STRUCTURE OF HIV CLEAVED SYNAPTIC COMPLEX (CSC) INTASOME BOUND WITH MAGNESIUM AND INSTI XZ419 (COMPOUND 4C) | 3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1 |
6V4W | THE CRYSTAL STRUCTURE OF A BETA-LACTAMASE FROM CHITINOPHAGA PINENSIS DSM 2588 | 3.5.2.6 |
6V51 | SPIN-LABELED T4 LYSOZYME (9/131FNBY)-(4-AMINO-TEMPO) | 3.2.1.17 |
6V54 | CRYSTAL STRUCTURE OF METALLO BETA LACTAMASE FROM HIRSCHIA BALTICA | 3.5.2.6 |
6V5B | HUMAN DROSHA AND DGCR8 IN COMPLEX WITH PRIMARY MICRORNA (MP/RNA COMPLEX) - ACTIVE STATE | 3.1.26.3 |
6V5C | HUMAN DROSHA AND DGCR8 IN COMPLEX WITH PRIMARY MICRORNA (MP/RNA COMPLEX) - PARTIALLY DOCKED STATE | 3.1.26.3 |
6V5E | CRYSTAL STRUCTURE OF CTX-M-14 P167S/D240G BETA-LACTAMASE | 3.5.2.6 |
6V5L | THE HADDOCK STRUCTURE MODEL OF GDP KRAS IN COMPLEX WITH ITS ALLOSTERIC INHIBITOR E22 | 3.6.5.2 |
6V5M | CRYSTAL STRUCTURE OF METALLO BETA LACTAMASE FROM HIRSCHIA BALTICA IN COMPLEX WITH SUCCINATE | 3.5.2.6 |
6V5T | CRYSTAL STRUCTURE OF HUMAN PRETHROMBIN-2 WITH TRYPTOPHANS REPLACED BY 5-F-TRYPTOPHAN | 3.4.21.5 |
6V61 | CRYSTAL STRUCTURE OF METALLO BETA LACTAMASE FROM HIRSCHIA BALTICA IN THE COMPLEX WITH THE INHIBITOR CAPTOPRIL | 3.5.2.6 |
6V64 | CRYSTAL STRUCTURE OF HUMAN THROMBIN BOUND TO PPACK WITH TRYPTOPHANS REPLACED BY 5-F-TRYPTOPHAN | 3.4.21.5 |
6V6G | CRYSTAL STRUCTURE OF CTX-M-14 E166A/P167S/D240G BETA-LACTAMASE | 3.5.2.6 |
6V6M | CRYSTAL STRUCTURE OF AN INACTIVE STATE OF GMPPNP-BOUND RHOA | 3.6.5.2 |
6V6N | THE CRYSTAL STRUCTURE OF A CLASS D BETA-LACTAMASE FROM AGROBACTERIUM TUMEFACIENS | 3.5.2.6 |
6V6P | CRYSTAL STRUCTURE OF CTX-M-14 E166A/D240G BETA-LACTAMASE | 3.5.2.6 |